{"idB": "1175680_12_item1_p12_s0", "idA": "1175680_11_item1_p11_s0", "sentA": "The Phase Ia study, conducted in 13 subjects suffering from HIV/AIDS, found Cytolin to be safe and well tolerated.", "sentB": "The Phase Ia study, conducted in 13 subjects suffering from HIV/Acquired Immune Deficiency Syndrome ( AIDS ), found Cytolin to be safe and well tolerated.", "type": 2, "words": ["<tag1>", "The", "Phase", "Ia", "study,", "conducted", "in", "13", "subjects", "suffering", "from", "HIV/AIDS,", "found", "Cytolin", "to", "be", "safe", "and", "well", "tolerated.", "<tag2>", "The", "Phase", "Ia", "study,", "conducted", "in", "13", "subjects", "suffering", "from", "HIV/Acquired", "Immune", "Deficiency", "Syndrome", "(", "AIDS", "),", "found", "Cytolin", "to", "be", "safe", "and", "well", "tolerated.", "<tag3>"], "wordsA": ["The", "Phase", "Ia", "study,", "conducted", "in", "13", "subjects", "suffering", "from", "HIV/AIDS,", "found", "Cytolin", "to", "be", "safe", "and", "well", "tolerated."], "wordsB": ["The", "Phase", "Ia", "study,", "conducted", "in", "13", "subjects", "suffering", "from", "HIV/Acquired", "Immune", "Deficiency", "Syndrome", "(", "AIDS", "),", "found", "Cytolin", "to", "be", "safe", "and", "well", "tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p15_s0", "idA": "1175680_11_item1_p13_s0", "sentA": "Cytolin - Current Research Under a Clinical Trial Agreement dated September 28, 2009 and as amended to date (the Clinical Trial Agreement ), in exchange for a research grant by CytoDyn, Massachusetts General Hospital ( MGH ) in Boston, Massachusetts agreed to conduct an ex-vivo study of Cytolin in accordance with a study protocol entitled An observational study to determine the in-vitro immunologic and virology activity of Cytolin (the Study ).", "sentB": "Cytolin - Current Research Under a Clinical Trial Agreement dated September 28, 2009 and as amended to date (the Clinical Trial Agreement ), in exchange for a research grant by the Company, Massachusetts General Hospital ( MGH ) in Boston, Massachusetts agreed to conduct an ex-vivo study of murine Cytolin in accordance with a study protocol entitled An observational study to determine the in-vitro immunologic and virology activity of Cytolin (the Study ).", "type": 2, "words": ["<tag1>", "Cytolin", "-", "Current", "Research", "Under", "a", "Clinical", "Trial", "Agreement", "dated", "September", "28,", "2009", "and", "as", "amended", "to", "date", "(the", "Clinical", "Trial", "Agreement", "),", "in", "exchange", "for", "a", "research", "grant", "by", "CytoDyn,", "Massachusetts", "General", "Hospital", "(", "MGH", ")", "in", "Boston,", "Massachusetts", "agreed", "to", "conduct", "an", "ex-vivo", "study", "of", "Cytolin", "in", "accordance", "with", "a", "study", "protocol", "entitled", "An", "observational", "study", "to", "determine", "the", "in-vitro", "immunologic", "and", "virology", "activity", "of", "Cytolin", "(the", "Study", ").", "<tag2>", "Cytolin", "-", "Current", "Research", "Under", "a", "Clinical", "Trial", "Agreement", "dated", "September", "28,", "2009", "and", "as", "amended", "to", "date", "(the", "Clinical", "Trial", "Agreement", "),", "in", "exchange", "for", "a", "research", "grant", "by", "the", "Company,", "Massachusetts", "General", "Hospital", "(", "MGH", ")", "in", "Boston,", "Massachusetts", "agreed", "to", "conduct", "an", "ex-vivo", "study", "of", "murine", "Cytolin", "in", "accordance", "with", "a", "study", "protocol", "entitled", "An", "observational", "study", "to", "determine", "the", "in-vitro", "immunologic", "and", "virology", "activity", "of", "Cytolin", "(the", "Study", ").", "<tag3>"], "wordsA": ["Cytolin", "-", "Current", "Research", "Under", "a", "Clinical", "Trial", "Agreement", "dated", "September", "28,", "2009", "and", "as", "amended", "to", "date", "(the", "Clinical", "Trial", "Agreement", "),", "in", "exchange", "for", "a", "research", "grant", "by", "CytoDyn,", "Massachusetts", "General", "Hospital", "(", "MGH", ")", "in", "Boston,", "Massachusetts", "agreed", "to", "conduct", "an", "ex-vivo", "study", "of", "Cytolin", "in", "accordance", "with", "a", "study", "protocol", "entitled", "An", "observational", "study", "to", "determine", "the", "in-vitro", "immunologic", "and", "virology", "activity", "of", "Cytolin", "(the", "Study", ")."], "wordsB": ["Cytolin", "-", "Current", "Research", "Under", "a", "Clinical", "Trial", "Agreement", "dated", "September", "28,", "2009", "and", "as", "amended", "to", "date", "(the", "Clinical", "Trial", "Agreement", "),", "in", "exchange", "for", "a", "research", "grant", "by", "the", "Company,", "Massachusetts", "General", "Hospital", "(", "MGH", ")", "in", "Boston,", "Massachusetts", "agreed", "to", "conduct", "an", "ex-vivo", "study", "of", "murine", "Cytolin", "in", "accordance", "with", "a", "study", "protocol", "entitled", "An", "observational", "study", "to", "determine", "the", "in-vitro", "immunologic", "and", "virology", "activity", "of", "Cytolin", "(the", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p15_s1", "idA": "1175680_11_item1_p13_s1", "sentA": "In addition to providing financial support for the Study, CytoDyn agreed to provide MGH with supplies of Cytolin needed for the Study.", "sentB": "In addition to providing financial support for the Study, the Company agreed to provide MGH with supplies of Cytolin needed for the Study.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "providing", "financial", "support", "for", "the", "Study,", "CytoDyn", "agreed", "to", "provide", "MGH", "with", "supplies", "of", "Cytolin", "needed", "for", "the", "Study.", "<tag2>", "In", "addition", "to", "providing", "financial", "support", "for", "the", "Study,", "the", "Company", "agreed", "to", "provide", "MGH", "with", "supplies", "of", "Cytolin", "needed", "for", "the", "Study.", "<tag3>"], "wordsA": ["In", "addition", "to", "providing", "financial", "support", "for", "the", "Study,", "CytoDyn", "agreed", "to", "provide", "MGH", "with", "supplies", "of", "Cytolin", "needed", "for", "the", "Study."], "wordsB": ["In", "addition", "to", "providing", "financial", "support", "for", "the", "Study,", "the", "Company", "agreed", "to", "provide", "MGH", "with", "supplies", "of", "Cytolin", "needed", "for", "the", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p16_s0", "idA": "1175680_11_item1_p13_s3", "sentA": "Human subjects have been recruited for the Study from Dr. Rosenberg s clinic.", "sentB": "Human subjects were recruited for the Study from Dr. Rosenberg s clinic.", "type": 2, "words": ["<tag1>", "Human", "subjects", "have", "been", "recruited", "for", "the", "Study", "from", "Dr.", "Rosenberg", "s", "clinic.", "<tag2>", "Human", "subjects", "were", "recruited", "for", "the", "Study", "from", "Dr.", "Rosenberg", "s", "clinic.", "<tag3>"], "wordsA": ["Human", "subjects", "have", "been", "recruited", "for", "the", "Study", "from", "Dr.", "Rosenberg", "s", "clinic."], "wordsB": ["Human", "subjects", "were", "recruited", "for", "the", "Study", "from", "Dr.", "Rosenberg", "s", "clinic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p18_s8", "idA": "1175680_11_item1_p13_s3", "sentA": "Human subjects have been recruited for the Study from Dr. Rosenberg s clinic.", "sentB": "The release of this or any data from the Study is entirely dependent on Dr. Rosenberg.", "type": 2, "words": ["<tag1>", "Human", "subjects", "have", "been", "recruited", "for", "the", "Study", "from", "Dr.", "Rosenberg", "s", "clinic.", "<tag2>", "The", "release", "of", "this", "or", "any", "data", "from", "the", "Study", "is", "entirely", "dependent", "on", "Dr.", "Rosenberg.", "<tag3>"], "wordsA": ["Human", "subjects", "have", "been", "recruited", "for", "the", "Study", "from", "Dr.", "Rosenberg", "s", "clinic."], "wordsB": ["The", "release", "of", "this", "or", "any", "data", "from", "the", "Study", "is", "entirely", "dependent", "on", "Dr.", "Rosenberg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p16_s1", "idA": "1175680_11_item1_p13_s4", "sentA": "The Study has enrolled 10 adults with early HIV infection and 10 healthy adults as the control arm, all of whom will be required to participate for six months.", "sentB": "The Study enrolled 10 adults with early HIV infection and 10 healthy adults as the control arm, all of whom were required to participate for six months.", "type": 2, "words": ["<tag1>", "The", "Study", "has", "enrolled", "10", "adults", "with", "early", "HIV", "infection", "and", "10", "healthy", "adults", "as", "the", "control", "arm,", "all", "of", "whom", "will", "be", "required", "to", "participate", "for", "six", "months.", "<tag2>", "The", "Study", "enrolled", "10", "adults", "with", "early", "HIV", "infection", "and", "10", "healthy", "adults", "as", "the", "control", "arm,", "all", "of", "whom", "were", "required", "to", "participate", "for", "six", "months.", "<tag3>"], "wordsA": ["The", "Study", "has", "enrolled", "10", "adults", "with", "early", "HIV", "infection", "and", "10", "healthy", "adults", "as", "the", "control", "arm,", "all", "of", "whom", "will", "be", "required", "to", "participate", "for", "six", "months."], "wordsB": ["The", "Study", "enrolled", "10", "adults", "with", "early", "HIV", "infection", "and", "10", "healthy", "adults", "as", "the", "control", "arm,", "all", "of", "whom", "were", "required", "to", "participate", "for", "six", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p16_s2", "idA": "1175680_11_item1_p13_s5", "sentA": "None of the patients enrolled in the study will receive injections of Cytolin; rather they will donate blood to allow one to examine the effects of Cytolin when it is added in the test tube to their peripheral blood mononuclear cells.", "sentB": "None of the patients enrolled in the study received injections of murine Cytolin ; rather they donated blood to allow one to examine the effects of Cytolin when it was added in the test tube to their peripheral blood mononuclear cells.", "type": 2, "words": ["<tag1>", "None", "of", "the", "patients", "enrolled", "in", "the", "study", "will", "receive", "injections", "of", "Cytolin;", "rather", "they", "will", "donate", "blood", "to", "allow", "one", "to", "examine", "the", "effects", "of", "Cytolin", "when", "it", "is", "added", "in", "the", "test", "tube", "to", "their", "peripheral", "blood", "mononuclear", "cells.", "<tag2>", "None", "of", "the", "patients", "enrolled", "in", "the", "study", "received", "injections", "of", "murine", "Cytolin", ";", "rather", "they", "donated", "blood", "to", "allow", "one", "to", "examine", "the", "effects", "of", "Cytolin", "when", "it", "was", "added", "in", "the", "test", "tube", "to", "their", "peripheral", "blood", "mononuclear", "cells.", "<tag3>"], "wordsA": ["None", "of", "the", "patients", "enrolled", "in", "the", "study", "will", "receive", "injections", "of", "Cytolin;", "rather", "they", "will", "donate", "blood", "to", "allow", "one", "to", "examine", "the", "effects", "of", "Cytolin", "when", "it", "is", "added", "in", "the", "test", "tube", "to", "their", "peripheral", "blood", "mononuclear", "cells."], "wordsB": ["None", "of", "the", "patients", "enrolled", "in", "the", "study", "received", "injections", "of", "murine", "Cytolin", ";", "rather", "they", "donated", "blood", "to", "allow", "one", "to", "examine", "the", "effects", "of", "Cytolin", "when", "it", "was", "added", "in", "the", "test", "tube", "to", "their", "peripheral", "blood", "mononuclear", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p18_s5", "idA": "1175680_11_item1_p15_s0", "sentA": "The Second amendment to the Clinical Trial Agreement provided that our research grant commitment for the Study would total $316,755.", "sentB": "As of May 31, 2012, the final payment in the amount of approximately $72,898 due to MGH in connection with the Clinical Trial Agreement was past due.", "type": 2, "words": ["<tag1>", "The", "Second", "amendment", "to", "the", "Clinical", "Trial", "Agreement", "provided", "that", "our", "research", "grant", "commitment", "for", "the", "Study", "would", "total", "$316,755.", "<tag2>", "As", "of", "May", "31,", "2012,", "the", "final", "payment", "in", "the", "amount", "of", "approximately", "$72,898", "due", "to", "MGH", "in", "connection", "with", "the", "Clinical", "Trial", "Agreement", "was", "past", "due.", "<tag3>"], "wordsA": ["The", "Second", "amendment", "to", "the", "Clinical", "Trial", "Agreement", "provided", "that", "our", "research", "grant", "commitment", "for", "the", "Study", "would", "total", "$316,755."], "wordsB": ["As", "of", "May", "31,", "2012,", "the", "final", "payment", "in", "the", "amount", "of", "approximately", "$72,898", "due", "to", "MGH", "in", "connection", "with", "the", "Clinical", "Trial", "Agreement", "was", "past", "due."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p18_s2", "idA": "1175680_11_item1_p15_s1", "sentA": "In March 2010, we agreed in a third amendment to the Clinical Trial Agreement to provide an additional $233,815 for the Study to enable the Principal Investigator to engage additional personnel.", "sentB": "In December 2010, we further agreed in a fourth amendment to the Clinical Trial Agreement to provide an additional $25,000 for the Study.", "type": 2, "words": ["<tag1>", "In", "March", "2010,", "we", "agreed", "in", "a", "third", "amendment", "to", "the", "Clinical", "Trial", "Agreement", "to", "provide", "an", "additional", "$233,815", "for", "the", "Study", "to", "enable", "the", "Principal", "Investigator", "to", "engage", "additional", "personnel.", "<tag2>", "In", "December", "2010,", "we", "further", "agreed", "in", "a", "fourth", "amendment", "to", "the", "Clinical", "Trial", "Agreement", "to", "provide", "an", "additional", "$25,000", "for", "the", "Study.", "<tag3>"], "wordsA": ["In", "March", "2010,", "we", "agreed", "in", "a", "third", "amendment", "to", "the", "Clinical", "Trial", "Agreement", "to", "provide", "an", "additional", "$233,815", "for", "the", "Study", "to", "enable", "the", "Principal", "Investigator", "to", "engage", "additional", "personnel."], "wordsB": ["In", "December", "2010,", "we", "further", "agreed", "in", "a", "fourth", "amendment", "to", "the", "Clinical", "Trial", "Agreement", "to", "provide", "an", "additional", "$25,000", "for", "the", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p18_s3", "idA": "1175680_11_item1_p16_s0", "sentA": "On May 20, 2011, we entered into a fifth amendment of the Clinical Trial Agreement with The General Hospital Corporation, d/b/a/ MGH to extend the Study enabling MGH Principal Investigator Eric Rosenberg, M.D., to further explore his initial findings regarding the potential mechanism of action of Cytolin to treat HIV-positive adults.", "sentB": "On May 20, 2011, we entered into a fifth amendment of the Clinical Trial Agreement with The General Hospital Corporation, d/b/a/ MGH to extend the Study enabling MGH Principal Investigator Eric Rosenberg, M.D., to further explore his initial findings regarding the potential mechanism of action of murine Cytolin to treat HIV-positive adults.", "type": 2, "words": ["<tag1>", "On", "May", "20,", "2011,", "we", "entered", "into", "a", "fifth", "amendment", "of", "the", "Clinical", "Trial", "Agreement", "with", "The", "General", "Hospital", "Corporation,", "d/b/a/", "MGH", "to", "extend", "the", "Study", "enabling", "MGH", "Principal", "Investigator", "Eric", "Rosenberg,", "M.D.,", "to", "further", "explore", "his", "initial", "findings", "regarding", "the", "potential", "mechanism", "of", "action", "of", "Cytolin", "to", "treat", "HIV-positive", "adults.", "<tag2>", "On", "May", "20,", "2011,", "we", "entered", "into", "a", "fifth", "amendment", "of", "the", "Clinical", "Trial", "Agreement", "with", "The", "General", "Hospital", "Corporation,", "d/b/a/", "MGH", "to", "extend", "the", "Study", "enabling", "MGH", "Principal", "Investigator", "Eric", "Rosenberg,", "M.D.,", "to", "further", "explore", "his", "initial", "findings", "regarding", "the", "potential", "mechanism", "of", "action", "of", "murine", "Cytolin", "to", "treat", "HIV-positive", "adults.", "<tag3>"], "wordsA": ["On", "May", "20,", "2011,", "we", "entered", "into", "a", "fifth", "amendment", "of", "the", "Clinical", "Trial", "Agreement", "with", "The", "General", "Hospital", "Corporation,", "d/b/a/", "MGH", "to", "extend", "the", "Study", "enabling", "MGH", "Principal", "Investigator", "Eric", "Rosenberg,", "M.D.,", "to", "further", "explore", "his", "initial", "findings", "regarding", "the", "potential", "mechanism", "of", "action", "of", "Cytolin", "to", "treat", "HIV-positive", "adults."], "wordsB": ["On", "May", "20,", "2011,", "we", "entered", "into", "a", "fifth", "amendment", "of", "the", "Clinical", "Trial", "Agreement", "with", "The", "General", "Hospital", "Corporation,", "d/b/a/", "MGH", "to", "extend", "the", "Study", "enabling", "MGH", "Principal", "Investigator", "Eric", "Rosenberg,", "M.D.,", "to", "further", "explore", "his", "initial", "findings", "regarding", "the", "potential", "mechanism", "of", "action", "of", "murine", "Cytolin", "to", "treat", "HIV-positive", "adults."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p19_s0", "idA": "1175680_11_item1_p17_s0", "sentA": "The Study is a science-intensive research study and is not intended to function as a registrational study (see Registrational Clinical Trials Process below).", "sentB": "The Study was a science-intensive research study and was not intended to function as a registrational study (see Registrational Clinical Trials Process below).", "type": 2, "words": ["<tag1>", "The", "Study", "is", "a", "science-intensive", "research", "study", "and", "is", "not", "intended", "to", "function", "as", "a", "registrational", "study", "(see", "Registrational", "Clinical", "Trials", "Process", "below).", "<tag2>", "The", "Study", "was", "a", "science-intensive", "research", "study", "and", "was", "not", "intended", "to", "function", "as", "a", "registrational", "study", "(see", "Registrational", "Clinical", "Trials", "Process", "below).", "<tag3>"], "wordsA": ["The", "Study", "is", "a", "science-intensive", "research", "study", "and", "is", "not", "intended", "to", "function", "as", "a", "registrational", "study", "(see", "Registrational", "Clinical", "Trials", "Process", "below)."], "wordsB": ["The", "Study", "was", "a", "science-intensive", "research", "study", "and", "was", "not", "intended", "to", "function", "as", "a", "registrational", "study", "(see", "Registrational", "Clinical", "Trials", "Process", "below)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p19_s1", "idA": "1175680_11_item1_p17_s1", "sentA": "CytoDyn contemplates that the Study will be followed by a clinical trial that may or may not be conducted at MGH or with Dr. Rosenberg as the Principal Investigator.", "sentB": "The Company contemplates that the Study may be followed by a clinical trial that may or may not be conducted at MGH or with Dr. Rosenberg as the Principal Investigator.", "type": 2, "words": ["<tag1>", "CytoDyn", "contemplates", "that", "the", "Study", "will", "be", "followed", "by", "a", "clinical", "trial", "that", "may", "or", "may", "not", "be", "conducted", "at", "MGH", "or", "with", "Dr.", "Rosenberg", "as", "the", "Principal", "Investigator.", "<tag2>", "The", "Company", "contemplates", "that", "the", "Study", "may", "be", "followed", "by", "a", "clinical", "trial", "that", "may", "or", "may", "not", "be", "conducted", "at", "MGH", "or", "with", "Dr.", "Rosenberg", "as", "the", "Principal", "Investigator.", "<tag3>"], "wordsA": ["CytoDyn", "contemplates", "that", "the", "Study", "will", "be", "followed", "by", "a", "clinical", "trial", "that", "may", "or", "may", "not", "be", "conducted", "at", "MGH", "or", "with", "Dr.", "Rosenberg", "as", "the", "Principal", "Investigator."], "wordsB": ["The", "Company", "contemplates", "that", "the", "Study", "may", "be", "followed", "by", "a", "clinical", "trial", "that", "may", "or", "may", "not", "be", "conducted", "at", "MGH", "or", "with", "Dr.", "Rosenberg", "as", "the", "Principal", "Investigator."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p19_s3", "idA": "1175680_11_item1_p17_s3", "sentA": "There is no assurance that the results of the Study will warrant further clinical trials, or that a strategic alliance for Cytolin will be available.", "sentB": "There is no assurance that the results of the Study will warrant further clinical trials, or that a strategic alliance for humanized Cytolin will be available.", "type": 2, "words": ["<tag1>", "There", "is", "no", "assurance", "that", "the", "results", "of", "the", "Study", "will", "warrant", "further", "clinical", "trials,", "or", "that", "a", "strategic", "alliance", "for", "Cytolin", "will", "be", "available.", "<tag2>", "There", "is", "no", "assurance", "that", "the", "results", "of", "the", "Study", "will", "warrant", "further", "clinical", "trials,", "or", "that", "a", "strategic", "alliance", "for", "humanized", "Cytolin", "will", "be", "available.", "<tag3>"], "wordsA": ["There", "is", "no", "assurance", "that", "the", "results", "of", "the", "Study", "will", "warrant", "further", "clinical", "trials,", "or", "that", "a", "strategic", "alliance", "for", "Cytolin", "will", "be", "available."], "wordsB": ["There", "is", "no", "assurance", "that", "the", "results", "of", "the", "Study", "will", "warrant", "further", "clinical", "trials,", "or", "that", "a", "strategic", "alliance", "for", "humanized", "Cytolin", "will", "be", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p20_s0", "idA": "1175680_11_item1_p18_s0", "sentA": "The Clinical Trial Agreement also governs the parties rights in Study data and the results of the Study ( Study Data and Results ).", "sentB": "The Clinical Trial Agreement governs the parties rights in Study data and the results of the Study ( Study Data and Results ).", "type": 2, "words": ["<tag1>", "The", "Clinical", "Trial", "Agreement", "also", "governs", "the", "parties", "rights", "in", "Study", "data", "and", "the", "results", "of", "the", "Study", "(", "Study", "Data", "and", "Results", ").", "<tag2>", "The", "Clinical", "Trial", "Agreement", "governs", "the", "parties", "rights", "in", "Study", "data", "and", "the", "results", "of", "the", "Study", "(", "Study", "Data", "and", "Results", ").", "<tag3>"], "wordsA": ["The", "Clinical", "Trial", "Agreement", "also", "governs", "the", "parties", "rights", "in", "Study", "data", "and", "the", "results", "of", "the", "Study", "(", "Study", "Data", "and", "Results", ")."], "wordsB": ["The", "Clinical", "Trial", "Agreement", "governs", "the", "parties", "rights", "in", "Study", "data", "and", "the", "results", "of", "the", "Study", "(", "Study", "Data", "and", "Results", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p29_s0", "idA": "1175680_11_item1_p18_s2", "sentA": "The Clinical Trial Agreement places limits on the Company s ability to use Study Data and Results.", "sentB": "Additionally, the Company s Australian App.", "type": 2, "words": ["<tag1>", "The", "Clinical", "Trial", "Agreement", "places", "limits", "on", "the", "Company", "s", "ability", "to", "use", "Study", "Data", "and", "Results.", "<tag2>", "Additionally,", "the", "Company", "s", "Australian", "App.", "<tag3>"], "wordsA": ["The", "Clinical", "Trial", "Agreement", "places", "limits", "on", "the", "Company", "s", "ability", "to", "use", "Study", "Data", "and", "Results."], "wordsB": ["Additionally,", "the", "Company", "s", "Australian", "App."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p41_s0", "idA": "1175680_11_item1_p18_s2", "sentA": "The Clinical Trial Agreement places limits on the Company s ability to use Study Data and Results.", "sentB": "Additionally, the Company s Australian App.", "type": 2, "words": ["<tag1>", "The", "Clinical", "Trial", "Agreement", "places", "limits", "on", "the", "Company", "s", "ability", "to", "use", "Study", "Data", "and", "Results.", "<tag2>", "Additionally,", "the", "Company", "s", "Australian", "App.", "<tag3>"], "wordsA": ["The", "Clinical", "Trial", "Agreement", "places", "limits", "on", "the", "Company", "s", "ability", "to", "use", "Study", "Data", "and", "Results."], "wordsB": ["Additionally,", "the", "Company", "s", "Australian", "App."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p6_s0", "idA": "1175680_11_item1_p18_s2", "sentA": "The Clinical Trial Agreement places limits on the Company s ability to use Study Data and Results.", "sentB": "Additionally, the Company s Australian App.", "type": 2, "words": ["<tag1>", "The", "Clinical", "Trial", "Agreement", "places", "limits", "on", "the", "Company", "s", "ability", "to", "use", "Study", "Data", "and", "Results.", "<tag2>", "Additionally,", "the", "Company", "s", "Australian", "App.", "<tag3>"], "wordsA": ["The", "Clinical", "Trial", "Agreement", "places", "limits", "on", "the", "Company", "s", "ability", "to", "use", "Study", "Data", "and", "Results."], "wordsB": ["Additionally,", "the", "Company", "s", "Australian", "App."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p20_s3", "idA": "1175680_11_item1_p18_s3", "sentA": "Specifically, the Company is permitted to use Study Data and Results that disclose individually identifiable health information only for purposes of the Study or related studies that concern Cytolin or medical conditions / disease area that are the subject of the Study, however, the Company is permitted to use information that is not identifiable for any research and development purposes.", "sentB": "Specifically, the Company is permitted to use Study Data and Results that disclose individually identifiable health information only for purposes of the Study or related studies that concern murine Cytolin or medical conditions / disease area that are the subject of the Study, however, the Company is permitted to use information that is not identifiable for any research and development purposes.", "type": 2, "words": ["<tag1>", "Specifically,", "the", "Company", "is", "permitted", "to", "use", "Study", "Data", "and", "Results", "that", "disclose", "individually", "identifiable", "health", "information", "only", "for", "purposes", "of", "the", "Study", "or", "related", "studies", "that", "concern", "Cytolin", "or", "medical", "conditions", "/", "disease", "area", "that", "are", "the", "subject", "of", "the", "Study,", "however,", "the", "Company", "is", "permitted", "to", "use", "information", "that", "is", "not", "identifiable", "for", "any", "research", "and", "development", "purposes.", "<tag2>", "Specifically,", "the", "Company", "is", "permitted", "to", "use", "Study", "Data", "and", "Results", "that", "disclose", "individually", "identifiable", "health", "information", "only", "for", "purposes", "of", "the", "Study", "or", "related", "studies", "that", "concern", "murine", "Cytolin", "or", "medical", "conditions", "/", "disease", "area", "that", "are", "the", "subject", "of", "the", "Study,", "however,", "the", "Company", "is", "permitted", "to", "use", "information", "that", "is", "not", "identifiable", "for", "any", "research", "and", "development", "purposes.", "<tag3>"], "wordsA": ["Specifically,", "the", "Company", "is", "permitted", "to", "use", "Study", "Data", "and", "Results", "that", "disclose", "individually", "identifiable", "health", "information", "only", "for", "purposes", "of", "the", "Study", "or", "related", "studies", "that", "concern", "Cytolin", "or", "medical", "conditions", "/", "disease", "area", "that", "are", "the", "subject", "of", "the", "Study,", "however,", "the", "Company", "is", "permitted", "to", "use", "information", "that", "is", "not", "identifiable", "for", "any", "research", "and", "development", "purposes."], "wordsB": ["Specifically,", "the", "Company", "is", "permitted", "to", "use", "Study", "Data", "and", "Results", "that", "disclose", "individually", "identifiable", "health", "information", "only", "for", "purposes", "of", "the", "Study", "or", "related", "studies", "that", "concern", "murine", "Cytolin", "or", "medical", "conditions", "/", "disease", "area", "that", "are", "the", "subject", "of", "the", "Study,", "however,", "the", "Company", "is", "permitted", "to", "use", "information", "that", "is", "not", "identifiable", "for", "any", "research", "and", "development", "purposes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p1_s1", "idA": "1175680_11_item1_p1_s1", "sentA": "In addition, we formed a wholly owned subsidiary, CytoDyn Veterinary Medicine LLC ( CVM ), which will explore the possible application of our existing proprietary monoclonal antibody technology to the treatment of Feline Immunodeficiency Virus ( FIV ).", "sentB": "In addition, we formed a wholly owned subsidiary, CytoDyn Veterinary Medicine LLC ( CVM ), which will explore the possible application of our existing proprietary monoclonal antibody technology to the treatment of Feline Immunodeficiency Virus, a retroviral infection in cats ( FIV ).", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", "),", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ").", "<tag2>", "In", "addition,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", "),", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "Feline", "Immunodeficiency", "Virus,", "a", "retroviral", "infection", "in", "cats", "(", "FIV", ").", "<tag3>"], "wordsA": ["In", "addition,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", "),", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ")."], "wordsB": ["In", "addition,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", "),", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "Feline", "Immunodeficiency", "Virus,", "a", "retroviral", "infection", "in", "cats", "(", "FIV", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p21_s0", "idA": "1175680_11_item1_p21_s1", "sentA": "This antigen is highly expressed on killer cells called cytotoxic T cells or CTLs.", "sentB": "The particular epitope recognized by murine Cytolin is highly expressed on killer cells called cytotoxic T cells or CTLs.", "type": 2, "words": ["<tag1>", "This", "antigen", "is", "highly", "expressed", "on", "killer", "cells", "called", "cytotoxic", "T", "cells", "or", "CTLs.", "<tag2>", "The", "particular", "epitope", "recognized", "by", "murine", "Cytolin", "is", "highly", "expressed", "on", "killer", "cells", "called", "cytotoxic", "T", "cells", "or", "CTLs.", "<tag3>"], "wordsA": ["This", "antigen", "is", "highly", "expressed", "on", "killer", "cells", "called", "cytotoxic", "T", "cells", "or", "CTLs."], "wordsB": ["The", "particular", "epitope", "recognized", "by", "murine", "Cytolin", "is", "highly", "expressed", "on", "killer", "cells", "called", "cytotoxic", "T", "cells", "or", "CTLs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p14_s0", "idA": "1175680_11_item1_p24_s3", "sentA": "Subsequent studies and analysis of the activity of Cytolin has shown that this antibody does not block Cytotoxic T cells.", "sentB": "To date, only the murine version of Cytolin has been tested in clinical, research and development studies.", "type": 2, "words": ["<tag1>", "Subsequent", "studies", "and", "analysis", "of", "the", "activity", "of", "Cytolin", "has", "shown", "that", "this", "antibody", "does", "not", "block", "Cytotoxic", "T", "cells.", "<tag2>", "To", "date,", "only", "the", "murine", "version", "of", "Cytolin", "has", "been", "tested", "in", "clinical,", "research", "and", "development", "studies.", "<tag3>"], "wordsA": ["Subsequent", "studies", "and", "analysis", "of", "the", "activity", "of", "Cytolin", "has", "shown", "that", "this", "antibody", "does", "not", "block", "Cytotoxic", "T", "cells."], "wordsB": ["To", "date,", "only", "the", "murine", "version", "of", "Cytolin", "has", "been", "tested", "in", "clinical,", "research", "and", "development", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p21_s1", "idA": "1175680_11_item1_p24_s3", "sentA": "Subsequent studies and analysis of the activity of Cytolin has shown that this antibody does not block Cytotoxic T cells.", "sentB": "However, subsequent studies and analysis of the activity of Cytolin has shown that while Cytolin is highly expressed on CTLs, this antibody does not block CTLs.", "type": 2, "words": ["<tag1>", "Subsequent", "studies", "and", "analysis", "of", "the", "activity", "of", "Cytolin", "has", "shown", "that", "this", "antibody", "does", "not", "block", "Cytotoxic", "T", "cells.", "<tag2>", "However,", "subsequent", "studies", "and", "analysis", "of", "the", "activity", "of", "Cytolin", "has", "shown", "that", "while", "Cytolin", "is", "highly", "expressed", "on", "CTLs,", "this", "antibody", "does", "not", "block", "CTLs.", "<tag3>"], "wordsA": ["Subsequent", "studies", "and", "analysis", "of", "the", "activity", "of", "Cytolin", "has", "shown", "that", "this", "antibody", "does", "not", "block", "Cytotoxic", "T", "cells."], "wordsB": ["However,", "subsequent", "studies", "and", "analysis", "of", "the", "activity", "of", "Cytolin", "has", "shown", "that", "while", "Cytolin", "is", "highly", "expressed", "on", "CTLs,", "this", "antibody", "does", "not", "block", "CTLs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p21_s2", "idA": "1175680_11_item1_p25_s0", "sentA": "being expressed on CTLs, the CD11a protein has also been reported to be present on the surface of the HIV virion, presumably to assist in the infectious cycle of the virus.", "sentB": "In addition to being expressed on CTLs, the CD11a protein has also been reported to be present on the surface of the HIV virion, presumably to assist in the infectious cycle of the virus.", "type": 2, "words": ["<tag1>", "being", "expressed", "on", "CTLs,", "the", "CD11a", "protein", "has", "also", "been", "reported", "to", "be", "present", "on", "the", "surface", "of", "the", "HIV", "virion,", "presumably", "to", "assist", "in", "the", "infectious", "cycle", "of", "the", "virus.", "<tag2>", "In", "addition", "to", "being", "expressed", "on", "CTLs,", "the", "CD11a", "protein", "has", "also", "been", "reported", "to", "be", "present", "on", "the", "surface", "of", "the", "HIV", "virion,", "presumably", "to", "assist", "in", "the", "infectious", "cycle", "of", "the", "virus.", "<tag3>"], "wordsA": ["being", "expressed", "on", "CTLs,", "the", "CD11a", "protein", "has", "also", "been", "reported", "to", "be", "present", "on", "the", "surface", "of", "the", "HIV", "virion,", "presumably", "to", "assist", "in", "the", "infectious", "cycle", "of", "the", "virus."], "wordsB": ["In", "addition", "to", "being", "expressed", "on", "CTLs,", "the", "CD11a", "protein", "has", "also", "been", "reported", "to", "be", "present", "on", "the", "surface", "of", "the", "HIV", "virion,", "presumably", "to", "assist", "in", "the", "infectious", "cycle", "of", "the", "virus."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p22_s0", "idA": "1175680_11_item1_p27_s0", "sentA": "In addition to CTLs, Cytolin also recognizes and binds to dendritic cells (DCs).", "sentB": "In addition to CTLs, murine Cytolin also recognizes and binds to dendritic cells (DCs).", "type": 2, "words": ["<tag1>", "In", "addition", "to", "CTLs,", "Cytolin", "also", "recognizes", "and", "binds", "to", "dendritic", "cells", "(DCs).", "<tag2>", "In", "addition", "to", "CTLs,", "murine", "Cytolin", "also", "recognizes", "and", "binds", "to", "dendritic", "cells", "(DCs).", "<tag3>"], "wordsA": ["In", "addition", "to", "CTLs,", "Cytolin", "also", "recognizes", "and", "binds", "to", "dendritic", "cells", "(DCs)."], "wordsB": ["In", "addition", "to", "CTLs,", "murine", "Cytolin", "also", "recognizes", "and", "binds", "to", "dendritic", "cells", "(DCs)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p22_s2", "idA": "1175680_11_item1_p27_s2", "sentA": "By binding to these cells, Cytolin appears to induce an antiviral activity that can impede infection of new cells and presumably lead to a reduction in viral burden.", "sentB": "By binding to these cells, it is also possible that Cytolin may induce an antiviral activity that may impede infection of new cells and presumably lead to a reduction in viral burden.", "type": 2, "words": ["<tag1>", "By", "binding", "to", "these", "cells,", "Cytolin", "appears", "to", "induce", "an", "antiviral", "activity", "that", "can", "impede", "infection", "of", "new", "cells", "and", "presumably", "lead", "to", "a", "reduction", "in", "viral", "burden.", "<tag2>", "By", "binding", "to", "these", "cells,", "it", "is", "also", "possible", "that", "Cytolin", "may", "induce", "an", "antiviral", "activity", "that", "may", "impede", "infection", "of", "new", "cells", "and", "presumably", "lead", "to", "a", "reduction", "in", "viral", "burden.", "<tag3>"], "wordsA": ["By", "binding", "to", "these", "cells,", "Cytolin", "appears", "to", "induce", "an", "antiviral", "activity", "that", "can", "impede", "infection", "of", "new", "cells", "and", "presumably", "lead", "to", "a", "reduction", "in", "viral", "burden."], "wordsB": ["By", "binding", "to", "these", "cells,", "it", "is", "also", "possible", "that", "Cytolin", "may", "induce", "an", "antiviral", "activity", "that", "may", "impede", "infection", "of", "new", "cells", "and", "presumably", "lead", "to", "a", "reduction", "in", "viral", "burden."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p7_s0", "idA": "1175680_11_item1_p28_s0", "sentA": "Monoclonal Antibodies Cytolin is part of a class of drugs called monoclonal antibodies or targeted therapies .", "sentB": "Research History of Cytolin Compound Cytolin is part of a class of drugs called monoclonal antibodies.", "type": 2, "words": ["<tag1>", "Monoclonal", "Antibodies", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies", "or", "targeted", "therapies", ".", "<tag2>", "Research", "History", "of", "Cytolin", "Compound", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies.", "<tag3>"], "wordsA": ["Monoclonal", "Antibodies", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies", "or", "targeted", "therapies", "."], "wordsB": ["Research", "History", "of", "Cytolin", "Compound", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p37_s2", "idA": "1175680_11_item1_p2_s3", "sentA": "No. 2156495 have been obtained as well.", "sentB": "No. 1438970, Monaco Patent No. 1438970, Netherlands Patent Nos. 1438970 and 0690725, Portuguese Patent Nos. 690725 and 1438970, and Swedish Patent Nos. 0410437.4 and 94912826.8 have been obtained as well.", "type": 2, "words": ["<tag1>", "No.", "2156495", "have", "been", "obtained", "as", "well.", "<tag2>", "No.", "1438970,", "Monaco", "Patent", "No.", "1438970,", "Netherlands", "Patent", "Nos.", "1438970", "and", "0690725,", "Portuguese", "Patent", "Nos.", "690725", "and", "1438970,", "and", "Swedish", "Patent", "Nos.", "0410437.4", "and", "94912826.8", "have", "been", "obtained", "as", "well.", "<tag3>"], "wordsA": ["No.", "2156495", "have", "been", "obtained", "as", "well."], "wordsB": ["No.", "1438970,", "Monaco", "Patent", "No.", "1438970,", "Netherlands", "Patent", "Nos.", "1438970", "and", "0690725,", "Portuguese", "Patent", "Nos.", "690725", "and", "1438970,", "and", "Swedish", "Patent", "Nos.", "0410437.4", "and", "94912826.8", "have", "been", "obtained", "as", "well."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p3_s0", "idA": "1175680_11_item1_p2_s3", "sentA": "No. 2156495 have been obtained as well.", "sentB": "No. 1438970, Monaco Patent No. 1438970, Netherlands Patent Nos. 1438970 and 0690725, Portuguese Patent Nos. 690725 and 1438970, and Swedish Patent Nos. 0410437.4 and 94912826.8 have been obtained as well.", "type": 2, "words": ["<tag1>", "No.", "2156495", "have", "been", "obtained", "as", "well.", "<tag2>", "No.", "1438970,", "Monaco", "Patent", "No.", "1438970,", "Netherlands", "Patent", "Nos.", "1438970", "and", "0690725,", "Portuguese", "Patent", "Nos.", "690725", "and", "1438970,", "and", "Swedish", "Patent", "Nos.", "0410437.4", "and", "94912826.8", "have", "been", "obtained", "as", "well.", "<tag3>"], "wordsA": ["No.", "2156495", "have", "been", "obtained", "as", "well."], "wordsB": ["No.", "1438970,", "Monaco", "Patent", "No.", "1438970,", "Netherlands", "Patent", "Nos.", "1438970", "and", "0690725,", "Portuguese", "Patent", "Nos.", "690725", "and", "1438970,", "and", "Swedish", "Patent", "Nos.", "0410437.4", "and", "94912826.8", "have", "been", "obtained", "as", "well."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p24_s0", "idA": "1175680_11_item1_p30_s0", "sentA": "On January 30, 2007, we acquired, from Utek Corp., our subsidiary Advanced Genetic Technologies, Inc., which holds the exclusive right to develop alternative antibodies that bind to the same cellular target as Cytolin.", "sentB": "On January 30, 2007, we acquired, from Utek Corp., our subsidiary Advanced Genetic Technologies, Inc., which holds the exclusive right to develop alternative antibodies that bind to the same cellular target as murine Cytolin .", "type": 2, "words": ["<tag1>", "On", "January", "30,", "2007,", "we", "acquired,", "from", "Utek", "Corp.,", "our", "subsidiary", "Advanced", "Genetic", "Technologies,", "Inc.,", "which", "holds", "the", "exclusive", "right", "to", "develop", "alternative", "antibodies", "that", "bind", "to", "the", "same", "cellular", "target", "as", "Cytolin.", "<tag2>", "On", "January", "30,", "2007,", "we", "acquired,", "from", "Utek", "Corp.,", "our", "subsidiary", "Advanced", "Genetic", "Technologies,", "Inc.,", "which", "holds", "the", "exclusive", "right", "to", "develop", "alternative", "antibodies", "that", "bind", "to", "the", "same", "cellular", "target", "as", "murine", "Cytolin", ".", "<tag3>"], "wordsA": ["On", "January", "30,", "2007,", "we", "acquired,", "from", "Utek", "Corp.,", "our", "subsidiary", "Advanced", "Genetic", "Technologies,", "Inc.,", "which", "holds", "the", "exclusive", "right", "to", "develop", "alternative", "antibodies", "that", "bind", "to", "the", "same", "cellular", "target", "as", "Cytolin."], "wordsB": ["On", "January", "30,", "2007,", "we", "acquired,", "from", "Utek", "Corp.,", "our", "subsidiary", "Advanced", "Genetic", "Technologies,", "Inc.,", "which", "holds", "the", "exclusive", "right", "to", "develop", "alternative", "antibodies", "that", "bind", "to", "the", "same", "cellular", "target", "as", "murine", "Cytolin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p24_s2", "idA": "1175680_11_item1_p30_s2", "sentA": "The Company has not used these two antibodies in our research and development efforts to date but we intend to use these in future research and development efforts.", "sentB": "The Company has not used these two antibodies in our research and development efforts to date but we may use these in future research and development efforts.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "not", "used", "these", "two", "antibodies", "in", "our", "research", "and", "development", "efforts", "to", "date", "but", "we", "intend", "to", "use", "these", "in", "future", "research", "and", "development", "efforts.", "<tag2>", "The", "Company", "has", "not", "used", "these", "two", "antibodies", "in", "our", "research", "and", "development", "efforts", "to", "date", "but", "we", "may", "use", "these", "in", "future", "research", "and", "development", "efforts.", "<tag3>"], "wordsA": ["The", "Company", "has", "not", "used", "these", "two", "antibodies", "in", "our", "research", "and", "development", "efforts", "to", "date", "but", "we", "intend", "to", "use", "these", "in", "future", "research", "and", "development", "efforts."], "wordsB": ["The", "Company", "has", "not", "used", "these", "two", "antibodies", "in", "our", "research", "and", "development", "efforts", "to", "date", "but", "we", "may", "use", "these", "in", "future", "research", "and", "development", "efforts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p30_s1", "idA": "1175680_11_item1_p30_s2", "sentA": "The Company has not used these two antibodies in our research and development efforts to date but we intend to use these in future research and development efforts.", "sentB": "The Company has assigned the Scripps Agreement to CVM.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "not", "used", "these", "two", "antibodies", "in", "our", "research", "and", "development", "efforts", "to", "date", "but", "we", "intend", "to", "use", "these", "in", "future", "research", "and", "development", "efforts.", "<tag2>", "The", "Company", "has", "assigned", "the", "Scripps", "Agreement", "to", "CVM.", "<tag3>"], "wordsA": ["The", "Company", "has", "not", "used", "these", "two", "antibodies", "in", "our", "research", "and", "development", "efforts", "to", "date", "but", "we", "intend", "to", "use", "these", "in", "future", "research", "and", "development", "efforts."], "wordsB": ["The", "Company", "has", "assigned", "the", "Scripps", "Agreement", "to", "CVM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p31_s1", "idA": "1175680_11_item1_p30_s2", "sentA": "The Company has not used these two antibodies in our research and development efforts to date but we intend to use these in future research and development efforts.", "sentB": "The Company has assigned the CSU Agreement to CVM.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "not", "used", "these", "two", "antibodies", "in", "our", "research", "and", "development", "efforts", "to", "date", "but", "we", "intend", "to", "use", "these", "in", "future", "research", "and", "development", "efforts.", "<tag2>", "The", "Company", "has", "assigned", "the", "CSU", "Agreement", "to", "CVM.", "<tag3>"], "wordsA": ["The", "Company", "has", "not", "used", "these", "two", "antibodies", "in", "our", "research", "and", "development", "efforts", "to", "date", "but", "we", "intend", "to", "use", "these", "in", "future", "research", "and", "development", "efforts."], "wordsB": ["The", "Company", "has", "assigned", "the", "CSU", "Agreement", "to", "CVM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p25_s0", "idA": "1175680_11_item1_p31_s0", "sentA": "Formation of CytoDyn Veterinary Medicine LLC On May 16, 2011, we formed a wholly owned subsidiary, CVM, which will explore the possible application of our existing proprietary monoclonal antibody technology to the treatment of FIV.", "sentB": "Formation of CytoDyn Veterinary Medicine LLC and Current Research On May 16, 2011, we formed a wholly owned subsidiary, CVM, which will explore the possible application of feline reactive monoclonal antibodies for the treatment of the feline immunodeficiency virus ( FIV ).", "type": 2, "words": ["<tag1>", "Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "FIV.", "<tag2>", "Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "and", "Current", "Research", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "the", "feline", "immunodeficiency", "virus", "(", "FIV", ").", "<tag3>"], "wordsA": ["Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "FIV."], "wordsB": ["Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "and", "Current", "Research", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "the", "feline", "immunodeficiency", "virus", "(", "FIV", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p30_s0", "idA": "1175680_11_item1_p31_s0", "sentA": "Formation of CytoDyn Veterinary Medicine LLC On May 16, 2011, we formed a wholly owned subsidiary, CVM, which will explore the possible application of our existing proprietary monoclonal antibody technology to the treatment of FIV.", "sentB": "On November 16, 2011, the Company and The Scripps Research Institute, a nonprofit institution ( Scripps Research ) entered into a six-month Research Funding and Option Agreement (the Scripps Agreement ) that enabled Dr. John H. Elder, Professor in the Department of Immunology and Microbial Science at Scripps Research, to explore the potential application of the Company s recently provisionally patented technology as an effective therapy in the treatment of FIV.", "type": 2, "words": ["<tag1>", "Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "FIV.", "<tag2>", "On", "November", "16,", "2011,", "the", "Company", "and", "The", "Scripps", "Research", "Institute,", "a", "nonprofit", "institution", "(", "Scripps", "Research", ")", "entered", "into", "a", "six-month", "Research", "Funding", "and", "Option", "Agreement", "(the", "Scripps", "Agreement", ")", "that", "enabled", "Dr.", "John", "H.", "Elder,", "Professor", "in", "the", "Department", "of", "Immunology", "and", "Microbial", "Science", "at", "Scripps", "Research,", "to", "explore", "the", "potential", "application", "of", "the", "Company", "s", "recently", "provisionally", "patented", "technology", "as", "an", "effective", "therapy", "in", "the", "treatment", "of", "FIV.", "<tag3>"], "wordsA": ["Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "FIV."], "wordsB": ["On", "November", "16,", "2011,", "the", "Company", "and", "The", "Scripps", "Research", "Institute,", "a", "nonprofit", "institution", "(", "Scripps", "Research", ")", "entered", "into", "a", "six-month", "Research", "Funding", "and", "Option", "Agreement", "(the", "Scripps", "Agreement", ")", "that", "enabled", "Dr.", "John", "H.", "Elder,", "Professor", "in", "the", "Department", "of", "Immunology", "and", "Microbial", "Science", "at", "Scripps", "Research,", "to", "explore", "the", "potential", "application", "of", "the", "Company", "s", "recently", "provisionally", "patented", "technology", "as", "an", "effective", "therapy", "in", "the", "treatment", "of", "FIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p31_s0", "idA": "1175680_11_item1_p31_s0", "sentA": "Formation of CytoDyn Veterinary Medicine LLC On May 16, 2011, we formed a wholly owned subsidiary, CVM, which will explore the possible application of our existing proprietary monoclonal antibody technology to the treatment of FIV.", "sentB": "On February 15, 2012, the Company and Colorado State University ( CSU ) entered into a Research Funding and Option Agreement (the CSU Agreement ) that will enable Dr. Susan VandeWoude Associate Dean for Research and Graduate Education, CVMBS; Professor, DMIP, to explore the potential application of the Company s recently provisionally patented technology as an effective therapy in the treatment of FIV in infected cats.", "type": 2, "words": ["<tag1>", "Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "FIV.", "<tag2>", "On", "February", "15,", "2012,", "the", "Company", "and", "Colorado", "State", "University", "(", "CSU", ")", "entered", "into", "a", "Research", "Funding", "and", "Option", "Agreement", "(the", "CSU", "Agreement", ")", "that", "will", "enable", "Dr.", "Susan", "VandeWoude", "Associate", "Dean", "for", "Research", "and", "Graduate", "Education,", "CVMBS;", "Professor,", "DMIP,", "to", "explore", "the", "potential", "application", "of", "the", "Company", "s", "recently", "provisionally", "patented", "technology", "as", "an", "effective", "therapy", "in", "the", "treatment", "of", "FIV", "in", "infected", "cats.", "<tag3>"], "wordsA": ["Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "the", "treatment", "of", "FIV."], "wordsB": ["On", "February", "15,", "2012,", "the", "Company", "and", "Colorado", "State", "University", "(", "CSU", ")", "entered", "into", "a", "Research", "Funding", "and", "Option", "Agreement", "(the", "CSU", "Agreement", ")", "that", "will", "enable", "Dr.", "Susan", "VandeWoude", "Associate", "Dean", "for", "Research", "and", "Graduate", "Education,", "CVMBS;", "Professor,", "DMIP,", "to", "explore", "the", "potential", "application", "of", "the", "Company", "s", "recently", "provisionally", "patented", "technology", "as", "an", "effective", "therapy", "in", "the", "treatment", "of", "FIV", "in", "infected", "cats."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p25_s1", "idA": "1175680_11_item1_p31_s1", "sentA": "We view the formation of CVM and the exploration of the application of our existing proprietary monoclonal antibody technology to FIV as an effort to strategically diversify the use of our proprietary monoclonal antibody technology.", "sentB": "We view the formation of CVM and the exploration of CD11a-specific monoclonal antibodies to treat FIV as an effort to strategically diversify the use of monoclonal antibody expertise.", "type": 2, "words": ["<tag1>", "We", "view", "the", "formation", "of", "CVM", "and", "the", "exploration", "of", "the", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "FIV", "as", "an", "effort", "to", "strategically", "diversify", "the", "use", "of", "our", "proprietary", "monoclonal", "antibody", "technology.", "<tag2>", "We", "view", "the", "formation", "of", "CVM", "and", "the", "exploration", "of", "CD11a-specific", "monoclonal", "antibodies", "to", "treat", "FIV", "as", "an", "effort", "to", "strategically", "diversify", "the", "use", "of", "monoclonal", "antibody", "expertise.", "<tag3>"], "wordsA": ["We", "view", "the", "formation", "of", "CVM", "and", "the", "exploration", "of", "the", "application", "of", "our", "existing", "proprietary", "monoclonal", "antibody", "technology", "to", "FIV", "as", "an", "effort", "to", "strategically", "diversify", "the", "use", "of", "our", "proprietary", "monoclonal", "antibody", "technology."], "wordsB": ["We", "view", "the", "formation", "of", "CVM", "and", "the", "exploration", "of", "CD11a-specific", "monoclonal", "antibodies", "to", "treat", "FIV", "as", "an", "effort", "to", "strategically", "diversify", "the", "use", "of", "monoclonal", "antibody", "expertise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p34_s0", "idA": "1175680_11_item1_p32_s0", "sentA": "Manufacturing and Source for Raw Materials We negotiated with a contract manufacturer, Vista Biologicals Corporation ( Vista ), to manufacture Cytolin suitable for use in our current ex vivo clinical trial of Cytolin at a cost of $565,000, all of which was paid by September 2008.", "sentB": "Manufacturing and Source for Raw Materials We negotiated with a contract manufacturer, Vista Biologicals Corporation ( Vista ), to manufacture murine Cytolin suitable for use in our current ex vivo clinical trial of Cytolin at a cost of $565,000, all of which was paid by September 2008.", "type": 2, "words": ["<tag1>", "Manufacturing", "and", "Source", "for", "Raw", "Materials", "We", "negotiated", "with", "a", "contract", "manufacturer,", "Vista", "Biologicals", "Corporation", "(", "Vista", "),", "to", "manufacture", "Cytolin", "suitable", "for", "use", "in", "our", "current", "ex", "vivo", "clinical", "trial", "of", "Cytolin", "at", "a", "cost", "of", "$565,000,", "all", "of", "which", "was", "paid", "by", "September", "2008.", "<tag2>", "Manufacturing", "and", "Source", "for", "Raw", "Materials", "We", "negotiated", "with", "a", "contract", "manufacturer,", "Vista", "Biologicals", "Corporation", "(", "Vista", "),", "to", "manufacture", "murine", "Cytolin", "suitable", "for", "use", "in", "our", "current", "ex", "vivo", "clinical", "trial", "of", "Cytolin", "at", "a", "cost", "of", "$565,000,", "all", "of", "which", "was", "paid", "by", "September", "2008.", "<tag3>"], "wordsA": ["Manufacturing", "and", "Source", "for", "Raw", "Materials", "We", "negotiated", "with", "a", "contract", "manufacturer,", "Vista", "Biologicals", "Corporation", "(", "Vista", "),", "to", "manufacture", "Cytolin", "suitable", "for", "use", "in", "our", "current", "ex", "vivo", "clinical", "trial", "of", "Cytolin", "at", "a", "cost", "of", "$565,000,", "all", "of", "which", "was", "paid", "by", "September", "2008."], "wordsB": ["Manufacturing", "and", "Source", "for", "Raw", "Materials", "We", "negotiated", "with", "a", "contract", "manufacturer,", "Vista", "Biologicals", "Corporation", "(", "Vista", "),", "to", "manufacture", "murine", "Cytolin", "suitable", "for", "use", "in", "our", "current", "ex", "vivo", "clinical", "trial", "of", "Cytolin", "at", "a", "cost", "of", "$565,000,", "all", "of", "which", "was", "paid", "by", "September", "2008."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p27_s1", "idA": "1175680_11_item1_p32_s3", "sentA": "There are ongoing negotiations related to the ultimate obligations of the Company and Vista under both the 2008 and 2010 contractual arrangements.", "sentB": "In February 2012, the Company filed foreign trademark applications claiming priority to the US application for CYTOFELINE, including Australian App.", "type": 2, "words": ["<tag1>", "There", "are", "ongoing", "negotiations", "related", "to", "the", "ultimate", "obligations", "of", "the", "Company", "and", "Vista", "under", "both", "the", "2008", "and", "2010", "contractual", "arrangements.", "<tag2>", "In", "February", "2012,", "the", "Company", "filed", "foreign", "trademark", "applications", "claiming", "priority", "to", "the", "US", "application", "for", "CYTOFELINE,", "including", "Australian", "App.", "<tag3>"], "wordsA": ["There", "are", "ongoing", "negotiations", "related", "to", "the", "ultimate", "obligations", "of", "the", "Company", "and", "Vista", "under", "both", "the", "2008", "and", "2010", "contractual", "arrangements."], "wordsB": ["In", "February", "2012,", "the", "Company", "filed", "foreign", "trademark", "applications", "claiming", "priority", "to", "the", "US", "application", "for", "CYTOFELINE,", "including", "Australian", "App."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p5_s1", "idA": "1175680_11_item1_p32_s3", "sentA": "There are ongoing negotiations related to the ultimate obligations of the Company and Vista under both the 2008 and 2010 contractual arrangements.", "sentB": "In February 2012, the Company filed foreign trademark applications claiming priority to the US application for CYTOFELINE, including Australian App.", "type": 2, "words": ["<tag1>", "There", "are", "ongoing", "negotiations", "related", "to", "the", "ultimate", "obligations", "of", "the", "Company", "and", "Vista", "under", "both", "the", "2008", "and", "2010", "contractual", "arrangements.", "<tag2>", "In", "February", "2012,", "the", "Company", "filed", "foreign", "trademark", "applications", "claiming", "priority", "to", "the", "US", "application", "for", "CYTOFELINE,", "including", "Australian", "App.", "<tag3>"], "wordsA": ["There", "are", "ongoing", "negotiations", "related", "to", "the", "ultimate", "obligations", "of", "the", "Company", "and", "Vista", "under", "both", "the", "2008", "and", "2010", "contractual", "arrangements."], "wordsB": ["In", "February", "2012,", "the", "Company", "filed", "foreign", "trademark", "applications", "claiming", "priority", "to", "the", "US", "application", "for", "CYTOFELINE,", "including", "Australian", "App."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p35_s0", "idA": "1175680_11_item1_p33_s0", "sentA": "Although a murine (mouse) version of Cytolin was used for previous human experience that included approximately 200 patients treated for up to two years, as well as an encouraging uncontrolled Phase I(b)/II(a) study, and our current ex-vivo clinical trial, the Company understands that a fully-humanized version is necessary for the controlled clinical trials that are expected to follow the previous ones.", "sentB": "Although a murine version of Cytolin was used for previous human experience that included approximately 200 patients treated for up to two years, as well as an encouraging uncontrolled Phase I(b)/II(a) study, and our current ex-vivo clinical trial, the Company understands that a fully-humanized version is necessary for the controlled clinical trials that are expected to follow the previous ones.", "type": 2, "words": ["<tag1>", "Although", "a", "murine", "(mouse)", "version", "of", "Cytolin", "was", "used", "for", "previous", "human", "experience", "that", "included", "approximately", "200", "patients", "treated", "for", "up", "to", "two", "years,", "as", "well", "as", "an", "encouraging", "uncontrolled", "Phase", "I(b)/II(a)", "study,", "and", "our", "current", "ex-vivo", "clinical", "trial,", "the", "Company", "understands", "that", "a", "fully-humanized", "version", "is", "necessary", "for", "the", "controlled", "clinical", "trials", "that", "are", "expected", "to", "follow", "the", "previous", "ones.", "<tag2>", "Although", "a", "murine", "version", "of", "Cytolin", "was", "used", "for", "previous", "human", "experience", "that", "included", "approximately", "200", "patients", "treated", "for", "up", "to", "two", "years,", "as", "well", "as", "an", "encouraging", "uncontrolled", "Phase", "I(b)/II(a)", "study,", "and", "our", "current", "ex-vivo", "clinical", "trial,", "the", "Company", "understands", "that", "a", "fully-humanized", "version", "is", "necessary", "for", "the", "controlled", "clinical", "trials", "that", "are", "expected", "to", "follow", "the", "previous", "ones.", "<tag3>"], "wordsA": ["Although", "a", "murine", "(mouse)", "version", "of", "Cytolin", "was", "used", "for", "previous", "human", "experience", "that", "included", "approximately", "200", "patients", "treated", "for", "up", "to", "two", "years,", "as", "well", "as", "an", "encouraging", "uncontrolled", "Phase", "I(b)/II(a)", "study,", "and", "our", "current", "ex-vivo", "clinical", "trial,", "the", "Company", "understands", "that", "a", "fully-humanized", "version", "is", "necessary", "for", "the", "controlled", "clinical", "trials", "that", "are", "expected", "to", "follow", "the", "previous", "ones."], "wordsB": ["Although", "a", "murine", "version", "of", "Cytolin", "was", "used", "for", "previous", "human", "experience", "that", "included", "approximately", "200", "patients", "treated", "for", "up", "to", "two", "years,", "as", "well", "as", "an", "encouraging", "uncontrolled", "Phase", "I(b)/II(a)", "study,", "and", "our", "current", "ex-vivo", "clinical", "trial,", "the", "Company", "understands", "that", "a", "fully-humanized", "version", "is", "necessary", "for", "the", "controlled", "clinical", "trials", "that", "are", "expected", "to", "follow", "the", "previous", "ones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p14_s1", "idA": "1175680_11_item1_p33_s1", "sentA": "The Company expects to begin discussions with a contract lab to manufacture the proprietary version of the humanized antibody.", "sentB": "The Company understands that registrational studies will require similar testing and confirmation of activity with its proprietary humanized version of Cytolin .", "type": 2, "words": ["<tag1>", "The", "Company", "expects", "to", "begin", "discussions", "with", "a", "contract", "lab", "to", "manufacture", "the", "proprietary", "version", "of", "the", "humanized", "antibody.", "<tag2>", "The", "Company", "understands", "that", "registrational", "studies", "will", "require", "similar", "testing", "and", "confirmation", "of", "activity", "with", "its", "proprietary", "humanized", "version", "of", "Cytolin", ".", "<tag3>"], "wordsA": ["The", "Company", "expects", "to", "begin", "discussions", "with", "a", "contract", "lab", "to", "manufacture", "the", "proprietary", "version", "of", "the", "humanized", "antibody."], "wordsB": ["The", "Company", "understands", "that", "registrational", "studies", "will", "require", "similar", "testing", "and", "confirmation", "of", "activity", "with", "its", "proprietary", "humanized", "version", "of", "Cytolin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p19_s2", "idA": "1175680_11_item1_p33_s1", "sentA": "The Company expects to begin discussions with a contract lab to manufacture the proprietary version of the humanized antibody.", "sentB": "The Company will determine if clinical trials with the humanized version of Cytolin are warranted based on these and other results from studies with the murine molecule and subsequent confirmation of activity with the humanized version of Cytolin .", "type": 2, "words": ["<tag1>", "The", "Company", "expects", "to", "begin", "discussions", "with", "a", "contract", "lab", "to", "manufacture", "the", "proprietary", "version", "of", "the", "humanized", "antibody.", "<tag2>", "The", "Company", "will", "determine", "if", "clinical", "trials", "with", "the", "humanized", "version", "of", "Cytolin", "are", "warranted", "based", "on", "these", "and", "other", "results", "from", "studies", "with", "the", "murine", "molecule", "and", "subsequent", "confirmation", "of", "activity", "with", "the", "humanized", "version", "of", "Cytolin", ".", "<tag3>"], "wordsA": ["The", "Company", "expects", "to", "begin", "discussions", "with", "a", "contract", "lab", "to", "manufacture", "the", "proprietary", "version", "of", "the", "humanized", "antibody."], "wordsB": ["The", "Company", "will", "determine", "if", "clinical", "trials", "with", "the", "humanized", "version", "of", "Cytolin", "are", "warranted", "based", "on", "these", "and", "other", "results", "from", "studies", "with", "the", "murine", "molecule", "and", "subsequent", "confirmation", "of", "activity", "with", "the", "humanized", "version", "of", "Cytolin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p33_s1", "idA": "1175680_11_item1_p33_s1", "sentA": "The Company expects to begin discussions with a contract lab to manufacture the proprietary version of the humanized antibody.", "sentB": "The Company expects to generate and provide the chimeric version of the antibody for Dr. VandeWoude in the next six months.", "type": 2, "words": ["<tag1>", "The", "Company", "expects", "to", "begin", "discussions", "with", "a", "contract", "lab", "to", "manufacture", "the", "proprietary", "version", "of", "the", "humanized", "antibody.", "<tag2>", "The", "Company", "expects", "to", "generate", "and", "provide", "the", "chimeric", "version", "of", "the", "antibody", "for", "Dr.", "VandeWoude", "in", "the", "next", "six", "months.", "<tag3>"], "wordsA": ["The", "Company", "expects", "to", "begin", "discussions", "with", "a", "contract", "lab", "to", "manufacture", "the", "proprietary", "version", "of", "the", "humanized", "antibody."], "wordsB": ["The", "Company", "expects", "to", "generate", "and", "provide", "the", "chimeric", "version", "of", "the", "antibody", "for", "Dr.", "VandeWoude", "in", "the", "next", "six", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p37_s0", "idA": "1175680_11_item1_p34_s0", "sentA": "Patents and Trademarks We have a License Agreement with Allen D. Allen, our former Chief Executive Officer and former Chairman of our Board of Directors that gives us the exclusive right to develop, market, and profit from his technology worldwide.", "sentB": "Patents and Trademarks We have a License Agreement with Allen D. Allen, our former Chief Executive Officer and former Chairman of the Company s board of directors (the Board ) that gives us the exclusive right to develop, market, and profit from his technology worldwide.", "type": 2, "words": ["<tag1>", "Patents", "and", "Trademarks", "We", "have", "a", "License", "Agreement", "with", "Allen", "D.", "Allen,", "our", "former", "Chief", "Executive", "Officer", "and", "former", "Chairman", "of", "our", "Board", "of", "Directors", "that", "gives", "us", "the", "exclusive", "right", "to", "develop,", "market,", "and", "profit", "from", "his", "technology", "worldwide.", "<tag2>", "Patents", "and", "Trademarks", "We", "have", "a", "License", "Agreement", "with", "Allen", "D.", "Allen,", "our", "former", "Chief", "Executive", "Officer", "and", "former", "Chairman", "of", "the", "Company", "s", "board", "of", "directors", "(the", "Board", ")", "that", "gives", "us", "the", "exclusive", "right", "to", "develop,", "market,", "and", "profit", "from", "his", "technology", "worldwide.", "<tag3>"], "wordsA": ["Patents", "and", "Trademarks", "We", "have", "a", "License", "Agreement", "with", "Allen", "D.", "Allen,", "our", "former", "Chief", "Executive", "Officer", "and", "former", "Chairman", "of", "our", "Board", "of", "Directors", "that", "gives", "us", "the", "exclusive", "right", "to", "develop,", "market,", "and", "profit", "from", "his", "technology", "worldwide."], "wordsB": ["Patents", "and", "Trademarks", "We", "have", "a", "License", "Agreement", "with", "Allen", "D.", "Allen,", "our", "former", "Chief", "Executive", "Officer", "and", "former", "Chairman", "of", "the", "Company", "s", "board", "of", "directors", "(the", "Board", ")", "that", "gives", "us", "the", "exclusive", "right", "to", "develop,", "market,", "and", "profit", "from", "his", "technology", "worldwide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p37_s3", "idA": "1175680_11_item1_p34_s3", "sentA": "We also acquired the federally registered trademarks, CYTODYN (U.S. Registration No. 2095498) and CYTOLIN (U.S. Registration No. 2095497), and a related trademark symbol.", "sentB": "We also acquired the federally registered trademarks, CYTODYN (U.S. Registration No. 2095498) and CYTOLIN (U.S. Registration No. 2095497), and a related design mark (U.S. Registration No. 2662777.", "type": 2, "words": ["<tag1>", "We", "also", "acquired", "the", "federally", "registered", "trademarks,", "CYTODYN", "(U.S.", "Registration", "No.", "2095498)", "and", "CYTOLIN", "(U.S.", "Registration", "No.", "2095497),", "and", "a", "related", "trademark", "symbol.", "<tag2>", "We", "also", "acquired", "the", "federally", "registered", "trademarks,", "CYTODYN", "(U.S.", "Registration", "No.", "2095498)", "and", "CYTOLIN", "(U.S.", "Registration", "No.", "2095497),", "and", "a", "related", "design", "mark", "(U.S.", "Registration", "No.", "2662777.", "<tag3>"], "wordsA": ["We", "also", "acquired", "the", "federally", "registered", "trademarks,", "CYTODYN", "(U.S.", "Registration", "No.", "2095498)", "and", "CYTOLIN", "(U.S.", "Registration", "No.", "2095497),", "and", "a", "related", "trademark", "symbol."], "wordsB": ["We", "also", "acquired", "the", "federally", "registered", "trademarks,", "CYTODYN", "(U.S.", "Registration", "No.", "2095498)", "and", "CYTOLIN", "(U.S.", "Registration", "No.", "2095497),", "and", "a", "related", "design", "mark", "(U.S.", "Registration", "No.", "2662777."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p3_s1", "idA": "1175680_11_item1_p34_s3", "sentA": "We also acquired the federally registered trademarks, CYTODYN (U.S. Registration No. 2095498) and CYTOLIN (U.S. Registration No. 2095497), and a related trademark symbol.", "sentB": "We also acquired the federally registered trademarks, CYTODYN (U.S. Registration No. 2095498) and CYTOLIN (U.S. Registration No. 2095497), and a related design mark (U.S. Registration No. 2662777.", "type": 2, "words": ["<tag1>", "We", "also", "acquired", "the", "federally", "registered", "trademarks,", "CYTODYN", "(U.S.", "Registration", "No.", "2095498)", "and", "CYTOLIN", "(U.S.", "Registration", "No.", "2095497),", "and", "a", "related", "trademark", "symbol.", "<tag2>", "We", "also", "acquired", "the", "federally", "registered", "trademarks,", "CYTODYN", "(U.S.", "Registration", "No.", "2095498)", "and", "CYTOLIN", "(U.S.", "Registration", "No.", "2095497),", "and", "a", "related", "design", "mark", "(U.S.", "Registration", "No.", "2662777.", "<tag3>"], "wordsA": ["We", "also", "acquired", "the", "federally", "registered", "trademarks,", "CYTODYN", "(U.S.", "Registration", "No.", "2095498)", "and", "CYTOLIN", "(U.S.", "Registration", "No.", "2095497),", "and", "a", "related", "trademark", "symbol."], "wordsB": ["We", "also", "acquired", "the", "federally", "registered", "trademarks,", "CYTODYN", "(U.S.", "Registration", "No.", "2095498)", "and", "CYTOLIN", "(U.S.", "Registration", "No.", "2095497),", "and", "a", "related", "design", "mark", "(U.S.", "Registration", "No.", "2662777."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p37_s7", "idA": "1175680_11_item1_p34_s6", "sentA": "The original expiration dates on the issued U.S. Patent Nos. 5,424,066; 5,651,970 and 6,534,057 are 2013, 2014 and 2013, respectively.", "sentB": "The original expiration dates for the foreign patents listed above are in 2013 or 2014, if the required annuity fee payments are paid by September 21, 2012.", "type": 2, "words": ["<tag1>", "The", "original", "expiration", "dates", "on", "the", "issued", "U.S.", "Patent", "Nos.", "5,424,066;", "5,651,970", "and", "6,534,057", "are", "2013,", "2014", "and", "2013,", "respectively.", "<tag2>", "The", "original", "expiration", "dates", "for", "the", "foreign", "patents", "listed", "above", "are", "in", "2013", "or", "2014,", "if", "the", "required", "annuity", "fee", "payments", "are", "paid", "by", "September", "21,", "2012.", "<tag3>"], "wordsA": ["The", "original", "expiration", "dates", "on", "the", "issued", "U.S.", "Patent", "Nos.", "5,424,066;", "5,651,970", "and", "6,534,057", "are", "2013,", "2014", "and", "2013,", "respectively."], "wordsB": ["The", "original", "expiration", "dates", "for", "the", "foreign", "patents", "listed", "above", "are", "in", "2013", "or", "2014,", "if", "the", "required", "annuity", "fee", "payments", "are", "paid", "by", "September", "21,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p3_s5", "idA": "1175680_11_item1_p34_s6", "sentA": "The original expiration dates on the issued U.S. Patent Nos. 5,424,066; 5,651,970 and 6,534,057 are 2013, 2014 and 2013, respectively.", "sentB": "The original expiration dates for the foreign patents listed above are in 2013 or 2014, if the required annuity fee payments are paid by September 21, 2012.", "type": 2, "words": ["<tag1>", "The", "original", "expiration", "dates", "on", "the", "issued", "U.S.", "Patent", "Nos.", "5,424,066;", "5,651,970", "and", "6,534,057", "are", "2013,", "2014", "and", "2013,", "respectively.", "<tag2>", "The", "original", "expiration", "dates", "for", "the", "foreign", "patents", "listed", "above", "are", "in", "2013", "or", "2014,", "if", "the", "required", "annuity", "fee", "payments", "are", "paid", "by", "September", "21,", "2012.", "<tag3>"], "wordsA": ["The", "original", "expiration", "dates", "on", "the", "issued", "U.S.", "Patent", "Nos.", "5,424,066;", "5,651,970", "and", "6,534,057", "are", "2013,", "2014", "and", "2013,", "respectively."], "wordsB": ["The", "original", "expiration", "dates", "for", "the", "foreign", "patents", "listed", "above", "are", "in", "2013", "or", "2014,", "if", "the", "required", "annuity", "fee", "payments", "are", "paid", "by", "September", "21,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p42_s1", "idA": "1175680_11_item1_p36_s0", "sentA": "state health care laws and regulations that apply to the operation of clinical laboratories, the business relationships between health care providers and suppliers, the privacy and security of health information and the conduct of clinical research.", "sentB": "For example, there are federal and state health care laws and regulations that apply to the operation of clinical laboratories, the business relationships between health care providers and suppliers, the privacy and security of health information and the conduct of clinical research.", "type": 2, "words": ["<tag1>", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "operation", "of", "clinical", "laboratories,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers,", "the", "privacy", "and", "security", "of", "health", "information", "and", "the", "conduct", "of", "clinical", "research.", "<tag2>", "For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "operation", "of", "clinical", "laboratories,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers,", "the", "privacy", "and", "security", "of", "health", "information", "and", "the", "conduct", "of", "clinical", "research.", "<tag3>"], "wordsA": ["state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "operation", "of", "clinical", "laboratories,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers,", "the", "privacy", "and", "security", "of", "health", "information", "and", "the", "conduct", "of", "clinical", "research."], "wordsB": ["For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "operation", "of", "clinical", "laboratories,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers,", "the", "privacy", "and", "security", "of", "health", "information", "and", "the", "conduct", "of", "clinical", "research."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p32_s0", "idA": "1175680_11_item1_p46_s2", "sentA": "These studies are designed to determine the metabolic and pharmacologic actions of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness.", "sentB": "This study is designed to determine the effect of a single dose of murine CytoFeline on FIV RNA and DNA as well as a panel of other virologic and safety markers.", "type": 2, "words": ["<tag1>", "These", "studies", "are", "designed", "to", "determine", "the", "metabolic", "and", "pharmacologic", "actions", "of", "the", "investigational", "product", "in", "humans,", "the", "side", "effects", "associated", "with", "increasing", "doses,", "and,", "if", "possible,", "to", "gain", "early", "evidence", "on", "effectiveness.", "<tag2>", "This", "study", "is", "designed", "to", "determine", "the", "effect", "of", "a", "single", "dose", "of", "murine", "CytoFeline", "on", "FIV", "RNA", "and", "DNA", "as", "well", "as", "a", "panel", "of", "other", "virologic", "and", "safety", "markers.", "<tag3>"], "wordsA": ["These", "studies", "are", "designed", "to", "determine", "the", "metabolic", "and", "pharmacologic", "actions", "of", "the", "investigational", "product", "in", "humans,", "the", "side", "effects", "associated", "with", "increasing", "doses,", "and,", "if", "possible,", "to", "gain", "early", "evidence", "on", "effectiveness."], "wordsB": ["This", "study", "is", "designed", "to", "determine", "the", "effect", "of", "a", "single", "dose", "of", "murine", "CytoFeline", "on", "FIV", "RNA", "and", "DNA", "as", "well", "as", "a", "panel", "of", "other", "virologic", "and", "safety", "markers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p38_s0", "idA": "1175680_11_item1_p4_s0", "sentA": "Until recently, our Cytolin-related patents were for a murine (mouse) version of the drug.", "sentB": "The Company s Cytolin-related patents referenced above are for a murine (mouse) version of the drug.", "type": 2, "words": ["<tag1>", "Until", "recently,", "our", "Cytolin-related", "patents", "were", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "The", "Company", "s", "Cytolin-related", "patents", "referenced", "above", "are", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag3>"], "wordsA": ["Until", "recently,", "our", "Cytolin-related", "patents", "were", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["The", "Company", "s", "Cytolin-related", "patents", "referenced", "above", "are", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p4_s0", "idA": "1175680_11_item1_p4_s0", "sentA": "Until recently, our Cytolin-related patents were for a murine (mouse) version of the drug.", "sentB": "The Company s Cytolin-related patents referenced above are for a murine (mouse) version of the drug.", "type": 2, "words": ["<tag1>", "Until", "recently,", "our", "Cytolin-related", "patents", "were", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "The", "Company", "s", "Cytolin-related", "patents", "referenced", "above", "are", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag3>"], "wordsA": ["Until", "recently,", "our", "Cytolin-related", "patents", "were", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["The", "Company", "s", "Cytolin-related", "patents", "referenced", "above", "are", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p38_s1", "idA": "1175680_11_item1_p4_s1", "sentA": "In addition, all of our research on Cytolin to date has utilized the current murine (mouse) version of the drug.", "sentB": "The Company s research on Cytolin to date has utilized the current murine version of the drug.", "type": 2, "words": ["<tag1>", "In", "addition,", "all", "of", "our", "research", "on", "Cytolin", "to", "date", "has", "utilized", "the", "current", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "The", "Company", "s", "research", "on", "Cytolin", "to", "date", "has", "utilized", "the", "current", "murine", "version", "of", "the", "drug.", "<tag3>"], "wordsA": ["In", "addition,", "all", "of", "our", "research", "on", "Cytolin", "to", "date", "has", "utilized", "the", "current", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["The", "Company", "s", "research", "on", "Cytolin", "to", "date", "has", "utilized", "the", "current", "murine", "version", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p4_s1", "idA": "1175680_11_item1_p4_s1", "sentA": "In addition, all of our research on Cytolin to date has utilized the current murine (mouse) version of the drug.", "sentB": "The Company s research on Cytolin to date has utilized the current murine version of the drug.", "type": 2, "words": ["<tag1>", "In", "addition,", "all", "of", "our", "research", "on", "Cytolin", "to", "date", "has", "utilized", "the", "current", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "The", "Company", "s", "research", "on", "Cytolin", "to", "date", "has", "utilized", "the", "current", "murine", "version", "of", "the", "drug.", "<tag3>"], "wordsA": ["In", "addition,", "all", "of", "our", "research", "on", "Cytolin", "to", "date", "has", "utilized", "the", "current", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["The", "Company", "s", "research", "on", "Cytolin", "to", "date", "has", "utilized", "the", "current", "murine", "version", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p26_s1", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "On June 15, 2012, the Company filed an international patent application (Serial No. PCT/US2012/042693) claiming priority to this provisional patent application.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p27_s0", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "On August 10, 2011, the Company filed an application for registration of the trademark CYTOFELINE, intended for use in conjunction with veterinary preparations for the treatment of FIV (U.S. App.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "On", "August", "10,", "2011,", "the", "Company", "filed", "an", "application", "for", "registration", "of", "the", "trademark", "CYTOFELINE,", "intended", "for", "use", "in", "conjunction", "with", "veterinary", "preparations", "for", "the", "treatment", "of", "FIV", "(U.S.", "App.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["On", "August", "10,", "2011,", "the", "Company", "filed", "an", "application", "for", "registration", "of", "the", "trademark", "CYTOFELINE,", "intended", "for", "use", "in", "conjunction", "with", "veterinary", "preparations", "for", "the", "treatment", "of", "FIV", "(U.S.", "App."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p36_s0", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "On September 23, 2011, the Company filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin , a monoclonal antibody for the treatment of HIV infection.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p38_s2", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "However, on September 23, 2011, the Company filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p38_s5", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "On June 15, 2012, the Company filed an international patent application (Serial No. PCT/US2012/042693) claiming priority to this provisional patent application.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p39_s0", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "On August 10, 2011, the Company filed an application for registration of the trademark CYTOFELINE, intended for use in conjunction with veterinary preparations for the treatment of FIV (U.S. App.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "On", "August", "10,", "2011,", "the", "Company", "filed", "an", "application", "for", "registration", "of", "the", "trademark", "CYTOFELINE,", "intended", "for", "use", "in", "conjunction", "with", "veterinary", "preparations", "for", "the", "treatment", "of", "FIV", "(U.S.", "App.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["On", "August", "10,", "2011,", "the", "Company", "filed", "an", "application", "for", "registration", "of", "the", "trademark", "CYTOFELINE,", "intended", "for", "use", "in", "conjunction", "with", "veterinary", "preparations", "for", "the", "treatment", "of", "FIV", "(U.S.", "App."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p4_s2", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "However, on September 23, 2011, the Company filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p4_s5", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "On June 15, 2012, the Company filed an international patent application (Serial No. PCT/US2012/042693) claiming priority to this provisional patent application.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p5_s0", "idA": "1175680_11_item1_p4_s2", "sentA": "However, on September 23, 2011, the Company filed a provisional patent application in the United States for its humanized version of its lead product Cytolin , a monoclonal antibody for the treatment of HIV Infection.", "sentB": "On August 10, 2011, the Company filed an application for registration of the trademark CYTOFELINE, intended for use in conjunction with veterinary preparations for the treatment of FIV (U.S. App.", "type": 2, "words": ["<tag1>", "However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection.", "<tag2>", "On", "August", "10,", "2011,", "the", "Company", "filed", "an", "application", "for", "registration", "of", "the", "trademark", "CYTOFELINE,", "intended", "for", "use", "in", "conjunction", "with", "veterinary", "preparations", "for", "the", "treatment", "of", "FIV", "(U.S.", "App.", "<tag3>"], "wordsA": ["However,", "on", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "its", "lead", "product", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "Infection."], "wordsB": ["On", "August", "10,", "2011,", "the", "Company", "filed", "an", "application", "for", "registration", "of", "the", "trademark", "CYTOFELINE,", "intended", "for", "use", "in", "conjunction", "with", "veterinary", "preparations", "for", "the", "treatment", "of", "FIV", "(U.S.", "App."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p36_s1", "idA": "1175680_11_item1_p4_s3", "sentA": "The Company is also exploring other antibodies as potential therapeutics for FIV.", "sentB": "The Company is currently in discussions with potential manufacturing sites to obtain clinical grade antibody for future clinical development of Cytolin .", "type": 2, "words": ["<tag1>", "The", "Company", "is", "also", "exploring", "other", "antibodies", "as", "potential", "therapeutics", "for", "FIV.", "<tag2>", "The", "Company", "is", "currently", "in", "discussions", "with", "potential", "manufacturing", "sites", "to", "obtain", "clinical", "grade", "antibody", "for", "future", "clinical", "development", "of", "Cytolin", ".", "<tag3>"], "wordsA": ["The", "Company", "is", "also", "exploring", "other", "antibodies", "as", "potential", "therapeutics", "for", "FIV."], "wordsB": ["The", "Company", "is", "currently", "in", "discussions", "with", "potential", "manufacturing", "sites", "to", "obtain", "clinical", "grade", "antibody", "for", "future", "clinical", "development", "of", "Cytolin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p26_s0", "idA": "1175680_11_item1_p4_s4", "sentA": "On June 17, 2011 the Company filed for a provisional patent in the United States for the use of these antibodies as well as selected small molecule antagonists and agonists for the treatment of FIV, a retroviral infection in cats.", "sentB": "On June 17, 2011, the Company filed a provisional patent application in the United States (Serial No. 61/498,029) for the use of certain antibodies as well as selected small molecule antagonists and agonists for the treatment of FIV.", "type": 2, "words": ["<tag1>", "On", "June", "17,", "2011", "the", "Company", "filed", "for", "a", "provisional", "patent", "in", "the", "United", "States", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV,", "a", "retroviral", "infection", "in", "cats.", "<tag2>", "On", "June", "17,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "certain", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV.", "<tag3>"], "wordsA": ["On", "June", "17,", "2011", "the", "Company", "filed", "for", "a", "provisional", "patent", "in", "the", "United", "States", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV,", "a", "retroviral", "infection", "in", "cats."], "wordsB": ["On", "June", "17,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "certain", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p38_s4", "idA": "1175680_11_item1_p4_s4", "sentA": "On June 17, 2011 the Company filed for a provisional patent in the United States for the use of these antibodies as well as selected small molecule antagonists and agonists for the treatment of FIV, a retroviral infection in cats.", "sentB": "On June 17, 2011, the Company filed a provisional patent application in the United States (Serial No. 61/498,029) for the use of these antibodies as well as selected small molecule antagonists and agonists for the treatment of FIV.", "type": 2, "words": ["<tag1>", "On", "June", "17,", "2011", "the", "Company", "filed", "for", "a", "provisional", "patent", "in", "the", "United", "States", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV,", "a", "retroviral", "infection", "in", "cats.", "<tag2>", "On", "June", "17,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV.", "<tag3>"], "wordsA": ["On", "June", "17,", "2011", "the", "Company", "filed", "for", "a", "provisional", "patent", "in", "the", "United", "States", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV,", "a", "retroviral", "infection", "in", "cats."], "wordsB": ["On", "June", "17,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p4_s4", "idA": "1175680_11_item1_p4_s4", "sentA": "On June 17, 2011 the Company filed for a provisional patent in the United States for the use of these antibodies as well as selected small molecule antagonists and agonists for the treatment of FIV, a retroviral infection in cats.", "sentB": "On June 17, 2011, the Company filed a provisional patent application in the United States (Serial No. 61/498,029) for the use of these antibodies as well as selected small molecule antagonists and agonists for the treatment of FIV.", "type": 2, "words": ["<tag1>", "On", "June", "17,", "2011", "the", "Company", "filed", "for", "a", "provisional", "patent", "in", "the", "United", "States", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV,", "a", "retroviral", "infection", "in", "cats.", "<tag2>", "On", "June", "17,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV.", "<tag3>"], "wordsA": ["On", "June", "17,", "2011", "the", "Company", "filed", "for", "a", "provisional", "patent", "in", "the", "United", "States", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV,", "a", "retroviral", "infection", "in", "cats."], "wordsB": ["On", "June", "17,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "these", "antibodies", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p18_s7", "idA": "1175680_11_item1_p4_s5", "sentA": "The Company anticipates it will apply to trademark this product under the name CytoFeline.", "sentB": "The Company anticipates that if there is sufficient data to warrant publication Dr. Rosenberg will draft and submit a manuscript detailing his results.", "type": 2, "words": ["<tag1>", "The", "Company", "anticipates", "it", "will", "apply", "to", "trademark", "this", "product", "under", "the", "name", "CytoFeline.", "<tag2>", "The", "Company", "anticipates", "that", "if", "there", "is", "sufficient", "data", "to", "warrant", "publication", "Dr.", "Rosenberg", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "his", "results.", "<tag3>"], "wordsA": ["The", "Company", "anticipates", "it", "will", "apply", "to", "trademark", "this", "product", "under", "the", "name", "CytoFeline."], "wordsB": ["The", "Company", "anticipates", "that", "if", "there", "is", "sufficient", "data", "to", "warrant", "publication", "Dr.", "Rosenberg", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "his", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p30_s5", "idA": "1175680_11_item1_p4_s5", "sentA": "The Company anticipates it will apply to trademark this product under the name CytoFeline.", "sentB": "The Company anticipates that if the data warrants publication Dr. Elder will draft and submit a manuscript detailing his results.", "type": 2, "words": ["<tag1>", "The", "Company", "anticipates", "it", "will", "apply", "to", "trademark", "this", "product", "under", "the", "name", "CytoFeline.", "<tag2>", "The", "Company", "anticipates", "that", "if", "the", "data", "warrants", "publication", "Dr.", "Elder", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "his", "results.", "<tag3>"], "wordsA": ["The", "Company", "anticipates", "it", "will", "apply", "to", "trademark", "this", "product", "under", "the", "name", "CytoFeline."], "wordsB": ["The", "Company", "anticipates", "that", "if", "the", "data", "warrants", "publication", "Dr.", "Elder", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "his", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p32_s1", "idA": "1175680_11_item1_p4_s5", "sentA": "The Company anticipates it will apply to trademark this product under the name CytoFeline.", "sentB": "The Company anticipates that if the data warrants publication Dr. VandeWoude will draft and submit a manuscript detailing her results.", "type": 2, "words": ["<tag1>", "The", "Company", "anticipates", "it", "will", "apply", "to", "trademark", "this", "product", "under", "the", "name", "CytoFeline.", "<tag2>", "The", "Company", "anticipates", "that", "if", "the", "data", "warrants", "publication", "Dr.", "VandeWoude", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "her", "results.", "<tag3>"], "wordsA": ["The", "Company", "anticipates", "it", "will", "apply", "to", "trademark", "this", "product", "under", "the", "name", "CytoFeline."], "wordsB": ["The", "Company", "anticipates", "that", "if", "the", "data", "warrants", "publication", "Dr.", "VandeWoude", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "her", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p33_s2", "idA": "1175680_11_item1_p4_s5", "sentA": "The Company anticipates it will apply to trademark this product under the name CytoFeline.", "sentB": "The Company anticipates that if the data from the study warrants publication Dr. VandeWoude and Dr. Trauger will draft and submit a manuscript detailing these results.", "type": 2, "words": ["<tag1>", "The", "Company", "anticipates", "it", "will", "apply", "to", "trademark", "this", "product", "under", "the", "name", "CytoFeline.", "<tag2>", "The", "Company", "anticipates", "that", "if", "the", "data", "from", "the", "study", "warrants", "publication", "Dr.", "VandeWoude", "and", "Dr.", "Trauger", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "these", "results.", "<tag3>"], "wordsA": ["The", "Company", "anticipates", "it", "will", "apply", "to", "trademark", "this", "product", "under", "the", "name", "CytoFeline."], "wordsB": ["The", "Company", "anticipates", "that", "if", "the", "data", "from", "the", "study", "warrants", "publication", "Dr.", "VandeWoude", "and", "Dr.", "Trauger", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "these", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p56_s0", "idA": "1175680_11_item1_p50_s0", "sentA": "CytoDyn may fund clinical trials using venture capital or through the sale of our common stock or other equity securities, or, at that time, may enter into a strategic alliance for completion of research and the subsequent marketing of Cytolin if approved.", "sentB": "The Company may fund clinical trials using venture capital or through the sale of our common stock or other equity securities, or, at that time, may enter into a strategic alliance for completion of research and the subsequent marketing of humanized Cytolin if approved.", "type": 2, "words": ["<tag1>", "CytoDyn", "may", "fund", "clinical", "trials", "using", "venture", "capital", "or", "through", "the", "sale", "of", "our", "common", "stock", "or", "other", "equity", "securities,", "or,", "at", "that", "time,", "may", "enter", "into", "a", "strategic", "alliance", "for", "completion", "of", "research", "and", "the", "subsequent", "marketing", "of", "Cytolin", "if", "approved.", "<tag2>", "The", "Company", "may", "fund", "clinical", "trials", "using", "venture", "capital", "or", "through", "the", "sale", "of", "our", "common", "stock", "or", "other", "equity", "securities,", "or,", "at", "that", "time,", "may", "enter", "into", "a", "strategic", "alliance", "for", "completion", "of", "research", "and", "the", "subsequent", "marketing", "of", "humanized", "Cytolin", "if", "approved.", "<tag3>"], "wordsA": ["CytoDyn", "may", "fund", "clinical", "trials", "using", "venture", "capital", "or", "through", "the", "sale", "of", "our", "common", "stock", "or", "other", "equity", "securities,", "or,", "at", "that", "time,", "may", "enter", "into", "a", "strategic", "alliance", "for", "completion", "of", "research", "and", "the", "subsequent", "marketing", "of", "Cytolin", "if", "approved."], "wordsB": ["The", "Company", "may", "fund", "clinical", "trials", "using", "venture", "capital", "or", "through", "the", "sale", "of", "our", "common", "stock", "or", "other", "equity", "securities,", "or,", "at", "that", "time,", "may", "enter", "into", "a", "strategic", "alliance", "for", "completion", "of", "research", "and", "the", "subsequent", "marketing", "of", "humanized", "Cytolin", "if", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p61_s0", "idA": "1175680_11_item1_p55_s0", "sentA": "Research and Development Costs Our sponsored research and development expenses were $480,765, $328,775, and $2,229,468 in fiscal 2011, 2010 and for the period October 28, 2003 through May 31, 2011, respectively.", "sentB": "Research and Development Costs Our sponsored research and development expenses were $530,027, $480,765 and $2,759,495 in fiscal 2012, 2011 and for the period October 28, 2003 through May 31, 2012, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "Development", "Costs", "Our", "sponsored", "research", "and", "development", "expenses", "were", "$480,765,", "$328,775,", "and", "$2,229,468", "in", "fiscal", "2011,", "2010", "and", "for", "the", "period", "October", "28,", "2003", "through", "May", "31,", "2011,", "respectively.", "<tag2>", "Research", "and", "Development", "Costs", "Our", "sponsored", "research", "and", "development", "expenses", "were", "$530,027,", "$480,765", "and", "$2,759,495", "in", "fiscal", "2012,", "2011", "and", "for", "the", "period", "October", "28,", "2003", "through", "May", "31,", "2012,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "Development", "Costs", "Our", "sponsored", "research", "and", "development", "expenses", "were", "$480,765,", "$328,775,", "and", "$2,229,468", "in", "fiscal", "2011,", "2010", "and", "for", "the", "period", "October", "28,", "2003", "through", "May", "31,", "2011,", "respectively."], "wordsB": ["Research", "and", "Development", "Costs", "Our", "sponsored", "research", "and", "development", "expenses", "were", "$530,027,", "$480,765", "and", "$2,759,495", "in", "fiscal", "2012,", "2011", "and", "for", "the", "period", "October", "28,", "2003", "through", "May", "31,", "2012,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p8_s0", "idA": "1175680_11_item1_p7_s0", "sentA": "In 1993, six HIV-infected patients were treated with Cytolin.", "sentB": "In 1993, six HIV-infected patients were treated with murine Cytolin .", "type": 2, "words": ["<tag1>", "In", "1993,", "six", "HIV-infected", "patients", "were", "treated", "with", "Cytolin.", "<tag2>", "In", "1993,", "six", "HIV-infected", "patients", "were", "treated", "with", "murine", "Cytolin", ".", "<tag3>"], "wordsA": ["In", "1993,", "six", "HIV-infected", "patients", "were", "treated", "with", "Cytolin."], "wordsB": ["In", "1993,", "six", "HIV-infected", "patients", "were", "treated", "with", "murine", "Cytolin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p9_s3", "idA": "1175680_11_item1_p7_s5", "sentA": "Four of the doctors using Cytolin allowed CytoDyn s predecessor to send in an independent Institutional Review Board to inspect the medical records of approximately 200 patients treated with Cytolin once or twice a month over 18 months.", "sentB": "Four of the doctors using Cytolin allowed the Company s predecessor to send in an independent Institutional Review Board to inspect the medical records of approximately 200 patients treated with Cytolin once or twice a month over 18 months.", "type": 2, "words": ["<tag1>", "Four", "of", "the", "doctors", "using", "Cytolin", "allowed", "CytoDyn", "s", "predecessor", "to", "send", "in", "an", "independent", "Institutional", "Review", "Board", "to", "inspect", "the", "medical", "records", "of", "approximately", "200", "patients", "treated", "with", "Cytolin", "once", "or", "twice", "a", "month", "over", "18", "months.", "<tag2>", "Four", "of", "the", "doctors", "using", "Cytolin", "allowed", "the", "Company", "s", "predecessor", "to", "send", "in", "an", "independent", "Institutional", "Review", "Board", "to", "inspect", "the", "medical", "records", "of", "approximately", "200", "patients", "treated", "with", "Cytolin", "once", "or", "twice", "a", "month", "over", "18", "months.", "<tag3>"], "wordsA": ["Four", "of", "the", "doctors", "using", "Cytolin", "allowed", "CytoDyn", "s", "predecessor", "to", "send", "in", "an", "independent", "Institutional", "Review", "Board", "to", "inspect", "the", "medical", "records", "of", "approximately", "200", "patients", "treated", "with", "Cytolin", "once", "or", "twice", "a", "month", "over", "18", "months."], "wordsB": ["Four", "of", "the", "doctors", "using", "Cytolin", "allowed", "the", "Company", "s", "predecessor", "to", "send", "in", "an", "independent", "Institutional", "Review", "Board", "to", "inspect", "the", "medical", "records", "of", "approximately", "200", "patients", "treated", "with", "Cytolin", "once", "or", "twice", "a", "month", "over", "18", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p10_s0", "idA": "1175680_11_item1_p8_s0", "sentA": "In 1996, the FDA approved a drug master file, designated BB-DMF#6836, for the manufacture of Cytolin at Vista Biologicals Corporation.", "sentB": "In 1996, the FDA approved a drug master file, designated BB-DMF#6836, for the manufacture of murine Cytolin at Vista Biologicals Corporation.", "type": 2, "words": ["<tag1>", "In", "1996,", "the", "FDA", "approved", "a", "drug", "master", "file,", "designated", "BB-DMF#6836,", "for", "the", "manufacture", "of", "Cytolin", "at", "Vista", "Biologicals", "Corporation.", "<tag2>", "In", "1996,", "the", "FDA", "approved", "a", "drug", "master", "file,", "designated", "BB-DMF#6836,", "for", "the", "manufacture", "of", "murine", "Cytolin", "at", "Vista", "Biologicals", "Corporation.", "<tag3>"], "wordsA": ["In", "1996,", "the", "FDA", "approved", "a", "drug", "master", "file,", "designated", "BB-DMF#6836,", "for", "the", "manufacture", "of", "Cytolin", "at", "Vista", "Biologicals", "Corporation."], "wordsB": ["In", "1996,", "the", "FDA", "approved", "a", "drug", "master", "file,", "designated", "BB-DMF#6836,", "for", "the", "manufacture", "of", "murine", "Cytolin", "at", "Vista", "Biologicals", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p10_s2", "idA": "1175680_11_item1_p9_s0", "sentA": "By contract with Vista Biologicals Corporation, CytoDyn of New Mexico, Inc. had the exclusive right to reference the drug master file, that is, to authorize Vista Biologicals Corporation to manufacture Cytolin in accordance with the terms of the drug master file.", "sentB": "In accordance with the practice of the FDA, the drug master file was issued to and became the property of the entity with the capacity to manufacture the drug, in this case Vista Biologicals Corporation.", "type": 2, "words": ["<tag1>", "By", "contract", "with", "Vista", "Biologicals", "Corporation,", "CytoDyn", "of", "New", "Mexico,", "Inc.", "had", "the", "exclusive", "right", "to", "reference", "the", "drug", "master", "file,", "that", "is,", "to", "authorize", "Vista", "Biologicals", "Corporation", "to", "manufacture", "Cytolin", "in", "accordance", "with", "the", "terms", "of", "the", "drug", "master", "file.", "<tag2>", "In", "accordance", "with", "the", "practice", "of", "the", "FDA,", "the", "drug", "master", "file", "was", "issued", "to", "and", "became", "the", "property", "of", "the", "entity", "with", "the", "capacity", "to", "manufacture", "the", "drug,", "in", "this", "case", "Vista", "Biologicals", "Corporation.", "<tag3>"], "wordsA": ["By", "contract", "with", "Vista", "Biologicals", "Corporation,", "CytoDyn", "of", "New", "Mexico,", "Inc.", "had", "the", "exclusive", "right", "to", "reference", "the", "drug", "master", "file,", "that", "is,", "to", "authorize", "Vista", "Biologicals", "Corporation", "to", "manufacture", "Cytolin", "in", "accordance", "with", "the", "terms", "of", "the", "drug", "master", "file."], "wordsB": ["In", "accordance", "with", "the", "practice", "of", "the", "FDA,", "the", "drug", "master", "file", "was", "issued", "to", "and", "became", "the", "property", "of", "the", "entity", "with", "the", "capacity", "to", "manufacture", "the", "drug,", "in", "this", "case", "Vista", "Biologicals", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_12_item1_p10_s4", "idA": "1175680_11_item1_p9_s1", "sentA": "In 1996, the FDA also designated our investigational new drug application for Cytolin as BB-IND #6845, and subsequently approved a clinical trial.", "sentB": "In 1996, the FDA also designated our investigational new drug application for murine Cytolin as BB-IND #6845, and subsequently approved a clinical trial.", "type": 2, "words": ["<tag1>", "In", "1996,", "the", "FDA", "also", "designated", "our", "investigational", "new", "drug", "application", "for", "Cytolin", "as", "BB-IND", "#6845,", "and", "subsequently", "approved", "a", "clinical", "trial.", "<tag2>", "In", "1996,", "the", "FDA", "also", "designated", "our", "investigational", "new", "drug", "application", "for", "murine", "Cytolin", "as", "BB-IND", "#6845,", "and", "subsequently", "approved", "a", "clinical", "trial.", "<tag3>"], "wordsA": ["In", "1996,", "the", "FDA", "also", "designated", "our", "investigational", "new", "drug", "application", "for", "Cytolin", "as", "BB-IND", "#6845,", "and", "subsequently", "approved", "a", "clinical", "trial."], "wordsB": ["In", "1996,", "the", "FDA", "also", "designated", "our", "investigational", "new", "drug", "application", "for", "murine", "Cytolin", "as", "BB-IND", "#6845,", "and", "subsequently", "approved", "a", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p0_s0", "idA": "1175680_12_item1_p0_s0", "sentA": "History CytoDyn Inc. (the Company ), is a Colorado corporation, with its principal business office at 110 Crenshaw Lake Road, Lutz, Florida 33548; telephone: (813) 527-6969, facsimile: (813) 527-6970, and website address: www.cytodyn.com.", "sentB": "History CytoDyn Inc. (the Company ) is a Colorado corporation, with its principal business office at 5 Centerpointe Drive, Suite 400, Lake Oswego, Oregon 97035; telephone: (971) 204-0382, and website address: www.cytodyn.com.", "type": 2, "words": ["<tag1>", "History", "CytoDyn", "Inc.", "(the", "Company", "),", "is", "a", "Colorado", "corporation,", "with", "its", "principal", "business", "office", "at", "110", "Crenshaw", "Lake", "Road,", "Lutz,", "Florida", "33548;", "telephone:", "(813)", "527-6969,", "facsimile:", "(813)", "527-6970,", "and", "website", "address:", "www.cytodyn.com.", "<tag2>", "History", "CytoDyn", "Inc.", "(the", "Company", ")", "is", "a", "Colorado", "corporation,", "with", "its", "principal", "business", "office", "at", "5", "Centerpointe", "Drive,", "Suite", "400,", "Lake", "Oswego,", "Oregon", "97035;", "telephone:", "(971)", "204-0382,", "and", "website", "address:", "www.cytodyn.com.", "<tag3>"], "wordsA": ["History", "CytoDyn", "Inc.", "(the", "Company", "),", "is", "a", "Colorado", "corporation,", "with", "its", "principal", "business", "office", "at", "110", "Crenshaw", "Lake", "Road,", "Lutz,", "Florida", "33548;", "telephone:", "(813)", "527-6969,", "facsimile:", "(813)", "527-6970,", "and", "website", "address:", "www.cytodyn.com."], "wordsB": ["History", "CytoDyn", "Inc.", "(the", "Company", ")", "is", "a", "Colorado", "corporation,", "with", "its", "principal", "business", "office", "at", "5", "Centerpointe", "Drive,", "Suite", "400,", "Lake", "Oswego,", "Oregon", "97035;", "telephone:", "(971)", "204-0382,", "and", "website", "address:", "www.cytodyn.com."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p6_s0", "idA": "1175680_12_item1_p14_s0", "sentA": "To date, only the murine version of Cytolin has been tested in clinical, research and development studies.", "sentB": "To date, PRO 140 has only been tested and administered to test subjects either intravenously or as a subcutaneous injection.", "type": 2, "words": ["<tag1>", "To", "date,", "only", "the", "murine", "version", "of", "Cytolin", "has", "been", "tested", "in", "clinical,", "research", "and", "development", "studies.", "<tag2>", "To", "date,", "PRO", "140", "has", "only", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection.", "<tag3>"], "wordsA": ["To", "date,", "only", "the", "murine", "version", "of", "Cytolin", "has", "been", "tested", "in", "clinical,", "research", "and", "development", "studies."], "wordsB": ["To", "date,", "PRO", "140", "has", "only", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p16_s6", "idA": "1175680_12_item1_p14_s1", "sentA": "The Company understands that registrational studies will require similar testing and confirmation of activity with its proprietary humanized version of Cytolin .", "sentB": "The Company understands that registrational studies will require similar testing and confirmation of activity with its proprietary humanized version of Cytolin should it want to pursue this product.", "type": 2, "words": ["<tag1>", "The", "Company", "understands", "that", "registrational", "studies", "will", "require", "similar", "testing", "and", "confirmation", "of", "activity", "with", "its", "proprietary", "humanized", "version", "of", "Cytolin", ".", "<tag2>", "The", "Company", "understands", "that", "registrational", "studies", "will", "require", "similar", "testing", "and", "confirmation", "of", "activity", "with", "its", "proprietary", "humanized", "version", "of", "Cytolin", "should", "it", "want", "to", "pursue", "this", "product.", "<tag3>"], "wordsA": ["The", "Company", "understands", "that", "registrational", "studies", "will", "require", "similar", "testing", "and", "confirmation", "of", "activity", "with", "its", "proprietary", "humanized", "version", "of", "Cytolin", "."], "wordsB": ["The", "Company", "understands", "that", "registrational", "studies", "will", "require", "similar", "testing", "and", "confirmation", "of", "activity", "with", "its", "proprietary", "humanized", "version", "of", "Cytolin", "should", "it", "want", "to", "pursue", "this", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p17_s0", "idA": "1175680_12_item1_p15_s0", "sentA": "Cytolin - Current Research Under a Clinical Trial Agreement dated September 28, 2009 and as amended to date (the Clinical Trial Agreement ), in exchange for a research grant by the Company, Massachusetts General Hospital ( MGH ) in Boston, Massachusetts agreed to conduct an ex-vivo study of murine Cytolin in accordance with a study protocol entitled An observational study to determine the in-vitro immunologic and virology activity of Cytolin (the Study ).", "sentB": "Under a Clinical Trial Agreement dated September 28, 2009 and as amended to date (the Clinical Trial Agreement ), in exchange for a research grant by the Company, Massachusetts General Hospital ( MGH ) in Boston, Massachusetts conducted an ex-vivo study of murine Cytolin in accordance with a study protocol entitled An observational study to determine the in-vitro immunologic and virology activity of Cytolin (the Study ).", "type": 2, "words": ["<tag1>", "Cytolin", "-", "Current", "Research", "Under", "a", "Clinical", "Trial", "Agreement", "dated", "September", "28,", "2009", "and", "as", "amended", "to", "date", "(the", "Clinical", "Trial", "Agreement", "),", "in", "exchange", "for", "a", "research", "grant", "by", "the", "Company,", "Massachusetts", "General", "Hospital", "(", "MGH", ")", "in", "Boston,", "Massachusetts", "agreed", "to", "conduct", "an", "ex-vivo", "study", "of", "murine", "Cytolin", "in", "accordance", "with", "a", "study", "protocol", "entitled", "An", "observational", "study", "to", "determine", "the", "in-vitro", "immunologic", "and", "virology", "activity", "of", "Cytolin", "(the", "Study", ").", "<tag2>", "Under", "a", "Clinical", "Trial", "Agreement", "dated", "September", "28,", "2009", "and", "as", "amended", "to", "date", "(the", "Clinical", "Trial", "Agreement", "),", "in", "exchange", "for", "a", "research", "grant", "by", "the", "Company,", "Massachusetts", "General", "Hospital", "(", "MGH", ")", "in", "Boston,", "Massachusetts", "conducted", "an", "ex-vivo", "study", "of", "murine", "Cytolin", "in", "accordance", "with", "a", "study", "protocol", "entitled", "An", "observational", "study", "to", "determine", "the", "in-vitro", "immunologic", "and", "virology", "activity", "of", "Cytolin", "(the", "Study", ").", "<tag3>"], "wordsA": ["Cytolin", "-", "Current", "Research", "Under", "a", "Clinical", "Trial", "Agreement", "dated", "September", "28,", "2009", "and", "as", "amended", "to", "date", "(the", "Clinical", "Trial", "Agreement", "),", "in", "exchange", "for", "a", "research", "grant", "by", "the", "Company,", "Massachusetts", "General", "Hospital", "(", "MGH", ")", "in", "Boston,", "Massachusetts", "agreed", "to", "conduct", "an", "ex-vivo", "study", "of", "murine", "Cytolin", "in", "accordance", "with", "a", "study", "protocol", "entitled", "An", "observational", "study", "to", "determine", "the", "in-vitro", "immunologic", "and", "virology", "activity", "of", "Cytolin", "(the", "Study", ")."], "wordsB": ["Under", "a", "Clinical", "Trial", "Agreement", "dated", "September", "28,", "2009", "and", "as", "amended", "to", "date", "(the", "Clinical", "Trial", "Agreement", "),", "in", "exchange", "for", "a", "research", "grant", "by", "the", "Company,", "Massachusetts", "General", "Hospital", "(", "MGH", ")", "in", "Boston,", "Massachusetts", "conducted", "an", "ex-vivo", "study", "of", "murine", "Cytolin", "in", "accordance", "with", "a", "study", "protocol", "entitled", "An", "observational", "study", "to", "determine", "the", "in-vitro", "immunologic", "and", "virology", "activity", "of", "Cytolin", "(the", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p17_s2", "idA": "1175680_12_item1_p15_s2", "sentA": "Under the Clinical Trial Agreement, Eric S. Rosenberg, M.D. is designated as the Principal Investigator for the Study.", "sentB": "Under the Clinical Trial Agreement, Eric S. Rosenberg, M.D. was designated as the Principal Investigator for the Study.", "type": 2, "words": ["<tag1>", "Under", "the", "Clinical", "Trial", "Agreement,", "Eric", "S.", "Rosenberg,", "M.D.", "is", "designated", "as", "the", "Principal", "Investigator", "for", "the", "Study.", "<tag2>", "Under", "the", "Clinical", "Trial", "Agreement,", "Eric", "S.", "Rosenberg,", "M.D.", "was", "designated", "as", "the", "Principal", "Investigator", "for", "the", "Study.", "<tag3>"], "wordsA": ["Under", "the", "Clinical", "Trial", "Agreement,", "Eric", "S.", "Rosenberg,", "M.D.", "is", "designated", "as", "the", "Principal", "Investigator", "for", "the", "Study."], "wordsB": ["Under", "the", "Clinical", "Trial", "Agreement,", "Eric", "S.", "Rosenberg,", "M.D.", "was", "designated", "as", "the", "Principal", "Investigator", "for", "the", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p17_s3", "idA": "1175680_12_item1_p16_s1", "sentA": "The Study enrolled 10 adults with early HIV infection and 10 healthy adults as the control arm, all of whom were required to participate for six months.", "sentB": "Ten adults with early HIV infection and 10 healthy adults were enrolled in the Study, all of whom were required to participate for six months.", "type": 2, "words": ["<tag1>", "The", "Study", "enrolled", "10", "adults", "with", "early", "HIV", "infection", "and", "10", "healthy", "adults", "as", "the", "control", "arm,", "all", "of", "whom", "were", "required", "to", "participate", "for", "six", "months.", "<tag2>", "Ten", "adults", "with", "early", "HIV", "infection", "and", "10", "healthy", "adults", "were", "enrolled", "in", "the", "Study,", "all", "of", "whom", "were", "required", "to", "participate", "for", "six", "months.", "<tag3>"], "wordsA": ["The", "Study", "enrolled", "10", "adults", "with", "early", "HIV", "infection", "and", "10", "healthy", "adults", "as", "the", "control", "arm,", "all", "of", "whom", "were", "required", "to", "participate", "for", "six", "months."], "wordsB": ["Ten", "adults", "with", "early", "HIV", "infection", "and", "10", "healthy", "adults", "were", "enrolled", "in", "the", "Study,", "all", "of", "whom", "were", "required", "to", "participate", "for", "six", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p17_s4", "idA": "1175680_12_item1_p16_s2", "sentA": "None of the patients enrolled in the study received injections of murine Cytolin ; rather they donated blood to allow one to examine the effects of Cytolin when it was added in the test tube to their peripheral blood mononuclear cells.", "sentB": "Each patient enrolled in the study donated blood to allow the study of the effects of Cytolin when it was added in the test tube to their peripheral blood mononuclear cells.", "type": 2, "words": ["<tag1>", "None", "of", "the", "patients", "enrolled", "in", "the", "study", "received", "injections", "of", "murine", "Cytolin", ";", "rather", "they", "donated", "blood", "to", "allow", "one", "to", "examine", "the", "effects", "of", "Cytolin", "when", "it", "was", "added", "in", "the", "test", "tube", "to", "their", "peripheral", "blood", "mononuclear", "cells.", "<tag2>", "Each", "patient", "enrolled", "in", "the", "study", "donated", "blood", "to", "allow", "the", "study", "of", "the", "effects", "of", "Cytolin", "when", "it", "was", "added", "in", "the", "test", "tube", "to", "their", "peripheral", "blood", "mononuclear", "cells.", "<tag3>"], "wordsA": ["None", "of", "the", "patients", "enrolled", "in", "the", "study", "received", "injections", "of", "murine", "Cytolin", ";", "rather", "they", "donated", "blood", "to", "allow", "one", "to", "examine", "the", "effects", "of", "Cytolin", "when", "it", "was", "added", "in", "the", "test", "tube", "to", "their", "peripheral", "blood", "mononuclear", "cells."], "wordsB": ["Each", "patient", "enrolled", "in", "the", "study", "donated", "blood", "to", "allow", "the", "study", "of", "the", "effects", "of", "Cytolin", "when", "it", "was", "added", "in", "the", "test", "tube", "to", "their", "peripheral", "blood", "mononuclear", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p14_s6", "idA": "1175680_12_item1_p16_s3", "sentA": "The Study design and objectives are available to view at the government s website at www.clinicaltrials.gov, ID NCT01048372.", "sentB": "Information regarding past and current study design, objectives and results are available at www.clinicaltrials.gov.", "type": 2, "words": ["<tag1>", "The", "Study", "design", "and", "objectives", "are", "available", "to", "view", "at", "the", "government", "s", "website", "at", "www.clinicaltrials.gov,", "ID", "NCT01048372.", "<tag2>", "Information", "regarding", "past", "and", "current", "study", "design,", "objectives", "and", "results", "are", "available", "at", "www.clinicaltrials.gov.", "<tag3>"], "wordsA": ["The", "Study", "design", "and", "objectives", "are", "available", "to", "view", "at", "the", "government", "s", "website", "at", "www.clinicaltrials.gov,", "ID", "NCT01048372."], "wordsB": ["Information", "regarding", "past", "and", "current", "study", "design,", "objectives", "and", "results", "are", "available", "at", "www.clinicaltrials.gov."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p17_s5", "idA": "1175680_12_item1_p16_s3", "sentA": "The Study design and objectives are available to view at the government s website at www.clinicaltrials.gov, ID NCT01048372.", "sentB": "The Study design and objectives are available at www.clinicaltrials.gov, ID NCT01048372.", "type": 2, "words": ["<tag1>", "The", "Study", "design", "and", "objectives", "are", "available", "to", "view", "at", "the", "government", "s", "website", "at", "www.clinicaltrials.gov,", "ID", "NCT01048372.", "<tag2>", "The", "Study", "design", "and", "objectives", "are", "available", "at", "www.clinicaltrials.gov,", "ID", "NCT01048372.", "<tag3>"], "wordsA": ["The", "Study", "design", "and", "objectives", "are", "available", "to", "view", "at", "the", "government", "s", "website", "at", "www.clinicaltrials.gov,", "ID", "NCT01048372."], "wordsB": ["The", "Study", "design", "and", "objectives", "are", "available", "at", "www.clinicaltrials.gov,", "ID", "NCT01048372."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p14_s7", "idA": "1175680_12_item1_p17_s1", "sentA": "To review public records for the Study on the government s website, enter Cytolin as the search term (case sensitive).", "sentB": "To review these records, enter PRO 140 as the search term.", "type": 2, "words": ["<tag1>", "To", "review", "public", "records", "for", "the", "Study", "on", "the", "government", "s", "website,", "enter", "Cytolin", "as", "the", "search", "term", "(case", "sensitive).", "<tag2>", "To", "review", "these", "records,", "enter", "PRO", "140", "as", "the", "search", "term.", "<tag3>"], "wordsA": ["To", "review", "public", "records", "for", "the", "Study", "on", "the", "government", "s", "website,", "enter", "Cytolin", "as", "the", "search", "term", "(case", "sensitive)."], "wordsB": ["To", "review", "these", "records,", "enter", "PRO", "140", "as", "the", "search", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p17_s7", "idA": "1175680_12_item1_p18_s6", "sentA": "The Study was completed subsequent to May 31, 2012.", "sentB": "The Study was completed in December 2012.", "type": 2, "words": ["<tag1>", "The", "Study", "was", "completed", "subsequent", "to", "May", "31,", "2012.", "<tag2>", "The", "Study", "was", "completed", "in", "December", "2012.", "<tag3>"], "wordsA": ["The", "Study", "was", "completed", "subsequent", "to", "May", "31,", "2012."], "wordsB": ["The", "Study", "was", "completed", "in", "December", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p17_s8", "idA": "1175680_12_item1_p18_s7", "sentA": "The Company anticipates that if there is sufficient data to warrant publication Dr. Rosenberg will draft and submit a manuscript detailing his results.", "sentB": "Dr. Rosenberg submitted a manuscript detailing his results, which can be found at Rychert J, Jones L, McGrath G, et al.", "type": 2, "words": ["<tag1>", "The", "Company", "anticipates", "that", "if", "there", "is", "sufficient", "data", "to", "warrant", "publication", "Dr.", "Rosenberg", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "his", "results.", "<tag2>", "Dr.", "Rosenberg", "submitted", "a", "manuscript", "detailing", "his", "results,", "which", "can", "be", "found", "at", "Rychert", "J,", "Jones", "L,", "McGrath", "G,", "et", "al.", "<tag3>"], "wordsA": ["The", "Company", "anticipates", "that", "if", "there", "is", "sufficient", "data", "to", "warrant", "publication", "Dr.", "Rosenberg", "will", "draft", "and", "submit", "a", "manuscript", "detailing", "his", "results."], "wordsB": ["Dr.", "Rosenberg", "submitted", "a", "manuscript", "detailing", "his", "results,", "which", "can", "be", "found", "at", "Rychert", "J,", "Jones", "L,", "McGrath", "G,", "et", "al."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p19_s2", "idA": "1175680_12_item1_p19_s2", "sentA": "The Company will determine if clinical trials with the humanized version of Cytolin are warranted based on these and other results from studies with the murine molecule and subsequent confirmation of activity with the humanized version of Cytolin .", "sentB": "The Company will determine if clinical trials with the humanized version of Cytolin are warranted based on results from studies with the murine molecule and available resources.", "type": 2, "words": ["<tag1>", "The", "Company", "will", "determine", "if", "clinical", "trials", "with", "the", "humanized", "version", "of", "Cytolin", "are", "warranted", "based", "on", "these", "and", "other", "results", "from", "studies", "with", "the", "murine", "molecule", "and", "subsequent", "confirmation", "of", "activity", "with", "the", "humanized", "version", "of", "Cytolin", ".", "<tag2>", "The", "Company", "will", "determine", "if", "clinical", "trials", "with", "the", "humanized", "version", "of", "Cytolin", "are", "warranted", "based", "on", "results", "from", "studies", "with", "the", "murine", "molecule", "and", "available", "resources.", "<tag3>"], "wordsA": ["The", "Company", "will", "determine", "if", "clinical", "trials", "with", "the", "humanized", "version", "of", "Cytolin", "are", "warranted", "based", "on", "these", "and", "other", "results", "from", "studies", "with", "the", "murine", "molecule", "and", "subsequent", "confirmation", "of", "activity", "with", "the", "humanized", "version", "of", "Cytolin", "."], "wordsB": ["The", "Company", "will", "determine", "if", "clinical", "trials", "with", "the", "humanized", "version", "of", "Cytolin", "are", "warranted", "based", "on", "results", "from", "studies", "with", "the", "murine", "molecule", "and", "available", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p1_s0", "idA": "1175680_12_item1_p1_s0", "sentA": "We are a development stage biotechnology company (concept company) focused on discovering and developing a class of therapeutic monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "sentB": "We are a publicly traded development stage biotechnology company focused on developing and potentially marketing a class of therapeutic monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "type": 2, "words": ["<tag1>", "We", "are", "a", "development", "stage", "biotechnology", "company", "(concept", "company)", "focused", "on", "discovering", "and", "developing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag2>", "We", "are", "a", "publicly", "traded", "development", "stage", "biotechnology", "company", "focused", "on", "developing", "and", "potentially", "marketing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag3>"], "wordsA": ["We", "are", "a", "development", "stage", "biotechnology", "company", "(concept", "company)", "focused", "on", "discovering", "and", "developing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "wordsB": ["We", "are", "a", "publicly", "traded", "development", "stage", "biotechnology", "company", "focused", "on", "developing", "and", "potentially", "marketing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p3_s1", "idA": "1175680_12_item1_p21_s1", "sentA": "However, subsequent studies and analysis of the activity of Cytolin has shown that while Cytolin is highly expressed on CTLs, this antibody does not block CTLs.", "sentB": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 receptor.", "type": 2, "words": ["<tag1>", "However,", "subsequent", "studies", "and", "analysis", "of", "the", "activity", "of", "Cytolin", "has", "shown", "that", "while", "Cytolin", "is", "highly", "expressed", "on", "CTLs,", "this", "antibody", "does", "not", "block", "CTLs.", "<tag2>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "receptor.", "<tag3>"], "wordsA": ["However,", "subsequent", "studies", "and", "analysis", "of", "the", "activity", "of", "Cytolin", "has", "shown", "that", "while", "Cytolin", "is", "highly", "expressed", "on", "CTLs,", "this", "antibody", "does", "not", "block", "CTLs."], "wordsB": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "receptor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p13_s0", "idA": "1175680_12_item1_p25_s0", "sentA": "Formation of CytoDyn Veterinary Medicine LLC and Current Research On May 16, 2011, we formed a wholly owned subsidiary, CVM, which will explore the possible application of feline reactive monoclonal antibodies for the treatment of the feline immunodeficiency virus ( FIV ).", "sentB": "In May 2011, we formed CytoDyn Veterinary Medicine LLC ( CVM ) to explore the possible application of feline reactive monoclonal antibodies for the treatment of FIV.", "type": 2, "words": ["<tag1>", "Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "and", "Current", "Research", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "the", "feline", "immunodeficiency", "virus", "(", "FIV", ").", "<tag2>", "In", "May", "2011,", "we", "formed", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", ")", "to", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "FIV.", "<tag3>"], "wordsA": ["Formation", "of", "CytoDyn", "Veterinary", "Medicine", "LLC", "and", "Current", "Research", "On", "May", "16,", "2011,", "we", "formed", "a", "wholly", "owned", "subsidiary,", "CVM,", "which", "will", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "the", "feline", "immunodeficiency", "virus", "(", "FIV", ")."], "wordsB": ["In", "May", "2011,", "we", "formed", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", ")", "to", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "FIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p12_s1", "idA": "1175680_12_item1_p26_s1", "sentA": "On June 15, 2012, the Company filed an international patent application (Serial No. PCT/US2012/042693) claiming priority to this provisional patent application.", "sentB": "On September 13, 2012, we filed an international patent application (Serial No. PCT/US2012/055132) claiming priority to a United States provisional patent application for our humanized version of Cytolin.", "type": 2, "words": ["<tag1>", "On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application.", "<tag2>", "On", "September", "13,", "2012,", "we", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/055132)", "claiming", "priority", "to", "a", "United", "States", "provisional", "patent", "application", "for", "our", "humanized", "version", "of", "Cytolin.", "<tag3>"], "wordsA": ["On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application."], "wordsB": ["On", "September", "13,", "2012,", "we", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/055132)", "claiming", "priority", "to", "a", "United", "States", "provisional", "patent", "application", "for", "our", "humanized", "version", "of", "Cytolin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p11_s0", "idA": "1175680_12_item1_p2_s0", "sentA": "In October 2003, the Company (under its previous name RexRay Corporation) entered into an Acquisition Agreement with CytoDyn of New Mexico, Inc.", "sentB": "We acquired rights to Cytolin in October 2003 pursuant to an agreement with CytoDyn of New Mexico, Inc. ( CytoDyn NM ).", "type": 2, "words": ["<tag1>", "In", "October", "2003,", "the", "Company", "(under", "its", "previous", "name", "RexRay", "Corporation)", "entered", "into", "an", "Acquisition", "Agreement", "with", "CytoDyn", "of", "New", "Mexico,", "Inc.", "<tag2>", "We", "acquired", "rights", "to", "Cytolin", "in", "October", "2003", "pursuant", "to", "an", "agreement", "with", "CytoDyn", "of", "New", "Mexico,", "Inc.", "(", "CytoDyn", "NM", ").", "<tag3>"], "wordsA": ["In", "October", "2003,", "the", "Company", "(under", "its", "previous", "name", "RexRay", "Corporation)", "entered", "into", "an", "Acquisition", "Agreement", "with", "CytoDyn", "of", "New", "Mexico,", "Inc."], "wordsB": ["We", "acquired", "rights", "to", "Cytolin", "in", "October", "2003", "pursuant", "to", "an", "agreement", "with", "CytoDyn", "of", "New", "Mexico,", "Inc.", "(", "CytoDyn", "NM", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p15_s1", "idA": "1175680_12_item1_p33_s1", "sentA": "The Company expects to generate and provide the chimeric version of the antibody for Dr. VandeWoude in the next six months.", "sentB": "Blood and skin tests of these patients suggested that the antibody might be producing improvements in the immune function of each patient.", "type": 2, "words": ["<tag1>", "The", "Company", "expects", "to", "generate", "and", "provide", "the", "chimeric", "version", "of", "the", "antibody", "for", "Dr.", "VandeWoude", "in", "the", "next", "six", "months.", "<tag2>", "Blood", "and", "skin", "tests", "of", "these", "patients", "suggested", "that", "the", "antibody", "might", "be", "producing", "improvements", "in", "the", "immune", "function", "of", "each", "patient.", "<tag3>"], "wordsA": ["The", "Company", "expects", "to", "generate", "and", "provide", "the", "chimeric", "version", "of", "the", "antibody", "for", "Dr.", "VandeWoude", "in", "the", "next", "six", "months."], "wordsB": ["Blood", "and", "skin", "tests", "of", "these", "patients", "suggested", "that", "the", "antibody", "might", "be", "producing", "improvements", "in", "the", "immune", "function", "of", "each", "patient."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p1_s3", "idA": "1175680_12_item1_p36_s0", "sentA": "On September 23, 2011, the Company filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin , a monoclonal antibody for the treatment of HIV infection.", "sentB": "Although CytoDyn intends to focus its efforts on PRO 140, the Company also holds certain rights in two proprietary platform technologies: Cytolin , a monoclonal antibody targeting HIV with a mechanism of action which may prove to be synergistic to that of PRO 140 and other treatments, and CytoFeline , a monoclonal antibody targeting Feline Immunodeficiency Virus ( FIV ).", "type": 2, "words": ["<tag1>", "On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection.", "<tag2>", "Although", "CytoDyn", "intends", "to", "focus", "its", "efforts", "on", "PRO", "140,", "the", "Company", "also", "holds", "certain", "rights", "in", "two", "proprietary", "platform", "technologies:", "Cytolin", ",", "a", "monoclonal", "antibody", "targeting", "HIV", "with", "a", "mechanism", "of", "action", "which", "may", "prove", "to", "be", "synergistic", "to", "that", "of", "PRO", "140", "and", "other", "treatments,", "and", "CytoFeline", ",", "a", "monoclonal", "antibody", "targeting", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ").", "<tag3>"], "wordsA": ["On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin", ",", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection."], "wordsB": ["Although", "CytoDyn", "intends", "to", "focus", "its", "efforts", "on", "PRO", "140,", "the", "Company", "also", "holds", "certain", "rights", "in", "two", "proprietary", "platform", "technologies:", "Cytolin", ",", "a", "monoclonal", "antibody", "targeting", "HIV", "with", "a", "mechanism", "of", "action", "which", "may", "prove", "to", "be", "synergistic", "to", "that", "of", "PRO", "140", "and", "other", "treatments,", "and", "CytoFeline", ",", "a", "monoclonal", "antibody", "targeting", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p11_s2", "idA": "1175680_12_item1_p38_s0", "sentA": "The Company s Cytolin-related patents referenced above are for a murine (mouse) version of the drug.", "sentB": "This patent is for a murine (mouse) version of the drug.", "type": 2, "words": ["<tag1>", "The", "Company", "s", "Cytolin-related", "patents", "referenced", "above", "are", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag3>"], "wordsA": ["The", "Company", "s", "Cytolin-related", "patents", "referenced", "above", "are", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p11_s1", "idA": "1175680_12_item1_p3_s2", "sentA": "The license acquired gives the Company the worldwide, exclusive right to develop, market and sell compounds disclosed by the patent claims, practice methods taught by the patent claims, and exploit specified technology related to the patents.", "sentB": "As part of the transaction, we acquired the drug candidate Cytolin and were assigned rights under the patent license agreement dated July 1, 1994, between CytoDyn NM and Allen D. Allen, covering United States Patent No. 5,651,970 (which describes a method for treating HIV disease with the use of monoclonal antibodies), including the worldwide, exclusive right to develop, market and sell compounds disclosed by the patent, to practice methods taught by the patent, and to exploit specified technology related to the patent.", "type": 2, "words": ["<tag1>", "The", "license", "acquired", "gives", "the", "Company", "the", "worldwide,", "exclusive", "right", "to", "develop,", "market", "and", "sell", "compounds", "disclosed", "by", "the", "patent", "claims,", "practice", "methods", "taught", "by", "the", "patent", "claims,", "and", "exploit", "specified", "technology", "related", "to", "the", "patents.", "<tag2>", "As", "part", "of", "the", "transaction,", "we", "acquired", "the", "drug", "candidate", "Cytolin", "and", "were", "assigned", "rights", "under", "the", "patent", "license", "agreement", "dated", "July", "1,", "1994,", "between", "CytoDyn", "NM", "and", "Allen", "D.", "Allen,", "covering", "United", "States", "Patent", "No.", "5,651,970", "(which", "describes", "a", "method", "for", "treating", "HIV", "disease", "with", "the", "use", "of", "monoclonal", "antibodies),", "including", "the", "worldwide,", "exclusive", "right", "to", "develop,", "market", "and", "sell", "compounds", "disclosed", "by", "the", "patent,", "to", "practice", "methods", "taught", "by", "the", "patent,", "and", "to", "exploit", "specified", "technology", "related", "to", "the", "patent.", "<tag3>"], "wordsA": ["The", "license", "acquired", "gives", "the", "Company", "the", "worldwide,", "exclusive", "right", "to", "develop,", "market", "and", "sell", "compounds", "disclosed", "by", "the", "patent", "claims,", "practice", "methods", "taught", "by", "the", "patent", "claims,", "and", "exploit", "specified", "technology", "related", "to", "the", "patents."], "wordsB": ["As", "part", "of", "the", "transaction,", "we", "acquired", "the", "drug", "candidate", "Cytolin", "and", "were", "assigned", "rights", "under", "the", "patent", "license", "agreement", "dated", "July", "1,", "1994,", "between", "CytoDyn", "NM", "and", "Allen", "D.", "Allen,", "covering", "United", "States", "Patent", "No.", "5,651,970", "(which", "describes", "a", "method", "for", "treating", "HIV", "disease", "with", "the", "use", "of", "monoclonal", "antibodies),", "including", "the", "worldwide,", "exclusive", "right", "to", "develop,", "market", "and", "sell", "compounds", "disclosed", "by", "the", "patent,", "to", "practice", "methods", "taught", "by", "the", "patent,", "and", "to", "exploit", "specified", "technology", "related", "to", "the", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p11_s3", "idA": "1175680_12_item1_p3_s3", "sentA": "The term of the license agreement is for the life of the patents of which the first will expire in 2013.", "sentB": "The license agreement expires on the original expiration date of the patent in July 2014.", "type": 2, "words": ["<tag1>", "The", "term", "of", "the", "license", "agreement", "is", "for", "the", "life", "of", "the", "patents", "of", "which", "the", "first", "will", "expire", "in", "2013.", "<tag2>", "The", "license", "agreement", "expires", "on", "the", "original", "expiration", "date", "of", "the", "patent", "in", "July", "2014.", "<tag3>"], "wordsA": ["The", "term", "of", "the", "license", "agreement", "is", "for", "the", "life", "of", "the", "patents", "of", "which", "the", "first", "will", "expire", "in", "2013."], "wordsB": ["The", "license", "agreement", "expires", "on", "the", "original", "expiration", "date", "of", "the", "patent", "in", "July", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p4_s2", "idA": "1175680_12_item1_p41_s1", "sentA": "No. 1473043 was registered on May 31, 2012.", "sentB": "We acquired the asset from Progenics in October 2012.", "type": 2, "words": ["<tag1>", "No.", "1473043", "was", "registered", "on", "May", "31,", "2012.", "<tag2>", "We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012.", "<tag3>"], "wordsA": ["No.", "1473043", "was", "registered", "on", "May", "31,", "2012."], "wordsB": ["We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p20_s0", "idA": "1175680_12_item1_p42_s0", "sentA": "The health care industry is highly regulated, and state and federal health care laws and regulations are applicable to certain aspects of our business.", "sentB": "Patents and Proprietary Technology Protection of our intellectual property rights is important to our business.", "type": 2, "words": ["<tag1>", "The", "health", "care", "industry", "is", "highly", "regulated,", "and", "state", "and", "federal", "health", "care", "laws", "and", "regulations", "are", "applicable", "to", "certain", "aspects", "of", "our", "business.", "<tag2>", "Patents", "and", "Proprietary", "Technology", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business.", "<tag3>"], "wordsA": ["The", "health", "care", "industry", "is", "highly", "regulated,", "and", "state", "and", "federal", "health", "care", "laws", "and", "regulations", "are", "applicable", "to", "certain", "aspects", "of", "our", "business."], "wordsB": ["Patents", "and", "Proprietary", "Technology", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p29_s0", "idA": "1175680_12_item1_p44_s1", "sentA": "The exercise of broad regulatory powers by the FDA through its Center for Devices and Radiological Health and its Center for Biological Evaluation and Research continues to result in increases in the amounts of testing and documentation for FDA clearance of current and new biologic products.", "sentB": "Health and its Center for Biological Evaluation and Research continues to result in increases in the amounts of testing and documentation for FDA clearance of current and new biologic products.", "type": 2, "words": ["<tag1>", "The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Devices", "and", "Radiological", "Health", "and", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "continues", "to", "result", "in", "increases", "in", "the", "amounts", "of", "testing", "and", "documentation", "for", "FDA", "clearance", "of", "current", "and", "new", "biologic", "products.", "<tag2>", "Health", "and", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "continues", "to", "result", "in", "increases", "in", "the", "amounts", "of", "testing", "and", "documentation", "for", "FDA", "clearance", "of", "current", "and", "new", "biologic", "products.", "<tag3>"], "wordsA": ["The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Devices", "and", "Radiological", "Health", "and", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "continues", "to", "result", "in", "increases", "in", "the", "amounts", "of", "testing", "and", "documentation", "for", "FDA", "clearance", "of", "current", "and", "new", "biologic", "products."], "wordsB": ["Health", "and", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "continues", "to", "result", "in", "increases", "in", "the", "amounts", "of", "testing", "and", "documentation", "for", "FDA", "clearance", "of", "current", "and", "new", "biologic", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p20_s1", "idA": "1175680_12_item1_p49_s0", "sentA": "Our research and development activities and the manufacture and marketing of our products are and will be subject to rigorous regulations relating to product safety and efficacy by numerous governmental authorities in the United States and other countries.", "sentB": "We may file patent applications in the U.S., Canada, Japan, European countries that are party to the European Patent Convention and other countries on a selective basis in order to protect inventions we consider to be important to the development of our business.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "and", "the", "manufacture", "and", "marketing", "of", "our", "products", "are", "and", "will", "be", "subject", "to", "rigorous", "regulations", "relating", "to", "product", "safety", "and", "efficacy", "by", "numerous", "governmental", "authorities", "in", "the", "United", "States", "and", "other", "countries.", "<tag2>", "We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "and", "the", "manufacture", "and", "marketing", "of", "our", "products", "are", "and", "will", "be", "subject", "to", "rigorous", "regulations", "relating", "to", "product", "safety", "and", "efficacy", "by", "numerous", "governmental", "authorities", "in", "the", "United", "States", "and", "other", "countries."], "wordsB": ["We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p44_s4", "idA": "1175680_12_item1_p50_s1", "sentA": "We believe that our operations comply in all material respects with applicable environmental laws and regulations.", "sentB": "For these reasons, we believe that our monoclonal antibody products may prove to be useful in patients that cannot tolerate existing HIV therapies.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "operations", "comply", "in", "all", "material", "respects", "with", "applicable", "environmental", "laws", "and", "regulations.", "<tag2>", "For", "these", "reasons,", "we", "believe", "that", "our", "monoclonal", "antibody", "products", "may", "prove", "to", "be", "useful", "in", "patients", "that", "cannot", "tolerate", "existing", "HIV", "therapies.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "operations", "comply", "in", "all", "material", "respects", "with", "applicable", "environmental", "laws", "and", "regulations."], "wordsB": ["For", "these", "reasons,", "we", "believe", "that", "our", "monoclonal", "antibody", "products", "may", "prove", "to", "be", "useful", "in", "patients", "that", "cannot", "tolerate", "existing", "HIV", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p36_s1", "idA": "1175680_12_item1_p51_s1", "sentA": "Under the Company s current business plan, much of this initial work may be sponsored and conducted by MGH, or a different clinical trial research facility, as determined by us at some point in the future and different studies may also be explored.", "sentB": "Under the Company s current business plan, most of this initial work may be sponsored and conducted by Drexel, or a different clinical trial research facility, as determined at some point in the future.", "type": 2, "words": ["<tag1>", "Under", "the", "Company", "s", "current", "business", "plan,", "much", "of", "this", "initial", "work", "may", "be", "sponsored", "and", "conducted", "by", "MGH,", "or", "a", "different", "clinical", "trial", "research", "facility,", "as", "determined", "by", "us", "at", "some", "point", "in", "the", "future", "and", "different", "studies", "may", "also", "be", "explored.", "<tag2>", "Under", "the", "Company", "s", "current", "business", "plan,", "most", "of", "this", "initial", "work", "may", "be", "sponsored", "and", "conducted", "by", "Drexel,", "or", "a", "different", "clinical", "trial", "research", "facility,", "as", "determined", "at", "some", "point", "in", "the", "future.", "<tag3>"], "wordsA": ["Under", "the", "Company", "s", "current", "business", "plan,", "much", "of", "this", "initial", "work", "may", "be", "sponsored", "and", "conducted", "by", "MGH,", "or", "a", "different", "clinical", "trial", "research", "facility,", "as", "determined", "by", "us", "at", "some", "point", "in", "the", "future", "and", "different", "studies", "may", "also", "be", "explored."], "wordsB": ["Under", "the", "Company", "s", "current", "business", "plan,", "most", "of", "this", "initial", "work", "may", "be", "sponsored", "and", "conducted", "by", "Drexel,", "or", "a", "different", "clinical", "trial", "research", "facility,", "as", "determined", "at", "some", "point", "in", "the", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p14_s5", "idA": "1175680_12_item1_p51_s3", "sentA": "The Company is exploring all options available to determine the most cost effective implementation of the clinical trial process.", "sentB": "Further trials are needed to determine the exposure time required for immunogenic responses to become significant.", "type": 2, "words": ["<tag1>", "The", "Company", "is", "exploring", "all", "options", "available", "to", "determine", "the", "most", "cost", "effective", "implementation", "of", "the", "clinical", "trial", "process.", "<tag2>", "Further", "trials", "are", "needed", "to", "determine", "the", "exposure", "time", "required", "for", "immunogenic", "responses", "to", "become", "significant.", "<tag3>"], "wordsA": ["The", "Company", "is", "exploring", "all", "options", "available", "to", "determine", "the", "most", "cost", "effective", "implementation", "of", "the", "clinical", "trial", "process."], "wordsB": ["Further", "trials", "are", "needed", "to", "determine", "the", "exposure", "time", "required", "for", "immunogenic", "responses", "to", "become", "significant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p14_s4", "idA": "1175680_12_item1_p52_s1", "sentA": "These studies are closely monitored and may be conducted in patients, but are usually conducted in a small number of healthy volunteer subjects.", "sentB": "While all protein therapeutic products are likely to have some immunogenicity that is, to cause the recipient to make antibodies against the protein therapeutic product only mild immunogenic responses were seen in a small number of subjects, and none of the immune response was associated with adverse effects or with an interference in the ability of PRO 140 to bind to its intended CCR5 target.", "type": 2, "words": ["<tag1>", "These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "subjects.", "<tag2>", "While", "all", "protein", "therapeutic", "products", "are", "likely", "to", "have", "some", "immunogenicity", "that", "is,", "to", "cause", "the", "recipient", "to", "make", "antibodies", "against", "the", "protein", "therapeutic", "product", "only", "mild", "immunogenic", "responses", "were", "seen", "in", "a", "small", "number", "of", "subjects,", "and", "none", "of", "the", "immune", "response", "was", "associated", "with", "adverse", "effects", "or", "with", "an", "interference", "in", "the", "ability", "of", "PRO", "140", "to", "bind", "to", "its", "intended", "CCR5", "target.", "<tag3>"], "wordsA": ["These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "subjects."], "wordsB": ["While", "all", "protein", "therapeutic", "products", "are", "likely", "to", "have", "some", "immunogenicity", "that", "is,", "to", "cause", "the", "recipient", "to", "make", "antibodies", "against", "the", "protein", "therapeutic", "product", "only", "mild", "immunogenic", "responses", "were", "seen", "in", "a", "small", "number", "of", "subjects,", "and", "none", "of", "the", "immune", "response", "was", "associated", "with", "adverse", "effects", "or", "with", "an", "interference", "in", "the", "ability", "of", "PRO", "140", "to", "bind", "to", "its", "intended", "CCR5", "target."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p43_s1", "idA": "1175680_12_item1_p58_s1", "sentA": "We will compete with other more established biotechnology companies which have greater financial resources than we have.", "sentB": "We compete with other more established biotechnology companies that have greater financial and managerial resources than we do.", "type": 2, "words": ["<tag1>", "We", "will", "compete", "with", "other", "more", "established", "biotechnology", "companies", "which", "have", "greater", "financial", "resources", "than", "we", "have.", "<tag2>", "We", "compete", "with", "other", "more", "established", "biotechnology", "companies", "that", "have", "greater", "financial", "and", "managerial", "resources", "than", "we", "do.", "<tag3>"], "wordsA": ["We", "will", "compete", "with", "other", "more", "established", "biotechnology", "companies", "which", "have", "greater", "financial", "resources", "than", "we", "have."], "wordsB": ["We", "compete", "with", "other", "more", "established", "biotechnology", "companies", "that", "have", "greater", "financial", "and", "managerial", "resources", "than", "we", "do."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p44_s7", "idA": "1175680_12_item1_p58_s2", "sentA": "Our potential competitors include entities that develop and produce therapeutic agents for treatment of human and animal disease.", "sentB": "Our potential competitors include entities that develop and produce therapeutic agents.", "type": 2, "words": ["<tag1>", "Our", "potential", "competitors", "include", "entities", "that", "develop", "and", "produce", "therapeutic", "agents", "for", "treatment", "of", "human", "and", "animal", "disease.", "<tag2>", "Our", "potential", "competitors", "include", "entities", "that", "develop", "and", "produce", "therapeutic", "agents.", "<tag3>"], "wordsA": ["Our", "potential", "competitors", "include", "entities", "that", "develop", "and", "produce", "therapeutic", "agents", "for", "treatment", "of", "human", "and", "animal", "disease."], "wordsB": ["Our", "potential", "competitors", "include", "entities", "that", "develop", "and", "produce", "therapeutic", "agents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p44_s9", "idA": "1175680_12_item1_p58_s4", "sentA": "Almost all of these potential competitors have substantially greater capital resources, research and development capabilities, manufacturing and marketing resources and experience than we have.", "sentB": "All of these potential competitors have substantially greater capital resources, management expertise, research and development capabilities, manufacturing and marketing resources and experience than we do.", "type": 2, "words": ["<tag1>", "Almost", "all", "of", "these", "potential", "competitors", "have", "substantially", "greater", "capital", "resources,", "research", "and", "development", "capabilities,", "manufacturing", "and", "marketing", "resources", "and", "experience", "than", "we", "have.", "<tag2>", "All", "of", "these", "potential", "competitors", "have", "substantially", "greater", "capital", "resources,", "management", "expertise,", "research", "and", "development", "capabilities,", "manufacturing", "and", "marketing", "resources", "and", "experience", "than", "we", "do.", "<tag3>"], "wordsA": ["Almost", "all", "of", "these", "potential", "competitors", "have", "substantially", "greater", "capital", "resources,", "research", "and", "development", "capabilities,", "manufacturing", "and", "marketing", "resources", "and", "experience", "than", "we", "have."], "wordsB": ["All", "of", "these", "potential", "competitors", "have", "substantially", "greater", "capital", "resources,", "management", "expertise,", "research", "and", "development", "capabilities,", "manufacturing", "and", "marketing", "resources", "and", "experience", "than", "we", "do."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p46_s0", "idA": "1175680_12_item1_p59_s0", "sentA": "Worldwide, there are many antiviral drugs for treating HIV and AIDS.", "sentB": "Worldwide, there are many antiviral drugs for treating HIV.", "type": 2, "words": ["<tag1>", "Worldwide,", "there", "are", "many", "antiviral", "drugs", "for", "treating", "HIV", "and", "AIDS.", "<tag2>", "Worldwide,", "there", "are", "many", "antiviral", "drugs", "for", "treating", "HIV.", "<tag3>"], "wordsA": ["Worldwide,", "there", "are", "many", "antiviral", "drugs", "for", "treating", "HIV", "and", "AIDS."], "wordsB": ["Worldwide,", "there", "are", "many", "antiviral", "drugs", "for", "treating", "HIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p47_s1", "idA": "1175680_12_item1_p60_s1", "sentA": "All of our potential competitors in this field have considerably greater financial and personnel resources than we possess.", "sentB": "All of our potential competitors in this field have considerably greater financial and management resources than we possess.", "type": 2, "words": ["<tag1>", "All", "of", "our", "potential", "competitors", "in", "this", "field", "have", "considerably", "greater", "financial", "and", "personnel", "resources", "than", "we", "possess.", "<tag2>", "All", "of", "our", "potential", "competitors", "in", "this", "field", "have", "considerably", "greater", "financial", "and", "management", "resources", "than", "we", "possess.", "<tag3>"], "wordsA": ["All", "of", "our", "potential", "competitors", "in", "this", "field", "have", "considerably", "greater", "financial", "and", "personnel", "resources", "than", "we", "possess."], "wordsB": ["All", "of", "our", "potential", "competitors", "in", "this", "field", "have", "considerably", "greater", "financial", "and", "management", "resources", "than", "we", "possess."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p48_s0", "idA": "1175680_12_item1_p61_s0", "sentA": "Research and Development Costs Our sponsored research and development expenses were $530,027, $480,765 and $2,759,495 in fiscal 2012, 2011 and for the period October 28, 2003 through May 31, 2012, respectively.", "sentB": "Research and Development Costs Our sponsored research and development expenses were $619,838, $530,027 and $3,379,333 in fiscal 2013, 2012 and for the period October 28, 2003 through May 31, 2013, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "Development", "Costs", "Our", "sponsored", "research", "and", "development", "expenses", "were", "$530,027,", "$480,765", "and", "$2,759,495", "in", "fiscal", "2012,", "2011", "and", "for", "the", "period", "October", "28,", "2003", "through", "May", "31,", "2012,", "respectively.", "<tag2>", "Research", "and", "Development", "Costs", "Our", "sponsored", "research", "and", "development", "expenses", "were", "$619,838,", "$530,027", "and", "$3,379,333", "in", "fiscal", "2013,", "2012", "and", "for", "the", "period", "October", "28,", "2003", "through", "May", "31,", "2013,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "Development", "Costs", "Our", "sponsored", "research", "and", "development", "expenses", "were", "$530,027,", "$480,765", "and", "$2,759,495", "in", "fiscal", "2012,", "2011", "and", "for", "the", "period", "October", "28,", "2003", "through", "May", "31,", "2012,", "respectively."], "wordsB": ["Research", "and", "Development", "Costs", "Our", "sponsored", "research", "and", "development", "expenses", "were", "$619,838,", "$530,027", "and", "$3,379,333", "in", "fiscal", "2013,", "2012", "and", "for", "the", "period", "October", "28,", "2003", "through", "May", "31,", "2013,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p44_s6", "idA": "1175680_12_item1_p61_s1", "sentA": "We expect that research and development expenses will increase as we seek to expand development of our current and future product pipeline.", "sentB": "We expect that these companies will compete fiercely to defend and expand their market share.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "research", "and", "development", "expenses", "will", "increase", "as", "we", "seek", "to", "expand", "development", "of", "our", "current", "and", "future", "product", "pipeline.", "<tag2>", "We", "expect", "that", "these", "companies", "will", "compete", "fiercely", "to", "defend", "and", "expand", "their", "market", "share.", "<tag3>"], "wordsA": ["We", "expect", "that", "research", "and", "development", "expenses", "will", "increase", "as", "we", "seek", "to", "expand", "development", "of", "our", "current", "and", "future", "product", "pipeline."], "wordsB": ["We", "expect", "that", "these", "companies", "will", "compete", "fiercely", "to", "defend", "and", "expand", "their", "market", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p48_s1", "idA": "1175680_12_item1_p61_s1", "sentA": "We expect that research and development expenses will increase as we seek to expand development of our current and future product pipeline.", "sentB": "We expect that research and development expenses will continue to be a significant expense as we seek to develop our current and future product pipeline.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "research", "and", "development", "expenses", "will", "increase", "as", "we", "seek", "to", "expand", "development", "of", "our", "current", "and", "future", "product", "pipeline.", "<tag2>", "We", "expect", "that", "research", "and", "development", "expenses", "will", "continue", "to", "be", "a", "significant", "expense", "as", "we", "seek", "to", "develop", "our", "current", "and", "future", "product", "pipeline.", "<tag3>"], "wordsA": ["We", "expect", "that", "research", "and", "development", "expenses", "will", "increase", "as", "we", "seek", "to", "expand", "development", "of", "our", "current", "and", "future", "product", "pipeline."], "wordsB": ["We", "expect", "that", "research", "and", "development", "expenses", "will", "continue", "to", "be", "a", "significant", "expense", "as", "we", "seek", "to", "develop", "our", "current", "and", "future", "product", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p48_s3", "idA": "1175680_12_item1_p62_s2", "sentA": "There can be no assurance we will be able to locate or secure suitable employees upon acceptable terms in the future.", "sentB": "There can be no assurance that we will be able to identify or hire and retain additional employees or consultants on acceptable terms in the future.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "we", "will", "be", "able", "to", "locate", "or", "secure", "suitable", "employees", "upon", "acceptable", "terms", "in", "the", "future.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "we", "will", "be", "able", "to", "identify", "or", "hire", "and", "retain", "additional", "employees", "or", "consultants", "on", "acceptable", "terms", "in", "the", "future.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "we", "will", "be", "able", "to", "locate", "or", "secure", "suitable", "employees", "upon", "acceptable", "terms", "in", "the", "future."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "we", "will", "be", "able", "to", "identify", "or", "hire", "and", "retain", "additional", "employees", "or", "consultants", "on", "acceptable", "terms", "in", "the", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p16_s7", "idA": "1175680_12_item1_p7_s0", "sentA": "Research History of Cytolin Compound Cytolin is part of a class of drugs called monoclonal antibodies.", "sentB": "The Company may explore the initiation of a study of Cytolin and PRO 140 used in combination to evaluate the possibility of collaborating with other companies in an effort to develop a course of treatment similar to the current standard known as HAART Highly Active Antiretroviral Therapy based on antibodies.", "type": 2, "words": ["<tag1>", "Research", "History", "of", "Cytolin", "Compound", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies.", "<tag2>", "The", "Company", "may", "explore", "the", "initiation", "of", "a", "study", "of", "Cytolin", "and", "PRO", "140", "used", "in", "combination", "to", "evaluate", "the", "possibility", "of", "collaborating", "with", "other", "companies", "in", "an", "effort", "to", "develop", "a", "course", "of", "treatment", "similar", "to", "the", "current", "standard", "known", "as", "HAART", "Highly", "Active", "Antiretroviral", "Therapy", "based", "on", "antibodies.", "<tag3>"], "wordsA": ["Research", "History", "of", "Cytolin", "Compound", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies."], "wordsB": ["The", "Company", "may", "explore", "the", "initiation", "of", "a", "study", "of", "Cytolin", "and", "PRO", "140", "used", "in", "combination", "to", "evaluate", "the", "possibility", "of", "collaborating", "with", "other", "companies", "in", "an", "effort", "to", "develop", "a", "course", "of", "treatment", "similar", "to", "the", "current", "standard", "known", "as", "HAART", "Highly", "Active", "Antiretroviral", "Therapy", "based", "on", "antibodies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p1_s1", "idA": "1175680_12_item1_p7_s0", "sentA": "Research History of Cytolin Compound Cytolin is part of a class of drugs called monoclonal antibodies.", "sentB": "Our lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors.", "type": 2, "words": ["<tag1>", "Research", "History", "of", "Cytolin", "Compound", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies.", "<tag2>", "Our", "lead", "product", "candidate,", "PRO", "140,", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors.", "<tag3>"], "wordsA": ["Research", "History", "of", "Cytolin", "Compound", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies."], "wordsB": ["Our", "lead", "product", "candidate,", "PRO", "140,", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p2_s0", "idA": "1175680_12_item1_p7_s0", "sentA": "Research History of Cytolin Compound Cytolin is part of a class of drugs called monoclonal antibodies.", "sentB": "The PRO 140 antibody belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells.", "type": 2, "words": ["<tag1>", "Research", "History", "of", "Cytolin", "Compound", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies.", "<tag2>", "The", "PRO", "140", "antibody", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors", "that", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells.", "<tag3>"], "wordsA": ["Research", "History", "of", "Cytolin", "Compound", "Cytolin", "is", "part", "of", "a", "class", "of", "drugs", "called", "monoclonal", "antibodies."], "wordsB": ["The", "PRO", "140", "antibody", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors", "that", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p10_s1", "idA": "1175680_12_item1_p7_s1", "sentA": "It targets a normal cell molecule called CD11a, part of the heterodimer that makes up the cell adhesion molecule lymphocyte function cell associated antigen ( LFA-1 ).", "sentB": "It targets a normal cell molecule called CD11a, part of the heterodimer that makes up the cell adhesion molecule lymphocyte function cell associated antigen.", "type": 2, "words": ["<tag1>", "It", "targets", "a", "normal", "cell", "molecule", "called", "CD11a,", "part", "of", "the", "heterodimer", "that", "makes", "up", "the", "cell", "adhesion", "molecule", "lymphocyte", "function", "cell", "associated", "antigen", "(", "LFA-1", ").", "<tag2>", "It", "targets", "a", "normal", "cell", "molecule", "called", "CD11a,", "part", "of", "the", "heterodimer", "that", "makes", "up", "the", "cell", "adhesion", "molecule", "lymphocyte", "function", "cell", "associated", "antigen.", "<tag3>"], "wordsA": ["It", "targets", "a", "normal", "cell", "molecule", "called", "CD11a,", "part", "of", "the", "heterodimer", "that", "makes", "up", "the", "cell", "adhesion", "molecule", "lymphocyte", "function", "cell", "associated", "antigen", "(", "LFA-1", ")."], "wordsB": ["It", "targets", "a", "normal", "cell", "molecule", "called", "CD11a,", "part", "of", "the", "heterodimer", "that", "makes", "up", "the", "cell", "adhesion", "molecule", "lymphocyte", "function", "cell", "associated", "antigen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p2_s1", "idA": "1175680_12_item1_p7_s1", "sentA": "It targets a normal cell molecule called CD11a, part of the heterodimer that makes up the cell adhesion molecule lymphocyte function cell associated antigen ( LFA-1 ).", "sentB": "PRO 140 blocks HIV from entering a cell by binding to a molecule called CCR5, a normal cell surface receptor protein to which HIV attaches as part of HIV s entry into a cell.", "type": 2, "words": ["<tag1>", "It", "targets", "a", "normal", "cell", "molecule", "called", "CD11a,", "part", "of", "the", "heterodimer", "that", "makes", "up", "the", "cell", "adhesion", "molecule", "lymphocyte", "function", "cell", "associated", "antigen", "(", "LFA-1", ").", "<tag2>", "PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell.", "<tag3>"], "wordsA": ["It", "targets", "a", "normal", "cell", "molecule", "called", "CD11a,", "part", "of", "the", "heterodimer", "that", "makes", "up", "the", "cell", "adhesion", "molecule", "lymphocyte", "function", "cell", "associated", "antigen", "(", "LFA-1", ")."], "wordsB": ["PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p10_s2", "idA": "1175680_12_item1_p7_s2", "sentA": "Published reports have suggested that blocking or engaging CD11a might somehow limit or prevent HIV infection of CD4 cells and monocytes.", "sentB": "Published reports have suggested that blocking or engaging CD11a might limit or prevent HIV infection of CD4 cells and monocytes.", "type": 2, "words": ["<tag1>", "Published", "reports", "have", "suggested", "that", "blocking", "or", "engaging", "CD11a", "might", "somehow", "limit", "or", "prevent", "HIV", "infection", "of", "CD4", "cells", "and", "monocytes.", "<tag2>", "Published", "reports", "have", "suggested", "that", "blocking", "or", "engaging", "CD11a", "might", "limit", "or", "prevent", "HIV", "infection", "of", "CD4", "cells", "and", "monocytes.", "<tag3>"], "wordsA": ["Published", "reports", "have", "suggested", "that", "blocking", "or", "engaging", "CD11a", "might", "somehow", "limit", "or", "prevent", "HIV", "infection", "of", "CD4", "cells", "and", "monocytes."], "wordsB": ["Published", "reports", "have", "suggested", "that", "blocking", "or", "engaging", "CD11a", "might", "limit", "or", "prevent", "HIV", "infection", "of", "CD4", "cells", "and", "monocytes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p16_s4", "idA": "1175680_12_item1_p9_s4", "sentA": "Data were recorded and summarized and formed part of the material presented to the U.S. Food Drug Administration (the FDA ) as an early indication of the safety and potential efficacy of Cytolin .", "sentB": "Data were recorded and summarized and formed part of the material presented to the FDA as an early indication of the safety and potential efficacy of Cytolin.", "type": 2, "words": ["<tag1>", "Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "U.S.", "Food", "Drug", "Administration", "(the", "FDA", ")", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin", ".", "<tag2>", "Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "FDA", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin.", "<tag3>"], "wordsA": ["Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "U.S.", "Food", "Drug", "Administration", "(the", "FDA", ")", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin", "."], "wordsB": ["Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "FDA", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_13_item1_p6_s1", "idA": "1175680_12_item1_p9_s4", "sentA": "Data were recorded and summarized and formed part of the material presented to the U.S. Food Drug Administration (the FDA ) as an early indication of the safety and potential efficacy of Cytolin .", "sentB": "We believe, however, that, if PRO 140 is approved for use as an injectible by the U.S. Food and Drug Administration (the FDA ), it may be an attractive and marketable therapeutic option (for patients with healthy CCR5) particularly in the following scenarios:", "type": 2, "words": ["<tag1>", "Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "U.S.", "Food", "Drug", "Administration", "(the", "FDA", ")", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin", ".", "<tag2>", "We", "believe,", "however,", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectible", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "(for", "patients", "with", "healthy", "CCR5)", "particularly", "in", "the", "following", "scenarios:", "<tag3>"], "wordsA": ["Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "U.S.", "Food", "Drug", "Administration", "(the", "FDA", ")", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin", "."], "wordsB": ["We", "believe,", "however,", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectible", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "(for", "patients", "with", "healthy", "CCR5)", "particularly", "in", "the", "following", "scenarios:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p0_s0", "idA": "1175680_13_item1_p0_s0", "sentA": "History CytoDyn Inc. (the Company ) is a Colorado corporation, with its principal business office at 5 Centerpointe Drive, Suite 400, Lake Oswego, Oregon 97035; telephone: (971) 204-0382, and website address: www.cytodyn.com.", "sentB": "CytoDyn Inc. is a Colorado corporation with its principal business office at 1111 Main Street, Suite 660, Vancouver, Washington 98660.", "type": 2, "words": ["<tag1>", "History", "CytoDyn", "Inc.", "(the", "Company", ")", "is", "a", "Colorado", "corporation,", "with", "its", "principal", "business", "office", "at", "5", "Centerpointe", "Drive,", "Suite", "400,", "Lake", "Oswego,", "Oregon", "97035;", "telephone:", "(971)", "204-0382,", "and", "website", "address:", "www.cytodyn.com.", "<tag2>", "CytoDyn", "Inc.", "is", "a", "Colorado", "corporation", "with", "its", "principal", "business", "office", "at", "1111", "Main", "Street,", "Suite", "660,", "Vancouver,", "Washington", "98660.", "<tag3>"], "wordsA": ["History", "CytoDyn", "Inc.", "(the", "Company", ")", "is", "a", "Colorado", "corporation,", "with", "its", "principal", "business", "office", "at", "5", "Centerpointe", "Drive,", "Suite", "400,", "Lake", "Oswego,", "Oregon", "97035;", "telephone:", "(971)", "204-0382,", "and", "website", "address:", "www.cytodyn.com."], "wordsB": ["CytoDyn", "Inc.", "is", "a", "Colorado", "corporation", "with", "its", "principal", "business", "office", "at", "1111", "Main", "Street,", "Suite", "660,", "Vancouver,", "Washington", "98660."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p0_s3", "idA": "1175680_13_item1_p0_s1", "sentA": "Unless the context otherwise requires, references in this report to CytoDyn, our, we, us, or the Company are to CytoDyn Inc. and its subsidiaries.", "sentB": "Unless the context otherwise requires, references in this annual report to CytoDyn, the Company, we, our, or us are to CytoDyn Inc. and its subsidiaries.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "otherwise", "requires,", "references", "in", "this", "report", "to", "CytoDyn,", "our,", "we,", "us,", "or", "the", "Company", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries.", "<tag2>", "Unless", "the", "context", "otherwise", "requires,", "references", "in", "this", "annual", "report", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries.", "<tag3>"], "wordsA": ["Unless", "the", "context", "otherwise", "requires,", "references", "in", "this", "report", "to", "CytoDyn,", "our,", "we,", "us,", "or", "the", "Company", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries."], "wordsB": ["Unless", "the", "context", "otherwise", "requires,", "references", "in", "this", "annual", "report", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p10_s9", "idA": "1175680_13_item1_p10_s0", "sentA": "Other Product Candidates A second product candidate, Cytolin, is also a monoclonal antibody.", "sentB": "Other Product Candidates A second product candidate, Cytolin, is also a humanized monoclonal antibody for the treatment of HIV infection.", "type": 2, "words": ["<tag1>", "Other", "Product", "Candidates", "A", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "monoclonal", "antibody.", "<tag2>", "Other", "Product", "Candidates", "A", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "humanized", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection.", "<tag3>"], "wordsA": ["Other", "Product", "Candidates", "A", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "monoclonal", "antibody."], "wordsB": ["Other", "Product", "Candidates", "A", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "humanized", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p12_s0", "idA": "1175680_13_item1_p12_s0", "sentA": "On September 23, 2011, the Company filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin, a monoclonal antibody for the treatment of HIV infection.", "sentB": "On September 23, 2011, the Company filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin.", "type": 2, "words": ["<tag1>", "On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin,", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection.", "<tag2>", "On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin.", "<tag3>"], "wordsA": ["On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin,", "a", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection."], "wordsB": ["On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p13_s0", "idA": "1175680_13_item1_p13_s0", "sentA": "In May 2011, we formed CytoDyn Veterinary Medicine LLC ( CVM ) to explore the possible application of feline reactive monoclonal antibodies for the treatment of FIV.", "sentB": "In May 2011, we formed CytoDyn Veterinary Medicine LLC ( CVM ) to explore the possible application of feline reactive monoclonal antibodies for the treatment of Feline Immunodeficiency Virus ( FIV ).", "type": 2, "words": ["<tag1>", "In", "May", "2011,", "we", "formed", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", ")", "to", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "FIV.", "<tag2>", "In", "May", "2011,", "we", "formed", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", ")", "to", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ").", "<tag3>"], "wordsA": ["In", "May", "2011,", "we", "formed", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", ")", "to", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "FIV."], "wordsB": ["In", "May", "2011,", "we", "formed", "CytoDyn", "Veterinary", "Medicine", "LLC", "(", "CVM", ")", "to", "explore", "the", "possible", "application", "of", "feline", "reactive", "monoclonal", "antibodies", "for", "the", "treatment", "of", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p14_s1", "idA": "1175680_13_item1_p13_s3", "sentA": "Until the clinical trials for PRO 140 commence, we plan to devote only a modest amount of resources towards the approval or commercialization of Cytolin or CytoFeline.", "sentB": "Until the clinical trials for PRO 140 have advanced further, we do not plan to devote any resources towards the development, research, testing, approval, or commercialization of Cytolin or CytoFeline.", "type": 2, "words": ["<tag1>", "Until", "the", "clinical", "trials", "for", "PRO", "140", "commence,", "we", "plan", "to", "devote", "only", "a", "modest", "amount", "of", "resources", "towards", "the", "approval", "or", "commercialization", "of", "Cytolin", "or", "CytoFeline.", "<tag2>", "Until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval,", "or", "commercialization", "of", "Cytolin", "or", "CytoFeline.", "<tag3>"], "wordsA": ["Until", "the", "clinical", "trials", "for", "PRO", "140", "commence,", "we", "plan", "to", "devote", "only", "a", "modest", "amount", "of", "resources", "towards", "the", "approval", "or", "commercialization", "of", "Cytolin", "or", "CytoFeline."], "wordsB": ["Until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval,", "or", "commercialization", "of", "Cytolin", "or", "CytoFeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p10_s8", "idA": "1175680_13_item1_p14_s0", "sentA": "A total of 113 subjects were treated for a period of up to three weeks with as much as a 324 mg dose of PRO 140 administered weekly subcutaneously and 10mg/kg intravenously.", "sentB": "PRO 140 is being administered as a 350mg subcutaneous dosage weekly for up to 14 weeks and participants are monitored for viral rebound on a weekly basis.", "type": 2, "words": ["<tag1>", "A", "total", "of", "113", "subjects", "were", "treated", "for", "a", "period", "of", "up", "to", "three", "weeks", "with", "as", "much", "as", "a", "324", "mg", "dose", "of", "PRO", "140", "administered", "weekly", "subcutaneously", "and", "10mg/kg", "intravenously.", "<tag2>", "PRO", "140", "is", "being", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "for", "up", "to", "14", "weeks", "and", "participants", "are", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis.", "<tag3>"], "wordsA": ["A", "total", "of", "113", "subjects", "were", "treated", "for", "a", "period", "of", "up", "to", "three", "weeks", "with", "as", "much", "as", "a", "324", "mg", "dose", "of", "PRO", "140", "administered", "weekly", "subcutaneously", "and", "10mg/kg", "intravenously."], "wordsB": ["PRO", "140", "is", "being", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "for", "up", "to", "14", "weeks", "and", "participants", "are", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p15_s2", "idA": "1175680_13_item1_p16_s4", "sentA": "Data were recorded and summarized and formed part of the material presented to the FDA as an early indication of the safety and potential efficacy of Cytolin.", "sentB": "The foregoing summary of the Progenics Agreement is qualified in its entirety by reference to the full terms of the Progenics Agreement, which is incorporated by reference as an exhibit to this report.", "type": 2, "words": ["<tag1>", "Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "FDA", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin.", "<tag2>", "The", "foregoing", "summary", "of", "the", "Progenics", "Agreement", "is", "qualified", "in", "its", "entirety", "by", "reference", "to", "the", "full", "terms", "of", "the", "Progenics", "Agreement,", "which", "is", "incorporated", "by", "reference", "as", "an", "exhibit", "to", "this", "report.", "<tag3>"], "wordsA": ["Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "FDA", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin."], "wordsB": ["The", "foregoing", "summary", "of", "the", "Progenics", "Agreement", "is", "qualified", "in", "its", "entirety", "by", "reference", "to", "the", "full", "terms", "of", "the", "Progenics", "Agreement,", "which", "is", "incorporated", "by", "reference", "as", "an", "exhibit", "to", "this", "report."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p16_s2", "idA": "1175680_13_item1_p16_s4", "sentA": "Data were recorded and summarized and formed part of the material presented to the FDA as an early indication of the safety and potential efficacy of Cytolin.", "sentB": "The foregoing summary of the PDL License is qualified in its entirety by reference to the full terms of the Progenics Agreement, which is incorporated by reference as an exhibit to this report.", "type": 2, "words": ["<tag1>", "Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "FDA", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin.", "<tag2>", "The", "foregoing", "summary", "of", "the", "PDL", "License", "is", "qualified", "in", "its", "entirety", "by", "reference", "to", "the", "full", "terms", "of", "the", "Progenics", "Agreement,", "which", "is", "incorporated", "by", "reference", "as", "an", "exhibit", "to", "this", "report.", "<tag3>"], "wordsA": ["Data", "were", "recorded", "and", "summarized", "and", "formed", "part", "of", "the", "material", "presented", "to", "the", "FDA", "as", "an", "early", "indication", "of", "the", "safety", "and", "potential", "efficacy", "of", "Cytolin."], "wordsB": ["The", "foregoing", "summary", "of", "the", "PDL", "License", "is", "qualified", "in", "its", "entirety", "by", "reference", "to", "the", "full", "terms", "of", "the", "Progenics", "Agreement,", "which", "is", "incorporated", "by", "reference", "as", "an", "exhibit", "to", "this", "report."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p0_s1", "idA": "1175680_13_item1_p17_s8", "sentA": "Dr. Rosenberg submitted a manuscript detailing his results, which can be found at Rychert J, Jones L, McGrath G, et al.", "sentB": "Our website can be found at www.cytodyn.com.", "type": 2, "words": ["<tag1>", "Dr.", "Rosenberg", "submitted", "a", "manuscript", "detailing", "his", "results,", "which", "can", "be", "found", "at", "Rychert", "J,", "Jones", "L,", "McGrath", "G,", "et", "al.", "<tag2>", "Our", "website", "can", "be", "found", "at", "www.cytodyn.com.", "<tag3>"], "wordsA": ["Dr.", "Rosenberg", "submitted", "a", "manuscript", "detailing", "his", "results,", "which", "can", "be", "found", "at", "Rychert", "J,", "Jones", "L,", "McGrath", "G,", "et", "al."], "wordsB": ["Our", "website", "can", "be", "found", "at", "www.cytodyn.com."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p1_s0", "idA": "1175680_13_item1_p1_s0", "sentA": "We are a publicly traded development stage biotechnology company focused on developing and potentially marketing a class of therapeutic monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "sentB": "We are a publicly traded biotechnology company focused on developing and potentially marketing a class of therapeutic monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "type": 2, "words": ["<tag1>", "We", "are", "a", "publicly", "traded", "development", "stage", "biotechnology", "company", "focused", "on", "developing", "and", "potentially", "marketing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag2>", "We", "are", "a", "publicly", "traded", "biotechnology", "company", "focused", "on", "developing", "and", "potentially", "marketing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag3>"], "wordsA": ["We", "are", "a", "publicly", "traded", "development", "stage", "biotechnology", "company", "focused", "on", "developing", "and", "potentially", "marketing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "wordsB": ["We", "are", "a", "publicly", "traded", "biotechnology", "company", "focused", "on", "developing", "and", "potentially", "marketing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p20_s1", "idA": "1175680_13_item1_p21_s1", "sentA": "The duration of foreign patents varies in accordance with the provisions of applicable local law, although most countries provide for patent terms of 20 years from the earliest asserted filing date and allow patent extensions similar to those permitted in the U.S. Patents may not enable us to preclude competitors from commercializing drugs in direct competition with our products, and consequently may not provide us with any meaningful competitive advantage.", "sentB": "The duration of foreign patents varies in accordance with the provisions of applicable local law, although most countries provide for patent terms of 20 years from the earliest asserted filing date and allow patent extensions similar to those permitted in the U.S.", "type": 2, "words": ["<tag1>", "The", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "although", "most", "countries", "provide", "for", "patent", "terms", "of", "20", "years", "from", "the", "earliest", "asserted", "filing", "date", "and", "allow", "patent", "extensions", "similar", "to", "those", "permitted", "in", "the", "U.S.", "Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage.", "<tag2>", "The", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "although", "most", "countries", "provide", "for", "patent", "terms", "of", "20", "years", "from", "the", "earliest", "asserted", "filing", "date", "and", "allow", "patent", "extensions", "similar", "to", "those", "permitted", "in", "the", "U.S.", "<tag3>"], "wordsA": ["The", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "although", "most", "countries", "provide", "for", "patent", "terms", "of", "20", "years", "from", "the", "earliest", "asserted", "filing", "date", "and", "allow", "patent", "extensions", "similar", "to", "those", "permitted", "in", "the", "U.S.", "Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage."], "wordsB": ["The", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "although", "most", "countries", "provide", "for", "patent", "terms", "of", "20", "years", "from", "the", "earliest", "asserted", "filing", "date", "and", "allow", "patent", "extensions", "similar", "to", "those", "permitted", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p21_s0", "idA": "1175680_13_item1_p21_s1", "sentA": "The duration of foreign patents varies in accordance with the provisions of applicable local law, although most countries provide for patent terms of 20 years from the earliest asserted filing date and allow patent extensions similar to those permitted in the U.S. Patents may not enable us to preclude competitors from commercializing drugs in direct competition with our products, and consequently may not provide us with any meaningful competitive advantage.", "sentB": "Patents may not enable us to preclude competitors from commercializing drugs in direct competition with our products, and consequently may not provide us with any meaningful competitive advantage.", "type": 2, "words": ["<tag1>", "The", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "although", "most", "countries", "provide", "for", "patent", "terms", "of", "20", "years", "from", "the", "earliest", "asserted", "filing", "date", "and", "allow", "patent", "extensions", "similar", "to", "those", "permitted", "in", "the", "U.S.", "Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage.", "<tag2>", "Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage.", "<tag3>"], "wordsA": ["The", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "although", "most", "countries", "provide", "for", "patent", "terms", "of", "20", "years", "from", "the", "earliest", "asserted", "filing", "date", "and", "allow", "patent", "extensions", "similar", "to", "those", "permitted", "in", "the", "U.S.", "Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage."], "wordsB": ["Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p22_s0", "idA": "1175680_13_item1_p22_s0", "sentA": "may also rely on trade secrets and proprietary know-how to develop and attempt to achieve a competitive position in our product areas.", "sentB": "We may also rely on trade secrets and proprietary know-how to develop and attempt to achieve a competitive position with our product candidates.", "type": 2, "words": ["<tag1>", "may", "also", "rely", "on", "trade", "secrets", "and", "proprietary", "know-how", "to", "develop", "and", "attempt", "to", "achieve", "a", "competitive", "position", "in", "our", "product", "areas.", "<tag2>", "We", "may", "also", "rely", "on", "trade", "secrets", "and", "proprietary", "know-how", "to", "develop", "and", "attempt", "to", "achieve", "a", "competitive", "position", "with", "our", "product", "candidates.", "<tag3>"], "wordsA": ["may", "also", "rely", "on", "trade", "secrets", "and", "proprietary", "know-how", "to", "develop", "and", "attempt", "to", "achieve", "a", "competitive", "position", "in", "our", "product", "areas."], "wordsB": ["We", "may", "also", "rely", "on", "trade", "secrets", "and", "proprietary", "know-how", "to", "develop", "and", "attempt", "to", "achieve", "a", "competitive", "position", "with", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p21_s1", "idA": "1175680_13_item1_p22_s2", "sentA": "Information with respect to our current patent portfolio is set forth below.", "sentB": "See related risk factors under Item 1A Risk Factors below.", "type": 2, "words": ["<tag1>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "is", "set", "forth", "below.", "<tag2>", "See", "related", "risk", "factors", "under", "Item", "1A", "Risk", "Factors", "below.", "<tag3>"], "wordsA": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "is", "set", "forth", "below."], "wordsB": ["See", "related", "risk", "factors", "under", "Item", "1A", "Risk", "Factors", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p5_s2", "idA": "1175680_13_item1_p22_s2", "sentA": "Information with respect to our current patent portfolio is set forth below.", "sentB": "To facilitate our self-funded and sponsored clinical research plans, we have engaged Amarex Clinical Research, LLC ( Amarex ), our principal contract research organization, to provide comprehensive clinical trial services with respect to our treatment substitution study, including managing our chemistry and manufacturing control ( CMC ) activities.", "type": 2, "words": ["<tag1>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "is", "set", "forth", "below.", "<tag2>", "To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans,", "we", "have", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "our", "principal", "contract", "research", "organization,", "to", "provide", "comprehensive", "clinical", "trial", "services", "with", "respect", "to", "our", "treatment", "substitution", "study,", "including", "managing", "our", "chemistry", "and", "manufacturing", "control", "(", "CMC", ")", "activities.", "<tag3>"], "wordsA": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "is", "set", "forth", "below."], "wordsB": ["To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans,", "we", "have", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "our", "principal", "contract", "research", "organization,", "to", "provide", "comprehensive", "clinical", "trial", "services", "with", "respect", "to", "our", "treatment", "substitution", "study,", "including", "managing", "our", "chemistry", "and", "manufacturing", "control", "(", "CMC", ")", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p10_s2", "idA": "1175680_13_item1_p36_s1", "sentA": "Under the Company s current business plan, most of this initial work may be sponsored and conducted by Drexel, or a different clinical trial research facility, as determined at some point in the future.", "sentB": "A third clinical trial of PRO 140 commenced in May 2014 and is sponsored and funded by the Company.", "type": 2, "words": ["<tag1>", "Under", "the", "Company", "s", "current", "business", "plan,", "most", "of", "this", "initial", "work", "may", "be", "sponsored", "and", "conducted", "by", "Drexel,", "or", "a", "different", "clinical", "trial", "research", "facility,", "as", "determined", "at", "some", "point", "in", "the", "future.", "<tag2>", "A", "third", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "the", "Company.", "<tag3>"], "wordsA": ["Under", "the", "Company", "s", "current", "business", "plan,", "most", "of", "this", "initial", "work", "may", "be", "sponsored", "and", "conducted", "by", "Drexel,", "or", "a", "different", "clinical", "trial", "research", "facility,", "as", "determined", "at", "some", "point", "in", "the", "future."], "wordsB": ["A", "third", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "the", "Company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p14_s0", "idA": "1175680_13_item1_p36_s1", "sentA": "Under the Company s current business plan, most of this initial work may be sponsored and conducted by Drexel, or a different clinical trial research facility, as determined at some point in the future.", "sentB": "CytoFeline is the Company s proprietary product targeted to treat FIV.", "type": 2, "words": ["<tag1>", "Under", "the", "Company", "s", "current", "business", "plan,", "most", "of", "this", "initial", "work", "may", "be", "sponsored", "and", "conducted", "by", "Drexel,", "or", "a", "different", "clinical", "trial", "research", "facility,", "as", "determined", "at", "some", "point", "in", "the", "future.", "<tag2>", "CytoFeline", "is", "the", "Company", "s", "proprietary", "product", "targeted", "to", "treat", "FIV.", "<tag3>"], "wordsA": ["Under", "the", "Company", "s", "current", "business", "plan,", "most", "of", "this", "initial", "work", "may", "be", "sponsored", "and", "conducted", "by", "Drexel,", "or", "a", "different", "clinical", "trial", "research", "facility,", "as", "determined", "at", "some", "point", "in", "the", "future."], "wordsB": ["CytoFeline", "is", "the", "Company", "s", "proprietary", "product", "targeted", "to", "treat", "FIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p5_s6", "idA": "1175680_13_item1_p36_s2", "sentA": "After these trials have been initiated, the Company could enter into a strategic alliance with a larger pharmaceutical company after development has progressed to a certain point.", "sentB": "In furtherance of our business strategy and subsequent to fiscal year-end 2014, the Company has entered into a manufacturing agreement with a contract manufacturing organization to initiate preparations for the potential future manufacturing of additional PRO 140.", "type": 2, "words": ["<tag1>", "After", "these", "trials", "have", "been", "initiated,", "the", "Company", "could", "enter", "into", "a", "strategic", "alliance", "with", "a", "larger", "pharmaceutical", "company", "after", "development", "has", "progressed", "to", "a", "certain", "point.", "<tag2>", "In", "furtherance", "of", "our", "business", "strategy", "and", "subsequent", "to", "fiscal", "year-end", "2014,", "the", "Company", "has", "entered", "into", "a", "manufacturing", "agreement", "with", "a", "contract", "manufacturing", "organization", "to", "initiate", "preparations", "for", "the", "potential", "future", "manufacturing", "of", "additional", "PRO", "140.", "<tag3>"], "wordsA": ["After", "these", "trials", "have", "been", "initiated,", "the", "Company", "could", "enter", "into", "a", "strategic", "alliance", "with", "a", "larger", "pharmaceutical", "company", "after", "development", "has", "progressed", "to", "a", "certain", "point."], "wordsB": ["In", "furtherance", "of", "our", "business", "strategy", "and", "subsequent", "to", "fiscal", "year-end", "2014,", "the", "Company", "has", "entered", "into", "a", "manufacturing", "agreement", "with", "a", "contract", "manufacturing", "organization", "to", "initiate", "preparations", "for", "the", "potential", "future", "manufacturing", "of", "additional", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p10_s0", "idA": "1175680_13_item1_p37_s0", "sentA": "Phase I Phase I includes the initial introduction of an investigational new drug or biologic into humans.", "sentB": "Pursuant to a clinical trial agreement with us, Drexel is now carrying the investigational new drug ( IND ) application.", "type": 2, "words": ["<tag1>", "Phase", "I", "Phase", "I", "includes", "the", "initial", "introduction", "of", "an", "investigational", "new", "drug", "or", "biologic", "into", "humans.", "<tag2>", "Pursuant", "to", "a", "clinical", "trial", "agreement", "with", "us,", "Drexel", "is", "now", "carrying", "the", "investigational", "new", "drug", "(", "IND", ")", "application.", "<tag3>"], "wordsA": ["Phase", "I", "Phase", "I", "includes", "the", "initial", "introduction", "of", "an", "investigational", "new", "drug", "or", "biologic", "into", "humans."], "wordsB": ["Pursuant", "to", "a", "clinical", "trial", "agreement", "with", "us,", "Drexel", "is", "now", "carrying", "the", "investigational", "new", "drug", "(", "IND", ")", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p9_s2", "idA": "1175680_13_item1_p37_s1", "sentA": "These studies are closely monitored and may be conducted in patients, but are usually conducted in a small number of healthy volunteer subjects.", "sentB": "These studies are funded directly through grants from NIH.", "type": 2, "words": ["<tag1>", "These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "subjects.", "<tag2>", "These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH.", "<tag3>"], "wordsA": ["These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "subjects."], "wordsB": ["These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p10_s1", "idA": "1175680_13_item1_p41_s0", "sentA": "Phase III Phase III studies are expanded controlled clinical studies.", "sentB": "As such, the Company is precluded from commenting on the Drexel sponsored studies.", "type": 2, "words": ["<tag1>", "Phase", "III", "Phase", "III", "studies", "are", "expanded", "controlled", "clinical", "studies.", "<tag2>", "As", "such,", "the", "Company", "is", "precluded", "from", "commenting", "on", "the", "Drexel", "sponsored", "studies.", "<tag3>"], "wordsA": ["Phase", "III", "Phase", "III", "studies", "are", "expanded", "controlled", "clinical", "studies."], "wordsB": ["As", "such,", "the", "Company", "is", "precluded", "from", "commenting", "on", "the", "Drexel", "sponsored", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p9_s1", "idA": "1175680_13_item1_p41_s0", "sentA": "Phase III Phase III studies are expanded controlled clinical studies.", "sentB": "Two studies are led by Drexel and Dr. Jeffrey Jacobson.", "type": 2, "words": ["<tag1>", "Phase", "III", "Phase", "III", "studies", "are", "expanded", "controlled", "clinical", "studies.", "<tag2>", "Two", "studies", "are", "led", "by", "Drexel", "and", "Dr.", "Jeffrey", "Jacobson.", "<tag3>"], "wordsA": ["Phase", "III", "Phase", "III", "studies", "are", "expanded", "controlled", "clinical", "studies."], "wordsB": ["Two", "studies", "are", "led", "by", "Drexel", "and", "Dr.", "Jeffrey", "Jacobson."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p18_s0", "idA": "1175680_13_item1_p42_s1", "sentA": "Dr. Jacobson has received two NIH grants to fund these clinical trials.", "sentB": "During fiscal 2014, CytoDyn fulfilled its obligation to Drexel to deliver finished drug product for use in its clinical trials.", "type": 2, "words": ["<tag1>", "Dr.", "Jacobson", "has", "received", "two", "NIH", "grants", "to", "fund", "these", "clinical", "trials.", "<tag2>", "During", "fiscal", "2014,", "CytoDyn", "fulfilled", "its", "obligation", "to", "Drexel", "to", "deliver", "finished", "drug", "product", "for", "use", "in", "its", "clinical", "trials.", "<tag3>"], "wordsA": ["Dr.", "Jacobson", "has", "received", "two", "NIH", "grants", "to", "fund", "these", "clinical", "trials."], "wordsB": ["During", "fiscal", "2014,", "CytoDyn", "fulfilled", "its", "obligation", "to", "Drexel", "to", "deliver", "finished", "drug", "product", "for", "use", "in", "its", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p9_s0", "idA": "1175680_13_item1_p42_s1", "sentA": "Dr. Jacobson has received two NIH grants to fund these clinical trials.", "sentB": "Current Clinical Trials PRO 140 is currently being studied in three clinical trials.", "type": 2, "words": ["<tag1>", "Dr.", "Jacobson", "has", "received", "two", "NIH", "grants", "to", "fund", "these", "clinical", "trials.", "<tag2>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "three", "clinical", "trials.", "<tag3>"], "wordsA": ["Dr.", "Jacobson", "has", "received", "two", "NIH", "grants", "to", "fund", "these", "clinical", "trials."], "wordsB": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "three", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p4_s0", "idA": "1175680_13_item1_p4_s1", "sentA": "Progenics led, and contributed to funding of, PRO 140 development and trials through 2011.", "sentB": "PRO 140 was originally developed by Progenics Pharmaceuticals, Inc. ( Progenics ), which led, and contributed to funding of, PRO 140 development and trials through 2011.", "type": 2, "words": ["<tag1>", "Progenics", "led,", "and", "contributed", "to", "funding", "of,", "PRO", "140", "development", "and", "trials", "through", "2011.", "<tag2>", "PRO", "140", "was", "originally", "developed", "by", "Progenics", "Pharmaceuticals,", "Inc.", "(", "Progenics", "),", "which", "led,", "and", "contributed", "to", "funding", "of,", "PRO", "140", "development", "and", "trials", "through", "2011.", "<tag3>"], "wordsA": ["Progenics", "led,", "and", "contributed", "to", "funding", "of,", "PRO", "140", "development", "and", "trials", "through", "2011."], "wordsB": ["PRO", "140", "was", "originally", "developed", "by", "Progenics", "Pharmaceuticals,", "Inc.", "(", "Progenics", "),", "which", "led,", "and", "contributed", "to", "funding", "of,", "PRO", "140", "development", "and", "trials", "through", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p5_s0", "idA": "1175680_13_item1_p5_s0", "sentA": "Current collaborative research relating to PRO 140 planned for late 2013 is being conducted by Jeffrey M. Jacobson, M.D., Professor of Medicine, Microbiology and Immunology, Chief, Drexel University College of Medicine ( Drexel ), and is partially funded through two grants awarded to Drexel and Dr. Jacobson by the National Institutes of Health ( NIH ).", "sentB": "Jeffrey M. Jacobson, M.D., Professor of Medicine, Microbiology and Immunology, Chief, Drexel University College of Medicine ( Drexel ), has conducted prior research relating to PRO 140, and is continuing to pursue two clinical trials partially funded through two grants awarded to Drexel and Dr. Jacobson by the National Institutes of Health ( NIH ).", "type": 2, "words": ["<tag1>", "Current", "collaborative", "research", "relating", "to", "PRO", "140", "planned", "for", "late", "2013", "is", "being", "conducted", "by", "Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "and", "is", "partially", "funded", "through", "two", "grants", "awarded", "to", "Drexel", "and", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ").", "<tag2>", "Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "has", "conducted", "prior", "research", "relating", "to", "PRO", "140,", "and", "is", "continuing", "to", "pursue", "two", "clinical", "trials", "partially", "funded", "through", "two", "grants", "awarded", "to", "Drexel", "and", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ").", "<tag3>"], "wordsA": ["Current", "collaborative", "research", "relating", "to", "PRO", "140", "planned", "for", "late", "2013", "is", "being", "conducted", "by", "Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "and", "is", "partially", "funded", "through", "two", "grants", "awarded", "to", "Drexel", "and", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ")."], "wordsB": ["Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "has", "conducted", "prior", "research", "relating", "to", "PRO", "140,", "and", "is", "continuing", "to", "pursue", "two", "clinical", "trials", "partially", "funded", "through", "two", "grants", "awarded", "to", "Drexel", "and", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p6_s1", "idA": "1175680_13_item1_p6_s1", "sentA": "We believe, however, that, if PRO 140 is approved for use as an injectible by the U.S. Food and Drug Administration (the FDA ), it may be an attractive and marketable therapeutic option (for patients with healthy CCR5) particularly in the following scenarios:", "sentB": "We believe that, if PRO 140 is approved for use as an injectable by the FDA, it may nonetheless be an attractive and marketable therapeutic option (for patients with healthy CCR5), particularly in the following scenarios:", "type": 2, "words": ["<tag1>", "We", "believe,", "however,", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectible", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "(for", "patients", "with", "healthy", "CCR5)", "particularly", "in", "the", "following", "scenarios:", "<tag2>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "(for", "patients", "with", "healthy", "CCR5),", "particularly", "in", "the", "following", "scenarios:", "<tag3>"], "wordsA": ["We", "believe,", "however,", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectible", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "(for", "patients", "with", "healthy", "CCR5)", "particularly", "in", "the", "following", "scenarios:"], "wordsB": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "(for", "patients", "with", "healthy", "CCR5),", "particularly", "in", "the", "following", "scenarios:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p8_s0", "idA": "1175680_13_item1_p8_s0", "sentA": "We believe PRO 140 has demonstrated potent, long-lived (as compared to existing treatments) antiretroviral activity and an encouraging safety profile in initial clinical testing, that PRO 140 has the potential to be the first long-acting (weekly or every other week), self-administered HIV therapy, and that PRO 140 may inhibit CCR5-tropic HIV while preserving CCR5 s natural activity.", "sentB": "We believe PRO 140 has demonstrated potent (as compared to existing treatments) antiretroviral activity and an encouraging safety profile in prior clinical testing, that PRO 140 has the potential to be the first long-acting (weekly or every other week), self-administered HIV therapy, and that PRO 140 may inhibit CCR5-tropic HIV while preserving CCR5 s natural activity.", "type": 2, "words": ["<tag1>", "We", "believe", "PRO", "140", "has", "demonstrated", "potent,", "long-lived", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "initial", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "may", "inhibit", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "activity.", "<tag2>", "We", "believe", "PRO", "140", "has", "demonstrated", "potent", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "prior", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "may", "inhibit", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "activity.", "<tag3>"], "wordsA": ["We", "believe", "PRO", "140", "has", "demonstrated", "potent,", "long-lived", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "initial", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "may", "inhibit", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "activity."], "wordsB": ["We", "believe", "PRO", "140", "has", "demonstrated", "potent", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "prior", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "may", "inhibit", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "activity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p8_s2", "idA": "1175680_13_item1_p8_s3", "sentA": "Overall, we believe PRO 140 represents a distinct class of CCR5 inhibitors with unique virological and immunological properties and may provide another distinct tool to treat HIV-infected subjects developing resistance to other therapies.", "sentB": "Overall, we believe PRO 140 represents a distinct class of CCR5 inhibitors with unique virological and immunological properties and may provide another distinct tool to treat HIV-infected subjects.", "type": 2, "words": ["<tag1>", "Overall,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects", "developing", "resistance", "to", "other", "therapies.", "<tag2>", "Overall,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects.", "<tag3>"], "wordsA": ["Overall,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects", "developing", "resistance", "to", "other", "therapies."], "wordsB": ["Overall,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p15_s0", "idA": "1175680_13_item1_p9_s0", "sentA": "The Company acquired PRO 140, as well as certain other related assets, including the existing inventory of PRO 140 bulk drug substance, intellectual property, and FDA regulatory filings, pursuant to an Asset Purchase Agreement, dated as of July 25, 2012, (the Progenics Agreement ) between CytoDyn and Progenics.", "sentB": "PRO 140 Acquisition We acquired PRO 140, as well as certain other related assets, including the existing inventory of PRO 140 bulk drug substance, intellectual property, and FDA regulatory filings, pursuant to an Asset Purchase Agreement, dated as of July 25, 2012 (the Progenics Agreement ), between CytoDyn and Progenics.", "type": 2, "words": ["<tag1>", "The", "Company", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012,", "(the", "Progenics", "Agreement", ")", "between", "CytoDyn", "and", "Progenics.", "<tag2>", "PRO", "140", "Acquisition", "We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Agreement", "),", "between", "CytoDyn", "and", "Progenics.", "<tag3>"], "wordsA": ["The", "Company", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012,", "(the", "Progenics", "Agreement", ")", "between", "CytoDyn", "and", "Progenics."], "wordsB": ["PRO", "140", "Acquisition", "We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Agreement", "),", "between", "CytoDyn", "and", "Progenics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p15_s1", "idA": "1175680_13_item1_p9_s1", "sentA": "The terms of the Progenics Agreement provided for an initial cash payment of $3,500,000, which was paid at closing in October 2012, as well as the following milestone payments and royalties to be paid to Progenics in the future: (i) $1,500,000 at the time of the first dosing in a U.S. Phase III trial or non-U.S. equivalent; (ii) $5,000,000 at the time of FDA approval of the first U.S. new drug application or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of 5% of net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years following the first commercial sale of PRO 140, in each case determined on a country-by-country basis.", "sentB": "The terms of the Progenics Agreement provided for an initial cash payment of $3,500,000, which was paid at closing in October 2012, as well as the following milestone payments and royalties to be paid to Progenics in the future: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-US equivalent; (ii) $5,000,000 at the time of the first US new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of 5% of net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years following the first commercialization sale of PRO 140, in each case determined on a country-by-country basis.", "type": 2, "words": ["<tag1>", "The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "III", "trial", "or", "non-U.S.", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "FDA", "approval", "of", "the", "first", "U.S.", "new", "drug", "application", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercial", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis.", "<tag2>", "The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis.", "<tag3>"], "wordsA": ["The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "III", "trial", "or", "non-U.S.", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "FDA", "approval", "of", "the", "first", "U.S.", "new", "drug", "application", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercial", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis."], "wordsB": ["The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p16_s0", "idA": "1175680_13_item1_p9_s2", "sentA": "In connection with the Progenics Agreement, the Company assumed Progenics rights and obligations under an additional license agreement (the PDL License ) with Protein Design Labs, Inc. (now AbbVie, Inc.), pursuant to which CytoDyn is required to pay the following milestone payments and royalties: (i) $1,000,000 upon initiation of a Phase III clinical trial of a licensed product; (ii) $500,000 at filing a new drug application for PRO 140 in the U.S. or non-U.S. equivalent; (iii) $500,000 at the time of FDA approval of the first U.S. new drug application or other approval for sale by certain non-U.S. regulatory bodies; and (iv) royalties of up to seven and one-half percent (7.5%) of net sales payable to licensors or sublicensees during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent licensed and (b) 10 years following the first commercial sale of PRO 140.", "sentB": "Payments to Progenics are in addition to payments due under a Development and License Agreement, dated April 30, 1999 (the PDL License ), between Protein Design Labs (now AbbVie Inc.) and Progenics, which was assigned to us in the PRO 140 transaction, pursuant to which we must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "Progenics", "Agreement,", "the", "Company", "assumed", "Progenics", "rights", "and", "obligations", "under", "an", "additional", "license", "agreement", "(the", "PDL", "License", ")", "with", "Protein", "Design", "Labs,", "Inc.", "(now", "AbbVie,", "Inc.),", "pursuant", "to", "which", "CytoDyn", "is", "required", "to", "pay", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "III", "clinical", "trial", "of", "a", "licensed", "product;", "(ii)", "$500,000", "at", "filing", "a", "new", "drug", "application", "for", "PRO", "140", "in", "the", "U.S.", "or", "non-U.S.", "equivalent;", "(iii)", "$500,000", "at", "the", "time", "of", "FDA", "approval", "of", "the", "first", "U.S.", "new", "drug", "application", "or", "other", "approval", "for", "sale", "by", "certain", "non-U.S.", "regulatory", "bodies;", "and", "(iv)", "royalties", "of", "up", "to", "seven", "and", "one-half", "percent", "(7.5%)", "of", "net", "sales", "payable", "to", "licensors", "or", "sublicensees", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "licensed", "and", "(b)", "10", "years", "following", "the", "first", "commercial", "sale", "of", "PRO", "140.", "<tag2>", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "PRO", "140", "transaction,", "pursuant", "to", "which", "we", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "Progenics", "Agreement,", "the", "Company", "assumed", "Progenics", "rights", "and", "obligations", "under", "an", "additional", "license", "agreement", "(the", "PDL", "License", ")", "with", "Protein", "Design", "Labs,", "Inc.", "(now", "AbbVie,", "Inc.),", "pursuant", "to", "which", "CytoDyn", "is", "required", "to", "pay", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "III", "clinical", "trial", "of", "a", "licensed", "product;", "(ii)", "$500,000", "at", "filing", "a", "new", "drug", "application", "for", "PRO", "140", "in", "the", "U.S.", "or", "non-U.S.", "equivalent;", "(iii)", "$500,000", "at", "the", "time", "of", "FDA", "approval", "of", "the", "first", "U.S.", "new", "drug", "application", "or", "other", "approval", "for", "sale", "by", "certain", "non-U.S.", "regulatory", "bodies;", "and", "(iv)", "royalties", "of", "up", "to", "seven", "and", "one-half", "percent", "(7.5%)", "of", "net", "sales", "payable", "to", "licensors", "or", "sublicensees", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "licensed", "and", "(b)", "10", "years", "following", "the", "first", "commercial", "sale", "of", "PRO", "140."], "wordsB": ["Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "PRO", "140", "transaction,", "pursuant", "to", "which", "we", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p16_s1", "idA": "1175680_13_item1_p9_s3", "sentA": "The PDL License also provides for an annual maintenance fee of $150,000 until royalties exceed that amount.", "sentB": "Additionally, the PDL License provides for an annual maintenance fee of $150,000 until royalties paid exceed that amount.", "type": 2, "words": ["<tag1>", "The", "PDL", "License", "also", "provides", "for", "an", "annual", "maintenance", "fee", "of", "$150,000", "until", "royalties", "exceed", "that", "amount.", "<tag2>", "Additionally,", "the", "PDL", "License", "provides", "for", "an", "annual", "maintenance", "fee", "of", "$150,000", "until", "royalties", "paid", "exceed", "that", "amount.", "<tag3>"], "wordsA": ["The", "PDL", "License", "also", "provides", "for", "an", "annual", "maintenance", "fee", "of", "$150,000", "until", "royalties", "exceed", "that", "amount."], "wordsB": ["Additionally,", "the", "PDL", "License", "provides", "for", "an", "annual", "maintenance", "fee", "of", "$150,000", "until", "royalties", "paid", "exceed", "that", "amount."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p17_s0", "idA": "1175680_13_item1_p9_s4", "sentA": "As an integral part of CytoDyn s acquisition of PRO 140, we entered into a collaboration agreement with Drexel, whereby CytoDyn will provide Drexel with the necessary quantity of PRO 140 to conduct the clinical trials and CytoDyn will have access to all clinical trial data and the right to use such data to maintain the IND (Investigational New Drug application) for PRO 140 and to support its application to the FDA.", "sentB": "As part of our acquisition of PRO 140, we entered into a collaboration agreement with Drexel, under which CytoDyn has provided Drexel with the necessary quantity of PRO 140 to conduct certain clinical trials.", "type": 2, "words": ["<tag1>", "As", "an", "integral", "part", "of", "CytoDyn", "s", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "whereby", "CytoDyn", "will", "provide", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "the", "clinical", "trials", "and", "CytoDyn", "will", "have", "access", "to", "all", "clinical", "trial", "data", "and", "the", "right", "to", "use", "such", "data", "to", "maintain", "the", "IND", "(Investigational", "New", "Drug", "application)", "for", "PRO", "140", "and", "to", "support", "its", "application", "to", "the", "FDA.", "<tag2>", "As", "part", "of", "our", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "under", "which", "CytoDyn", "has", "provided", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "certain", "clinical", "trials.", "<tag3>"], "wordsA": ["As", "an", "integral", "part", "of", "CytoDyn", "s", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "whereby", "CytoDyn", "will", "provide", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "the", "clinical", "trials", "and", "CytoDyn", "will", "have", "access", "to", "all", "clinical", "trial", "data", "and", "the", "right", "to", "use", "such", "data", "to", "maintain", "the", "IND", "(Investigational", "New", "Drug", "application)", "for", "PRO", "140", "and", "to", "support", "its", "application", "to", "the", "FDA."], "wordsB": ["As", "part", "of", "our", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "under", "which", "CytoDyn", "has", "provided", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "certain", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_14_item1_p17_s1", "idA": "1175680_13_item1_p9_s4", "sentA": "As an integral part of CytoDyn s acquisition of PRO 140, we entered into a collaboration agreement with Drexel, whereby CytoDyn will provide Drexel with the necessary quantity of PRO 140 to conduct the clinical trials and CytoDyn will have access to all clinical trial data and the right to use such data to maintain the IND (Investigational New Drug application) for PRO 140 and to support its application to the FDA.", "sentB": "CytoDyn will have access to all clinical trial data and the right to use such data.", "type": 2, "words": ["<tag1>", "As", "an", "integral", "part", "of", "CytoDyn", "s", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "whereby", "CytoDyn", "will", "provide", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "the", "clinical", "trials", "and", "CytoDyn", "will", "have", "access", "to", "all", "clinical", "trial", "data", "and", "the", "right", "to", "use", "such", "data", "to", "maintain", "the", "IND", "(Investigational", "New", "Drug", "application)", "for", "PRO", "140", "and", "to", "support", "its", "application", "to", "the", "FDA.", "<tag2>", "CytoDyn", "will", "have", "access", "to", "all", "clinical", "trial", "data", "and", "the", "right", "to", "use", "such", "data.", "<tag3>"], "wordsA": ["As", "an", "integral", "part", "of", "CytoDyn", "s", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "whereby", "CytoDyn", "will", "provide", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "the", "clinical", "trials", "and", "CytoDyn", "will", "have", "access", "to", "all", "clinical", "trial", "data", "and", "the", "right", "to", "use", "such", "data", "to", "maintain", "the", "IND", "(Investigational", "New", "Drug", "application)", "for", "PRO", "140", "and", "to", "support", "its", "application", "to", "the", "FDA."], "wordsB": ["CytoDyn", "will", "have", "access", "to", "all", "clinical", "trial", "data", "and", "the", "right", "to", "use", "such", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p40_s0", "idA": "1175680_14_item1_p10_s0", "sentA": "Pursuant to a clinical trial agreement with us, Drexel is now carrying the investigational new drug ( IND ) application.", "sentB": "Phase 1 Phase 1 includes the initial introduction of an investigational new drug or biologic into humans.", "type": 2, "words": ["<tag1>", "Pursuant", "to", "a", "clinical", "trial", "agreement", "with", "us,", "Drexel", "is", "now", "carrying", "the", "investigational", "new", "drug", "(", "IND", ")", "application.", "<tag2>", "Phase", "1", "Phase", "1", "includes", "the", "initial", "introduction", "of", "an", "investigational", "new", "drug", "or", "biologic", "into", "humans.", "<tag3>"], "wordsA": ["Pursuant", "to", "a", "clinical", "trial", "agreement", "with", "us,", "Drexel", "is", "now", "carrying", "the", "investigational", "new", "drug", "(", "IND", ")", "application."], "wordsB": ["Phase", "1", "Phase", "1", "includes", "the", "initial", "introduction", "of", "an", "investigational", "new", "drug", "or", "biologic", "into", "humans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p9_s1", "idA": "1175680_14_item1_p10_s1", "sentA": "As such, the Company is precluded from commenting on the Drexel sponsored studies.", "sentB": "As such, we are precluded from commenting on the NIH sponsored study.", "type": 2, "words": ["<tag1>", "As", "such,", "the", "Company", "is", "precluded", "from", "commenting", "on", "the", "Drexel", "sponsored", "studies.", "<tag2>", "As", "such,", "we", "are", "precluded", "from", "commenting", "on", "the", "NIH", "sponsored", "study.", "<tag3>"], "wordsA": ["As", "such,", "the", "Company", "is", "precluded", "from", "commenting", "on", "the", "Drexel", "sponsored", "studies."], "wordsB": ["As", "such,", "we", "are", "precluded", "from", "commenting", "on", "the", "NIH", "sponsored", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p13_s4", "idA": "1175680_14_item1_p10_s2", "sentA": "A third clinical trial of PRO 140 commenced in May 2014 and is sponsored and funded by the Company.", "sentB": "The Company announced on June 9, 2015, the FDA s approval of the Company s Phase 3 protocol for an additional indication for PRO 140 and expects to commence its first Phase 3 clinical trial in mid-2015.", "type": 2, "words": ["<tag1>", "A", "third", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "the", "Company.", "<tag2>", "The", "Company", "announced", "on", "June", "9,", "2015,", "the", "FDA", "s", "approval", "of", "the", "Company", "s", "Phase", "3", "protocol", "for", "an", "additional", "indication", "for", "PRO", "140", "and", "expects", "to", "commence", "its", "first", "Phase", "3", "clinical", "trial", "in", "mid-2015.", "<tag3>"], "wordsA": ["A", "third", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "the", "Company."], "wordsB": ["The", "Company", "announced", "on", "June", "9,", "2015,", "the", "FDA", "s", "approval", "of", "the", "Company", "s", "Phase", "3", "protocol", "for", "an", "additional", "indication", "for", "PRO", "140", "and", "expects", "to", "commence", "its", "first", "Phase", "3", "clinical", "trial", "in", "mid-2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p41_s12", "idA": "1175680_14_item1_p10_s2", "sentA": "A third clinical trial of PRO 140 commenced in May 2014 and is sponsored and funded by the Company.", "sentB": "We are required to pay significant fees to third parties upon the first patient dosing in a Phase 3 trial of PRO 140.", "type": 2, "words": ["<tag1>", "A", "third", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "the", "Company.", "<tag2>", "We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140.", "<tag3>"], "wordsA": ["A", "third", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "the", "Company."], "wordsB": ["We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p9_s2", "idA": "1175680_14_item1_p10_s2", "sentA": "A third clinical trial of PRO 140 commenced in May 2014 and is sponsored and funded by the Company.", "sentB": "A second clinical trial of PRO 140 commenced in May 2014 and is sponsored and funded by CytoDyn.", "type": 2, "words": ["<tag1>", "A", "third", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "the", "Company.", "<tag2>", "A", "second", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "CytoDyn.", "<tag3>"], "wordsA": ["A", "third", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "the", "Company."], "wordsB": ["A", "second", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "CytoDyn."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p10_s0", "idA": "1175680_14_item1_p10_s3", "sentA": "This Phase 2b trial is known as treatment substitution.", "sentB": "The Company s Phase 2b treatment substitution clinical trial results through May 31, 2015, (excluding patients who failed due to having the Dual/Mix[II1] virus, therefore were screening failures) are as follows:", "type": 2, "words": ["<tag1>", "This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution.", "<tag2>", "The", "Company", "s", "Phase", "2b", "treatment", "substitution", "clinical", "trial", "results", "through", "May", "31,", "2015,", "(excluding", "patients", "who", "failed", "due", "to", "having", "the", "Dual/Mix[II1]", "virus,", "therefore", "were", "screening", "failures)", "are", "as", "follows:", "<tag3>"], "wordsA": ["This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution."], "wordsB": ["The", "Company", "s", "Phase", "2b", "treatment", "substitution", "clinical", "trial", "results", "through", "May", "31,", "2015,", "(excluding", "patients", "who", "failed", "due", "to", "having", "the", "Dual/Mix[II1]", "virus,", "therefore", "were", "screening", "failures)", "are", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p13_s5", "idA": "1175680_14_item1_p10_s3", "sentA": "This Phase 2b trial is known as treatment substitution.", "sentB": "The Company also plans to request a meeting with the FDA to discuss potential additional indications for HIV therapy following the submission of the top-line report of the recently completed Phase 2b treatment substitution study.", "type": 2, "words": ["<tag1>", "This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution.", "<tag2>", "The", "Company", "also", "plans", "to", "request", "a", "meeting", "with", "the", "FDA", "to", "discuss", "potential", "additional", "indications", "for", "HIV", "therapy", "following", "the", "submission", "of", "the", "top-line", "report", "of", "the", "recently", "completed", "Phase", "2b", "treatment", "substitution", "study.", "<tag3>"], "wordsA": ["This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution."], "wordsB": ["The", "Company", "also", "plans", "to", "request", "a", "meeting", "with", "the", "FDA", "to", "discuss", "potential", "additional", "indications", "for", "HIV", "therapy", "following", "the", "submission", "of", "the", "top-line", "report", "of", "the", "recently", "completed", "Phase", "2b", "treatment", "substitution", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p41_s6", "idA": "1175680_14_item1_p10_s3", "sentA": "This Phase 2b trial is known as treatment substitution.", "sentB": "We believe studies conducted under the direction of Dr. Jacobson at Drexel will collectively constitute a Phase 2b trial.", "type": 2, "words": ["<tag1>", "This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution.", "<tag2>", "We", "believe", "studies", "conducted", "under", "the", "direction", "of", "Dr.", "Jacobson", "at", "Drexel", "will", "collectively", "constitute", "a", "Phase", "2b", "trial.", "<tag3>"], "wordsA": ["This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution."], "wordsB": ["We", "believe", "studies", "conducted", "under", "the", "direction", "of", "Dr.", "Jacobson", "at", "Drexel", "will", "collectively", "constitute", "a", "Phase", "2b", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p41_s7", "idA": "1175680_14_item1_p10_s3", "sentA": "This Phase 2b trial is known as treatment substitution.", "sentB": "Our treatment substitution clinical trial is a Phase 2b trial.", "type": 2, "words": ["<tag1>", "This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution.", "<tag2>", "Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial.", "<tag3>"], "wordsA": ["This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution."], "wordsB": ["Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p9_s4", "idA": "1175680_14_item1_p10_s3", "sentA": "This Phase 2b trial is known as treatment substitution.", "sentB": "This Phase 2b trial was completed in January 2015 and several patients are continuing in extension studies of this monotherapy of a weekly injection of PRO 140.", "type": 2, "words": ["<tag1>", "This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution.", "<tag2>", "This", "Phase", "2b", "trial", "was", "completed", "in", "January", "2015", "and", "several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "of", "a", "weekly", "injection", "of", "PRO", "140.", "<tag3>"], "wordsA": ["This", "Phase", "2b", "trial", "is", "known", "as", "treatment", "substitution."], "wordsB": ["This", "Phase", "2b", "trial", "was", "completed", "in", "January", "2015", "and", "several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "of", "a", "weekly", "injection", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p9_s6", "idA": "1175680_14_item1_p10_s4", "sentA": "Our ongoing treatment substitution study has two objectives: (1) to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression after being used in substitution of a patient s antiretroviral therapy regimen and (2) to assess the clinical safety and tolerability parameters for PRO 140 following use in substitution of antiretroviral therapy.", "sentB": "Our ongoing treatment substitution extension study has two objectives: (1) to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression after being used in substitution of a patient s HAART regimen and (2) to assess the clinical safety and tolerability parameters for PRO 140 following use in substitution of HAART.", "type": 2, "words": ["<tag1>", "Our", "ongoing", "treatment", "substitution", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "antiretroviral", "therapy", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "antiretroviral", "therapy.", "<tag2>", "Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART.", "<tag3>"], "wordsA": ["Our", "ongoing", "treatment", "substitution", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "antiretroviral", "therapy", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "antiretroviral", "therapy."], "wordsB": ["Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p9_s7", "idA": "1175680_14_item1_p10_s5", "sentA": "The study protocol requires patients to be stable on combination antiretroviral therapy.", "sentB": "The study protocol requires patients to be stable on HAART with an undetectable viral load.", "type": 2, "words": ["<tag1>", "The", "study", "protocol", "requires", "patients", "to", "be", "stable", "on", "combination", "antiretroviral", "therapy.", "<tag2>", "The", "study", "protocol", "requires", "patients", "to", "be", "stable", "on", "HAART", "with", "an", "undetectable", "viral", "load.", "<tag3>"], "wordsA": ["The", "study", "protocol", "requires", "patients", "to", "be", "stable", "on", "combination", "antiretroviral", "therapy."], "wordsB": ["The", "study", "protocol", "requires", "patients", "to", "be", "stable", "on", "HAART", "with", "an", "undetectable", "viral", "load."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p25_s6", "idA": "1175680_14_item1_p10_s6", "sentA": "The current trial design provides that patients will be shifted from combination antiretroviral regimen to PRO 140 monotherapy for 12 weeks.", "sentB": "Further, no other applications referencing PRO 140 will be accepted by FDA for a 4-year period measured from the first date of FDA licensure.", "type": 2, "words": ["<tag1>", "The", "current", "trial", "design", "provides", "that", "patients", "will", "be", "shifted", "from", "combination", "antiretroviral", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks.", "<tag2>", "Further,", "no", "other", "applications", "referencing", "PRO", "140", "will", "be", "accepted", "by", "FDA", "for", "a", "4-year", "period", "measured", "from", "the", "first", "date", "of", "FDA", "licensure.", "<tag3>"], "wordsA": ["The", "current", "trial", "design", "provides", "that", "patients", "will", "be", "shifted", "from", "combination", "antiretroviral", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks."], "wordsB": ["Further,", "no", "other", "applications", "referencing", "PRO", "140", "will", "be", "accepted", "by", "FDA", "for", "a", "4-year", "period", "measured", "from", "the", "first", "date", "of", "FDA", "licensure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p9_s8", "idA": "1175680_14_item1_p10_s6", "sentA": "The current trial design provides that patients will be shifted from combination antiretroviral regimen to PRO 140 monotherapy for 12 weeks.", "sentB": "The trial design provided that patients will be shifted from HAART regimen to PRO 140 monotherapy for 12 weeks.", "type": 2, "words": ["<tag1>", "The", "current", "trial", "design", "provides", "that", "patients", "will", "be", "shifted", "from", "combination", "antiretroviral", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks.", "<tag2>", "The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks.", "<tag3>"], "wordsA": ["The", "current", "trial", "design", "provides", "that", "patients", "will", "be", "shifted", "from", "combination", "antiretroviral", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks."], "wordsB": ["The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p9_s10", "idA": "1175680_14_item1_p10_s7", "sentA": "Total treatment duration with PRO 140 will be up to 14 weeks with one week overlap of existing retroviral regimen and PRO 140 at the beginning of the study period and also one week of overlap at the end in subjects who did not experience virologic failure.", "sentB": "Total treatment duration with PRO 140 in the initial study was up to 14 weeks with one week overlap of existing retroviral regimen and PRO 140 at the beginning of the study period and also one week of overlap at the end in subjects who did not experience virologic failure, which is defined as a viral load above 400 two weeks in a row.", "type": 2, "words": ["<tag1>", "Total", "treatment", "duration", "with", "PRO", "140", "will", "be", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure.", "<tag2>", "Total", "treatment", "duration", "with", "PRO", "140", "in", "the", "initial", "study", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "which", "is", "defined", "as", "a", "viral", "load", "above", "400", "two", "weeks", "in", "a", "row.", "<tag3>"], "wordsA": ["Total", "treatment", "duration", "with", "PRO", "140", "will", "be", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure."], "wordsB": ["Total", "treatment", "duration", "with", "PRO", "140", "in", "the", "initial", "study", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "which", "is", "defined", "as", "a", "viral", "load", "above", "400", "two", "weeks", "in", "a", "row."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p9_s9", "idA": "1175680_14_item1_p10_s8", "sentA": "PRO 140 is being administered as a 350mg subcutaneous dosage weekly for up to 14 weeks and participants are monitored for viral rebound on a weekly basis.", "sentB": "PRO 140 is being administered as a 350mg subcutaneous dosage weekly and participants are monitored for viral rebound on a weekly basis.", "type": 2, "words": ["<tag1>", "PRO", "140", "is", "being", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "for", "up", "to", "14", "weeks", "and", "participants", "are", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis.", "<tag2>", "PRO", "140", "is", "being", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "and", "participants", "are", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis.", "<tag3>"], "wordsA": ["PRO", "140", "is", "being", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "for", "up", "to", "14", "weeks", "and", "participants", "are", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis."], "wordsB": ["PRO", "140", "is", "being", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "and", "participants", "are", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p15_s3", "idA": "1175680_14_item1_p10_s9", "sentA": "Other Product Candidates A second product candidate, Cytolin, is also a humanized monoclonal antibody for the treatment of HIV infection.", "sentB": "Other Product Candidates Our second product candidate, Cytolin, is also a humanized monoclonal antibody for the treatment of HIV infection.", "type": 2, "words": ["<tag1>", "Other", "Product", "Candidates", "A", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "humanized", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection.", "<tag2>", "Other", "Product", "Candidates", "Our", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "humanized", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection.", "<tag3>"], "wordsA": ["Other", "Product", "Candidates", "A", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "humanized", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection."], "wordsB": ["Other", "Product", "Candidates", "Our", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "humanized", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p17_s2", "idA": "1175680_14_item1_p11_s2", "sentA": "This patent is for a murine (mouse) version of the drug.", "sentB": "We now refer to Cytolin as the humanized version of the old Cytolin, which was the murine monoclonal antibody.", "type": 2, "words": ["<tag1>", "This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "We", "now", "refer", "to", "Cytolin", "as", "the", "humanized", "version", "of", "the", "old", "Cytolin,", "which", "was", "the", "murine", "monoclonal", "antibody.", "<tag3>"], "wordsA": ["This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["We", "now", "refer", "to", "Cytolin", "as", "the", "humanized", "version", "of", "the", "old", "Cytolin,", "which", "was", "the", "murine", "monoclonal", "antibody."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p41_s1", "idA": "1175680_14_item1_p11_s2", "sentA": "This patent is for a murine (mouse) version of the drug.", "sentB": "Phase 2 Phase 2 includes the early controlled clinical studies conducted to obtain some preliminary data on the effectiveness of the drug for a particular indication or indications in patients with the disease or condition.", "type": 2, "words": ["<tag1>", "This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "Phase", "2", "Phase", "2", "includes", "the", "early", "controlled", "clinical", "studies", "conducted", "to", "obtain", "some", "preliminary", "data", "on", "the", "effectiveness", "of", "the", "drug", "for", "a", "particular", "indication", "or", "indications", "in", "patients", "with", "the", "disease", "or", "condition.", "<tag3>"], "wordsA": ["This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["Phase", "2", "Phase", "2", "includes", "the", "early", "controlled", "clinical", "studies", "conducted", "to", "obtain", "some", "preliminary", "data", "on", "the", "effectiveness", "of", "the", "drug", "for", "a", "particular", "indication", "or", "indications", "in", "patients", "with", "the", "disease", "or", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p41_s2", "idA": "1175680_14_item1_p11_s2", "sentA": "This patent is for a murine (mouse) version of the drug.", "sentB": "This phase of testing also helps determine the common short-term side effects and risks associated with the drug.", "type": 2, "words": ["<tag1>", "This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "This", "phase", "of", "testing", "also", "helps", "determine", "the", "common", "short-term", "side", "effects", "and", "risks", "associated", "with", "the", "drug.", "<tag3>"], "wordsA": ["This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["This", "phase", "of", "testing", "also", "helps", "determine", "the", "common", "short-term", "side", "effects", "and", "risks", "associated", "with", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p41_s9", "idA": "1175680_14_item1_p11_s2", "sentA": "This patent is for a murine (mouse) version of the drug.", "sentB": "They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained in Phase 2, and are intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit/risk relationship of the drug.", "type": 2, "words": ["<tag1>", "This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "They", "are", "performed", "after", "preliminary", "evidence", "suggesting", "effectiveness", "of", "the", "drug", "has", "been", "obtained", "in", "Phase", "2,", "and", "are", "intended", "to", "gather", "the", "additional", "information", "about", "effectiveness", "and", "safety", "that", "is", "needed", "to", "evaluate", "the", "overall", "benefit/risk", "relationship", "of", "the", "drug.", "<tag3>"], "wordsA": ["This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["They", "are", "performed", "after", "preliminary", "evidence", "suggesting", "effectiveness", "of", "the", "drug", "has", "been", "obtained", "in", "Phase", "2,", "and", "are", "intended", "to", "gather", "the", "additional", "information", "about", "effectiveness", "and", "safety", "that", "is", "needed", "to", "evaluate", "the", "overall", "benefit/risk", "relationship", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p16_s3", "idA": "1175680_14_item1_p11_s3", "sentA": "The license agreement expires on the original expiration date of the patent in July 2014.", "sentB": "The license agreement expired on the original expiration date of the patent in July 2014.", "type": 2, "words": ["<tag1>", "The", "license", "agreement", "expires", "on", "the", "original", "expiration", "date", "of", "the", "patent", "in", "July", "2014.", "<tag2>", "The", "license", "agreement", "expired", "on", "the", "original", "expiration", "date", "of", "the", "patent", "in", "July", "2014.", "<tag3>"], "wordsA": ["The", "license", "agreement", "expires", "on", "the", "original", "expiration", "date", "of", "the", "patent", "in", "July", "2014."], "wordsB": ["The", "license", "agreement", "expired", "on", "the", "original", "expiration", "date", "of", "the", "patent", "in", "July", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p17_s0", "idA": "1175680_14_item1_p12_s0", "sentA": "On September 23, 2011, the Company filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin.", "sentB": "On September 23, 2011, we filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin.", "type": 2, "words": ["<tag1>", "On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin.", "<tag2>", "On", "September", "23,", "2011,", "we", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin.", "<tag3>"], "wordsA": ["On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin."], "wordsB": ["On", "September", "23,", "2011,", "we", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p37_s0", "idA": "1175680_14_item1_p12_s0", "sentA": "On September 23, 2011, the Company filed a provisional patent application (Serial No. 61/534,942) in the United States for its humanized version of Cytolin.", "sentB": "Our research and development activities and the manufacture and marketing of our products are and will be subject to rigorous regulations relating to product safety and efficacy by numerous governmental authorities in the United States and other countries.", "type": 2, "words": ["<tag1>", "On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin.", "<tag2>", "Our", "research", "and", "development", "activities", "and", "the", "manufacture", "and", "marketing", "of", "our", "products", "are", "and", "will", "be", "subject", "to", "rigorous", "regulations", "relating", "to", "product", "safety", "and", "efficacy", "by", "numerous", "governmental", "authorities", "in", "the", "United", "States", "and", "other", "countries.", "<tag3>"], "wordsA": ["On", "September", "23,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "(Serial", "No.", "61/534,942)", "in", "the", "United", "States", "for", "its", "humanized", "version", "of", "Cytolin."], "wordsB": ["Our", "research", "and", "development", "activities", "and", "the", "manufacture", "and", "marketing", "of", "our", "products", "are", "and", "will", "be", "subject", "to", "rigorous", "regulations", "relating", "to", "product", "safety", "and", "efficacy", "by", "numerous", "governmental", "authorities", "in", "the", "United", "States", "and", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p18_s1", "idA": "1175680_14_item1_p13_s1", "sentA": "On June 17, 2011, the Company filed a provisional patent application in the United States (Serial No. 61/498,029) for the use of these antibodies, as well as selected small molecule antagonists and agonists for the treatment of FIV.", "sentB": "On June 17, 2011, we filed a provisional patent application in the United States (Serial No. 61/498,029) for the use of these antibodies, as well as selected small molecule antagonists and agonists for the treatment of FIV.", "type": 2, "words": ["<tag1>", "On", "June", "17,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "these", "antibodies,", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV.", "<tag2>", "On", "June", "17,", "2011,", "we", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "these", "antibodies,", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV.", "<tag3>"], "wordsA": ["On", "June", "17,", "2011,", "the", "Company", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "these", "antibodies,", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV."], "wordsB": ["On", "June", "17,", "2011,", "we", "filed", "a", "provisional", "patent", "application", "in", "the", "United", "States", "(Serial", "No.", "61/498,029)", "for", "the", "use", "of", "these", "antibodies,", "as", "well", "as", "selected", "small", "molecule", "antagonists", "and", "agonists", "for", "the", "treatment", "of", "FIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p18_s2", "idA": "1175680_14_item1_p13_s2", "sentA": "On June 15, 2012, the Company filed an international patent application (Serial No. PCT/US2012/042693) claiming priority to this provisional patent application.", "sentB": "On June 15, 2012, we filed an international patent application (Serial No. PCT/US2012/042693) and claimed priority to this provisional patent application.", "type": 2, "words": ["<tag1>", "On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application.", "<tag2>", "On", "June", "15,", "2012,", "we", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "and", "claimed", "priority", "to", "this", "provisional", "patent", "application.", "<tag3>"], "wordsA": ["On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application."], "wordsB": ["On", "June", "15,", "2012,", "we", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "and", "claimed", "priority", "to", "this", "provisional", "patent", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p18_s3", "idA": "1175680_14_item1_p13_s2", "sentA": "On June 15, 2012, the Company filed an international patent application (Serial No. PCT/US2012/042693) claiming priority to this provisional patent application.", "sentB": "This international patent application has since entered European regional and U.S. and Canadian national stage examinations.", "type": 2, "words": ["<tag1>", "On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application.", "<tag2>", "This", "international", "patent", "application", "has", "since", "entered", "European", "regional", "and", "U.S.", "and", "Canadian", "national", "stage", "examinations.", "<tag3>"], "wordsA": ["On", "June", "15,", "2012,", "the", "Company", "filed", "an", "international", "patent", "application", "(Serial", "No.", "PCT/US2012/042693)", "claiming", "priority", "to", "this", "provisional", "patent", "application."], "wordsB": ["This", "international", "patent", "application", "has", "since", "entered", "European", "regional", "and", "U.S.", "and", "Canadian", "national", "stage", "examinations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p19_s0", "idA": "1175680_14_item1_p14_s0", "sentA": "CytoFeline is the Company s proprietary product targeted to treat FIV.", "sentB": "CytoFeline is our felinized proprietary product targeted to treat FIV.", "type": 2, "words": ["<tag1>", "CytoFeline", "is", "the", "Company", "s", "proprietary", "product", "targeted", "to", "treat", "FIV.", "<tag2>", "CytoFeline", "is", "our", "felinized", "proprietary", "product", "targeted", "to", "treat", "FIV.", "<tag3>"], "wordsA": ["CytoFeline", "is", "the", "Company", "s", "proprietary", "product", "targeted", "to", "treat", "FIV."], "wordsB": ["CytoFeline", "is", "our", "felinized", "proprietary", "product", "targeted", "to", "treat", "FIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p47_s0", "idA": "1175680_14_item1_p15_s0", "sentA": "PRO 140 Acquisition We acquired PRO 140, as well as certain other related assets, including the existing inventory of PRO 140 bulk drug substance, intellectual property, and FDA regulatory filings, pursuant to an Asset Purchase Agreement, dated as of July 25, 2012 (the Progenics Agreement ), between CytoDyn and Progenics.", "sentB": "Employees and Consultants We have three full-time employees, our CEO, CFO and Director of Accounting, as well as several independent consultants assisting us with our clinical trials of PRO 140 and manufacturing activities.", "type": 2, "words": ["<tag1>", "PRO", "140", "Acquisition", "We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Agreement", "),", "between", "CytoDyn", "and", "Progenics.", "<tag2>", "Employees", "and", "Consultants", "We", "have", "three", "full-time", "employees,", "our", "CEO,", "CFO", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities.", "<tag3>"], "wordsA": ["PRO", "140", "Acquisition", "We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Agreement", "),", "between", "CytoDyn", "and", "Progenics."], "wordsB": ["Employees", "and", "Consultants", "We", "have", "three", "full-time", "employees,", "our", "CEO,", "CFO", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p20_s1", "idA": "1175680_14_item1_p15_s1", "sentA": "The terms of the Progenics Agreement provided for an initial cash payment of $3,500,000, which was paid at closing in October 2012, as well as the following milestone payments and royalties to be paid to Progenics in the future: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-US equivalent; (ii) $5,000,000 at the time of the first US new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of 5% of net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years following the first commercialization sale of PRO 140, in each case determined on a country-by-country basis.", "sentB": "The terms of the Progenics Agreement provided for an initial cash payment of $3,500,000, which was paid at closing in October 2012, as well as the following milestone payments and royalties to be paid to Progenics in the future: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-US equivalent; (ii) $5,000,000 at the time of the first U.S. new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of 5% of net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years following the first commercialization sale of PRO 140, in each case determined on a country-by-country basis.", "type": 2, "words": ["<tag1>", "The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis.", "<tag2>", "The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U.S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis.", "<tag3>"], "wordsA": ["The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis."], "wordsB": ["The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U.S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p20_s4", "idA": "1175680_14_item1_p15_s1", "sentA": "The terms of the Progenics Agreement provided for an initial cash payment of $3,500,000, which was paid at closing in October 2012, as well as the following milestone payments and royalties to be paid to Progenics in the future: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-US equivalent; (ii) $5,000,000 at the time of the first US new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of 5% of net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years following the first commercialization sale of PRO 140, in each case determined on a country-by-country basis.", "sentB": "As of the date of this filing, management has reasonably estimated the likelihood of paying the first milestone payments, as probable, and accordingly, as of May 31, 2015, the Company has accrued $2,500,000 for the initial milestone associated with the first dosing in a Phase 3 trial.", "type": 2, "words": ["<tag1>", "The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis.", "<tag2>", "As", "of", "the", "date", "of", "this", "filing,", "management", "has", "reasonably", "estimated", "the", "likelihood", "of", "paying", "the", "first", "milestone", "payments,", "as", "probable,", "and", "accordingly,", "as", "of", "May", "31,", "2015,", "the", "Company", "has", "accrued", "$2,500,000", "for", "the", "initial", "milestone", "associated", "with", "the", "first", "dosing", "in", "a", "Phase", "3", "trial.", "<tag3>"], "wordsA": ["The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis."], "wordsB": ["As", "of", "the", "date", "of", "this", "filing,", "management", "has", "reasonably", "estimated", "the", "likelihood", "of", "paying", "the", "first", "milestone", "payments,", "as", "probable,", "and", "accordingly,", "as", "of", "May", "31,", "2015,", "the", "Company", "has", "accrued", "$2,500,000", "for", "the", "initial", "milestone", "associated", "with", "the", "first", "dosing", "in", "a", "Phase", "3", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p20_s2", "idA": "1175680_14_item1_p16_s0", "sentA": "Payments to Progenics are in addition to payments due under a Development and License Agreement, dated April 30, 1999 (the PDL License ), between Protein Design Labs (now AbbVie Inc.) and Progenics, which was assigned to us in the PRO 140 transaction, pursuant to which we must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "sentB": "The Progenics Agreement is filed as an exhibit to this annual report on Form 10-K. Payments to Progenics are in addition to payments due under a Development and License Agreement, dated April 30, 1999 (the PDL License ), between Protein Design Labs (now AbbVie Inc.) and Progenics, which was assigned to us in the PRO 140 transaction, pursuant to which we must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "type": 2, "words": ["<tag1>", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "PRO", "140", "transaction,", "pursuant", "to", "which", "we", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag2>", "The", "Progenics", "Agreement", "is", "filed", "as", "an", "exhibit", "to", "this", "annual", "report", "on", "Form", "10-K.", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "PRO", "140", "transaction,", "pursuant", "to", "which", "we", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag3>"], "wordsA": ["Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "PRO", "140", "transaction,", "pursuant", "to", "which", "we", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "wordsB": ["The", "Progenics", "Agreement", "is", "filed", "as", "an", "exhibit", "to", "this", "annual", "report", "on", "Form", "10-K.", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "PRO", "140", "transaction,", "pursuant", "to", "which", "we", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p13_s0", "idA": "1175680_14_item1_p17_s0", "sentA": "As part of our acquisition of PRO 140, we entered into a collaboration agreement with Drexel, under which CytoDyn has provided Drexel with the necessary quantity of PRO 140 to conduct certain clinical trials.", "sentB": "On May 4, 2015, the Company announced that it has reached an agreement with the FDA on the Company s previously submitted Phase 3 protocol synopsis for PRO 140 and submitted the full Phase 3 protocol to the FDA.", "type": 2, "words": ["<tag1>", "As", "part", "of", "our", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "under", "which", "CytoDyn", "has", "provided", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "certain", "clinical", "trials.", "<tag2>", "On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA.", "<tag3>"], "wordsA": ["As", "part", "of", "our", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "under", "which", "CytoDyn", "has", "provided", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "certain", "clinical", "trials."], "wordsB": ["On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p41_s0", "idA": "1175680_14_item1_p17_s0", "sentA": "As part of our acquisition of PRO 140, we entered into a collaboration agreement with Drexel, under which CytoDyn has provided Drexel with the necessary quantity of PRO 140 to conduct certain clinical trials.", "sentB": "Phase 1 studies of PRO 140 have been conducted and completed by or on behalf of Progenics by Dr. Jacobson and others prior to our acquisition of PRO 140.", "type": 2, "words": ["<tag1>", "As", "part", "of", "our", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "under", "which", "CytoDyn", "has", "provided", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "certain", "clinical", "trials.", "<tag2>", "Phase", "1", "studies", "of", "PRO", "140", "have", "been", "conducted", "and", "completed", "by", "or", "on", "behalf", "of", "Progenics", "by", "Dr.", "Jacobson", "and", "others", "prior", "to", "our", "acquisition", "of", "PRO", "140.", "<tag3>"], "wordsA": ["As", "part", "of", "our", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "under", "which", "CytoDyn", "has", "provided", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "certain", "clinical", "trials."], "wordsB": ["Phase", "1", "studies", "of", "PRO", "140", "have", "been", "conducted", "and", "completed", "by", "or", "on", "behalf", "of", "Progenics", "by", "Dr.", "Jacobson", "and", "others", "prior", "to", "our", "acquisition", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p23_s0", "idA": "1175680_14_item1_p19_s0", "sentA": "Patents and Proprietary Technology Protection of our intellectual property rights is important to our business.", "sentB": "Patents, Proprietary Technology, and Data Exclusivity Protection of our intellectual property rights is important to our business.", "type": 2, "words": ["<tag1>", "Patents", "and", "Proprietary", "Technology", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business.", "<tag2>", "Patents,", "Proprietary", "Technology,", "and", "Data", "Exclusivity", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business.", "<tag3>"], "wordsA": ["Patents", "and", "Proprietary", "Technology", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business."], "wordsB": ["Patents,", "Proprietary", "Technology,", "and", "Data", "Exclusivity", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p30_s0", "idA": "1175680_14_item1_p19_s0", "sentA": "Patents and Proprietary Technology Protection of our intellectual property rights is important to our business.", "sentB": "The health care industry is highly regulated, and state and federal health care laws and regulations are applicable to certain aspects of our business.", "type": 2, "words": ["<tag1>", "Patents", "and", "Proprietary", "Technology", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business.", "<tag2>", "The", "health", "care", "industry", "is", "highly", "regulated,", "and", "state", "and", "federal", "health", "care", "laws", "and", "regulations", "are", "applicable", "to", "certain", "aspects", "of", "our", "business.", "<tag3>"], "wordsA": ["Patents", "and", "Proprietary", "Technology", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business."], "wordsB": ["The", "health", "care", "industry", "is", "highly", "regulated,", "and", "state", "and", "federal", "health", "care", "laws", "and", "regulations", "are", "applicable", "to", "certain", "aspects", "of", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p37_s2", "idA": "1175680_14_item1_p19_s0", "sentA": "Patents and Proprietary Technology Protection of our intellectual property rights is important to our business.", "sentB": "The extent of government regulation applying to our business that might result from any legislative or administrative action cannot be accurately predicted.", "type": 2, "words": ["<tag1>", "Patents", "and", "Proprietary", "Technology", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business.", "<tag2>", "The", "extent", "of", "government", "regulation", "applying", "to", "our", "business", "that", "might", "result", "from", "any", "legislative", "or", "administrative", "action", "cannot", "be", "accurately", "predicted.", "<tag3>"], "wordsA": ["Patents", "and", "Proprietary", "Technology", "Protection", "of", "our", "intellectual", "property", "rights", "is", "important", "to", "our", "business."], "wordsB": ["The", "extent", "of", "government", "regulation", "applying", "to", "our", "business", "that", "might", "result", "from", "any", "legislative", "or", "administrative", "action", "cannot", "be", "accurately", "predicted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p23_s1", "idA": "1175680_14_item1_p19_s1", "sentA": "We may file patent applications in the U.S., Canada, and Japan, European countries that are party to the European Patent Convention and other countries on a selective basis in order to protect inventions we consider to be important to the development of our business.", "sentB": "We may file patent applications in the U.S., Canada, China, Japan, European countries that are party to the European Patent Convention and other countries on a selective basis in order to protect inventions we consider to be important to the development of our business.", "type": 2, "words": ["<tag1>", "We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "and", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag2>", "We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "China,", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag3>"], "wordsA": ["We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "and", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business."], "wordsB": ["We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "China,", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p0_s3", "idA": "1175680_14_item1_p1_s0", "sentA": "We are a publicly traded biotechnology company focused on developing and potentially marketing a class of therapeutic monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "sentB": "We are a publicly traded biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "type": 2, "words": ["<tag1>", "We", "are", "a", "publicly", "traded", "biotechnology", "company", "focused", "on", "developing", "and", "potentially", "marketing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag2>", "We", "are", "a", "publicly", "traded", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag3>"], "wordsA": ["We", "are", "a", "publicly", "traded", "biotechnology", "company", "focused", "on", "developing", "and", "potentially", "marketing", "a", "class", "of", "therapeutic", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "wordsB": ["We", "are", "a", "publicly", "traded", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p39_s2", "idA": "1175680_14_item1_p1_s1", "sentA": "Our lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors.", "sentB": "Additional clinical studies of our lead product candidate, PRO 140, are being sponsored by Drexel and funded at least in part by the NIH but are less critical to the viability of our business.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate,", "PRO", "140,", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors.", "<tag2>", "Additional", "clinical", "studies", "of", "our", "lead", "product", "candidate,", "PRO", "140,", "are", "being", "sponsored", "by", "Drexel", "and", "funded", "at", "least", "in", "part", "by", "the", "NIH", "but", "are", "less", "critical", "to", "the", "viability", "of", "our", "business.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate,", "PRO", "140,", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors."], "wordsB": ["Additional", "clinical", "studies", "of", "our", "lead", "product", "candidate,", "PRO", "140,", "are", "being", "sponsored", "by", "Drexel", "and", "funded", "at", "least", "in", "part", "by", "the", "NIH", "but", "are", "less", "critical", "to", "the", "viability", "of", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p0_s5", "idA": "1175680_14_item1_p1_s2", "sentA": "These therapies potentially block HIV from entering into and infecting certain cells.", "sentB": "These therapies block HIV from entering into and infecting certain cells.", "type": 2, "words": ["<tag1>", "These", "therapies", "potentially", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells.", "<tag2>", "These", "therapies", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells.", "<tag3>"], "wordsA": ["These", "therapies", "potentially", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells."], "wordsB": ["These", "therapies", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p0_s6", "idA": "1175680_14_item1_p1_s3", "sentA": "Although CytoDyn intends to focus its efforts on PRO 140, the Company also holds certain rights in two proprietary platform technologies: Cytolin , a monoclonal antibody targeting HIV with a mechanism of action which may prove to be synergistic to that of PRO 140 and other treatments; and CytoFeline , a monoclonal antibody targeting Feline Immunodeficiency Virus ( FIV ).", "sentB": "Although CytoDyn intends to focus its efforts on PRO 140, we also hold certain rights in two proprietary platform technologies: Cytolin , a humanized monoclonal antibody targeting HIV with a mechanism of action which may prove to be synergistic to that of PRO 140 and other treatments, and CytoFeline , a felinized-monoclonal antibody targeting Feline Immunodeficiency Virus ( FIV ).", "type": 2, "words": ["<tag1>", "Although", "CytoDyn", "intends", "to", "focus", "its", "efforts", "on", "PRO", "140,", "the", "Company", "also", "holds", "certain", "rights", "in", "two", "proprietary", "platform", "technologies:", "Cytolin", ",", "a", "monoclonal", "antibody", "targeting", "HIV", "with", "a", "mechanism", "of", "action", "which", "may", "prove", "to", "be", "synergistic", "to", "that", "of", "PRO", "140", "and", "other", "treatments;", "and", "CytoFeline", ",", "a", "monoclonal", "antibody", "targeting", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ").", "<tag2>", "Although", "CytoDyn", "intends", "to", "focus", "its", "efforts", "on", "PRO", "140,", "we", "also", "hold", "certain", "rights", "in", "two", "proprietary", "platform", "technologies:", "Cytolin", ",", "a", "humanized", "monoclonal", "antibody", "targeting", "HIV", "with", "a", "mechanism", "of", "action", "which", "may", "prove", "to", "be", "synergistic", "to", "that", "of", "PRO", "140", "and", "other", "treatments,", "and", "CytoFeline", ",", "a", "felinized-monoclonal", "antibody", "targeting", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ").", "<tag3>"], "wordsA": ["Although", "CytoDyn", "intends", "to", "focus", "its", "efforts", "on", "PRO", "140,", "the", "Company", "also", "holds", "certain", "rights", "in", "two", "proprietary", "platform", "technologies:", "Cytolin", ",", "a", "monoclonal", "antibody", "targeting", "HIV", "with", "a", "mechanism", "of", "action", "which", "may", "prove", "to", "be", "synergistic", "to", "that", "of", "PRO", "140", "and", "other", "treatments;", "and", "CytoFeline", ",", "a", "monoclonal", "antibody", "targeting", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ")."], "wordsB": ["Although", "CytoDyn", "intends", "to", "focus", "its", "efforts", "on", "PRO", "140,", "we", "also", "hold", "certain", "rights", "in", "two", "proprietary", "platform", "technologies:", "Cytolin", ",", "a", "humanized", "monoclonal", "antibody", "targeting", "HIV", "with", "a", "mechanism", "of", "action", "which", "may", "prove", "to", "be", "synergistic", "to", "that", "of", "PRO", "140", "and", "other", "treatments,", "and", "CytoFeline", ",", "a", "felinized-monoclonal", "antibody", "targeting", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p43_s4", "idA": "1175680_14_item1_p1_s3", "sentA": "Although CytoDyn intends to focus its efforts on PRO 140, the Company also holds certain rights in two proprietary platform technologies: Cytolin , a monoclonal antibody targeting HIV with a mechanism of action which may prove to be synergistic to that of PRO 140 and other treatments; and CytoFeline , a monoclonal antibody targeting Feline Immunodeficiency Virus ( FIV ).", "sentB": "For these reasons, we believe that our lead product, PRO 140, a monoclonal antibody may prove to be useful in patients that cannot tolerate existing HIV therapies or desire a respite from those therapies.", "type": 2, "words": ["<tag1>", "Although", "CytoDyn", "intends", "to", "focus", "its", "efforts", "on", "PRO", "140,", "the", "Company", "also", "holds", "certain", "rights", "in", "two", "proprietary", "platform", "technologies:", "Cytolin", ",", "a", "monoclonal", "antibody", "targeting", "HIV", "with", "a", "mechanism", "of", "action", "which", "may", "prove", "to", "be", "synergistic", "to", "that", "of", "PRO", "140", "and", "other", "treatments;", "and", "CytoFeline", ",", "a", "monoclonal", "antibody", "targeting", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ").", "<tag2>", "For", "these", "reasons,", "we", "believe", "that", "our", "lead", "product,", "PRO", "140,", "a", "monoclonal", "antibody", "may", "prove", "to", "be", "useful", "in", "patients", "that", "cannot", "tolerate", "existing", "HIV", "therapies", "or", "desire", "a", "respite", "from", "those", "therapies.", "<tag3>"], "wordsA": ["Although", "CytoDyn", "intends", "to", "focus", "its", "efforts", "on", "PRO", "140,", "the", "Company", "also", "holds", "certain", "rights", "in", "two", "proprietary", "platform", "technologies:", "Cytolin", ",", "a", "monoclonal", "antibody", "targeting", "HIV", "with", "a", "mechanism", "of", "action", "which", "may", "prove", "to", "be", "synergistic", "to", "that", "of", "PRO", "140", "and", "other", "treatments;", "and", "CytoFeline", ",", "a", "monoclonal", "antibody", "targeting", "Feline", "Immunodeficiency", "Virus", "(", "FIV", ")."], "wordsB": ["For", "these", "reasons,", "we", "believe", "that", "our", "lead", "product,", "PRO", "140,", "a", "monoclonal", "antibody", "may", "prove", "to", "be", "useful", "in", "patients", "that", "cannot", "tolerate", "existing", "HIV", "therapies", "or", "desire", "a", "respite", "from", "those", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p0_s7", "idA": "1175680_14_item1_p1_s4", "sentA": "PRO 140 We believe the PRO 140 antibody shows promise as a powerful anti-viral agent while not being a drug, which means fewer side effects and less frequent dosing requirements as compared to daily drug therapies currently in use.", "sentB": "PRO 140 We believe the PRO 140 antibody shows promise as a powerful anti-viral agent while not being a chemically synthesized drug, which means fewer side effects, lower toxicity and less frequent dosing requirements, as compared to daily drug therapies currently in use.", "type": 2, "words": ["<tag1>", "PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "drug,", "which", "means", "fewer", "side", "effects", "and", "less", "frequent", "dosing", "requirements", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use.", "<tag2>", "PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use.", "<tag3>"], "wordsA": ["PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "drug,", "which", "means", "fewer", "side", "effects", "and", "less", "frequent", "dosing", "requirements", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use."], "wordsB": ["PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p15_s2", "idA": "1175680_14_item1_p1_s4", "sentA": "PRO 140 We believe the PRO 140 antibody shows promise as a powerful anti-viral agent while not being a drug, which means fewer side effects and less frequent dosing requirements as compared to daily drug therapies currently in use.", "sentB": "These advantages include less toxicity, fewer side effects and once-a-week versus daily administration which together may improve patient compliance.", "type": 2, "words": ["<tag1>", "PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "drug,", "which", "means", "fewer", "side", "effects", "and", "less", "frequent", "dosing", "requirements", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use.", "<tag2>", "These", "advantages", "include", "less", "toxicity,", "fewer", "side", "effects", "and", "once-a-week", "versus", "daily", "administration", "which", "together", "may", "improve", "patient", "compliance.", "<tag3>"], "wordsA": ["PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "drug,", "which", "means", "fewer", "side", "effects", "and", "less", "frequent", "dosing", "requirements", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use."], "wordsB": ["These", "advantages", "include", "less", "toxicity,", "fewer", "side", "effects", "and", "once-a-week", "versus", "daily", "administration", "which", "together", "may", "improve", "patient", "compliance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p23_s2", "idA": "1175680_14_item1_p20_s0", "sentA": "Generally, patents issued in the U.S. are effective for either (i) 20 years from the earliest asserted filing date, if the application was filed on or after June 8, 1995, or (ii) the longer of 17 years from the date of issue or 20 years from the earliest asserted filing date, if the application was filed prior to that date, subject to a five-year extension in certain instances.", "sentB": "Generally, patents issued in the U.S. are effective for either (i) 20 years from the earliest asserted filing date, if the application was filed on or after June 8, 1995, or (ii) the longer of 17 years from the date of issue or 20 years from the earliest asserted filing date, if the application was filed prior to that date.", "type": 2, "words": ["<tag1>", "Generally,", "patents", "issued", "in", "the", "U.S.", "are", "effective", "for", "either", "(i)", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "on", "or", "after", "June", "8,", "1995,", "or", "(ii)", "the", "longer", "of", "17", "years", "from", "the", "date", "of", "issue", "or", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "prior", "to", "that", "date,", "subject", "to", "a", "five-year", "extension", "in", "certain", "instances.", "<tag2>", "Generally,", "patents", "issued", "in", "the", "U.S.", "are", "effective", "for", "either", "(i)", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "on", "or", "after", "June", "8,", "1995,", "or", "(ii)", "the", "longer", "of", "17", "years", "from", "the", "date", "of", "issue", "or", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "prior", "to", "that", "date.", "<tag3>"], "wordsA": ["Generally,", "patents", "issued", "in", "the", "U.S.", "are", "effective", "for", "either", "(i)", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "on", "or", "after", "June", "8,", "1995,", "or", "(ii)", "the", "longer", "of", "17", "years", "from", "the", "date", "of", "issue", "or", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "prior", "to", "that", "date,", "subject", "to", "a", "five-year", "extension", "in", "certain", "instances."], "wordsB": ["Generally,", "patents", "issued", "in", "the", "U.S.", "are", "effective", "for", "either", "(i)", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "on", "or", "after", "June", "8,", "1995,", "or", "(ii)", "the", "longer", "of", "17", "years", "from", "the", "date", "of", "issue", "or", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "prior", "to", "that", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p23_s3", "idA": "1175680_14_item1_p20_s0", "sentA": "Generally, patents issued in the U.S. are effective for either (i) 20 years from the earliest asserted filing date, if the application was filed on or after June 8, 1995, or (ii) the longer of 17 years from the date of issue or 20 years from the earliest asserted filing date, if the application was filed prior to that date, subject to a five-year extension in certain instances.", "sentB": "A U.S. patent, to be selected by the company upon receipt of FDA regulatory approval, may be subject to up to a five-year patent term extension in certain instances.", "type": 2, "words": ["<tag1>", "Generally,", "patents", "issued", "in", "the", "U.S.", "are", "effective", "for", "either", "(i)", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "on", "or", "after", "June", "8,", "1995,", "or", "(ii)", "the", "longer", "of", "17", "years", "from", "the", "date", "of", "issue", "or", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "prior", "to", "that", "date,", "subject", "to", "a", "five-year", "extension", "in", "certain", "instances.", "<tag2>", "A", "U.S.", "patent,", "to", "be", "selected", "by", "the", "company", "upon", "receipt", "of", "FDA", "regulatory", "approval,", "may", "be", "subject", "to", "up", "to", "a", "five-year", "patent", "term", "extension", "in", "certain", "instances.", "<tag3>"], "wordsA": ["Generally,", "patents", "issued", "in", "the", "U.S.", "are", "effective", "for", "either", "(i)", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "on", "or", "after", "June", "8,", "1995,", "or", "(ii)", "the", "longer", "of", "17", "years", "from", "the", "date", "of", "issue", "or", "20", "years", "from", "the", "earliest", "asserted", "filing", "date,", "if", "the", "application", "was", "filed", "prior", "to", "that", "date,", "subject", "to", "a", "five-year", "extension", "in", "certain", "instances."], "wordsB": ["A", "U.S.", "patent,", "to", "be", "selected", "by", "the", "company", "upon", "receipt", "of", "FDA", "regulatory", "approval,", "may", "be", "subject", "to", "up", "to", "a", "five-year", "patent", "term", "extension", "in", "certain", "instances."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p23_s4", "idA": "1175680_14_item1_p20_s1", "sentA": "The duration of foreign patents varies in accordance with the provisions of applicable local law, although most countries provide for patent terms of 20 years from the earliest asserted filing date and allow patent extensions similar to those permitted in the U.S.", "sentB": "While the duration of foreign patents varies in accordance with the provisions of applicable local law, most countries provide for a patent term of 20 years measured from the application filing date and some may also allow for patent term extension to compensate for regulatory approval delay.", "type": 2, "words": ["<tag1>", "The", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "although", "most", "countries", "provide", "for", "patent", "terms", "of", "20", "years", "from", "the", "earliest", "asserted", "filing", "date", "and", "allow", "patent", "extensions", "similar", "to", "those", "permitted", "in", "the", "U.S.", "<tag2>", "While", "the", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "most", "countries", "provide", "for", "a", "patent", "term", "of", "20", "years", "measured", "from", "the", "application", "filing", "date", "and", "some", "may", "also", "allow", "for", "patent", "term", "extension", "to", "compensate", "for", "regulatory", "approval", "delay.", "<tag3>"], "wordsA": ["The", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "although", "most", "countries", "provide", "for", "patent", "terms", "of", "20", "years", "from", "the", "earliest", "asserted", "filing", "date", "and", "allow", "patent", "extensions", "similar", "to", "those", "permitted", "in", "the", "U.S."], "wordsB": ["While", "the", "duration", "of", "foreign", "patents", "varies", "in", "accordance", "with", "the", "provisions", "of", "applicable", "local", "law,", "most", "countries", "provide", "for", "a", "patent", "term", "of", "20", "years", "measured", "from", "the", "application", "filing", "date", "and", "some", "may", "also", "allow", "for", "patent", "term", "extension", "to", "compensate", "for", "regulatory", "approval", "delay."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p25_s0", "idA": "1175680_14_item1_p21_s0", "sentA": "Patents may not enable us to preclude competitors from commercializing drugs in direct competition with our products, and consequently may not provide us with any meaningful competitive advantage.", "sentB": "Patents do not enable us to preclude competitors from commercializing drugs in direct competition with our products that are not covered by granted and enforceable patent claims.", "type": 2, "words": ["<tag1>", "Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage.", "<tag2>", "Patents", "do", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products", "that", "are", "not", "covered", "by", "granted", "and", "enforceable", "patent", "claims.", "<tag3>"], "wordsA": ["Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage."], "wordsB": ["Patents", "do", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products", "that", "are", "not", "covered", "by", "granted", "and", "enforceable", "patent", "claims."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p25_s1", "idA": "1175680_14_item1_p21_s0", "sentA": "Patents may not enable us to preclude competitors from commercializing drugs in direct competition with our products, and consequently may not provide us with any meaningful competitive advantage.", "sentB": "Consequently, patents may not provide us with any meaningful competitive advantage.", "type": 2, "words": ["<tag1>", "Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage.", "<tag2>", "Consequently,", "patents", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage.", "<tag3>"], "wordsA": ["Patents", "may", "not", "enable", "us", "to", "preclude", "competitors", "from", "commercializing", "drugs", "in", "direct", "competition", "with", "our", "products,", "and", "consequently", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage."], "wordsB": ["Consequently,", "patents", "may", "not", "provide", "us", "with", "any", "meaningful", "competitive", "advantage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p20_s5", "idA": "1175680_14_item1_p21_s1", "sentA": "See related risk factors under Item 1A Risk Factors below.", "sentB": "See Note 7 to the financial statements included herein under Item 8.", "type": 2, "words": ["<tag1>", "See", "related", "risk", "factors", "under", "Item", "1A", "Risk", "Factors", "below.", "<tag2>", "See", "Note", "7", "to", "the", "financial", "statements", "included", "herein", "under", "Item", "8.", "<tag3>"], "wordsA": ["See", "related", "risk", "factors", "under", "Item", "1A", "Risk", "Factors", "below."], "wordsB": ["See", "Note", "7", "to", "the", "financial", "statements", "included", "herein", "under", "Item", "8."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p25_s2", "idA": "1175680_14_item1_p21_s1", "sentA": "See related risk factors under Item 1A Risk Factors below.", "sentB": "See related risk factors under the heading Risk Factors above.", "type": 2, "words": ["<tag1>", "See", "related", "risk", "factors", "under", "Item", "1A", "Risk", "Factors", "below.", "<tag2>", "See", "related", "risk", "factors", "under", "the", "heading", "Risk", "Factors", "above.", "<tag3>"], "wordsA": ["See", "related", "risk", "factors", "under", "Item", "1A", "Risk", "Factors", "below."], "wordsB": ["See", "related", "risk", "factors", "under", "the", "heading", "Risk", "Factors", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p25_s3", "idA": "1175680_14_item1_p22_s0", "sentA": "We may also rely on trade secrets and proprietary know-how to develop and attempt to achieve a competitive position with our product candidates.", "sentB": "We may also rely on data exclusivity, trade secrets and proprietary know-how to develop and attempt to achieve a competitive position with our product candidates.", "type": 2, "words": ["<tag1>", "We", "may", "also", "rely", "on", "trade", "secrets", "and", "proprietary", "know-how", "to", "develop", "and", "attempt", "to", "achieve", "a", "competitive", "position", "with", "our", "product", "candidates.", "<tag2>", "We", "may", "also", "rely", "on", "data", "exclusivity,", "trade", "secrets", "and", "proprietary", "know-how", "to", "develop", "and", "attempt", "to", "achieve", "a", "competitive", "position", "with", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "may", "also", "rely", "on", "trade", "secrets", "and", "proprietary", "know-how", "to", "develop", "and", "attempt", "to", "achieve", "a", "competitive", "position", "with", "our", "product", "candidates."], "wordsB": ["We", "may", "also", "rely", "on", "data", "exclusivity,", "trade", "secrets", "and", "proprietary", "know-how", "to", "develop", "and", "attempt", "to", "achieve", "a", "competitive", "position", "with", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p27_s0", "idA": "1175680_14_item1_p22_s2", "sentA": "Information with respect to our current patent portfolio is set forth below.", "sentB": "Information with respect to our current patent portfolio as of May 31, 2015, is set forth below.", "type": 2, "words": ["<tag1>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "is", "set", "forth", "below.", "<tag2>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2015,", "is", "set", "forth", "below.", "<tag3>"], "wordsA": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "is", "set", "forth", "below."], "wordsB": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2015,", "is", "set", "forth", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p1_s1", "idA": "1175680_14_item1_p2_s1", "sentA": "PRO 140 blocks HIV from entering a cell by binding to a molecule called CCR5, a normal cell surface receptor protein to which HIV attaches as part of HIV s entry into a cell.", "sentB": "PRO 140 blocks HIV from entering a cell by binding to a molecule called CCR5, a normal cell surface co-receptor protein to which HIV attaches as part of HIV s entry into a cell.", "type": 2, "words": ["<tag1>", "PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell.", "<tag2>", "PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "co-receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell.", "<tag3>"], "wordsA": ["PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell."], "wordsB": ["PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "co-receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p43_s0", "idA": "1175680_14_item1_p2_s1", "sentA": "PRO 140 blocks HIV from entering a cell by binding to a molecule called CCR5, a normal cell surface receptor protein to which HIV attaches as part of HIV s entry into a cell.", "sentB": "PRO 140 blocks a cell receptor called CCR5, which is the entry point for most strains of HIV virus.", "type": 2, "words": ["<tag1>", "PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell.", "<tag2>", "PRO", "140", "blocks", "a", "cell", "receptor", "called", "CCR5,", "which", "is", "the", "entry", "point", "for", "most", "strains", "of", "HIV", "virus.", "<tag3>"], "wordsA": ["PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell."], "wordsB": ["PRO", "140", "blocks", "a", "cell", "receptor", "called", "CCR5,", "which", "is", "the", "entry", "point", "for", "most", "strains", "of", "HIV", "virus."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p2_s0", "idA": "1175680_14_item1_p3_s0", "sentA": "PRO 140 is an antibody and not a drug, and through preliminary, short-term trials it has demonstrated efficacy without issues relating to toxicity and autoimmune resistance.", "sentB": "PRO 140 is an antibody and not a chemically synthesized drug, and through preliminary, short-term trials it has demonstrated efficacy without issues relating to toxicity and autoimmune resistance.", "type": 2, "words": ["<tag1>", "PRO", "140", "is", "an", "antibody", "and", "not", "a", "drug,", "and", "through", "preliminary,", "short-term", "trials", "it", "has", "demonstrated", "efficacy", "without", "issues", "relating", "to", "toxicity", "and", "autoimmune", "resistance.", "<tag2>", "PRO", "140", "is", "an", "antibody", "and", "not", "a", "chemically", "synthesized", "drug,", "and", "through", "preliminary,", "short-term", "trials", "it", "has", "demonstrated", "efficacy", "without", "issues", "relating", "to", "toxicity", "and", "autoimmune", "resistance.", "<tag3>"], "wordsA": ["PRO", "140", "is", "an", "antibody", "and", "not", "a", "drug,", "and", "through", "preliminary,", "short-term", "trials", "it", "has", "demonstrated", "efficacy", "without", "issues", "relating", "to", "toxicity", "and", "autoimmune", "resistance."], "wordsB": ["PRO", "140", "is", "an", "antibody", "and", "not", "a", "chemically", "synthesized", "drug,", "and", "through", "preliminary,", "short-term", "trials", "it", "has", "demonstrated", "efficacy", "without", "issues", "relating", "to", "toxicity", "and", "autoimmune", "resistance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p2_s1", "idA": "1175680_14_item1_p3_s1", "sentA": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 receptor.", "sentB": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "receptor.", "<tag2>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "receptor."], "wordsB": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p4_s0", "idA": "1175680_14_item1_p5_s0", "sentA": "Jeffrey M. Jacobson, M.D., Professor of Medicine, Microbiology and Immunology, Chief, Drexel University College of Medicine ( Drexel ), has conducted prior research relating to PRO 140, and is continuing to pursue two clinical trials partially funded through two grants awarded to Drexel and Dr. Jacobson by the National Institutes of Health ( NIH ).", "sentB": "Jeffrey M. Jacobson, M.D., Professor of Medicine, Microbiology and Immunology, Chief, Drexel University College of Medicine ( Drexel ), has conducted prior research relating to PRO 140, and is continuing to pursue one clinical trial partially funded through one grant awarded to Dr. Jacobson by the National Institutes of Health ( NIH ).", "type": 2, "words": ["<tag1>", "Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "has", "conducted", "prior", "research", "relating", "to", "PRO", "140,", "and", "is", "continuing", "to", "pursue", "two", "clinical", "trials", "partially", "funded", "through", "two", "grants", "awarded", "to", "Drexel", "and", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ").", "<tag2>", "Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "has", "conducted", "prior", "research", "relating", "to", "PRO", "140,", "and", "is", "continuing", "to", "pursue", "one", "clinical", "trial", "partially", "funded", "through", "one", "grant", "awarded", "to", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ").", "<tag3>"], "wordsA": ["Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "has", "conducted", "prior", "research", "relating", "to", "PRO", "140,", "and", "is", "continuing", "to", "pursue", "two", "clinical", "trials", "partially", "funded", "through", "two", "grants", "awarded", "to", "Drexel", "and", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ")."], "wordsB": ["Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "has", "conducted", "prior", "research", "relating", "to", "PRO", "140,", "and", "is", "continuing", "to", "pursue", "one", "clinical", "trial", "partially", "funded", "through", "one", "grant", "awarded", "to", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p14_s0", "idA": "1175680_14_item1_p5_s1", "sentA": "We have also initiated steps to explore additional therapeutic indications for PRO 140 under our own auspices, primary among which is our current clinical trial exploring PRO 140 as a short-term treatment substitution for existing drug regimens.", "sentB": "The Company s first Phase 3 study is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "type": 2, "words": ["<tag1>", "We", "have", "also", "initiated", "steps", "to", "explore", "additional", "therapeutic", "indications", "for", "PRO", "140", "under", "our", "own", "auspices,", "primary", "among", "which", "is", "our", "current", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "for", "existing", "drug", "regimens.", "<tag2>", "The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag3>"], "wordsA": ["We", "have", "also", "initiated", "steps", "to", "explore", "additional", "therapeutic", "indications", "for", "PRO", "140", "under", "our", "own", "auspices,", "primary", "among", "which", "is", "our", "current", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "for", "existing", "drug", "regimens."], "wordsB": ["The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p4_s1", "idA": "1175680_14_item1_p5_s1", "sentA": "We have also initiated steps to explore additional therapeutic indications for PRO 140 under our own auspices, primary among which is our current clinical trial exploring PRO 140 as a short-term treatment substitution for existing drug regimens.", "sentB": "We have also recently completed a successful Phase 2b clinical trial exploring PRO 140 as a short-term treatment substitution (as a monotherapy of PRO 140) for existing drug regimens.", "type": 2, "words": ["<tag1>", "We", "have", "also", "initiated", "steps", "to", "explore", "additional", "therapeutic", "indications", "for", "PRO", "140", "under", "our", "own", "auspices,", "primary", "among", "which", "is", "our", "current", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "for", "existing", "drug", "regimens.", "<tag2>", "We", "have", "also", "recently", "completed", "a", "successful", "Phase", "2b", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "drug", "regimens.", "<tag3>"], "wordsA": ["We", "have", "also", "initiated", "steps", "to", "explore", "additional", "therapeutic", "indications", "for", "PRO", "140", "under", "our", "own", "auspices,", "primary", "among", "which", "is", "our", "current", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "for", "existing", "drug", "regimens."], "wordsB": ["We", "have", "also", "recently", "completed", "a", "successful", "Phase", "2b", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "drug", "regimens."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p5_s0", "idA": "1175680_14_item1_p5_s2", "sentA": "To facilitate our self-funded and sponsored clinical research plans, we have engaged Amarex Clinical Research, LLC ( Amarex ), our principal contract research organization, to provide comprehensive clinical trial services with respect to our treatment substitution study, including managing our chemistry and manufacturing control ( CMC ) activities.", "sentB": "To facilitate our self-funded and sponsored clinical research plans, we have engaged Amarex Clinical Research, LLC ( Amarex ), our principal contract research organization, to provide comprehensive clinical trial services, including managing our chemistry, manufacturing and controls ( CMC ) activities.", "type": 2, "words": ["<tag1>", "To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans,", "we", "have", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "our", "principal", "contract", "research", "organization,", "to", "provide", "comprehensive", "clinical", "trial", "services", "with", "respect", "to", "our", "treatment", "substitution", "study,", "including", "managing", "our", "chemistry", "and", "manufacturing", "control", "(", "CMC", ")", "activities.", "<tag2>", "To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans,", "we", "have", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "our", "principal", "contract", "research", "organization,", "to", "provide", "comprehensive", "clinical", "trial", "services,", "including", "managing", "our", "chemistry,", "manufacturing", "and", "controls", "(", "CMC", ")", "activities.", "<tag3>"], "wordsA": ["To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans,", "we", "have", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "our", "principal", "contract", "research", "organization,", "to", "provide", "comprehensive", "clinical", "trial", "services", "with", "respect", "to", "our", "treatment", "substitution", "study,", "including", "managing", "our", "chemistry", "and", "manufacturing", "control", "(", "CMC", ")", "activities."], "wordsB": ["To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans,", "we", "have", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "our", "principal", "contract", "research", "organization,", "to", "provide", "comprehensive", "clinical", "trial", "services,", "including", "managing", "our", "chemistry,", "manufacturing", "and", "controls", "(", "CMC", ")", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p5_s1", "idA": "1175680_14_item1_p5_s6", "sentA": "In furtherance of our business strategy and subsequent to fiscal year-end 2014, the Company has entered into a manufacturing agreement with a contract manufacturing organization to initiate preparations for the potential future manufacturing of additional PRO 140.", "sentB": "In furtherance of our business strategy, in mid-2014 we entered into a manufacturing agreement with a contract manufacturing organization to initiate preparations for the future manufacturing of additional PRO 140.", "type": 2, "words": ["<tag1>", "In", "furtherance", "of", "our", "business", "strategy", "and", "subsequent", "to", "fiscal", "year-end", "2014,", "the", "Company", "has", "entered", "into", "a", "manufacturing", "agreement", "with", "a", "contract", "manufacturing", "organization", "to", "initiate", "preparations", "for", "the", "potential", "future", "manufacturing", "of", "additional", "PRO", "140.", "<tag2>", "In", "furtherance", "of", "our", "business", "strategy,", "in", "mid-2014", "we", "entered", "into", "a", "manufacturing", "agreement", "with", "a", "contract", "manufacturing", "organization", "to", "initiate", "preparations", "for", "the", "future", "manufacturing", "of", "additional", "PRO", "140.", "<tag3>"], "wordsA": ["In", "furtherance", "of", "our", "business", "strategy", "and", "subsequent", "to", "fiscal", "year-end", "2014,", "the", "Company", "has", "entered", "into", "a", "manufacturing", "agreement", "with", "a", "contract", "manufacturing", "organization", "to", "initiate", "preparations", "for", "the", "potential", "future", "manufacturing", "of", "additional", "PRO", "140."], "wordsB": ["In", "furtherance", "of", "our", "business", "strategy,", "in", "mid-2014", "we", "entered", "into", "a", "manufacturing", "agreement", "with", "a", "contract", "manufacturing", "organization", "to", "initiate", "preparations", "for", "the", "future", "manufacturing", "of", "additional", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p7_s3", "idA": "1175680_14_item1_p6_s0", "sentA": "To date, PRO 140 has only been tested and administered to test subjects either intravenously or as a subcutaneous injection.", "sentB": "PRO 140 has no effect on strains of HIV called X4 exclusive virus.", "type": 2, "words": ["<tag1>", "To", "date,", "PRO", "140", "has", "only", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection.", "<tag2>", "PRO", "140", "has", "no", "effect", "on", "strains", "of", "HIV", "called", "X4", "exclusive", "virus.", "<tag3>"], "wordsA": ["To", "date,", "PRO", "140", "has", "only", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection."], "wordsB": ["PRO", "140", "has", "no", "effect", "on", "strains", "of", "HIV", "called", "X4", "exclusive", "virus."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p6_s1", "idA": "1175680_14_item1_p6_s1", "sentA": "We believe that, if PRO 140 is approved for use as an injectable by the FDA, it may nonetheless be an attractive and marketable therapeutic option (for patients with healthy CCR5), particularly in the following scenarios:", "sentB": "We believe that, if PRO 140 is approved for use as an injectable by the FDA, it may nonetheless be an attractive and marketable therapeutic option for patients with healthy CCR5, particularly in the following scenarios:", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "(for", "patients", "with", "healthy", "CCR5),", "particularly", "in", "the", "following", "scenarios:", "<tag2>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients", "with", "healthy", "CCR5,", "particularly", "in", "the", "following", "scenarios:", "<tag3>"], "wordsA": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "(for", "patients", "with", "healthy", "CCR5),", "particularly", "in", "the", "following", "scenarios:"], "wordsB": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients", "with", "healthy", "CCR5,", "particularly", "in", "the", "following", "scenarios:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p15_s1", "idA": "1175680_14_item1_p9_s0", "sentA": "Current Clinical Trials PRO 140 is currently being studied in three clinical trials.", "sentB": "PRO 140 is currently being tested as a once-a-week subcutaneous injection of 350mg dose).", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "three", "clinical", "trials.", "<tag2>", "PRO", "140", "is", "currently", "being", "tested", "as", "a", "once-a-week", "subcutaneous", "injection", "of", "350mg", "dose).", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "three", "clinical", "trials."], "wordsB": ["PRO", "140", "is", "currently", "being", "tested", "as", "a", "once-a-week", "subcutaneous", "injection", "of", "350mg", "dose)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p42_s2", "idA": "1175680_14_item1_p9_s0", "sentA": "Current Clinical Trials PRO 140 is currently being studied in three clinical trials.", "sentB": "Advancing PRO 140 is our highest priority.", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "three", "clinical", "trials.", "<tag2>", "Advancing", "PRO", "140", "is", "our", "highest", "priority.", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "three", "clinical", "trials."], "wordsB": ["Advancing", "PRO", "140", "is", "our", "highest", "priority."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p8_s0", "idA": "1175680_14_item1_p9_s0", "sentA": "Current Clinical Trials PRO 140 is currently being studied in three clinical trials.", "sentB": "Current Clinical Trials PRO 140 is currently being studied in two clinical trials.", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "three", "clinical", "trials.", "<tag2>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials.", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "three", "clinical", "trials."], "wordsB": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p8_s1", "idA": "1175680_14_item1_p9_s1", "sentA": "Two studies are led by Drexel and Dr. Jeffrey Jacobson.", "sentB": "One study is led by Dr. Jeffrey Jacobson.", "type": 2, "words": ["<tag1>", "Two", "studies", "are", "led", "by", "Drexel", "and", "Dr.", "Jeffrey", "Jacobson.", "<tag2>", "One", "study", "is", "led", "by", "Dr.", "Jeffrey", "Jacobson.", "<tag3>"], "wordsA": ["Two", "studies", "are", "led", "by", "Drexel", "and", "Dr.", "Jeffrey", "Jacobson."], "wordsB": ["One", "study", "is", "led", "by", "Dr.", "Jeffrey", "Jacobson."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p40_s1", "idA": "1175680_14_item1_p9_s2", "sentA": "These studies are funded directly through grants from NIH.", "sentB": "These studies are closely monitored and may be conducted in patients, but are usually conducted in a small number of healthy volunteer subjects.", "type": 2, "words": ["<tag1>", "These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH.", "<tag2>", "These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "subjects.", "<tag3>"], "wordsA": ["These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH."], "wordsB": ["These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "subjects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p40_s2", "idA": "1175680_14_item1_p9_s2", "sentA": "These studies are funded directly through grants from NIH.", "sentB": "These studies are designed to determine the metabolic and pharmacologic actions of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness.", "type": 2, "words": ["<tag1>", "These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH.", "<tag2>", "These", "studies", "are", "designed", "to", "determine", "the", "metabolic", "and", "pharmacologic", "actions", "of", "the", "investigational", "product", "in", "humans,", "the", "side", "effects", "associated", "with", "increasing", "doses,", "and,", "if", "possible,", "to", "gain", "early", "evidence", "on", "effectiveness.", "<tag3>"], "wordsA": ["These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH."], "wordsB": ["These", "studies", "are", "designed", "to", "determine", "the", "metabolic", "and", "pharmacologic", "actions", "of", "the", "investigational", "product", "in", "humans,", "the", "side", "effects", "associated", "with", "increasing", "doses,", "and,", "if", "possible,", "to", "gain", "early", "evidence", "on", "effectiveness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p41_s8", "idA": "1175680_14_item1_p9_s2", "sentA": "These studies are funded directly through grants from NIH.", "sentB": "Phase 3 Phase 3 studies are expanded controlled clinical studies.", "type": 2, "words": ["<tag1>", "These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH.", "<tag2>", "Phase", "3", "Phase", "3", "studies", "are", "expanded", "controlled", "clinical", "studies.", "<tag3>"], "wordsA": ["These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH."], "wordsB": ["Phase", "3", "Phase", "3", "studies", "are", "expanded", "controlled", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_15_item1_p8_s2", "idA": "1175680_14_item1_p9_s2", "sentA": "These studies are funded directly through grants from NIH.", "sentB": "This study is funded directly through grants from NIH.", "type": 2, "words": ["<tag1>", "These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH.", "<tag2>", "This", "study", "is", "funded", "directly", "through", "grants", "from", "NIH.", "<tag3>"], "wordsA": ["These", "studies", "are", "funded", "directly", "through", "grants", "from", "NIH."], "wordsB": ["This", "study", "is", "funded", "directly", "through", "grants", "from", "NIH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p1_s0", "idA": "1175680_15_item1_p0_s0", "sentA": "CytoDyn Inc. is a Colorado corporation with its principal business office at 1111 Main Street, Suite 660, Vancouver, Washington 98660.", "sentB": "Our principal business office is 1111 Main Street, Suite 660, Vancouver, Washington 98660.", "type": 2, "words": ["<tag1>", "CytoDyn", "Inc.", "is", "a", "Colorado", "corporation", "with", "its", "principal", "business", "office", "at", "1111", "Main", "Street,", "Suite", "660,", "Vancouver,", "Washington", "98660.", "<tag2>", "Our", "principal", "business", "office", "is", "1111", "Main", "Street,", "Suite", "660,", "Vancouver,", "Washington", "98660.", "<tag3>"], "wordsA": ["CytoDyn", "Inc.", "is", "a", "Colorado", "corporation", "with", "its", "principal", "business", "office", "at", "1111", "Main", "Street,", "Suite", "660,", "Vancouver,", "Washington", "98660."], "wordsB": ["Our", "principal", "business", "office", "is", "1111", "Main", "Street,", "Suite", "660,", "Vancouver,", "Washington", "98660."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p2_s0", "idA": "1175680_15_item1_p0_s3", "sentA": "We are a publicly traded biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "sentB": "We are a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "type": 2, "words": ["<tag1>", "We", "are", "a", "publicly", "traded", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag2>", "We", "are", "a", "clinical-stage", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag3>"], "wordsA": ["We", "are", "a", "publicly", "traded", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "wordsB": ["We", "are", "a", "clinical-stage", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p4_s0", "idA": "1175680_15_item1_p0_s7", "sentA": "PRO 140 We believe the PRO 140 antibody shows promise as a powerful anti-viral agent while not being a chemically synthesized drug, which means fewer side effects, lower toxicity and less frequent dosing requirements, as compared to daily drug therapies currently in use.", "sentB": "PRO 140 We believe the PRO 140 antibody shows promise as a powerful anti-viral agent while not being a chemically synthesized drug, which means fewer side effects, lower toxicity and less frequent dosing requirements, as compared to daily drug therapies currently in use for the treatment of HIV.", "type": 2, "words": ["<tag1>", "PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use.", "<tag2>", "PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use", "for", "the", "treatment", "of", "HIV.", "<tag3>"], "wordsA": ["PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use."], "wordsB": ["PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use", "for", "the", "treatment", "of", "HIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p20_s0", "idA": "1175680_15_item1_p10_s0", "sentA": "The Company s Phase 2b treatment substitution clinical trial results through May 31, 2015, (excluding patients who failed due to having the Dual/Mix[II1] virus, therefore were screening failures) are as follows:", "sentB": "Below are the results from our Phase 2b treatment substitution clinical trial, excluding certain patients who violated trial protocol or were later categorized by third party tropism tests as not being infected by CCR5-tropic virus strains exclusively.", "type": 2, "words": ["<tag1>", "The", "Company", "s", "Phase", "2b", "treatment", "substitution", "clinical", "trial", "results", "through", "May", "31,", "2015,", "(excluding", "patients", "who", "failed", "due", "to", "having", "the", "Dual/Mix[II1]", "virus,", "therefore", "were", "screening", "failures)", "are", "as", "follows:", "<tag2>", "Below", "are", "the", "results", "from", "our", "Phase", "2b", "treatment", "substitution", "clinical", "trial,", "excluding", "certain", "patients", "who", "violated", "trial", "protocol", "or", "were", "later", "categorized", "by", "third", "party", "tropism", "tests", "as", "not", "being", "infected", "by", "CCR5-tropic", "virus", "strains", "exclusively.", "<tag3>"], "wordsA": ["The", "Company", "s", "Phase", "2b", "treatment", "substitution", "clinical", "trial", "results", "through", "May", "31,", "2015,", "(excluding", "patients", "who", "failed", "due", "to", "having", "the", "Dual/Mix[II1]", "virus,", "therefore", "were", "screening", "failures)", "are", "as", "follows:"], "wordsB": ["Below", "are", "the", "results", "from", "our", "Phase", "2b", "treatment", "substitution", "clinical", "trial,", "excluding", "certain", "patients", "who", "violated", "trial", "protocol", "or", "were", "later", "categorized", "by", "third", "party", "tropism", "tests", "as", "not", "being", "infected", "by", "CCR5-tropic", "virus", "strains", "exclusively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p21_s0", "idA": "1175680_15_item1_p12_s0", "sentA": "As only HIV patients who have CCR5 virus exclusively can benefit from PRO 140, each patient is required to take a DNA Trofile test prior to enrollment in the study.", "sentB": "Because only patients who have HIV R5 virus exclusively can benefit from PRO 140, prior to enrollment in the study, each patient was required to take a DNA tropism test to determine whether the strain of HIV present in the patient was exclusively the R5 strain, making the patient a suitable candidate for PRO 140 therapy.", "type": 2, "words": ["<tag1>", "As", "only", "HIV", "patients", "who", "have", "CCR5", "virus", "exclusively", "can", "benefit", "from", "PRO", "140,", "each", "patient", "is", "required", "to", "take", "a", "DNA", "Trofile", "test", "prior", "to", "enrollment", "in", "the", "study.", "<tag2>", "Because", "only", "patients", "who", "have", "HIV", "R5", "virus", "exclusively", "can", "benefit", "from", "PRO", "140,", "prior", "to", "enrollment", "in", "the", "study,", "each", "patient", "was", "required", "to", "take", "a", "DNA", "tropism", "test", "to", "determine", "whether", "the", "strain", "of", "HIV", "present", "in", "the", "patient", "was", "exclusively", "the", "R5", "strain,", "making", "the", "patient", "a", "suitable", "candidate", "for", "PRO", "140", "therapy.", "<tag3>"], "wordsA": ["As", "only", "HIV", "patients", "who", "have", "CCR5", "virus", "exclusively", "can", "benefit", "from", "PRO", "140,", "each", "patient", "is", "required", "to", "take", "a", "DNA", "Trofile", "test", "prior", "to", "enrollment", "in", "the", "study."], "wordsB": ["Because", "only", "patients", "who", "have", "HIV", "R5", "virus", "exclusively", "can", "benefit", "from", "PRO", "140,", "prior", "to", "enrollment", "in", "the", "study,", "each", "patient", "was", "required", "to", "take", "a", "DNA", "tropism", "test", "to", "determine", "whether", "the", "strain", "of", "HIV", "present", "in", "the", "patient", "was", "exclusively", "the", "R5", "strain,", "making", "the", "patient", "a", "suitable", "candidate", "for", "PRO", "140", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p17_s0", "idA": "1175680_15_item1_p12_s1", "sentA": "However, this test is not very accurate in patients with an undetectable viral load.", "sentB": "The third ongoing trial is a strategic Phase 3 trial including 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "type": 2, "words": ["<tag1>", "However,", "this", "test", "is", "not", "very", "accurate", "in", "patients", "with", "an", "undetectable", "viral", "load.", "<tag2>", "The", "third", "ongoing", "trial", "is", "a", "strategic", "Phase", "3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag3>"], "wordsA": ["However,", "this", "test", "is", "not", "very", "accurate", "in", "patients", "with", "an", "undetectable", "viral", "load."], "wordsB": ["The", "third", "ongoing", "trial", "is", "a", "strategic", "Phase", "3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p21_s1", "idA": "1175680_15_item1_p12_s1", "sentA": "However, this test is not very accurate in patients with an undetectable viral load.", "sentB": "The tropism test, however, is not accurate in patients with an undetectable viral load, which was one of the primary inclusion criteria for the Phase 2b trial.", "type": 2, "words": ["<tag1>", "However,", "this", "test", "is", "not", "very", "accurate", "in", "patients", "with", "an", "undetectable", "viral", "load.", "<tag2>", "The", "tropism", "test,", "however,", "is", "not", "accurate", "in", "patients", "with", "an", "undetectable", "viral", "load,", "which", "was", "one", "of", "the", "primary", "inclusion", "criteria", "for", "the", "Phase", "2b", "trial.", "<tag3>"], "wordsA": ["However,", "this", "test", "is", "not", "very", "accurate", "in", "patients", "with", "an", "undetectable", "viral", "load."], "wordsB": ["The", "tropism", "test,", "however,", "is", "not", "accurate", "in", "patients", "with", "an", "undetectable", "viral", "load,", "which", "was", "one", "of", "the", "primary", "inclusion", "criteria", "for", "the", "Phase", "2b", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p27_s0", "idA": "1175680_15_item1_p12_s1", "sentA": "However, this test is not very accurate in patients with an undetectable viral load.", "sentB": "Phase 3 Trial for HIV, as Long-term Monotherapy A strategic Phase 3 trial including 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "type": 2, "words": ["<tag1>", "However,", "this", "test", "is", "not", "very", "accurate", "in", "patients", "with", "an", "undetectable", "viral", "load.", "<tag2>", "Phase", "3", "Trial", "for", "HIV,", "as", "Long-term", "Monotherapy", "A", "strategic", "Phase", "3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag3>"], "wordsA": ["However,", "this", "test", "is", "not", "very", "accurate", "in", "patients", "with", "an", "undetectable", "viral", "load."], "wordsB": ["Phase", "3", "Trial", "for", "HIV,", "as", "Long-term", "Monotherapy", "A", "strategic", "Phase", "3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p21_s2", "idA": "1175680_15_item1_p12_s2", "sentA": "Therefore, the occurrence of a number of viral rebounds due to inaccurate trofile screening was not unexpected.", "sentB": "The occurrence of a number of viral rebounds due to inaccurate tropism screening, as demonstrated in the trial data, was not unexpected.", "type": 2, "words": ["<tag1>", "Therefore,", "the", "occurrence", "of", "a", "number", "of", "viral", "rebounds", "due", "to", "inaccurate", "trofile", "screening", "was", "not", "unexpected.", "<tag2>", "The", "occurrence", "of", "a", "number", "of", "viral", "rebounds", "due", "to", "inaccurate", "tropism", "screening,", "as", "demonstrated", "in", "the", "trial", "data,", "was", "not", "unexpected.", "<tag3>"], "wordsA": ["Therefore,", "the", "occurrence", "of", "a", "number", "of", "viral", "rebounds", "due", "to", "inaccurate", "trofile", "screening", "was", "not", "unexpected."], "wordsB": ["The", "occurrence", "of", "a", "number", "of", "viral", "rebounds", "due", "to", "inaccurate", "tropism", "screening,", "as", "demonstrated", "in", "the", "trial", "data,", "was", "not", "unexpected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p18_s5", "idA": "1175680_15_item1_p13_s0", "sentA": "On May 4, 2015, the Company announced that it has reached an agreement with the FDA on the Company s previously submitted Phase 3 protocol synopsis for PRO 140 and submitted the full Phase 3 protocol to the FDA.", "sentB": "Treatment na ve or patients who have yet to begin an antiretroviral therapy are highly contagious and the Company believes such an application for PRO 140 can be highly advantageous to the patients and the HIV population.", "type": 2, "words": ["<tag1>", "On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA.", "<tag2>", "Treatment", "na", "ve", "or", "patients", "who", "have", "yet", "to", "begin", "an", "antiretroviral", "therapy", "are", "highly", "contagious", "and", "the", "Company", "believes", "such", "an", "application", "for", "PRO", "140", "can", "be", "highly", "advantageous", "to", "the", "patients", "and", "the", "HIV", "population.", "<tag3>"], "wordsA": ["On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA."], "wordsB": ["Treatment", "na", "ve", "or", "patients", "who", "have", "yet", "to", "begin", "an", "antiretroviral", "therapy", "are", "highly", "contagious", "and", "the", "Company", "believes", "such", "an", "application", "for", "PRO", "140", "can", "be", "highly", "advantageous", "to", "the", "patients", "and", "the", "HIV", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p26_s0", "idA": "1175680_15_item1_p13_s0", "sentA": "On May 4, 2015, the Company announced that it has reached an agreement with the FDA on the Company s previously submitted Phase 3 protocol synopsis for PRO 140 and submitted the full Phase 3 protocol to the FDA.", "sentB": "In late January 2016, we announced that we had filed a request with the FDA for designation as a breakthrough therapy treatment for certain HIV patients.", "type": 2, "words": ["<tag1>", "On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA.", "<tag2>", "In", "late", "January", "2016,", "we", "announced", "that", "we", "had", "filed", "a", "request", "with", "the", "FDA", "for", "designation", "as", "a", "breakthrough", "therapy", "treatment", "for", "certain", "HIV", "patients.", "<tag3>"], "wordsA": ["On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA."], "wordsB": ["In", "late", "January", "2016,", "we", "announced", "that", "we", "had", "filed", "a", "request", "with", "the", "FDA", "for", "designation", "as", "a", "breakthrough", "therapy", "treatment", "for", "certain", "HIV", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p32_s6", "idA": "1175680_15_item1_p13_s0", "sentA": "On May 4, 2015, the Company announced that it has reached an agreement with the FDA on the Company s previously submitted Phase 3 protocol synopsis for PRO 140 and submitted the full Phase 3 protocol to the FDA.", "sentB": "In late December 2015, we announced that we had filed with the FDA for designation of PRO 140 as an orphan drug, in connection with our GvHD Phase 2 trial and remains open at this time pending submission by the Company of additional clinical data.", "type": 2, "words": ["<tag1>", "On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA.", "<tag2>", "In", "late", "December", "2015,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "for", "designation", "of", "PRO", "140", "as", "an", "orphan", "drug,", "in", "connection", "with", "our", "GvHD", "Phase", "2", "trial", "and", "remains", "open", "at", "this", "time", "pending", "submission", "by", "the", "Company", "of", "additional", "clinical", "data.", "<tag3>"], "wordsA": ["On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA."], "wordsB": ["In", "late", "December", "2015,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "for", "designation", "of", "PRO", "140", "as", "an", "orphan", "drug,", "in", "connection", "with", "our", "GvHD", "Phase", "2", "trial", "and", "remains", "open", "at", "this", "time", "pending", "submission", "by", "the", "Company", "of", "additional", "clinical", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p34_s3", "idA": "1175680_15_item1_p13_s0", "sentA": "On May 4, 2015, the Company announced that it has reached an agreement with the FDA on the Company s previously submitted Phase 3 protocol synopsis for PRO 140 and submitted the full Phase 3 protocol to the FDA.", "sentB": "To the extent that such milestone payments and royalties are not timely made, under the terms of the PDL License, AbbVie Inc. has certain termination rights relating to the Company s license of PRO 140 thereunder.", "type": 2, "words": ["<tag1>", "On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA.", "<tag2>", "To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "the", "Company", "s", "license", "of", "PRO", "140", "thereunder.", "<tag3>"], "wordsA": ["On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA."], "wordsB": ["To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "the", "Company", "s", "license", "of", "PRO", "140", "thereunder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p72_s4", "idA": "1175680_15_item1_p13_s0", "sentA": "On May 4, 2015, the Company announced that it has reached an agreement with the FDA on the Company s previously submitted Phase 3 protocol synopsis for PRO 140 and submitted the full Phase 3 protocol to the FDA.", "sentB": "This contract manufacturer previously produced multi-Kg scale bulk batches of PRO 140 under cGMP for our Phase 2 clinical studies and is capable of producing sufficient quantities of PRO 140 for all the clinical studies required prior to submitting a BLA to the FDA.", "type": 2, "words": ["<tag1>", "On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA.", "<tag2>", "This", "contract", "manufacturer", "previously", "produced", "multi-Kg", "scale", "bulk", "batches", "of", "PRO", "140", "under", "cGMP", "for", "our", "Phase", "2", "clinical", "studies", "and", "is", "capable", "of", "producing", "sufficient", "quantities", "of", "PRO", "140", "for", "all", "the", "clinical", "studies", "required", "prior", "to", "submitting", "a", "BLA", "to", "the", "FDA.", "<tag3>"], "wordsA": ["On", "May", "4,", "2015,", "the", "Company", "announced", "that", "it", "has", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "Company", "s", "previously", "submitted", "Phase", "3", "protocol", "synopsis", "for", "PRO", "140", "and", "submitted", "the", "full", "Phase", "3", "protocol", "to", "the", "FDA."], "wordsB": ["This", "contract", "manufacturer", "previously", "produced", "multi-Kg", "scale", "bulk", "batches", "of", "PRO", "140", "under", "cGMP", "for", "our", "Phase", "2", "clinical", "studies", "and", "is", "capable", "of", "producing", "sufficient", "quantities", "of", "PRO", "140", "for", "all", "the", "clinical", "studies", "required", "prior", "to", "submitting", "a", "BLA", "to", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p26_s2", "idA": "1175680_15_item1_p13_s1", "sentA": "The Company s Phase 3 protocol provides for a 25-week study with 300 HIV patients.", "sentB": "The Company will respond to this request.", "type": 2, "words": ["<tag1>", "The", "Company", "s", "Phase", "3", "protocol", "provides", "for", "a", "25-week", "study", "with", "300", "HIV", "patients.", "<tag2>", "The", "Company", "will", "respond", "to", "this", "request.", "<tag3>"], "wordsA": ["The", "Company", "s", "Phase", "3", "protocol", "provides", "for", "a", "25-week", "study", "with", "300", "HIV", "patients."], "wordsB": ["The", "Company", "will", "respond", "to", "this", "request."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p24_s2", "idA": "1175680_15_item1_p13_s2", "sentA": "The Company believes that upon successful completion of this Phase 3 study, CytoDyn will have the opportunity to seek accelerated approval for PRO 140 based on previously granted FDA fast-track candidate designation.", "sentB": "We believe that, upon successful completion of this Phase 3 study, we will have the opportunity to seek accelerated approval for PRO 140 based on previously granted FDA fast-track candidate designation.", "type": 2, "words": ["<tag1>", "The", "Company", "believes", "that", "upon", "successful", "completion", "of", "this", "Phase", "3", "study,", "CytoDyn", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "candidate", "designation.", "<tag2>", "We", "believe", "that,", "upon", "successful", "completion", "of", "this", "Phase", "3", "study,", "we", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "candidate", "designation.", "<tag3>"], "wordsA": ["The", "Company", "believes", "that", "upon", "successful", "completion", "of", "this", "Phase", "3", "study,", "CytoDyn", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "candidate", "designation."], "wordsB": ["We", "believe", "that,", "upon", "successful", "completion", "of", "this", "Phase", "3", "study,", "we", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "candidate", "designation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p51_s2", "idA": "1175680_15_item1_p13_s4", "sentA": "The Company announced on June 9, 2015, the FDA s approval of the Company s Phase 3 protocol for an additional indication for PRO 140 and expects to commence its first Phase 3 clinical trial in mid-2015.", "sentB": "A successful inspection of the manufacturing facility by the FDA is a prerequisite for final approval of a biological product like PRO140.", "type": 2, "words": ["<tag1>", "The", "Company", "announced", "on", "June", "9,", "2015,", "the", "FDA", "s", "approval", "of", "the", "Company", "s", "Phase", "3", "protocol", "for", "an", "additional", "indication", "for", "PRO", "140", "and", "expects", "to", "commence", "its", "first", "Phase", "3", "clinical", "trial", "in", "mid-2015.", "<tag2>", "A", "successful", "inspection", "of", "the", "manufacturing", "facility", "by", "the", "FDA", "is", "a", "prerequisite", "for", "final", "approval", "of", "a", "biological", "product", "like", "PRO140.", "<tag3>"], "wordsA": ["The", "Company", "announced", "on", "June", "9,", "2015,", "the", "FDA", "s", "approval", "of", "the", "Company", "s", "Phase", "3", "protocol", "for", "an", "additional", "indication", "for", "PRO", "140", "and", "expects", "to", "commence", "its", "first", "Phase", "3", "clinical", "trial", "in", "mid-2015."], "wordsB": ["A", "successful", "inspection", "of", "the", "manufacturing", "facility", "by", "the", "FDA", "is", "a", "prerequisite", "for", "final", "approval", "of", "a", "biological", "product", "like", "PRO140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p51_s3", "idA": "1175680_15_item1_p13_s4", "sentA": "The Company announced on June 9, 2015, the FDA s approval of the Company s Phase 3 protocol for an additional indication for PRO 140 and expects to commence its first Phase 3 clinical trial in mid-2015.", "sentB": "Following approval of the NDA or BLA, we and our third-party manufacturers remain subject to periodic inspections by the FDA.", "type": 2, "words": ["<tag1>", "The", "Company", "announced", "on", "June", "9,", "2015,", "the", "FDA", "s", "approval", "of", "the", "Company", "s", "Phase", "3", "protocol", "for", "an", "additional", "indication", "for", "PRO", "140", "and", "expects", "to", "commence", "its", "first", "Phase", "3", "clinical", "trial", "in", "mid-2015.", "<tag2>", "Following", "approval", "of", "the", "NDA", "or", "BLA,", "we", "and", "our", "third-party", "manufacturers", "remain", "subject", "to", "periodic", "inspections", "by", "the", "FDA.", "<tag3>"], "wordsA": ["The", "Company", "announced", "on", "June", "9,", "2015,", "the", "FDA", "s", "approval", "of", "the", "Company", "s", "Phase", "3", "protocol", "for", "an", "additional", "indication", "for", "PRO", "140", "and", "expects", "to", "commence", "its", "first", "Phase", "3", "clinical", "trial", "in", "mid-2015."], "wordsB": ["Following", "approval", "of", "the", "NDA", "or", "BLA,", "we", "and", "our", "third-party", "manufacturers", "remain", "subject", "to", "periodic", "inspections", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p12_s3", "idA": "1175680_15_item1_p14_s0", "sentA": "The Company s first Phase 3 study is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "sentB": "Our ongoing HIV-related clinical trials, described in greater detail below, have been designed to demonstrate the proof of concept that PRO 140 monotherapy can reduce the viral load in certain HIV-infected, treatment-experienced patients.", "type": 2, "words": ["<tag1>", "The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag2>", "Our", "ongoing", "HIV-related", "clinical", "trials,", "described", "in", "greater", "detail", "below,", "have", "been", "designed", "to", "demonstrate", "the", "proof", "of", "concept", "that", "PRO", "140", "monotherapy", "can", "reduce", "the", "viral", "load", "in", "certain", "HIV-infected,", "treatment-experienced", "patients.", "<tag3>"], "wordsA": ["The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "wordsB": ["Our", "ongoing", "HIV-related", "clinical", "trials,", "described", "in", "greater", "detail", "below,", "have", "been", "designed", "to", "demonstrate", "the", "proof", "of", "concept", "that", "PRO", "140", "monotherapy", "can", "reduce", "the", "viral", "load", "in", "certain", "HIV-infected,", "treatment-experienced", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p18_s1", "idA": "1175680_15_item1_p14_s0", "sentA": "The Company s first Phase 3 study is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "sentB": "This trial, a randomized, double-blind, placebo-controlled, multi-center 100-day study with 60 patients is designed to evaluate the feasibility of the use of PRO 140 as an add-on therapy to standard GvHD prophylaxis treatment for prevention of acute GvHD in adult patients with acute myeloid leukemia ( AML ) or myelodysplastic syndrome ( MDS ) undergoing allogeneic hematopoietic stem cell transplantation ( HST ).", "type": 2, "words": ["<tag1>", "The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag2>", "This", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "100-day", "study", "with", "60", "patients", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ").", "<tag3>"], "wordsA": ["The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "wordsB": ["This", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "100-day", "study", "with", "60", "patients", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p18_s3", "idA": "1175680_15_item1_p14_s0", "sentA": "The Company s first Phase 3 study is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "sentB": "The Company s recently announced fifth clinical trial is expected to commence in the near future and will evaluate PRO 140 for treatment na ve HIV patients.", "type": 2, "words": ["<tag1>", "The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag2>", "The", "Company", "s", "recently", "announced", "fifth", "clinical", "trial", "is", "expected", "to", "commence", "in", "the", "near", "future", "and", "will", "evaluate", "PRO", "140", "for", "treatment", "na", "ve", "HIV", "patients.", "<tag3>"], "wordsA": ["The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "wordsB": ["The", "Company", "s", "recently", "announced", "fifth", "clinical", "trial", "is", "expected", "to", "commence", "in", "the", "near", "future", "and", "will", "evaluate", "PRO", "140", "for", "treatment", "na", "ve", "HIV", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p24_s3", "idA": "1175680_15_item1_p14_s0", "sentA": "The Company s first Phase 3 study is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "sentB": "The Phase 3 combination therapy trial is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "type": 2, "words": ["<tag1>", "The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag2>", "The", "Phase", "3", "combination", "therapy", "trial", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag3>"], "wordsA": ["The", "Company", "s", "first", "Phase", "3", "study", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "wordsB": ["The", "Phase", "3", "combination", "therapy", "trial", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p69_s3", "idA": "1175680_15_item1_p15_s0", "sentA": "CytoDyn believes that its PRO 140 antibody has compelling advantages over Maraviroc, the only other CCR5 antagonist for HIV therapy (Maraviroc is a pill taken orally twice a day.", "sentB": "The only drug in EI class approved by the FDA is Maraviroc, a drug taken orally twice a day.", "type": 2, "words": ["<tag1>", "CytoDyn", "believes", "that", "its", "PRO", "140", "antibody", "has", "compelling", "advantages", "over", "Maraviroc,", "the", "only", "other", "CCR5", "antagonist", "for", "HIV", "therapy", "(Maraviroc", "is", "a", "pill", "taken", "orally", "twice", "a", "day.", "<tag2>", "The", "only", "drug", "in", "EI", "class", "approved", "by", "the", "FDA", "is", "Maraviroc,", "a", "drug", "taken", "orally", "twice", "a", "day.", "<tag3>"], "wordsA": ["CytoDyn", "believes", "that", "its", "PRO", "140", "antibody", "has", "compelling", "advantages", "over", "Maraviroc,", "the", "only", "other", "CCR5", "antagonist", "for", "HIV", "therapy", "(Maraviroc", "is", "a", "pill", "taken", "orally", "twice", "a", "day."], "wordsB": ["The", "only", "drug", "in", "EI", "class", "approved", "by", "the", "FDA", "is", "Maraviroc,", "a", "drug", "taken", "orally", "twice", "a", "day."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p2_s2", "idA": "1175680_15_item1_p15_s3", "sentA": "Other Product Candidates Our second product candidate, Cytolin, is also a humanized monoclonal antibody for the treatment of HIV infection.", "sentB": "We believe that monoclonal antibodies are a new emerging class of therapeutics for the treatment of HIV to address unmet medical needs in the area of HIV and graft versus host disease.", "type": 2, "words": ["<tag1>", "Other", "Product", "Candidates", "Our", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "humanized", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection.", "<tag2>", "We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "graft", "versus", "host", "disease.", "<tag3>"], "wordsA": ["Other", "Product", "Candidates", "Our", "second", "product", "candidate,", "Cytolin,", "is", "also", "a", "humanized", "monoclonal", "antibody", "for", "the", "treatment", "of", "HIV", "infection."], "wordsB": ["We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "graft", "versus", "host", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p18_s6", "idA": "1175680_15_item1_p16_s2", "sentA": "This patent is for a murine (mouse) version of the drug.", "sentB": "Each of the foregoing trials are described more fully below.", "type": 2, "words": ["<tag1>", "This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug.", "<tag2>", "Each", "of", "the", "foregoing", "trials", "are", "described", "more", "fully", "below.", "<tag3>"], "wordsA": ["This", "patent", "is", "for", "a", "murine", "(mouse)", "version", "of", "the", "drug."], "wordsB": ["Each", "of", "the", "foregoing", "trials", "are", "described", "more", "fully", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p33_s3", "idA": "1175680_15_item1_p19_s1", "sentA": "Until the clinical trials for PRO 140 have advanced further, we do not plan to devote any resources towards the development, research, testing, approval, or commercialization of Cytolin or CytoFeline.", "sentB": "Other Product Candidates Until the clinical trials for PRO 140 have advanced further, we do not plan to devote any resources towards the development, research, testing, approval or commercialization of other product candidates.", "type": 2, "words": ["<tag1>", "Until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval,", "or", "commercialization", "of", "Cytolin", "or", "CytoFeline.", "<tag2>", "Other", "Product", "Candidates", "Until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval", "or", "commercialization", "of", "other", "product", "candidates.", "<tag3>"], "wordsA": ["Until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval,", "or", "commercialization", "of", "Cytolin", "or", "CytoFeline."], "wordsB": ["Other", "Product", "Candidates", "Until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval", "or", "commercialization", "of", "other", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p2_s1", "idA": "1175680_15_item1_p1_s0", "sentA": "The PRO 140 antibody belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells.", "sentB": "Our lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells.", "type": 2, "words": ["<tag1>", "The", "PRO", "140", "antibody", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors", "that", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells.", "<tag2>", "Our", "lead", "product", "candidate,", "PRO", "140,", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors", "that", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells.", "<tag3>"], "wordsA": ["The", "PRO", "140", "antibody", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors", "that", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells."], "wordsB": ["Our", "lead", "product", "candidate,", "PRO", "140,", "belongs", "to", "a", "class", "of", "HIV", "therapies", "known", "as", "entry", "inhibitors", "that", "block", "HIV", "from", "entering", "into", "and", "infecting", "certain", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p5_s1", "idA": "1175680_15_item1_p1_s1", "sentA": "PRO 140 blocks HIV from entering a cell by binding to a molecule called CCR5, a normal cell surface co-receptor protein to which HIV attaches as part of HIV s entry into a cell.", "sentB": "PRO 140 blocks HIV from entering a cell by binding to a molecule called the C-C chemokine receptor type 5 ( CCR5 ), a normal cell surface co-receptor protein to which certain strains of HIV, referred to as R5 strains, attach as part of HIV s entry into a cell.", "type": 2, "words": ["<tag1>", "PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "co-receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell.", "<tag2>", "PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "the", "C-C", "chemokine", "receptor", "type", "5", "(", "CCR5", "),", "a", "normal", "cell", "surface", "co-receptor", "protein", "to", "which", "certain", "strains", "of", "HIV,", "referred", "to", "as", "R5", "strains,", "attach", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell.", "<tag3>"], "wordsA": ["PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "CCR5,", "a", "normal", "cell", "surface", "co-receptor", "protein", "to", "which", "HIV", "attaches", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell."], "wordsB": ["PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "the", "C-C", "chemokine", "receptor", "type", "5", "(", "CCR5", "),", "a", "normal", "cell", "surface", "co-receptor", "protein", "to", "which", "certain", "strains", "of", "HIV,", "referred", "to", "as", "R5", "strains,", "attach", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p33_s4", "idA": "1175680_15_item1_p20_s0", "sentA": "PRO 140 Acquisition We acquired PRO 140, as well as certain other related assets, including the existing inventory of PRO 140 bulk drug substance, intellectual property, and FDA regulatory filings, pursuant to an Asset Purchase Agreement, dated as of July 25, 2012 (the Progenics Agreement ), between CytoDyn and Progenics.", "sentB": "We acquired PRO 140, as well as certain other related assets, including the existing inventory of PRO 140 bulk drug substance, intellectual property, and FDA regulatory filings, pursuant to an Asset Purchase Agreement, dated as of July 25, 2012 (the Progenics Purchase Agreement ), between CytoDyn and Progenics.", "type": 2, "words": ["<tag1>", "PRO", "140", "Acquisition", "We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Agreement", "),", "between", "CytoDyn", "and", "Progenics.", "<tag2>", "We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Purchase", "Agreement", "),", "between", "CytoDyn", "and", "Progenics.", "<tag3>"], "wordsA": ["PRO", "140", "Acquisition", "We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Agreement", "),", "between", "CytoDyn", "and", "Progenics."], "wordsB": ["We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Purchase", "Agreement", "),", "between", "CytoDyn", "and", "Progenics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p33_s6", "idA": "1175680_15_item1_p20_s1", "sentA": "The terms of the Progenics Agreement provided for an initial cash payment of $3,500,000, which was paid at closing in October 2012, as well as the following milestone payments and royalties to be paid to Progenics in the future: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-US equivalent; (ii) $5,000,000 at the time of the first U.S. new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of 5% of net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years following the first commercialization sale of PRO 140, in each case determined on a country-by-country basis.", "sentB": "The Company is also required to pay Progenics the following milestone payments and royalties: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-US equivalent, which was paid during the year ended May 31, 2016; (ii) $5,000,000 at the time of the first US new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of up to 5% on net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years, in each case determined on a country-by country basis.", "type": 2, "words": ["<tag1>", "The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U.S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis.", "<tag2>", "The", "Company", "is", "also", "required", "to", "pay", "Progenics", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent,", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis.", "<tag3>"], "wordsA": ["The", "terms", "of", "the", "Progenics", "Agreement", "provided", "for", "an", "initial", "cash", "payment", "of", "$3,500,000,", "which", "was", "paid", "at", "closing", "in", "October", "2012,", "as", "well", "as", "the", "following", "milestone", "payments", "and", "royalties", "to", "be", "paid", "to", "Progenics", "in", "the", "future:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U.S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "5%", "of", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years", "following", "the", "first", "commercialization", "sale", "of", "PRO", "140,", "in", "each", "case", "determined", "on", "a", "country-by-country", "basis."], "wordsB": ["The", "Company", "is", "also", "required", "to", "pay", "Progenics", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent,", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p34_s0", "idA": "1175680_15_item1_p20_s2", "sentA": "The Progenics Agreement is filed as an exhibit to this annual report on Form 10-K. Payments to Progenics are in addition to payments due under a Development and License Agreement, dated April 30, 1999 (the PDL License ), between Protein Design Labs (now AbbVie Inc.) and Progenics, which was assigned to us in the PRO 140 transaction, pursuant to which we must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "sentB": "Payments to Progenics are in addition to payments due under a Development and License Agreement, dated April 30, 1999 (the PDL License ), between Protein Design Labs (now AbbVie Inc.) ( PDL ) and Progenics, which was assigned to the Company in the Progenics Purchase Agreement, pursuant to which the Company has an exclusive worldwide license to develop, make, have made, import, use, sell, offer to sell or have sold products that incorporate the humanized form of the PRO 140 antibody developed by PDL under the agreement and must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial, which was paid during the year ended May 31, 2016; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "type": 2, "words": ["<tag1>", "The", "Progenics", "Agreement", "is", "filed", "as", "an", "exhibit", "to", "this", "annual", "report", "on", "Form", "10-K.", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "PRO", "140", "transaction,", "pursuant", "to", "which", "we", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag2>", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "the", "Company", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "the", "Company", "has", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag3>"], "wordsA": ["The", "Progenics", "Agreement", "is", "filed", "as", "an", "exhibit", "to", "this", "annual", "report", "on", "Form", "10-K.", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "PRO", "140", "transaction,", "pursuant", "to", "which", "we", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "wordsB": ["Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "the", "Company", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "the", "Company", "has", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p36_s5", "idA": "1175680_15_item1_p20_s3", "sentA": "Additionally, the PDL License provides for an annual maintenance fee of $150,000 until royalties paid exceed that amount.", "sentB": "The licensor does not charge an annual license fee of 300,000 when it serves as the manufacturer.", "type": 2, "words": ["<tag1>", "Additionally,", "the", "PDL", "License", "provides", "for", "an", "annual", "maintenance", "fee", "of", "$150,000", "until", "royalties", "paid", "exceed", "that", "amount.", "<tag2>", "The", "licensor", "does", "not", "charge", "an", "annual", "license", "fee", "of", "300,000", "when", "it", "serves", "as", "the", "manufacturer.", "<tag3>"], "wordsA": ["Additionally,", "the", "PDL", "License", "provides", "for", "an", "annual", "maintenance", "fee", "of", "$150,000", "until", "royalties", "paid", "exceed", "that", "amount."], "wordsB": ["The", "licensor", "does", "not", "charge", "an", "annual", "license", "fee", "of", "300,000", "when", "it", "serves", "as", "the", "manufacturer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p33_s7", "idA": "1175680_15_item1_p20_s4", "sentA": "As of the date of this filing, management has reasonably estimated the likelihood of paying the first milestone payments, as probable, and accordingly, as of May 31, 2015, the Company has accrued $2,500,000 for the initial milestone associated with the first dosing in a Phase 3 trial.", "sentB": "During the year ended May 31, 2016, the Company paid $1.5 million of such milestones owed to Progenics as a result of the first dosing in a U.S. Phase 3 trial.", "type": 2, "words": ["<tag1>", "As", "of", "the", "date", "of", "this", "filing,", "management", "has", "reasonably", "estimated", "the", "likelihood", "of", "paying", "the", "first", "milestone", "payments,", "as", "probable,", "and", "accordingly,", "as", "of", "May", "31,", "2015,", "the", "Company", "has", "accrued", "$2,500,000", "for", "the", "initial", "milestone", "associated", "with", "the", "first", "dosing", "in", "a", "Phase", "3", "trial.", "<tag2>", "During", "the", "year", "ended", "May", "31,", "2016,", "the", "Company", "paid", "$1.5", "million", "of", "such", "milestones", "owed", "to", "Progenics", "as", "a", "result", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial.", "<tag3>"], "wordsA": ["As", "of", "the", "date", "of", "this", "filing,", "management", "has", "reasonably", "estimated", "the", "likelihood", "of", "paying", "the", "first", "milestone", "payments,", "as", "probable,", "and", "accordingly,", "as", "of", "May", "31,", "2015,", "the", "Company", "has", "accrued", "$2,500,000", "for", "the", "initial", "milestone", "associated", "with", "the", "first", "dosing", "in", "a", "Phase", "3", "trial."], "wordsB": ["During", "the", "year", "ended", "May", "31,", "2016,", "the", "Company", "paid", "$1.5", "million", "of", "such", "milestones", "owed", "to", "Progenics", "as", "a", "result", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p35_s0", "idA": "1175680_15_item1_p20_s4", "sentA": "As of the date of this filing, management has reasonably estimated the likelihood of paying the first milestone payments, as probable, and accordingly, as of May 31, 2015, the Company has accrued $2,500,000 for the initial milestone associated with the first dosing in a Phase 3 trial.", "sentB": "Pursuant to the foregoing Progenics Purchase Agreement and PDL License, the Company accrued an expense of $2,500,000 as of May 31, 2015 in connection with the anticipated milestone payments related to the first patient dosing in a Phase 3 clinical trial, all of which was paid during the year ended May 31, 2016.", "type": 2, "words": ["<tag1>", "As", "of", "the", "date", "of", "this", "filing,", "management", "has", "reasonably", "estimated", "the", "likelihood", "of", "paying", "the", "first", "milestone", "payments,", "as", "probable,", "and", "accordingly,", "as", "of", "May", "31,", "2015,", "the", "Company", "has", "accrued", "$2,500,000", "for", "the", "initial", "milestone", "associated", "with", "the", "first", "dosing", "in", "a", "Phase", "3", "trial.", "<tag2>", "Pursuant", "to", "the", "foregoing", "Progenics", "Purchase", "Agreement", "and", "PDL", "License,", "the", "Company", "accrued", "an", "expense", "of", "$2,500,000", "as", "of", "May", "31,", "2015", "in", "connection", "with", "the", "anticipated", "milestone", "payments", "related", "to", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "clinical", "trial,", "all", "of", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016.", "<tag3>"], "wordsA": ["As", "of", "the", "date", "of", "this", "filing,", "management", "has", "reasonably", "estimated", "the", "likelihood", "of", "paying", "the", "first", "milestone", "payments,", "as", "probable,", "and", "accordingly,", "as", "of", "May", "31,", "2015,", "the", "Company", "has", "accrued", "$2,500,000", "for", "the", "initial", "milestone", "associated", "with", "the", "first", "dosing", "in", "a", "Phase", "3", "trial."], "wordsB": ["Pursuant", "to", "the", "foregoing", "Progenics", "Purchase", "Agreement", "and", "PDL", "License,", "the", "Company", "accrued", "an", "expense", "of", "$2,500,000", "as", "of", "May", "31,", "2015", "in", "connection", "with", "the", "anticipated", "milestone", "payments", "related", "to", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "clinical", "trial,", "all", "of", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p36_s2", "idA": "1175680_15_item1_p20_s4", "sentA": "As of the date of this filing, management has reasonably estimated the likelihood of paying the first milestone payments, as probable, and accordingly, as of May 31, 2015, the Company has accrued $2,500,000 for the initial milestone associated with the first dosing in a Phase 3 trial.", "sentB": "In connection with this license agreement, the Company became the primary obligor of an additional 600,000, which was accrued in the first quarter of the fiscal year ended May 31, 2016 and was timely paid by June 30, 2016.", "type": 2, "words": ["<tag1>", "As", "of", "the", "date", "of", "this", "filing,", "management", "has", "reasonably", "estimated", "the", "likelihood", "of", "paying", "the", "first", "milestone", "payments,", "as", "probable,", "and", "accordingly,", "as", "of", "May", "31,", "2015,", "the", "Company", "has", "accrued", "$2,500,000", "for", "the", "initial", "milestone", "associated", "with", "the", "first", "dosing", "in", "a", "Phase", "3", "trial.", "<tag2>", "In", "connection", "with", "this", "license", "agreement,", "the", "Company", "became", "the", "primary", "obligor", "of", "an", "additional", "600,000,", "which", "was", "accrued", "in", "the", "first", "quarter", "of", "the", "fiscal", "year", "ended", "May", "31,", "2016", "and", "was", "timely", "paid", "by", "June", "30,", "2016.", "<tag3>"], "wordsA": ["As", "of", "the", "date", "of", "this", "filing,", "management", "has", "reasonably", "estimated", "the", "likelihood", "of", "paying", "the", "first", "milestone", "payments,", "as", "probable,", "and", "accordingly,", "as", "of", "May", "31,", "2015,", "the", "Company", "has", "accrued", "$2,500,000", "for", "the", "initial", "milestone", "associated", "with", "the", "first", "dosing", "in", "a", "Phase", "3", "trial."], "wordsB": ["In", "connection", "with", "this", "license", "agreement,", "the", "Company", "became", "the", "primary", "obligor", "of", "an", "additional", "600,000,", "which", "was", "accrued", "in", "the", "first", "quarter", "of", "the", "fiscal", "year", "ended", "May", "31,", "2016", "and", "was", "timely", "paid", "by", "June", "30,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p72_s1", "idA": "1175680_15_item1_p21_s0", "sentA": "As part of our acquisition of PRO 140, we entered into a collaboration agreement with Drexel, under which CytoDyn has provided Drexel with the necessary quantity of PRO 140 to conduct certain clinical trials.", "sentB": "We expect to depend on third-party suppliers and manufacturing organizations for all of our clinical trial quantities of PRO 140, in addition to previously manufactured supplies of PRO 140.", "type": 2, "words": ["<tag1>", "As", "part", "of", "our", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "under", "which", "CytoDyn", "has", "provided", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "certain", "clinical", "trials.", "<tag2>", "We", "expect", "to", "depend", "on", "third-party", "suppliers", "and", "manufacturing", "organizations", "for", "all", "of", "our", "clinical", "trial", "quantities", "of", "PRO", "140,", "in", "addition", "to", "previously", "manufactured", "supplies", "of", "PRO", "140.", "<tag3>"], "wordsA": ["As", "part", "of", "our", "acquisition", "of", "PRO", "140,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "Drexel,", "under", "which", "CytoDyn", "has", "provided", "Drexel", "with", "the", "necessary", "quantity", "of", "PRO", "140", "to", "conduct", "certain", "clinical", "trials."], "wordsB": ["We", "expect", "to", "depend", "on", "third-party", "suppliers", "and", "manufacturing", "organizations", "for", "all", "of", "our", "clinical", "trial", "quantities", "of", "PRO", "140,", "in", "addition", "to", "previously", "manufactured", "supplies", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p55_s3", "idA": "1175680_15_item1_p23_s3", "sentA": "A U.S. patent, to be selected by the company upon receipt of FDA regulatory approval, may be subject to up to a five-year patent term extension in certain instances.", "sentB": "The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.", "type": 2, "words": ["<tag1>", "A", "U.S.", "patent,", "to", "be", "selected", "by", "the", "company", "upon", "receipt", "of", "FDA", "regulatory", "approval,", "may", "be", "subject", "to", "up", "to", "a", "five-year", "patent", "term", "extension", "in", "certain", "instances.", "<tag2>", "The", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability.", "<tag3>"], "wordsA": ["A", "U.S.", "patent,", "to", "be", "selected", "by", "the", "company", "upon", "receipt", "of", "FDA", "regulatory", "approval,", "may", "be", "subject", "to", "up", "to", "a", "five-year", "patent", "term", "extension", "in", "certain", "instances."], "wordsB": ["The", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p51_s0", "idA": "1175680_15_item1_p24_s0", "sentA": "We pursue opportunities for seeking new meaningful patent protection on an ongoing basis.", "sentB": "Among the conditions for an NDA or BLA approval is the requirement that the manufacturing operations conform on an ongoing basis with current Good Manufacturing Practices, or cGMPs.", "type": 2, "words": ["<tag1>", "We", "pursue", "opportunities", "for", "seeking", "new", "meaningful", "patent", "protection", "on", "an", "ongoing", "basis.", "<tag2>", "Among", "the", "conditions", "for", "an", "NDA", "or", "BLA", "approval", "is", "the", "requirement", "that", "the", "manufacturing", "operations", "conform", "on", "an", "ongoing", "basis", "with", "current", "Good", "Manufacturing", "Practices,", "or", "cGMPs.", "<tag3>"], "wordsA": ["We", "pursue", "opportunities", "for", "seeking", "new", "meaningful", "patent", "protection", "on", "an", "ongoing", "basis."], "wordsB": ["Among", "the", "conditions", "for", "an", "NDA", "or", "BLA", "approval", "is", "the", "requirement", "that", "the", "manufacturing", "operations", "conform", "on", "an", "ongoing", "basis", "with", "current", "Good", "Manufacturing", "Practices,", "or", "cGMPs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p41_s0", "idA": "1175680_15_item1_p27_s0", "sentA": "Information with respect to our current patent portfolio as of May 31, 2015, is set forth below.", "sentB": "Information with respect to our current patent portfolio as of May 31, 2016, is set forth below.", "type": 2, "words": ["<tag1>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2015,", "is", "set", "forth", "below.", "<tag2>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2016,", "is", "set", "forth", "below.", "<tag3>"], "wordsA": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2015,", "is", "set", "forth", "below."], "wordsB": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2016,", "is", "set", "forth", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p6_s0", "idA": "1175680_15_item1_p2_s0", "sentA": "PRO 140 is an antibody and not a chemically synthesized drug, and through preliminary, short-term trials it has demonstrated efficacy without issues relating to toxicity and autoimmune resistance.", "sentB": "PRO 140 is an antibody, and through several, short-term clinical trials it has demonstrated efficacy without issues relating to toxicity and autoimmune resistance.", "type": 2, "words": ["<tag1>", "PRO", "140", "is", "an", "antibody", "and", "not", "a", "chemically", "synthesized", "drug,", "and", "through", "preliminary,", "short-term", "trials", "it", "has", "demonstrated", "efficacy", "without", "issues", "relating", "to", "toxicity", "and", "autoimmune", "resistance.", "<tag2>", "PRO", "140", "is", "an", "antibody,", "and", "through", "several,", "short-term", "clinical", "trials", "it", "has", "demonstrated", "efficacy", "without", "issues", "relating", "to", "toxicity", "and", "autoimmune", "resistance.", "<tag3>"], "wordsA": ["PRO", "140", "is", "an", "antibody", "and", "not", "a", "chemically", "synthesized", "drug,", "and", "through", "preliminary,", "short-term", "trials", "it", "has", "demonstrated", "efficacy", "without", "issues", "relating", "to", "toxicity", "and", "autoimmune", "resistance."], "wordsB": ["PRO", "140", "is", "an", "antibody,", "and", "through", "several,", "short-term", "clinical", "trials", "it", "has", "demonstrated", "efficacy", "without", "issues", "relating", "to", "toxicity", "and", "autoimmune", "resistance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p30_s3", "idA": "1175680_15_item1_p2_s1", "sentA": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "sentB": "PRO 140 targets the CCR5 receptor, binding to it in a way that prevents HIV from using it as an entry gateway without activating the immune function of the receptor.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag2>", "PRO", "140", "targets", "the", "CCR5", "receptor,", "binding", "to", "it", "in", "a", "way", "that", "prevents", "HIV", "from", "using", "it", "as", "an", "entry", "gateway", "without", "activating", "the", "immune", "function", "of", "the", "receptor.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "wordsB": ["PRO", "140", "targets", "the", "CCR5", "receptor,", "binding", "to", "it", "in", "a", "way", "that", "prevents", "HIV", "from", "using", "it", "as", "an", "entry", "gateway", "without", "activating", "the", "immune", "function", "of", "the", "receptor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p30_s4", "idA": "1175680_15_item1_p2_s1", "sentA": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "sentB": "Our recent research data indicate that PRO 140 also interferes with activation of the receptor by the mediator CCL5.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag2>", "Our", "recent", "research", "data", "indicate", "that", "PRO", "140", "also", "interferes", "with", "activation", "of", "the", "receptor", "by", "the", "mediator", "CCL5.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "wordsB": ["Our", "recent", "research", "data", "indicate", "that", "PRO", "140", "also", "interferes", "with", "activation", "of", "the", "receptor", "by", "the", "mediator", "CCL5."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p32_s2", "idA": "1175680_15_item1_p2_s1", "sentA": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "sentB": "We believe that PRO 140 has significant advantages over Maraviroc in more favorable dosing and pharmacokinetics, less toxicity and side effects, and no direct stimulation (agonist activity) of the CCR5 receptor.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag2>", "We", "believe", "that", "PRO", "140", "has", "significant", "advantages", "over", "Maraviroc", "in", "more", "favorable", "dosing", "and", "pharmacokinetics,", "less", "toxicity", "and", "side", "effects,", "and", "no", "direct", "stimulation", "(agonist", "activity)", "of", "the", "CCR5", "receptor.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "wordsB": ["We", "believe", "that", "PRO", "140", "has", "significant", "advantages", "over", "Maraviroc", "in", "more", "favorable", "dosing", "and", "pharmacokinetics,", "less", "toxicity", "and", "side", "effects,", "and", "no", "direct", "stimulation", "(agonist", "activity)", "of", "the", "CCR5", "receptor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p69_s4", "idA": "1175680_15_item1_p2_s1", "sentA": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "sentB": "Upon approval, we believe that PRO 140 will be the only approved drug outside of the main four classes of drugs approved for HIV since 2007.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag2>", "Upon", "approval,", "we", "believe", "that", "PRO", "140", "will", "be", "the", "only", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "wordsB": ["Upon", "approval,", "we", "believe", "that", "PRO", "140", "will", "be", "the", "only", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p69_s6", "idA": "1175680_15_item1_p2_s1", "sentA": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "sentB": "Ibalizumab targets the CD4 receptor on T-cells which is one of the two co-receptors required for HIV entry into T-cells.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag2>", "Ibalizumab", "targets", "the", "CD4", "receptor", "on", "T-cells", "which", "is", "one", "of", "the", "two", "co-receptors", "required", "for", "HIV", "entry", "into", "T-cells.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "wordsB": ["Ibalizumab", "targets", "the", "CD4", "receptor", "on", "T-cells", "which", "is", "one", "of", "the", "two", "co-receptors", "required", "for", "HIV", "entry", "into", "T-cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p9_s2", "idA": "1175680_15_item1_p2_s1", "sentA": "Moreover, these trials suggested that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "sentB": "The results of these studies established that PRO 140 s antiviral activity was potent, rapid, prolonged, dose-dependent, and statistically significant following a single dose.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag2>", "The", "results", "of", "these", "studies", "established", "that", "PRO", "140", "s", "antiviral", "activity", "was", "potent,", "rapid,", "prolonged,", "dose-dependent,", "and", "statistically", "significant", "following", "a", "single", "dose.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggested", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "wordsB": ["The", "results", "of", "these", "studies", "established", "that", "PRO", "140", "s", "antiviral", "activity", "was", "potent,", "rapid,", "prolonged,", "dose-dependent,", "and", "statistically", "significant", "following", "a", "single", "dose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p6_s2", "idA": "1175680_15_item1_p2_s2", "sentA": "Instead, PRO 140 binds to a precise site on CCR5 that HIV uses to enter the cell and, in doing so, inhibits the ability of HIV to infect the cell without affecting the cell s normal function.", "sentB": "Instead, PRO 140 binds to a precise site on CCR5 that R5 strains of HIV use to enter the cell and, in doing so, inhibits the ability of these strains of HIV to infect the cell without affecting the cell s normal function.", "type": 2, "words": ["<tag1>", "Instead,", "PRO", "140", "binds", "to", "a", "precise", "site", "on", "CCR5", "that", "HIV", "uses", "to", "enter", "the", "cell", "and,", "in", "doing", "so,", "inhibits", "the", "ability", "of", "HIV", "to", "infect", "the", "cell", "without", "affecting", "the", "cell", "s", "normal", "function.", "<tag2>", "Instead,", "PRO", "140", "binds", "to", "a", "precise", "site", "on", "CCR5", "that", "R5", "strains", "of", "HIV", "use", "to", "enter", "the", "cell", "and,", "in", "doing", "so,", "inhibits", "the", "ability", "of", "these", "strains", "of", "HIV", "to", "infect", "the", "cell", "without", "affecting", "the", "cell", "s", "normal", "function.", "<tag3>"], "wordsA": ["Instead,", "PRO", "140", "binds", "to", "a", "precise", "site", "on", "CCR5", "that", "HIV", "uses", "to", "enter", "the", "cell", "and,", "in", "doing", "so,", "inhibits", "the", "ability", "of", "HIV", "to", "infect", "the", "cell", "without", "affecting", "the", "cell", "s", "normal", "function."], "wordsB": ["Instead,", "PRO", "140", "binds", "to", "a", "precise", "site", "on", "CCR5", "that", "R5", "strains", "of", "HIV", "use", "to", "enter", "the", "cell", "and,", "in", "doing", "so,", "inhibits", "the", "ability", "of", "these", "strains", "of", "HIV", "to", "infect", "the", "cell", "without", "affecting", "the", "cell", "s", "normal", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p50_s4", "idA": "1175680_15_item1_p34_s1", "sentA": "Failure to comply with applicable regulations can result in refusal by the FDA to approve product license applications.", "sentB": "If the FDA imposes a clinical hold, clinical trials cannot commence or recommence without FDA authorization and then only under terms authorized by the FDA.", "type": 2, "words": ["<tag1>", "Failure", "to", "comply", "with", "applicable", "regulations", "can", "result", "in", "refusal", "by", "the", "FDA", "to", "approve", "product", "license", "applications.", "<tag2>", "If", "the", "FDA", "imposes", "a", "clinical", "hold,", "clinical", "trials", "cannot", "commence", "or", "recommence", "without", "FDA", "authorization", "and", "then", "only", "under", "terms", "authorized", "by", "the", "FDA.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "applicable", "regulations", "can", "result", "in", "refusal", "by", "the", "FDA", "to", "approve", "product", "license", "applications."], "wordsB": ["If", "the", "FDA", "imposes", "a", "clinical", "hold,", "clinical", "trials", "cannot", "commence", "or", "recommence", "without", "FDA", "authorization", "and", "then", "only", "under", "terms", "authorized", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p16_s2", "idA": "1175680_15_item1_p34_s2", "sentA": "The FDA also has the authority to revoke previously granted product approvals.", "sentB": "The FDA recently reduced this requirement to 150 subjects.", "type": 2, "words": ["<tag1>", "The", "FDA", "also", "has", "the", "authority", "to", "revoke", "previously", "granted", "product", "approvals.", "<tag2>", "The", "FDA", "recently", "reduced", "this", "requirement", "to", "150", "subjects.", "<tag3>"], "wordsA": ["The", "FDA", "also", "has", "the", "authority", "to", "revoke", "previously", "granted", "product", "approvals."], "wordsB": ["The", "FDA", "recently", "reduced", "this", "requirement", "to", "150", "subjects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p55_s4", "idA": "1175680_15_item1_p34_s2", "sentA": "The FDA also has the authority to revoke previously granted product approvals.", "sentB": "The FDA also requires substantiation of any claims of superiority of one product over another, including the requirement that such claims be proven by adequate and well-controlled head-to-head clinical trials.", "type": 2, "words": ["<tag1>", "The", "FDA", "also", "has", "the", "authority", "to", "revoke", "previously", "granted", "product", "approvals.", "<tag2>", "The", "FDA", "also", "requires", "substantiation", "of", "any", "claims", "of", "superiority", "of", "one", "product", "over", "another,", "including", "the", "requirement", "that", "such", "claims", "be", "proven", "by", "adequate", "and", "well-controlled", "head-to-head", "clinical", "trials.", "<tag3>"], "wordsA": ["The", "FDA", "also", "has", "the", "authority", "to", "revoke", "previously", "granted", "product", "approvals."], "wordsB": ["The", "FDA", "also", "requires", "substantiation", "of", "any", "claims", "of", "superiority", "of", "one", "product", "over", "another,", "including", "the", "requirement", "that", "such", "claims", "be", "proven", "by", "adequate", "and", "well-controlled", "head-to-head", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p55_s5", "idA": "1175680_15_item1_p34_s2", "sentA": "The FDA also has the authority to revoke previously granted product approvals.", "sentB": "The FDA also requires all promotional materials that discuss the use or effectiveness of a prescription drug or biologic to disclose in a balanced manner the risks and safety profile of the product .", "type": 2, "words": ["<tag1>", "The", "FDA", "also", "has", "the", "authority", "to", "revoke", "previously", "granted", "product", "approvals.", "<tag2>", "The", "FDA", "also", "requires", "all", "promotional", "materials", "that", "discuss", "the", "use", "or", "effectiveness", "of", "a", "prescription", "drug", "or", "biologic", "to", "disclose", "in", "a", "balanced", "manner", "the", "risks", "and", "safety", "profile", "of", "the", "product", ".", "<tag3>"], "wordsA": ["The", "FDA", "also", "has", "the", "authority", "to", "revoke", "previously", "granted", "product", "approvals."], "wordsB": ["The", "FDA", "also", "requires", "all", "promotional", "materials", "that", "discuss", "the", "use", "or", "effectiveness", "of", "a", "prescription", "drug", "or", "biologic", "to", "disclose", "in", "a", "balanced", "manner", "the", "risks", "and", "safety", "profile", "of", "the", "product", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p57_s0", "idA": "1175680_15_item1_p35_s1", "sentA": "CLIA regulates clinical laboratories by requiring that the laboratory be certified by the federal government, licensed by the state and comply with various operational, personnel and quality requirements intended to ensure that clinical laboratory test results are accurate, reliable and timely.", "sentB": "laboratory be certified by the federal government, licensed by the state and comply with various operational, personnel and quality requirements intended to ensure that clinical laboratory test results are accurate, reliable and timely.", "type": 2, "words": ["<tag1>", "CLIA", "regulates", "clinical", "laboratories", "by", "requiring", "that", "the", "laboratory", "be", "certified", "by", "the", "federal", "government,", "licensed", "by", "the", "state", "and", "comply", "with", "various", "operational,", "personnel", "and", "quality", "requirements", "intended", "to", "ensure", "that", "clinical", "laboratory", "test", "results", "are", "accurate,", "reliable", "and", "timely.", "<tag2>", "laboratory", "be", "certified", "by", "the", "federal", "government,", "licensed", "by", "the", "state", "and", "comply", "with", "various", "operational,", "personnel", "and", "quality", "requirements", "intended", "to", "ensure", "that", "clinical", "laboratory", "test", "results", "are", "accurate,", "reliable", "and", "timely.", "<tag3>"], "wordsA": ["CLIA", "regulates", "clinical", "laboratories", "by", "requiring", "that", "the", "laboratory", "be", "certified", "by", "the", "federal", "government,", "licensed", "by", "the", "state", "and", "comply", "with", "various", "operational,", "personnel", "and", "quality", "requirements", "intended", "to", "ensure", "that", "clinical", "laboratory", "test", "results", "are", "accurate,", "reliable", "and", "timely."], "wordsB": ["laboratory", "be", "certified", "by", "the", "federal", "government,", "licensed", "by", "the", "state", "and", "comply", "with", "various", "operational,", "personnel", "and", "quality", "requirements", "intended", "to", "ensure", "that", "clinical", "laboratory", "test", "results", "are", "accurate,", "reliable", "and", "timely."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p52_s0", "idA": "1175680_15_item1_p37_s0", "sentA": "Our research and development activities and the manufacture and marketing of our products are and will be subject to rigorous regulations relating to product safety and efficacy by numerous governmental authorities in the United States and other countries.", "sentB": "Regulatory requirements and approval processes in E.U. countries are similar in principle to those in the United States and can be at least as costly and uncertain.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "and", "the", "manufacture", "and", "marketing", "of", "our", "products", "are", "and", "will", "be", "subject", "to", "rigorous", "regulations", "relating", "to", "product", "safety", "and", "efficacy", "by", "numerous", "governmental", "authorities", "in", "the", "United", "States", "and", "other", "countries.", "<tag2>", "Regulatory", "requirements", "and", "approval", "processes", "in", "E.U.", "countries", "are", "similar", "in", "principle", "to", "those", "in", "the", "United", "States", "and", "can", "be", "at", "least", "as", "costly", "and", "uncertain.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "and", "the", "manufacture", "and", "marketing", "of", "our", "products", "are", "and", "will", "be", "subject", "to", "rigorous", "regulations", "relating", "to", "product", "safety", "and", "efficacy", "by", "numerous", "governmental", "authorities", "in", "the", "United", "States", "and", "other", "countries."], "wordsB": ["Regulatory", "requirements", "and", "approval", "processes", "in", "E.U.", "countries", "are", "similar", "in", "principle", "to", "those", "in", "the", "United", "States", "and", "can", "be", "at", "least", "as", "costly", "and", "uncertain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p30_s0", "idA": "1175680_15_item1_p38_s0", "sentA": "We are subject to a variety of federal, state and local environmental protection measures.", "sentB": "The CCR5 receptor is expressed on a variety of cells that play a central role in inflammatory responses.", "type": 2, "words": ["<tag1>", "We", "are", "subject", "to", "a", "variety", "of", "federal,", "state", "and", "local", "environmental", "protection", "measures.", "<tag2>", "The", "CCR5", "receptor", "is", "expressed", "on", "a", "variety", "of", "cells", "that", "play", "a", "central", "role", "in", "inflammatory", "responses.", "<tag3>"], "wordsA": ["We", "are", "subject", "to", "a", "variety", "of", "federal,", "state", "and", "local", "environmental", "protection", "measures."], "wordsB": ["The", "CCR5", "receptor", "is", "expressed", "on", "a", "variety", "of", "cells", "that", "play", "a", "central", "role", "in", "inflammatory", "responses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p62_s0", "idA": "1175680_15_item1_p39_s1", "sentA": "Our current business strategy is to focus primarily on the PRO 140 Phase 3 trial, seeking additional indications in Phase 3 trials, which we will sponsor and fund (subject to the availability of sufficient capital to pursue additional paths), and to continue to evaluate and leverage the clinical data from our recently completed Phase 2b treatment substitution trial.", "sentB": "Our current business strategy is to focus primarily on our PRO 140 Phase 3 trials, seeking additional indications in trials that we will sponsor and fund (subject to the availability of sufficient capital to pursue additional paths to approval), to manage our Phase 2 trial for GvHD and to continue to evaluate and leverage the clinical data from our recently completed Phase 2b treatment substitution trial.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "is", "to", "focus", "primarily", "on", "the", "PRO", "140", "Phase", "3", "trial,", "seeking", "additional", "indications", "in", "Phase", "3", "trials,", "which", "we", "will", "sponsor", "and", "fund", "(subject", "to", "the", "availability", "of", "sufficient", "capital", "to", "pursue", "additional", "paths),", "and", "to", "continue", "to", "evaluate", "and", "leverage", "the", "clinical", "data", "from", "our", "recently", "completed", "Phase", "2b", "treatment", "substitution", "trial.", "<tag2>", "Our", "current", "business", "strategy", "is", "to", "focus", "primarily", "on", "our", "PRO", "140", "Phase", "3", "trials,", "seeking", "additional", "indications", "in", "trials", "that", "we", "will", "sponsor", "and", "fund", "(subject", "to", "the", "availability", "of", "sufficient", "capital", "to", "pursue", "additional", "paths", "to", "approval),", "to", "manage", "our", "Phase", "2", "trial", "for", "GvHD", "and", "to", "continue", "to", "evaluate", "and", "leverage", "the", "clinical", "data", "from", "our", "recently", "completed", "Phase", "2b", "treatment", "substitution", "trial.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "is", "to", "focus", "primarily", "on", "the", "PRO", "140", "Phase", "3", "trial,", "seeking", "additional", "indications", "in", "Phase", "3", "trials,", "which", "we", "will", "sponsor", "and", "fund", "(subject", "to", "the", "availability", "of", "sufficient", "capital", "to", "pursue", "additional", "paths),", "and", "to", "continue", "to", "evaluate", "and", "leverage", "the", "clinical", "data", "from", "our", "recently", "completed", "Phase", "2b", "treatment", "substitution", "trial."], "wordsB": ["Our", "current", "business", "strategy", "is", "to", "focus", "primarily", "on", "our", "PRO", "140", "Phase", "3", "trials,", "seeking", "additional", "indications", "in", "trials", "that", "we", "will", "sponsor", "and", "fund", "(subject", "to", "the", "availability", "of", "sufficient", "capital", "to", "pursue", "additional", "paths", "to", "approval),", "to", "manage", "our", "Phase", "2", "trial", "for", "GvHD", "and", "to", "continue", "to", "evaluate", "and", "leverage", "the", "clinical", "data", "from", "our", "recently", "completed", "Phase", "2b", "treatment", "substitution", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p51_s5", "idA": "1175680_15_item1_p39_s2", "sentA": "Additional clinical studies of our lead product candidate, PRO 140, are being sponsored by Drexel and funded at least in part by the NIH but are less critical to the viability of our business.", "sentB": "Any determination by the FDA or other regulatory authorities of manufacturing or other deficiencies could materially adversely affect our business.", "type": 2, "words": ["<tag1>", "Additional", "clinical", "studies", "of", "our", "lead", "product", "candidate,", "PRO", "140,", "are", "being", "sponsored", "by", "Drexel", "and", "funded", "at", "least", "in", "part", "by", "the", "NIH", "but", "are", "less", "critical", "to", "the", "viability", "of", "our", "business.", "<tag2>", "Any", "determination", "by", "the", "FDA", "or", "other", "regulatory", "authorities", "of", "manufacturing", "or", "other", "deficiencies", "could", "materially", "adversely", "affect", "our", "business.", "<tag3>"], "wordsA": ["Additional", "clinical", "studies", "of", "our", "lead", "product", "candidate,", "PRO", "140,", "are", "being", "sponsored", "by", "Drexel", "and", "funded", "at", "least", "in", "part", "by", "the", "NIH", "but", "are", "less", "critical", "to", "the", "viability", "of", "our", "business."], "wordsB": ["Any", "determination", "by", "the", "FDA", "or", "other", "regulatory", "authorities", "of", "manufacturing", "or", "other", "deficiencies", "could", "materially", "adversely", "affect", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p3_s0", "idA": "1175680_15_item1_p3_s0", "sentA": "PRO 140 was originally developed by Progenics Pharmaceuticals, Inc. ( Progenics ), which led, and contributed to funding of, PRO 140 development and trials through 2011.", "sentB": "The preclinical and clinical development of PRO 140 was led by Progenics Pharmaceuticals, Inc. ( Progenics ) through 2011.", "type": 2, "words": ["<tag1>", "PRO", "140", "was", "originally", "developed", "by", "Progenics", "Pharmaceuticals,", "Inc.", "(", "Progenics", "),", "which", "led,", "and", "contributed", "to", "funding", "of,", "PRO", "140", "development", "and", "trials", "through", "2011.", "<tag2>", "The", "preclinical", "and", "clinical", "development", "of", "PRO", "140", "was", "led", "by", "Progenics", "Pharmaceuticals,", "Inc.", "(", "Progenics", ")", "through", "2011.", "<tag3>"], "wordsA": ["PRO", "140", "was", "originally", "developed", "by", "Progenics", "Pharmaceuticals,", "Inc.", "(", "Progenics", "),", "which", "led,", "and", "contributed", "to", "funding", "of,", "PRO", "140", "development", "and", "trials", "through", "2011."], "wordsB": ["The", "preclinical", "and", "clinical", "development", "of", "PRO", "140", "was", "led", "by", "Progenics", "Pharmaceuticals,", "Inc.", "(", "Progenics", ")", "through", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p3_s1", "idA": "1175680_15_item1_p3_s1", "sentA": "We acquired the asset from Progenics in October 2012.", "sentB": "We acquired the asset from Progenics in October 2012, as described under PRO 140 Acquisition and Licensing Arrangements below.", "type": 2, "words": ["<tag1>", "We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012.", "<tag2>", "We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012,", "as", "described", "under", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "below.", "<tag3>"], "wordsA": ["We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012."], "wordsB": ["We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012,", "as", "described", "under", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p55_s2", "idA": "1175680_15_item1_p40_s0", "sentA": "Phase 1 Phase 1 includes the initial introduction of an investigational new drug or biologic into humans.", "sentB": "In particular, a drug or biologic may not be promoted for uses that are not approved by the FDA as reflected in the product s approved labeling.", "type": 2, "words": ["<tag1>", "Phase", "1", "Phase", "1", "includes", "the", "initial", "introduction", "of", "an", "investigational", "new", "drug", "or", "biologic", "into", "humans.", "<tag2>", "In", "particular,", "a", "drug", "or", "biologic", "may", "not", "be", "promoted", "for", "uses", "that", "are", "not", "approved", "by", "the", "FDA", "as", "reflected", "in", "the", "product", "s", "approved", "labeling.", "<tag3>"], "wordsA": ["Phase", "1", "Phase", "1", "includes", "the", "initial", "introduction", "of", "an", "investigational", "new", "drug", "or", "biologic", "into", "humans."], "wordsB": ["In", "particular,", "a", "drug", "or", "biologic", "may", "not", "be", "promoted", "for", "uses", "that", "are", "not", "approved", "by", "the", "FDA", "as", "reflected", "in", "the", "product", "s", "approved", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p50_s8", "idA": "1175680_15_item1_p41_s10", "sentA": "Phase 3 studies also provide an adequate basis for extrapolating the results to the general population and transmitting that information in the physician labeling.", "sentB": "In responding to an NDA or BLA, the FDA may grant marketing approval, request additional information in a complete response letter, or deny the approval if it determines that the NDA or BLA does not provide an adequate basis for approval.", "type": 2, "words": ["<tag1>", "Phase", "3", "studies", "also", "provide", "an", "adequate", "basis", "for", "extrapolating", "the", "results", "to", "the", "general", "population", "and", "transmitting", "that", "information", "in", "the", "physician", "labeling.", "<tag2>", "In", "responding", "to", "an", "NDA", "or", "BLA,", "the", "FDA", "may", "grant", "marketing", "approval,", "request", "additional", "information", "in", "a", "complete", "response", "letter,", "or", "deny", "the", "approval", "if", "it", "determines", "that", "the", "NDA", "or", "BLA", "does", "not", "provide", "an", "adequate", "basis", "for", "approval.", "<tag3>"], "wordsA": ["Phase", "3", "studies", "also", "provide", "an", "adequate", "basis", "for", "extrapolating", "the", "results", "to", "the", "general", "population", "and", "transmitting", "that", "information", "in", "the", "physician", "labeling."], "wordsB": ["In", "responding", "to", "an", "NDA", "or", "BLA,", "the", "FDA", "may", "grant", "marketing", "approval,", "request", "additional", "information", "in", "a", "complete", "response", "letter,", "or", "deny", "the", "approval", "if", "it", "determines", "that", "the", "NDA", "or", "BLA", "does", "not", "provide", "an", "adequate", "basis", "for", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p18_s0", "idA": "1175680_15_item1_p41_s12", "sentA": "We are required to pay significant fees to third parties upon the first patient dosing in a Phase 3 trial of PRO 140.", "sentB": "Our fourth ongoing trial of PRO 140 is a Phase 2 study for Graft versus Host Disease ( GvHD ) and is the first non-HIV indication for PRO 140.", "type": 2, "words": ["<tag1>", "We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140.", "<tag2>", "Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft", "versus", "Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "indication", "for", "PRO", "140.", "<tag3>"], "wordsA": ["We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140."], "wordsB": ["Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft", "versus", "Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "indication", "for", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p18_s2", "idA": "1175680_15_item1_p41_s12", "sentA": "We are required to pay significant fees to third parties upon the first patient dosing in a Phase 3 trial of PRO 140.", "sentB": "Enrollment of the first patient has not been announced.", "type": 2, "words": ["<tag1>", "We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140.", "<tag2>", "Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced.", "<tag3>"], "wordsA": ["We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140."], "wordsB": ["Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p32_s5", "idA": "1175680_15_item1_p41_s12", "sentA": "We are required to pay significant fees to third parties upon the first patient dosing in a Phase 3 trial of PRO 140.", "sentB": "Enrollment of the first patient has not been announced.", "type": 2, "words": ["<tag1>", "We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140.", "<tag2>", "Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced.", "<tag3>"], "wordsA": ["We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140."], "wordsB": ["Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p72_s0", "idA": "1175680_15_item1_p41_s12", "sentA": "We are required to pay significant fees to third parties upon the first patient dosing in a Phase 3 trial of PRO 140.", "sentB": "Manufacturing We do not own or operate manufacturing facilities for the production of PRO 140.", "type": 2, "words": ["<tag1>", "We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140.", "<tag2>", "Manufacturing", "We", "do", "not", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "PRO", "140.", "<tag3>"], "wordsA": ["We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140."], "wordsB": ["Manufacturing", "We", "do", "not", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p65_s5", "idA": "1175680_15_item1_p41_s13", "sentA": "See the discussion under the subheading PRO 140 Acquisition above.", "sentB": "See the discussion under the subheading PRO 140 Acquisition and Licensing Arrangements above.", "type": 2, "words": ["<tag1>", "See", "the", "discussion", "under", "the", "subheading", "PRO", "140", "Acquisition", "above.", "<tag2>", "See", "the", "discussion", "under", "the", "subheading", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "above.", "<tag3>"], "wordsA": ["See", "the", "discussion", "under", "the", "subheading", "PRO", "140", "Acquisition", "above."], "wordsB": ["See", "the", "discussion", "under", "the", "subheading", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p32_s1", "idA": "1175680_15_item1_p41_s3", "sentA": "Phase 2 studies are typically well-controlled, closely monitored, and conducted in a relatively small number of patients, often involving several hundred people.", "sentB": "The only approved CCR5 inhibitor, Maraviroc, is currently in a Phase 2 study for GvHD indications, and results are expected in 2016.", "type": 2, "words": ["<tag1>", "Phase", "2", "studies", "are", "typically", "well-controlled,", "closely", "monitored,", "and", "conducted", "in", "a", "relatively", "small", "number", "of", "patients,", "often", "involving", "several", "hundred", "people.", "<tag2>", "The", "only", "approved", "CCR5", "inhibitor,", "Maraviroc,", "is", "currently", "in", "a", "Phase", "2", "study", "for", "GvHD", "indications,", "and", "results", "are", "expected", "in", "2016.", "<tag3>"], "wordsA": ["Phase", "2", "studies", "are", "typically", "well-controlled,", "closely", "monitored,", "and", "conducted", "in", "a", "relatively", "small", "number", "of", "patients,", "often", "involving", "several", "hundred", "people."], "wordsB": ["The", "only", "approved", "CCR5", "inhibitor,", "Maraviroc,", "is", "currently", "in", "a", "Phase", "2", "study", "for", "GvHD", "indications,", "and", "results", "are", "expected", "in", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p15_s0", "idA": "1175680_15_item1_p41_s7", "sentA": "Our treatment substitution clinical trial is a Phase 2b trial.", "sentB": "Our first ongoing clinical trial is an extension study of our Phase 2b treatment substitution trial, which was initially completed in January 2015.", "type": 2, "words": ["<tag1>", "Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial.", "<tag2>", "Our", "first", "ongoing", "clinical", "trial", "is", "an", "extension", "study", "of", "our", "Phase", "2b", "treatment", "substitution", "trial,", "which", "was", "initially", "completed", "in", "January", "2015.", "<tag3>"], "wordsA": ["Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial."], "wordsB": ["Our", "first", "ongoing", "clinical", "trial", "is", "an", "extension", "study", "of", "our", "Phase", "2b", "treatment", "substitution", "trial,", "which", "was", "initially", "completed", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p27_s3", "idA": "1175680_15_item1_p41_s7", "sentA": "Our treatment substitution clinical trial is a Phase 2b trial.", "sentB": "Enrollment of first patient is anticipated to occur within the next quarter and is expected to accelerate, as experienced in the previous Phase 2b monotherapy trial.", "type": 2, "words": ["<tag1>", "Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial.", "<tag2>", "Enrollment", "of", "first", "patient", "is", "anticipated", "to", "occur", "within", "the", "next", "quarter", "and", "is", "expected", "to", "accelerate,", "as", "experienced", "in", "the", "previous", "Phase", "2b", "monotherapy", "trial.", "<tag3>"], "wordsA": ["Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial."], "wordsB": ["Enrollment", "of", "first", "patient", "is", "anticipated", "to", "occur", "within", "the", "next", "quarter", "and", "is", "expected", "to", "accelerate,", "as", "experienced", "in", "the", "previous", "Phase", "2b", "monotherapy", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p31_s1", "idA": "1175680_15_item1_p41_s7", "sentA": "Our treatment substitution clinical trial is a Phase 2b trial.", "sentB": "GvHD is a life-threatening complication for patients undergoing stem cell transplants.", "type": 2, "words": ["<tag1>", "Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial.", "<tag2>", "GvHD", "is", "a", "life-threatening", "complication", "for", "patients", "undergoing", "stem", "cell", "transplants.", "<tag3>"], "wordsA": ["Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial."], "wordsB": ["GvHD", "is", "a", "life-threatening", "complication", "for", "patients", "undergoing", "stem", "cell", "transplants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p32_s4", "idA": "1175680_15_item1_p41_s7", "sentA": "Our treatment substitution clinical trial is a Phase 2b trial.", "sentB": "The trial is a 100-day study with 60 patients.", "type": 2, "words": ["<tag1>", "Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial.", "<tag2>", "The", "trial", "is", "a", "100-day", "study", "with", "60", "patients.", "<tag3>"], "wordsA": ["Our", "treatment", "substitution", "clinical", "trial", "is", "a", "Phase", "2b", "trial."], "wordsB": ["The", "trial", "is", "a", "100-day", "study", "with", "60", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p72_s5", "idA": "1175680_15_item1_p41_s8", "sentA": "Phase 3 Phase 3 studies are expanded controlled clinical studies.", "sentB": "In addition, we have undertaken certain comparability studies which supported the use of previously manufactured amounts of PRO 140 in current and planned clinical studies.", "type": 2, "words": ["<tag1>", "Phase", "3", "Phase", "3", "studies", "are", "expanded", "controlled", "clinical", "studies.", "<tag2>", "In", "addition,", "we", "have", "undertaken", "certain", "comparability", "studies", "which", "supported", "the", "use", "of", "previously", "manufactured", "amounts", "of", "PRO", "140", "in", "current", "and", "planned", "clinical", "studies.", "<tag3>"], "wordsA": ["Phase", "3", "Phase", "3", "studies", "are", "expanded", "controlled", "clinical", "studies."], "wordsB": ["In", "addition,", "we", "have", "undertaken", "certain", "comparability", "studies", "which", "supported", "the", "use", "of", "previously", "manufactured", "amounts", "of", "PRO", "140", "in", "current", "and", "planned", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p43_s0", "idA": "1175680_15_item1_p42_s2", "sentA": "Advancing PRO 140 is our highest priority.", "sentB": "(2) PRO 140 patents and applications relate to HIV-1 and GvHD treatments.", "type": 2, "words": ["<tag1>", "Advancing", "PRO", "140", "is", "our", "highest", "priority.", "<tag2>", "(2)", "PRO", "140", "patents", "and", "applications", "relate", "to", "HIV-1", "and", "GvHD", "treatments.", "<tag3>"], "wordsA": ["Advancing", "PRO", "140", "is", "our", "highest", "priority."], "wordsB": ["(2)", "PRO", "140", "patents", "and", "applications", "relate", "to", "HIV-1", "and", "GvHD", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p66_s2", "idA": "1175680_15_item1_p42_s2", "sentA": "Advancing PRO 140 is our highest priority.", "sentB": "Advancing PRO 140 to commercialization is our highest priority.", "type": 2, "words": ["<tag1>", "Advancing", "PRO", "140", "is", "our", "highest", "priority.", "<tag2>", "Advancing", "PRO", "140", "to", "commercialization", "is", "our", "highest", "priority.", "<tag3>"], "wordsA": ["Advancing", "PRO", "140", "is", "our", "highest", "priority."], "wordsB": ["Advancing", "PRO", "140", "to", "commercialization", "is", "our", "highest", "priority."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p68_s0", "idA": "1175680_15_item1_p43_s3", "sentA": "Both of these drugs must be taken daily and are believed to have significant side effects.", "sentB": "Maraviroc like all other HIV approved drugs must be taken daily and are believed to have significant side effects.", "type": 2, "words": ["<tag1>", "Both", "of", "these", "drugs", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects.", "<tag2>", "Maraviroc", "like", "all", "other", "HIV", "approved", "drugs", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects.", "<tag3>"], "wordsA": ["Both", "of", "these", "drugs", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects."], "wordsB": ["Maraviroc", "like", "all", "other", "HIV", "approved", "drugs", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p68_s1", "idA": "1175680_15_item1_p43_s4", "sentA": "For these reasons, we believe that our lead product, PRO 140, a monoclonal antibody may prove to be useful in patients that cannot tolerate existing HIV therapies or desire a respite from those therapies.", "sentB": "For these reasons, we believe that our lead product, PRO 140, a monoclonal antibody, may prove to be useful in patients that cannot tolerate existing HIV therapies or desire a respite from those therapies.", "type": 2, "words": ["<tag1>", "For", "these", "reasons,", "we", "believe", "that", "our", "lead", "product,", "PRO", "140,", "a", "monoclonal", "antibody", "may", "prove", "to", "be", "useful", "in", "patients", "that", "cannot", "tolerate", "existing", "HIV", "therapies", "or", "desire", "a", "respite", "from", "those", "therapies.", "<tag2>", "For", "these", "reasons,", "we", "believe", "that", "our", "lead", "product,", "PRO", "140,", "a", "monoclonal", "antibody,", "may", "prove", "to", "be", "useful", "in", "patients", "that", "cannot", "tolerate", "existing", "HIV", "therapies", "or", "desire", "a", "respite", "from", "those", "therapies.", "<tag3>"], "wordsA": ["For", "these", "reasons,", "we", "believe", "that", "our", "lead", "product,", "PRO", "140,", "a", "monoclonal", "antibody", "may", "prove", "to", "be", "useful", "in", "patients", "that", "cannot", "tolerate", "existing", "HIV", "therapies", "or", "desire", "a", "respite", "from", "those", "therapies."], "wordsB": ["For", "these", "reasons,", "we", "believe", "that", "our", "lead", "product,", "PRO", "140,", "a", "monoclonal", "antibody,", "may", "prove", "to", "be", "useful", "in", "patients", "that", "cannot", "tolerate", "existing", "HIV", "therapies", "or", "desire", "a", "respite", "from", "those", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p68_s2", "idA": "1175680_15_item1_p43_s5", "sentA": "Nonetheless, manufacturers of current therapies, such as Pfizer and Gilead Sciences, are very large, multi-national corporations with significant resources.", "sentB": "Nonetheless, manufacturers of current therapies, such as Pfizer, Gilead Sciences, Merck, Bristol-Myers Squibb and ViiV Healthcare, are very large, multi-national corporations with significant resources.", "type": 2, "words": ["<tag1>", "Nonetheless,", "manufacturers", "of", "current", "therapies,", "such", "as", "Pfizer", "and", "Gilead", "Sciences,", "are", "very", "large,", "multi-national", "corporations", "with", "significant", "resources.", "<tag2>", "Nonetheless,", "manufacturers", "of", "current", "therapies,", "such", "as", "Pfizer,", "Gilead", "Sciences,", "Merck,", "Bristol-Myers", "Squibb", "and", "ViiV", "Healthcare,", "are", "very", "large,", "multi-national", "corporations", "with", "significant", "resources.", "<tag3>"], "wordsA": ["Nonetheless,", "manufacturers", "of", "current", "therapies,", "such", "as", "Pfizer", "and", "Gilead", "Sciences,", "are", "very", "large,", "multi-national", "corporations", "with", "significant", "resources."], "wordsB": ["Nonetheless,", "manufacturers", "of", "current", "therapies,", "such", "as", "Pfizer,", "Gilead", "Sciences,", "Merck,", "Bristol-Myers", "Squibb", "and", "ViiV", "Healthcare,", "are", "very", "large,", "multi-national", "corporations", "with", "significant", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p71_s2", "idA": "1175680_15_item1_p43_s9", "sentA": "All of these potential competitors have substantially greater capital resources, management expertise, research and development capabilities, manufacturing and marketing resources and experience than we do.", "sentB": "Many of these potential competitors have substantially greater capital resources, management expertise, research and development capabilities, manufacturing and marketing resources and experience than we do.", "type": 2, "words": ["<tag1>", "All", "of", "these", "potential", "competitors", "have", "substantially", "greater", "capital", "resources,", "management", "expertise,", "research", "and", "development", "capabilities,", "manufacturing", "and", "marketing", "resources", "and", "experience", "than", "we", "do.", "<tag2>", "Many", "of", "these", "potential", "competitors", "have", "substantially", "greater", "capital", "resources,", "management", "expertise,", "research", "and", "development", "capabilities,", "manufacturing", "and", "marketing", "resources", "and", "experience", "than", "we", "do.", "<tag3>"], "wordsA": ["All", "of", "these", "potential", "competitors", "have", "substantially", "greater", "capital", "resources,", "management", "expertise,", "research", "and", "development", "capabilities,", "manufacturing", "and", "marketing", "resources", "and", "experience", "than", "we", "do."], "wordsB": ["Many", "of", "these", "potential", "competitors", "have", "substantially", "greater", "capital", "resources,", "management", "expertise,", "research", "and", "development", "capabilities,", "manufacturing", "and", "marketing", "resources", "and", "experience", "than", "we", "do."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p69_s1", "idA": "1175680_15_item1_p44_s0", "sentA": "Worldwide, there are many antiviral drugs for treating HIV.", "sentB": "Currently there are only five different classes of drugs.", "type": 2, "words": ["<tag1>", "Worldwide,", "there", "are", "many", "antiviral", "drugs", "for", "treating", "HIV.", "<tag2>", "Currently", "there", "are", "only", "five", "different", "classes", "of", "drugs.", "<tag3>"], "wordsA": ["Worldwide,", "there", "are", "many", "antiviral", "drugs", "for", "treating", "HIV."], "wordsB": ["Currently", "there", "are", "only", "five", "different", "classes", "of", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p71_s1", "idA": "1175680_15_item1_p45_s0", "sentA": "In seeking to manufacture, distribute and market the potential drugs we hope to have approved, we face competition from established pharmaceutical companies.", "sentB": "In seeking to manufacture, distribute and market the potential drugs we hope to have approved, we face competition from established pharmaceutical companies..", "type": 2, "words": ["<tag1>", "In", "seeking", "to", "manufacture,", "distribute", "and", "market", "the", "potential", "drugs", "we", "hope", "to", "have", "approved,", "we", "face", "competition", "from", "established", "pharmaceutical", "companies.", "<tag2>", "In", "seeking", "to", "manufacture,", "distribute", "and", "market", "the", "potential", "drugs", "we", "hope", "to", "have", "approved,", "we", "face", "competition", "from", "established", "pharmaceutical", "companies..", "<tag3>"], "wordsA": ["In", "seeking", "to", "manufacture,", "distribute", "and", "market", "the", "potential", "drugs", "we", "hope", "to", "have", "approved,", "we", "face", "competition", "from", "established", "pharmaceutical", "companies."], "wordsB": ["In", "seeking", "to", "manufacture,", "distribute", "and", "market", "the", "potential", "drugs", "we", "hope", "to", "have", "approved,", "we", "face", "competition", "from", "established", "pharmaceutical", "companies.."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p26_s1", "idA": "1175680_15_item1_p45_s2", "sentA": "We also expect that the number of our competitors and potential competitors will increase as more potential drugs receive commercial marketing approvals from the FDA or analogous foreign regulatory agencies.", "sentB": "In response to our filing, the FDA requested that the Company submit data from the population for which the breakthrough therapy is requested.", "type": 2, "words": ["<tag1>", "We", "also", "expect", "that", "the", "number", "of", "our", "competitors", "and", "potential", "competitors", "will", "increase", "as", "more", "potential", "drugs", "receive", "commercial", "marketing", "approvals", "from", "the", "FDA", "or", "analogous", "foreign", "regulatory", "agencies.", "<tag2>", "In", "response", "to", "our", "filing,", "the", "FDA", "requested", "that", "the", "Company", "submit", "data", "from", "the", "population", "for", "which", "the", "breakthrough", "therapy", "is", "requested.", "<tag3>"], "wordsA": ["We", "also", "expect", "that", "the", "number", "of", "our", "competitors", "and", "potential", "competitors", "will", "increase", "as", "more", "potential", "drugs", "receive", "commercial", "marketing", "approvals", "from", "the", "FDA", "or", "analogous", "foreign", "regulatory", "agencies."], "wordsB": ["In", "response", "to", "our", "filing,", "the", "FDA", "requested", "that", "the", "Company", "submit", "data", "from", "the", "population", "for", "which", "the", "breakthrough", "therapy", "is", "requested."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p34_s2", "idA": "1175680_15_item1_p46_s0", "sentA": "Research and Development Costs Our research and development expenses totaled approximately $15.2 million and $4.0 million for the fiscal years ended May 31, 2015 and May 31, 2014, respectively.", "sentB": "During the year ended May 31, 2016 the Company paid $1 million of such milestones.", "type": 2, "words": ["<tag1>", "Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$15.2", "million", "and", "$4.0", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2015", "and", "May", "31,", "2014,", "respectively.", "<tag2>", "During", "the", "year", "ended", "May", "31,", "2016", "the", "Company", "paid", "$1", "million", "of", "such", "milestones.", "<tag3>"], "wordsA": ["Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$15.2", "million", "and", "$4.0", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2015", "and", "May", "31,", "2014,", "respectively."], "wordsB": ["During", "the", "year", "ended", "May", "31,", "2016", "the", "Company", "paid", "$1", "million", "of", "such", "milestones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p73_s0", "idA": "1175680_15_item1_p46_s0", "sentA": "Research and Development Costs Our research and development expenses totaled approximately $15.2 million and $4.0 million for the fiscal years ended May 31, 2015 and May 31, 2014, respectively.", "sentB": "Research and Development Costs Our research and development expenses totaled approximately $13.7 million and $15.2 million for the fiscal years ended May 31, 2016 and May 31, 2015, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$15.2", "million", "and", "$4.0", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2015", "and", "May", "31,", "2014,", "respectively.", "<tag2>", "Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$13.7", "million", "and", "$15.2", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2016", "and", "May", "31,", "2015,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$15.2", "million", "and", "$4.0", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2015", "and", "May", "31,", "2014,", "respectively."], "wordsB": ["Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$13.7", "million", "and", "$15.2", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2016", "and", "May", "31,", "2015,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p73_s1", "idA": "1175680_15_item1_p46_s1", "sentA": "We expect that research and development expenses will continue to be a significant expense as we seek to develop our current and future product pipeline.", "sentB": "We expect the Company s research and development expenses to continue to increase in future periods as the activity within the Company s clinical trials expands and the Company s biologics manufacturing processes and related regulatory compliance activities increase.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "research", "and", "development", "expenses", "will", "continue", "to", "be", "a", "significant", "expense", "as", "we", "seek", "to", "develop", "our", "current", "and", "future", "product", "pipeline.", "<tag2>", "We", "expect", "the", "Company", "s", "research", "and", "development", "expenses", "to", "continue", "to", "increase", "in", "future", "periods", "as", "the", "activity", "within", "the", "Company", "s", "clinical", "trials", "expands", "and", "the", "Company", "s", "biologics", "manufacturing", "processes", "and", "related", "regulatory", "compliance", "activities", "increase.", "<tag3>"], "wordsA": ["We", "expect", "that", "research", "and", "development", "expenses", "will", "continue", "to", "be", "a", "significant", "expense", "as", "we", "seek", "to", "develop", "our", "current", "and", "future", "product", "pipeline."], "wordsB": ["We", "expect", "the", "Company", "s", "research", "and", "development", "expenses", "to", "continue", "to", "increase", "in", "future", "periods", "as", "the", "activity", "within", "the", "Company", "s", "clinical", "trials", "expands", "and", "the", "Company", "s", "biologics", "manufacturing", "processes", "and", "related", "regulatory", "compliance", "activities", "increase."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p36_s7", "idA": "1175680_15_item1_p47_s0", "sentA": "Employees and Consultants We have three full-time employees, our CEO, CFO and Director of Accounting, as well as several independent consultants assisting us with our clinical trials of PRO 140 and manufacturing activities.", "sentB": "If that arrangement continues, the annual license fee of 300,000 would continue to apply, as well as a royalty of 1.0% of the net selling price upon commercialization of PRO 140 (excluding value added taxes and similar amounts).", "type": 2, "words": ["<tag1>", "Employees", "and", "Consultants", "We", "have", "three", "full-time", "employees,", "our", "CEO,", "CFO", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities.", "<tag2>", "If", "that", "arrangement", "continues,", "the", "annual", "license", "fee", "of", "300,000", "would", "continue", "to", "apply,", "as", "well", "as", "a", "royalty", "of", "1.0%", "of", "the", "net", "selling", "price", "upon", "commercialization", "of", "PRO", "140", "(excluding", "value", "added", "taxes", "and", "similar", "amounts).", "<tag3>"], "wordsA": ["Employees", "and", "Consultants", "We", "have", "three", "full-time", "employees,", "our", "CEO,", "CFO", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities."], "wordsB": ["If", "that", "arrangement", "continues,", "the", "annual", "license", "fee", "of", "300,000", "would", "continue", "to", "apply,", "as", "well", "as", "a", "royalty", "of", "1.0%", "of", "the", "net", "selling", "price", "upon", "commercialization", "of", "PRO", "140", "(excluding", "value", "added", "taxes", "and", "similar", "amounts)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p74_s0", "idA": "1175680_15_item1_p47_s0", "sentA": "Employees and Consultants We have three full-time employees, our CEO, CFO and Director of Accounting, as well as several independent consultants assisting us with our clinical trials of PRO 140 and manufacturing activities.", "sentB": "Employees and Consultants We have five full-time employees, our CEO, CFO, Senior Vice President of Manufacturing, Associate Director Process Sciences and Director of Accounting, as well as several independent consultants assisting us with our clinical trials of PRO 140 and manufacturing activities.", "type": 2, "words": ["<tag1>", "Employees", "and", "Consultants", "We", "have", "three", "full-time", "employees,", "our", "CEO,", "CFO", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities.", "<tag2>", "Employees", "and", "Consultants", "We", "have", "five", "full-time", "employees,", "our", "CEO,", "CFO,", "Senior", "Vice", "President", "of", "Manufacturing,", "Associate", "Director", "Process", "Sciences", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities.", "<tag3>"], "wordsA": ["Employees", "and", "Consultants", "We", "have", "three", "full-time", "employees,", "our", "CEO,", "CFO", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities."], "wordsB": ["Employees", "and", "Consultants", "We", "have", "five", "full-time", "employees,", "our", "CEO,", "CFO,", "Senior", "Vice", "President", "of", "Manufacturing,", "Associate", "Director", "Process", "Sciences", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p50_s6", "idA": "1175680_15_item1_p4_s0", "sentA": "Jeffrey M. Jacobson, M.D., Professor of Medicine, Microbiology and Immunology, Chief, Drexel University College of Medicine ( Drexel ), has conducted prior research relating to PRO 140, and is continuing to pursue one clinical trial partially funded through one grant awarded to Dr. Jacobson by the National Institutes of Health ( NIH ).", "sentB": "Information for certain clinical trials also must be publicly disclosed within certain time limits on the clinical trial registry and results databank maintained by the National Institutes of Health, or NIH.", "type": 2, "words": ["<tag1>", "Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "has", "conducted", "prior", "research", "relating", "to", "PRO", "140,", "and", "is", "continuing", "to", "pursue", "one", "clinical", "trial", "partially", "funded", "through", "one", "grant", "awarded", "to", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ").", "<tag2>", "Information", "for", "certain", "clinical", "trials", "also", "must", "be", "publicly", "disclosed", "within", "certain", "time", "limits", "on", "the", "clinical", "trial", "registry", "and", "results", "databank", "maintained", "by", "the", "National", "Institutes", "of", "Health,", "or", "NIH.", "<tag3>"], "wordsA": ["Jeffrey", "M.", "Jacobson,", "M.D.,", "Professor", "of", "Medicine,", "Microbiology", "and", "Immunology,", "Chief,", "Drexel", "University", "College", "of", "Medicine", "(", "Drexel", "),", "has", "conducted", "prior", "research", "relating", "to", "PRO", "140,", "and", "is", "continuing", "to", "pursue", "one", "clinical", "trial", "partially", "funded", "through", "one", "grant", "awarded", "to", "Dr.", "Jacobson", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ")."], "wordsB": ["Information", "for", "certain", "clinical", "trials", "also", "must", "be", "publicly", "disclosed", "within", "certain", "time", "limits", "on", "the", "clinical", "trial", "registry", "and", "results", "databank", "maintained", "by", "the", "National", "Institutes", "of", "Health,", "or", "NIH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p16_s0", "idA": "1175680_15_item1_p4_s1", "sentA": "We have also recently completed a successful Phase 2b clinical trial exploring PRO 140 as a short-term treatment substitution (as a monotherapy of PRO 140) for existing drug regimens.", "sentB": "Our second ongoing clinical trial is a pivotal Phase 2b/3 trial for PRO 140 as a combination therapy to existing HAART drug regimens.", "type": 2, "words": ["<tag1>", "We", "have", "also", "recently", "completed", "a", "successful", "Phase", "2b", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "drug", "regimens.", "<tag2>", "Our", "second", "ongoing", "clinical", "trial", "is", "a", "pivotal", "Phase", "2b/3", "trial", "for", "PRO", "140", "as", "a", "combination", "therapy", "to", "existing", "HAART", "drug", "regimens.", "<tag3>"], "wordsA": ["We", "have", "also", "recently", "completed", "a", "successful", "Phase", "2b", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "drug", "regimens."], "wordsB": ["Our", "second", "ongoing", "clinical", "trial", "is", "a", "pivotal", "Phase", "2b/3", "trial", "for", "PRO", "140", "as", "a", "combination", "therapy", "to", "existing", "HAART", "drug", "regimens."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p18_s9", "idA": "1175680_15_item1_p4_s1", "sentA": "We have also recently completed a successful Phase 2b clinical trial exploring PRO 140 as a short-term treatment substitution (as a monotherapy of PRO 140) for existing drug regimens.", "sentB": "This Phase 2b trial, referred to as a treatment substitution trial, investigated PRO 140 as a short-term treatment substitution (as a monotherapy of PRO 140) for existing HAART drug regimens.", "type": 2, "words": ["<tag1>", "We", "have", "also", "recently", "completed", "a", "successful", "Phase", "2b", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "drug", "regimens.", "<tag2>", "This", "Phase", "2b", "trial,", "referred", "to", "as", "a", "treatment", "substitution", "trial,", "investigated", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "HAART", "drug", "regimens.", "<tag3>"], "wordsA": ["We", "have", "also", "recently", "completed", "a", "successful", "Phase", "2b", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "drug", "regimens."], "wordsB": ["This", "Phase", "2b", "trial,", "referred", "to", "as", "a", "treatment", "substitution", "trial,", "investigated", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "HAART", "drug", "regimens."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p24_s0", "idA": "1175680_15_item1_p4_s1", "sentA": "We have also recently completed a successful Phase 2b clinical trial exploring PRO 140 as a short-term treatment substitution (as a monotherapy of PRO 140) for existing drug regimens.", "sentB": "In view of PRO 140 being established as a safe and efficacious substitution therapy in the initial Phase 2b monotherapy trial and ongoing extension study, following the FDA s clearance of a new trial protocol, we initiated in mid-2015 a pivotal Phase 2b/3 trial for PRO 140 as combination therapy to existing HAART drug regimens.", "type": 2, "words": ["<tag1>", "We", "have", "also", "recently", "completed", "a", "successful", "Phase", "2b", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "drug", "regimens.", "<tag2>", "In", "view", "of", "PRO", "140", "being", "established", "as", "a", "safe", "and", "efficacious", "substitution", "therapy", "in", "the", "initial", "Phase", "2b", "monotherapy", "trial", "and", "ongoing", "extension", "study,", "following", "the", "FDA", "s", "clearance", "of", "a", "new", "trial", "protocol,", "we", "initiated", "in", "mid-2015", "a", "pivotal", "Phase", "2b/3", "trial", "for", "PRO", "140", "as", "combination", "therapy", "to", "existing", "HAART", "drug", "regimens.", "<tag3>"], "wordsA": ["We", "have", "also", "recently", "completed", "a", "successful", "Phase", "2b", "clinical", "trial", "exploring", "PRO", "140", "as", "a", "short-term", "treatment", "substitution", "(as", "a", "monotherapy", "of", "PRO", "140)", "for", "existing", "drug", "regimens."], "wordsB": ["In", "view", "of", "PRO", "140", "being", "established", "as", "a", "safe", "and", "efficacious", "substitution", "therapy", "in", "the", "initial", "Phase", "2b", "monotherapy", "trial", "and", "ongoing", "extension", "study,", "following", "the", "FDA", "s", "clearance", "of", "a", "new", "trial", "protocol,", "we", "initiated", "in", "mid-2015", "a", "pivotal", "Phase", "2b/3", "trial", "for", "PRO", "140", "as", "combination", "therapy", "to", "existing", "HAART", "drug", "regimens."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p13_s0", "idA": "1175680_15_item1_p5_s0", "sentA": "To facilitate our self-funded and sponsored clinical research plans, we have engaged Amarex Clinical Research, LLC ( Amarex ), our principal contract research organization, to provide comprehensive clinical trial services, including managing our chemistry, manufacturing and controls ( CMC ) activities.", "sentB": "To facilitate our self-funded and sponsored clinical research plans and trials, we engaged Amarex Clinical Research, LLC ( Amarex ), as our principal contract research organization ( CRO ), to provide comprehensive clinical trial management services.", "type": 2, "words": ["<tag1>", "To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans,", "we", "have", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "our", "principal", "contract", "research", "organization,", "to", "provide", "comprehensive", "clinical", "trial", "services,", "including", "managing", "our", "chemistry,", "manufacturing", "and", "controls", "(", "CMC", ")", "activities.", "<tag2>", "To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans", "and", "trials,", "we", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "as", "our", "principal", "contract", "research", "organization", "(", "CRO", "),", "to", "provide", "comprehensive", "clinical", "trial", "management", "services.", "<tag3>"], "wordsA": ["To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans,", "we", "have", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "our", "principal", "contract", "research", "organization,", "to", "provide", "comprehensive", "clinical", "trial", "services,", "including", "managing", "our", "chemistry,", "manufacturing", "and", "controls", "(", "CMC", ")", "activities."], "wordsB": ["To", "facilitate", "our", "self-funded", "and", "sponsored", "clinical", "research", "plans", "and", "trials,", "we", "engaged", "Amarex", "Clinical", "Research,", "LLC", "(", "Amarex", "),", "as", "our", "principal", "contract", "research", "organization", "(", "CRO", "),", "to", "provide", "comprehensive", "clinical", "trial", "management", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p11_s0", "idA": "1175680_15_item1_p6_s0", "sentA": "To date, PRO 140 has only been tested and administered to test subjects either intravenously or as a subcutaneous injection.", "sentB": "To date, PRO 140 has been tested and administered to test subjects either intravenously or as a subcutaneous injection.", "type": 2, "words": ["<tag1>", "To", "date,", "PRO", "140", "has", "only", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection.", "<tag2>", "To", "date,", "PRO", "140", "has", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection.", "<tag3>"], "wordsA": ["To", "date,", "PRO", "140", "has", "only", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection."], "wordsB": ["To", "date,", "PRO", "140", "has", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p8_s0", "idA": "1175680_15_item1_p6_s1", "sentA": "We believe that, if PRO 140 is approved for use as an injectable by the FDA, it may nonetheless be an attractive and marketable therapeutic option for patients with healthy CCR5, particularly in the following scenarios:", "sentB": "We believe PRO 140 is uniquely positioned to address a growing HIV market as an alternative or in addition to current therapies, which are failing primarily due to drug resistance.", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients", "with", "healthy", "CCR5,", "particularly", "in", "the", "following", "scenarios:", "<tag2>", "We", "believe", "PRO", "140", "is", "uniquely", "positioned", "to", "address", "a", "growing", "HIV", "market", "as", "an", "alternative", "or", "in", "addition", "to", "current", "therapies,", "which", "are", "failing", "primarily", "due", "to", "drug", "resistance.", "<tag3>"], "wordsA": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients", "with", "healthy", "CCR5,", "particularly", "in", "the", "following", "scenarios:"], "wordsB": ["We", "believe", "PRO", "140", "is", "uniquely", "positioned", "to", "address", "a", "growing", "HIV", "market", "as", "an", "alternative", "or", "in", "addition", "to", "current", "therapies,", "which", "are", "failing", "primarily", "due", "to", "drug", "resistance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p7_s0", "idA": "1175680_15_item1_p7_s3", "sentA": "PRO 140 has no effect on strains of HIV called X4 exclusive virus.", "sentB": "The R5 strains of HIV currently represent approximately 67% of all HIV infections in the U.S.", "type": 2, "words": ["<tag1>", "PRO", "140", "has", "no", "effect", "on", "strains", "of", "HIV", "called", "X4", "exclusive", "virus.", "<tag2>", "The", "R5", "strains", "of", "HIV", "currently", "represent", "approximately", "67%", "of", "all", "HIV", "infections", "in", "the", "U.S.", "<tag3>"], "wordsA": ["PRO", "140", "has", "no", "effect", "on", "strains", "of", "HIV", "called", "X4", "exclusive", "virus."], "wordsB": ["The", "R5", "strains", "of", "HIV", "currently", "represent", "approximately", "67%", "of", "all", "HIV", "infections", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p12_s2", "idA": "1175680_15_item1_p7_s4", "sentA": "Overall, we believe PRO 140 represents a distinct class of CCR5 inhibitors with unique virological and immunological properties and may provide another distinct tool to treat HIV-infected subjects.", "sentB": "We believe PRO 140 represents a distinct class of CCR5 inhibitors with unique virological and immunological properties and may provide another distinct tool to treat HIV-infected subjects.", "type": 2, "words": ["<tag1>", "Overall,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects.", "<tag2>", "We", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects.", "<tag3>"], "wordsA": ["Overall,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects."], "wordsB": ["We", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p7_s1", "idA": "1175680_15_item1_p7_s4", "sentA": "Overall, we believe PRO 140 represents a distinct class of CCR5 inhibitors with unique virological and immunological properties and may provide another distinct tool to treat HIV-infected subjects.", "sentB": "As a result, we believe PRO 140 represents a distinct class of CCR5 inhibitors with advantageous virological and immunological properties and may provide a unique tool to treat HIV infected patients.", "type": 2, "words": ["<tag1>", "Overall,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects.", "<tag2>", "As", "a", "result,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "advantageous", "virological", "and", "immunological", "properties", "and", "may", "provide", "a", "unique", "tool", "to", "treat", "HIV", "infected", "patients.", "<tag3>"], "wordsA": ["Overall,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects."], "wordsB": ["As", "a", "result,", "we", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "advantageous", "virological", "and", "immunological", "properties", "and", "may", "provide", "a", "unique", "tool", "to", "treat", "HIV", "infected", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p14_s0", "idA": "1175680_15_item1_p8_s0", "sentA": "Current Clinical Trials PRO 140 is currently being studied in two clinical trials.", "sentB": "Current Clinical Trials PRO 140 is currently being studied in four ongoing clinical trials:", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials.", "<tag2>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "four", "ongoing", "clinical", "trials:", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials."], "wordsB": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "four", "ongoing", "clinical", "trials:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p50_s3", "idA": "1175680_15_item1_p8_s0", "sentA": "Current Clinical Trials PRO 140 is currently being studied in two clinical trials.", "sentB": "In addition, the FDA, an IRB or we may, at any time, impose a clinical hold on ongoing clinical trials.", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials.", "<tag2>", "In", "addition,", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials.", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials."], "wordsB": ["In", "addition,", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p72_s6", "idA": "1175680_15_item1_p8_s0", "sentA": "Current Clinical Trials PRO 140 is currently being studied in two clinical trials.", "sentB": "This process has been completed and all PRO 140 drug substance can be used in our clinical trials.", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials.", "<tag2>", "This", "process", "has", "been", "completed", "and", "all", "PRO", "140", "drug", "substance", "can", "be", "used", "in", "our", "clinical", "trials.", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials."], "wordsB": ["This", "process", "has", "been", "completed", "and", "all", "PRO", "140", "drug", "substance", "can", "be", "used", "in", "our", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p9_s0", "idA": "1175680_15_item1_p8_s0", "sentA": "Current Clinical Trials PRO 140 is currently being studied in two clinical trials.", "sentB": "In seven clinical trials previously conducted, PRO 140 was generally well tolerated, and no drug-related serious adverse events, or SAEs, or dose-proportional adverse events, or AEs, were reported.", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials.", "<tag2>", "In", "seven", "clinical", "trials", "previously", "conducted,", "PRO", "140", "was", "generally", "well", "tolerated,", "and", "no", "drug-related", "serious", "adverse", "events,", "or", "SAEs,", "or", "dose-proportional", "adverse", "events,", "or", "AEs,", "were", "reported.", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "two", "clinical", "trials."], "wordsB": ["In", "seven", "clinical", "trials", "previously", "conducted,", "PRO", "140", "was", "generally", "well", "tolerated,", "and", "no", "drug-related", "serious", "adverse", "events,", "or", "SAEs,", "or", "dose-proportional", "adverse", "events,", "or", "AEs,", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p31_s0", "idA": "1175680_15_item1_p9_s0", "sentA": "Pursuant to a clinical trial agreement with us, Drexel is now carrying the investigational new drug ( IND ) application.", "sentB": "Following new research data relating to PRO 140 s mechanism of action, in October 2015, we filed with the FDA an investigational new drug (or IND ) application and a full protocol for a Phase 2 clinical trial for a transplantation indication called Graft versus Host Disease (or GvHD ), as our first non-HIV clinical indication.", "type": 2, "words": ["<tag1>", "Pursuant", "to", "a", "clinical", "trial", "agreement", "with", "us,", "Drexel", "is", "now", "carrying", "the", "investigational", "new", "drug", "(", "IND", ")", "application.", "<tag2>", "Following", "new", "research", "data", "relating", "to", "PRO", "140", "s", "mechanism", "of", "action,", "in", "October", "2015,", "we", "filed", "with", "the", "FDA", "an", "investigational", "new", "drug", "(or", "IND", ")", "application", "and", "a", "full", "protocol", "for", "a", "Phase", "2", "clinical", "trial", "for", "a", "transplantation", "indication", "called", "Graft", "versus", "Host", "Disease", "(or", "GvHD", "),", "as", "our", "first", "non-HIV", "clinical", "indication.", "<tag3>"], "wordsA": ["Pursuant", "to", "a", "clinical", "trial", "agreement", "with", "us,", "Drexel", "is", "now", "carrying", "the", "investigational", "new", "drug", "(", "IND", ")", "application."], "wordsB": ["Following", "new", "research", "data", "relating", "to", "PRO", "140", "s", "mechanism", "of", "action,", "in", "October", "2015,", "we", "filed", "with", "the", "FDA", "an", "investigational", "new", "drug", "(or", "IND", ")", "application", "and", "a", "full", "protocol", "for", "a", "Phase", "2", "clinical", "trial", "for", "a", "transplantation", "indication", "called", "Graft", "versus", "Host", "Disease", "(or", "GvHD", "),", "as", "our", "first", "non-HIV", "clinical", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p19_s4", "idA": "1175680_15_item1_p9_s10", "sentA": "Total treatment duration with PRO 140 in the initial study was up to 14 weeks with one week overlap of existing retroviral regimen and PRO 140 at the beginning of the study period and also one week of overlap at the end in subjects who did not experience virologic failure, which is defined as a viral load above 400 two weeks in a row.", "sentB": "Total treatment duration with PRO 140 was up to 14 weeks with one week overlap of existing retroviral regimen and PRO 140 at the beginning of the study period and also one week of overlap at the end for subjects who did not experience virologic failure, defined as a viral load above 400 HIV RNA particles per milliliter of blood for two consecutive weeks.", "type": 2, "words": ["<tag1>", "Total", "treatment", "duration", "with", "PRO", "140", "in", "the", "initial", "study", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "which", "is", "defined", "as", "a", "viral", "load", "above", "400", "two", "weeks", "in", "a", "row.", "<tag2>", "Total", "treatment", "duration", "with", "PRO", "140", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "for", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "defined", "as", "a", "viral", "load", "above", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks.", "<tag3>"], "wordsA": ["Total", "treatment", "duration", "with", "PRO", "140", "in", "the", "initial", "study", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "which", "is", "defined", "as", "a", "viral", "load", "above", "400", "two", "weeks", "in", "a", "row."], "wordsB": ["Total", "treatment", "duration", "with", "PRO", "140", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "for", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "defined", "as", "a", "viral", "load", "above", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p23_s2", "idA": "1175680_15_item1_p9_s10", "sentA": "Total treatment duration with PRO 140 in the initial study was up to 14 weeks with one week overlap of existing retroviral regimen and PRO 140 at the beginning of the study period and also one week of overlap at the end in subjects who did not experience virologic failure, which is defined as a viral load above 400 two weeks in a row.", "sentB": "Out of these 14 patients, 10 patients are currently ongoing and have completed up to 23 months of PRO 140 monotherapy without experiencing virologic failure (defined, as in the initial study, as a viral load above 400 HIV RNA particles per milliliter of blood for two consecutive weeks).", "type": 2, "words": ["<tag1>", "Total", "treatment", "duration", "with", "PRO", "140", "in", "the", "initial", "study", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "which", "is", "defined", "as", "a", "viral", "load", "above", "400", "two", "weeks", "in", "a", "row.", "<tag2>", "Out", "of", "these", "14", "patients,", "10", "patients", "are", "currently", "ongoing", "and", "have", "completed", "up", "to", "23", "months", "of", "PRO", "140", "monotherapy", "without", "experiencing", "virologic", "failure", "(defined,", "as", "in", "the", "initial", "study,", "as", "a", "viral", "load", "above", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks).", "<tag3>"], "wordsA": ["Total", "treatment", "duration", "with", "PRO", "140", "in", "the", "initial", "study", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "which", "is", "defined", "as", "a", "viral", "load", "above", "400", "two", "weeks", "in", "a", "row."], "wordsB": ["Out", "of", "these", "14", "patients,", "10", "patients", "are", "currently", "ongoing", "and", "have", "completed", "up", "to", "23", "months", "of", "PRO", "140", "monotherapy", "without", "experiencing", "virologic", "failure", "(defined,", "as", "in", "the", "initial", "study,", "as", "a", "viral", "load", "above", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p28_s2", "idA": "1175680_15_item1_p9_s10", "sentA": "Total treatment duration with PRO 140 in the initial study was up to 14 weeks with one week overlap of existing retroviral regimen and PRO 140 at the beginning of the study period and also one week of overlap at the end in subjects who did not experience virologic failure, which is defined as a viral load above 400 two weeks in a row.", "sentB": "Consenting patients will be shifted from combination antiretroviral regimen to weekly PRO 140 monotherapy for 48 weeks during the Treatment Phase with the one week overlap of existing retroviral regimen and PRO 140 at the beginning of the study treatment and also one week overlap at the end of the treatment in subjects who do not experience virologic failure.", "type": 2, "words": ["<tag1>", "Total", "treatment", "duration", "with", "PRO", "140", "in", "the", "initial", "study", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "which", "is", "defined", "as", "a", "viral", "load", "above", "400", "two", "weeks", "in", "a", "row.", "<tag2>", "Consenting", "patients", "will", "be", "shifted", "from", "combination", "antiretroviral", "regimen", "to", "weekly", "PRO", "140", "monotherapy", "for", "48", "weeks", "during", "the", "Treatment", "Phase", "with", "the", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "treatment", "and", "also", "one", "week", "overlap", "at", "the", "end", "of", "the", "treatment", "in", "subjects", "who", "do", "not", "experience", "virologic", "failure.", "<tag3>"], "wordsA": ["Total", "treatment", "duration", "with", "PRO", "140", "in", "the", "initial", "study", "was", "up", "to", "14", "weeks", "with", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "period", "and", "also", "one", "week", "of", "overlap", "at", "the", "end", "in", "subjects", "who", "did", "not", "experience", "virologic", "failure,", "which", "is", "defined", "as", "a", "viral", "load", "above", "400", "two", "weeks", "in", "a", "row."], "wordsB": ["Consenting", "patients", "will", "be", "shifted", "from", "combination", "antiretroviral", "regimen", "to", "weekly", "PRO", "140", "monotherapy", "for", "48", "weeks", "during", "the", "Treatment", "Phase", "with", "the", "one", "week", "overlap", "of", "existing", "retroviral", "regimen", "and", "PRO", "140", "at", "the", "beginning", "of", "the", "study", "treatment", "and", "also", "one", "week", "overlap", "at", "the", "end", "of", "the", "treatment", "in", "subjects", "who", "do", "not", "experience", "virologic", "failure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p19_s5", "idA": "1175680_15_item1_p9_s11", "sentA": "An independent Data Safety Monitoring Board ( DSMB ) is required to monitor the study to ensure patient safety and to assess efficacy.", "sentB": "An independent Data Safety Monitoring Board ( DSMB ) was required to monitor the study to ensure patient safety and to assess efficacy.", "type": 2, "words": ["<tag1>", "An", "independent", "Data", "Safety", "Monitoring", "Board", "(", "DSMB", ")", "is", "required", "to", "monitor", "the", "study", "to", "ensure", "patient", "safety", "and", "to", "assess", "efficacy.", "<tag2>", "An", "independent", "Data", "Safety", "Monitoring", "Board", "(", "DSMB", ")", "was", "required", "to", "monitor", "the", "study", "to", "ensure", "patient", "safety", "and", "to", "assess", "efficacy.", "<tag3>"], "wordsA": ["An", "independent", "Data", "Safety", "Monitoring", "Board", "(", "DSMB", ")", "is", "required", "to", "monitor", "the", "study", "to", "ensure", "patient", "safety", "and", "to", "assess", "efficacy."], "wordsB": ["An", "independent", "Data", "Safety", "Monitoring", "Board", "(", "DSMB", ")", "was", "required", "to", "monitor", "the", "study", "to", "ensure", "patient", "safety", "and", "to", "assess", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p19_s6", "idA": "1175680_15_item1_p9_s12", "sentA": "The DSMB operates in conformance with the FDA guidelines for its independence, management and oversight.", "sentB": "The DSMB operates in conformance with the FDA guidelines for its independence.", "type": 2, "words": ["<tag1>", "The", "DSMB", "operates", "in", "conformance", "with", "the", "FDA", "guidelines", "for", "its", "independence,", "management", "and", "oversight.", "<tag2>", "The", "DSMB", "operates", "in", "conformance", "with", "the", "FDA", "guidelines", "for", "its", "independence.", "<tag3>"], "wordsA": ["The", "DSMB", "operates", "in", "conformance", "with", "the", "FDA", "guidelines", "for", "its", "independence,", "management", "and", "oversight."], "wordsB": ["The", "DSMB", "operates", "in", "conformance", "with", "the", "FDA", "guidelines", "for", "its", "independence."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p18_s8", "idA": "1175680_15_item1_p9_s2", "sentA": "A second clinical trial of PRO 140 commenced in May 2014 and is sponsored and funded by CytoDyn.", "sentB": "Phase 2b Treatment Substitution Trial for HIV, as Monotherapy Our first Phase 2b clinical trial of PRO 140 commenced in May 2014 and concluded in January 2015.", "type": 2, "words": ["<tag1>", "A", "second", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "CytoDyn.", "<tag2>", "Phase", "2b", "Treatment", "Substitution", "Trial", "for", "HIV,", "as", "Monotherapy", "Our", "first", "Phase", "2b", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "concluded", "in", "January", "2015.", "<tag3>"], "wordsA": ["A", "second", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "CytoDyn."], "wordsB": ["Phase", "2b", "Treatment", "Substitution", "Trial", "for", "HIV,", "as", "Monotherapy", "Our", "first", "Phase", "2b", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "concluded", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p23_s1", "idA": "1175680_15_item1_p9_s2", "sentA": "A second clinical trial of PRO 140 commenced in May 2014 and is sponsored and funded by CytoDyn.", "sentB": "14 patients successfully passed 29 weeks of PRO 140 monotherapy.", "type": 2, "words": ["<tag1>", "A", "second", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "CytoDyn.", "<tag2>", "14", "patients", "successfully", "passed", "29", "weeks", "of", "PRO", "140", "monotherapy.", "<tag3>"], "wordsA": ["A", "second", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "CytoDyn."], "wordsB": ["14", "patients", "successfully", "passed", "29", "weeks", "of", "PRO", "140", "monotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p33_s0", "idA": "1175680_15_item1_p9_s2", "sentA": "A second clinical trial of PRO 140 commenced in May 2014 and is sponsored and funded by CytoDyn.", "sentB": "Upon randomization, subjects will receive two doses of PRO 140 or placebo given seven days apart.", "type": 2, "words": ["<tag1>", "A", "second", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "CytoDyn.", "<tag2>", "Upon", "randomization,", "subjects", "will", "receive", "two", "doses", "of", "PRO", "140", "or", "placebo", "given", "seven", "days", "apart.", "<tag3>"], "wordsA": ["A", "second", "clinical", "trial", "of", "PRO", "140", "commenced", "in", "May", "2014", "and", "is", "sponsored", "and", "funded", "by", "CytoDyn."], "wordsB": ["Upon", "randomization,", "subjects", "will", "receive", "two", "doses", "of", "PRO", "140", "or", "placebo", "given", "seven", "days", "apart."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p15_s1", "idA": "1175680_15_item1_p9_s4", "sentA": "This Phase 2b trial was completed in January 2015 and several patients are continuing in extension studies of this monotherapy of a weekly injection of PRO 140.", "sentB": "Several patients are continuing in extension studies of this monotherapy trial by taking a weekly injection of PRO 140.", "type": 2, "words": ["<tag1>", "This", "Phase", "2b", "trial", "was", "completed", "in", "January", "2015", "and", "several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "of", "a", "weekly", "injection", "of", "PRO", "140.", "<tag2>", "Several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "trial", "by", "taking", "a", "weekly", "injection", "of", "PRO", "140.", "<tag3>"], "wordsA": ["This", "Phase", "2b", "trial", "was", "completed", "in", "January", "2015", "and", "several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "of", "a", "weekly", "injection", "of", "PRO", "140."], "wordsB": ["Several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "trial", "by", "taking", "a", "weekly", "injection", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p19_s7", "idA": "1175680_15_item1_p9_s4", "sentA": "This Phase 2b trial was completed in January 2015 and several patients are continuing in extension studies of this monotherapy of a weekly injection of PRO 140.", "sentB": "DSMB s management and oversight of the trial was successfully completed in January 2015.", "type": 2, "words": ["<tag1>", "This", "Phase", "2b", "trial", "was", "completed", "in", "January", "2015", "and", "several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "of", "a", "weekly", "injection", "of", "PRO", "140.", "<tag2>", "DSMB", "s", "management", "and", "oversight", "of", "the", "trial", "was", "successfully", "completed", "in", "January", "2015.", "<tag3>"], "wordsA": ["This", "Phase", "2b", "trial", "was", "completed", "in", "January", "2015", "and", "several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "of", "a", "weekly", "injection", "of", "PRO", "140."], "wordsB": ["DSMB", "s", "management", "and", "oversight", "of", "the", "trial", "was", "successfully", "completed", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p12_s4", "idA": "1175680_15_item1_p9_s5", "sentA": "Results from these extension studies thus far indicate some patients are now reaching eight months of suppressed viral load achieved through a successful monotherapy of PRO 140.", "sentB": "Once the viral load is undetectable, weekly administration of PRO 140 can help maintain the suppressed viral load in a subpopulation of R5 patients over an extended period of time (currently shown to be approaching two years).", "type": 2, "words": ["<tag1>", "Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "some", "patients", "are", "now", "reaching", "eight", "months", "of", "suppressed", "viral", "load", "achieved", "through", "a", "successful", "monotherapy", "of", "PRO", "140.", "<tag2>", "Once", "the", "viral", "load", "is", "undetectable,", "weekly", "administration", "of", "PRO", "140", "can", "help", "maintain", "the", "suppressed", "viral", "load", "in", "a", "subpopulation", "of", "R5", "patients", "over", "an", "extended", "period", "of", "time", "(currently", "shown", "to", "be", "approaching", "two", "years).", "<tag3>"], "wordsA": ["Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "some", "patients", "are", "now", "reaching", "eight", "months", "of", "suppressed", "viral", "load", "achieved", "through", "a", "successful", "monotherapy", "of", "PRO", "140."], "wordsB": ["Once", "the", "viral", "load", "is", "undetectable,", "weekly", "administration", "of", "PRO", "140", "can", "help", "maintain", "the", "suppressed", "viral", "load", "in", "a", "subpopulation", "of", "R5", "patients", "over", "an", "extended", "period", "of", "time", "(currently", "shown", "to", "be", "approaching", "two", "years)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p15_s2", "idA": "1175680_15_item1_p9_s5", "sentA": "Results from these extension studies thus far indicate some patients are now reaching eight months of suppressed viral load achieved through a successful monotherapy of PRO 140.", "sentB": "Results from these extension studies thus far indicate some patients are now reaching 24 months of suppressed viral load achieved through a successful monotherapy of PRO 140.", "type": 2, "words": ["<tag1>", "Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "some", "patients", "are", "now", "reaching", "eight", "months", "of", "suppressed", "viral", "load", "achieved", "through", "a", "successful", "monotherapy", "of", "PRO", "140.", "<tag2>", "Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "some", "patients", "are", "now", "reaching", "24", "months", "of", "suppressed", "viral", "load", "achieved", "through", "a", "successful", "monotherapy", "of", "PRO", "140.", "<tag3>"], "wordsA": ["Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "some", "patients", "are", "now", "reaching", "eight", "months", "of", "suppressed", "viral", "load", "achieved", "through", "a", "successful", "monotherapy", "of", "PRO", "140."], "wordsB": ["Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "some", "patients", "are", "now", "reaching", "24", "months", "of", "suppressed", "viral", "load", "achieved", "through", "a", "successful", "monotherapy", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p19_s0", "idA": "1175680_15_item1_p9_s6", "sentA": "Our ongoing treatment substitution extension study has two objectives: (1) to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression after being used in substitution of a patient s HAART regimen and (2) to assess the clinical safety and tolerability parameters for PRO 140 following use in substitution of HAART.", "sentB": "The treatment substitution trial had two primary objectives: (1) to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression after being used in substitution of a patient s HAART regimen, and (2) to assess the clinical safety and tolerability parameters for PRO 140 following use in substitution of HAART.", "type": 2, "words": ["<tag1>", "Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART.", "<tag2>", "The", "treatment", "substitution", "trial", "had", "two", "primary", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen,", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART.", "<tag3>"], "wordsA": ["Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART."], "wordsB": ["The", "treatment", "substitution", "trial", "had", "two", "primary", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen,", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p22_s0", "idA": "1175680_15_item1_p9_s6", "sentA": "Our ongoing treatment substitution extension study has two objectives: (1) to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression after being used in substitution of a patient s HAART regimen and (2) to assess the clinical safety and tolerability parameters for PRO 140 following use in substitution of HAART.", "sentB": "The extension study of our initial Phase 2b trial was designed to evaluate the efficacy, safety, and tolerability of PRO 140 monotherapy for the maintenance of viral suppression in subjects who completed 12 weeks of monotherapy in the initial Phase 2b treatment substitution trial without experiencing virologic failure.", "type": 2, "words": ["<tag1>", "Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART.", "<tag2>", "The", "extension", "study", "of", "our", "initial", "Phase", "2b", "trial", "was", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "in", "subjects", "who", "completed", "12", "weeks", "of", "monotherapy", "in", "the", "initial", "Phase", "2b", "treatment", "substitution", "trial", "without", "experiencing", "virologic", "failure.", "<tag3>"], "wordsA": ["Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART."], "wordsB": ["The", "extension", "study", "of", "our", "initial", "Phase", "2b", "trial", "was", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "in", "subjects", "who", "completed", "12", "weeks", "of", "monotherapy", "in", "the", "initial", "Phase", "2b", "treatment", "substitution", "trial", "without", "experiencing", "virologic", "failure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p32_s7", "idA": "1175680_15_item1_p9_s6", "sentA": "Our ongoing treatment substitution extension study has two objectives: (1) to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression after being used in substitution of a patient s HAART regimen and (2) to assess the clinical safety and tolerability parameters for PRO 140 following use in substitution of HAART.", "sentB": "Designation as an orphan product provides potentially faster pathways to approval and other financial incentives for drugs and biologics that are intended for the safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S. Phase 2b Trial for HIV, as a Monotherapy for Treatment-Na ve Patients We recently announced a Phase 2b, randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of PRO 140 in treatment-na ve adults with HIV-1 infection.", "type": 2, "words": ["<tag1>", "Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART.", "<tag2>", "Designation", "as", "an", "orphan", "product", "provides", "potentially", "faster", "pathways", "to", "approval", "and", "other", "financial", "incentives", "for", "drugs", "and", "biologics", "that", "are", "intended", "for", "the", "safe", "and", "effective", "treatment,", "diagnosis", "or", "prevention", "of", "rare", "diseases", "or", "disorders", "that", "affect", "fewer", "than", "200,000", "people", "in", "the", "U.S.", "Phase", "2b", "Trial", "for", "HIV,", "as", "a", "Monotherapy", "for", "Treatment-Na", "ve", "Patients", "We", "recently", "announced", "a", "Phase", "2b,", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "study", "to", "assess", "the", "safety", "and", "efficacy", "of", "PRO", "140", "in", "treatment-na", "ve", "adults", "with", "HIV-1", "infection.", "<tag3>"], "wordsA": ["Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART."], "wordsB": ["Designation", "as", "an", "orphan", "product", "provides", "potentially", "faster", "pathways", "to", "approval", "and", "other", "financial", "incentives", "for", "drugs", "and", "biologics", "that", "are", "intended", "for", "the", "safe", "and", "effective", "treatment,", "diagnosis", "or", "prevention", "of", "rare", "diseases", "or", "disorders", "that", "affect", "fewer", "than", "200,000", "people", "in", "the", "U.S.", "Phase", "2b", "Trial", "for", "HIV,", "as", "a", "Monotherapy", "for", "Treatment-Na", "ve", "Patients", "We", "recently", "announced", "a", "Phase", "2b,", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "study", "to", "assess", "the", "safety", "and", "efficacy", "of", "PRO", "140", "in", "treatment-na", "ve", "adults", "with", "HIV-1", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p32_s8", "idA": "1175680_15_item1_p9_s6", "sentA": "Our ongoing treatment substitution extension study has two objectives: (1) to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression after being used in substitution of a patient s HAART regimen and (2) to assess the clinical safety and tolerability parameters for PRO 140 following use in substitution of HAART.", "sentB": "This trial is designed to evaluate the safety and efficacy of PRO 140 SC compared to placebo for the reduction of viral load in 60 treatment-na ve adults patients with HIV-1 infection for a period of two weeks.", "type": 2, "words": ["<tag1>", "Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART.", "<tag2>", "This", "trial", "is", "designed", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "PRO", "140", "SC", "compared", "to", "placebo", "for", "the", "reduction", "of", "viral", "load", "in", "60", "treatment-na", "ve", "adults", "patients", "with", "HIV-1", "infection", "for", "a", "period", "of", "two", "weeks.", "<tag3>"], "wordsA": ["Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART."], "wordsB": ["This", "trial", "is", "designed", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "PRO", "140", "SC", "compared", "to", "placebo", "for", "the", "reduction", "of", "viral", "load", "in", "60", "treatment-na", "ve", "adults", "patients", "with", "HIV-1", "infection", "for", "a", "period", "of", "two", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p33_s1", "idA": "1175680_15_item1_p9_s6", "sentA": "Our ongoing treatment substitution extension study has two objectives: (1) to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression after being used in substitution of a patient s HAART regimen and (2) to assess the clinical safety and tolerability parameters for PRO 140 following use in substitution of HAART.", "sentB": "The first dose of PRO 140 or placebo will be given on the day of randomization followed by second dose (one week after) at the initiation of HAART.", "type": 2, "words": ["<tag1>", "Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART.", "<tag2>", "The", "first", "dose", "of", "PRO", "140", "or", "placebo", "will", "be", "given", "on", "the", "day", "of", "randomization", "followed", "by", "second", "dose", "(one", "week", "after)", "at", "the", "initiation", "of", "HAART.", "<tag3>"], "wordsA": ["Our", "ongoing", "treatment", "substitution", "extension", "study", "has", "two", "objectives:", "(1)", "to", "assess", "the", "efficacy", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "after", "being", "used", "in", "substitution", "of", "a", "patient", "s", "HAART", "regimen", "and", "(2)", "to", "assess", "the", "clinical", "safety", "and", "tolerability", "parameters", "for", "PRO", "140", "following", "use", "in", "substitution", "of", "HAART."], "wordsB": ["The", "first", "dose", "of", "PRO", "140", "or", "placebo", "will", "be", "given", "on", "the", "day", "of", "randomization", "followed", "by", "second", "dose", "(one", "week", "after)", "at", "the", "initiation", "of", "HAART."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p19_s1", "idA": "1175680_15_item1_p9_s7", "sentA": "The study protocol requires patients to be stable on HAART with an undetectable viral load.", "sentB": "The study protocol required patients to be stable on HAART with patient s viral load not more than 400 HIV RNA particles per milliliter of blood for two consecutive weeks.", "type": 2, "words": ["<tag1>", "The", "study", "protocol", "requires", "patients", "to", "be", "stable", "on", "HAART", "with", "an", "undetectable", "viral", "load.", "<tag2>", "The", "study", "protocol", "required", "patients", "to", "be", "stable", "on", "HAART", "with", "patient", "s", "viral", "load", "not", "more", "than", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks.", "<tag3>"], "wordsA": ["The", "study", "protocol", "requires", "patients", "to", "be", "stable", "on", "HAART", "with", "an", "undetectable", "viral", "load."], "wordsB": ["The", "study", "protocol", "required", "patients", "to", "be", "stable", "on", "HAART", "with", "patient", "s", "viral", "load", "not", "more", "than", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p50_s0", "idA": "1175680_15_item1_p9_s7", "sentA": "The study protocol requires patients to be stable on HAART with an undetectable viral load.", "sentB": "The study protocol and informed consent information for patients in clinical trials must also be submitted to an independent institutional review board, or IRB, for approval.", "type": 2, "words": ["<tag1>", "The", "study", "protocol", "requires", "patients", "to", "be", "stable", "on", "HAART", "with", "an", "undetectable", "viral", "load.", "<tag2>", "The", "study", "protocol", "and", "informed", "consent", "information", "for", "patients", "in", "clinical", "trials", "must", "also", "be", "submitted", "to", "an", "independent", "institutional", "review", "board,", "or", "IRB,", "for", "approval.", "<tag3>"], "wordsA": ["The", "study", "protocol", "requires", "patients", "to", "be", "stable", "on", "HAART", "with", "an", "undetectable", "viral", "load."], "wordsB": ["The", "study", "protocol", "and", "informed", "consent", "information", "for", "patients", "in", "clinical", "trials", "must", "also", "be", "submitted", "to", "an", "independent", "institutional", "review", "board,", "or", "IRB,", "for", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p17_s1", "idA": "1175680_15_item1_p9_s8", "sentA": "The trial design provided that patients will be shifted from HAART regimen to PRO 140 monotherapy for 12 weeks.", "sentB": "The primary endpoint is the number of patients who can maintain suppressed viral load under a PRO 140 monotherapy replacing their HAART regimen for 48 weeks.", "type": 2, "words": ["<tag1>", "The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks.", "<tag2>", "The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks.", "<tag3>"], "wordsA": ["The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks."], "wordsB": ["The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p19_s2", "idA": "1175680_15_item1_p9_s8", "sentA": "The trial design provided that patients will be shifted from HAART regimen to PRO 140 monotherapy for 12 weeks.", "sentB": "The trial design provided that patients would be shifted from HAART regimen to PRO 140 monotherapy for 12 weeks.", "type": 2, "words": ["<tag1>", "The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks.", "<tag2>", "The", "trial", "design", "provided", "that", "patients", "would", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks.", "<tag3>"], "wordsA": ["The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks."], "wordsB": ["The", "trial", "design", "provided", "that", "patients", "would", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p27_s1", "idA": "1175680_15_item1_p9_s8", "sentA": "The trial design provided that patients will be shifted from HAART regimen to PRO 140 monotherapy for 12 weeks.", "sentB": "The primary endpoint is the number of patients who can maintain suppressed viral load under a PRO 140 monotherapy replacing their HAART regimen for 48 weeks.", "type": 2, "words": ["<tag1>", "The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks.", "<tag2>", "The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks.", "<tag3>"], "wordsA": ["The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks."], "wordsB": ["The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p28_s1", "idA": "1175680_15_item1_p9_s8", "sentA": "The trial design provided that patients will be shifted from HAART regimen to PRO 140 monotherapy for 12 weeks.", "sentB": "This study is a multi-center study designed to evaluate the efficacy, safety, and tolerability of the strategy of shifting clinically stable patients receiving suppressive combination antiretroviral therapy to PRO 140 monotherapy and maintaining viral suppression for 48 weeks following study entry.", "type": 2, "words": ["<tag1>", "The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks.", "<tag2>", "This", "study", "is", "a", "multi-center", "study", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "the", "strategy", "of", "shifting", "clinically", "stable", "patients", "receiving", "suppressive", "combination", "antiretroviral", "therapy", "to", "PRO", "140", "monotherapy", "and", "maintaining", "viral", "suppression", "for", "48", "weeks", "following", "study", "entry.", "<tag3>"], "wordsA": ["The", "trial", "design", "provided", "that", "patients", "will", "be", "shifted", "from", "HAART", "regimen", "to", "PRO", "140", "monotherapy", "for", "12", "weeks."], "wordsB": ["This", "study", "is", "a", "multi-center", "study", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "the", "strategy", "of", "shifting", "clinically", "stable", "patients", "receiving", "suppressive", "combination", "antiretroviral", "therapy", "to", "PRO", "140", "monotherapy", "and", "maintaining", "viral", "suppression", "for", "48", "weeks", "following", "study", "entry."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_16_item1_p19_s3", "idA": "1175680_15_item1_p9_s9", "sentA": "PRO 140 is being administered as a 350mg subcutaneous dosage weekly and participants are monitored for viral rebound on a weekly basis.", "sentB": "PRO 140 was administered as a 350mg subcutaneous dosage weekly and participants were monitored for viral rebound on a weekly basis.", "type": 2, "words": ["<tag1>", "PRO", "140", "is", "being", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "and", "participants", "are", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis.", "<tag2>", "PRO", "140", "was", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "and", "participants", "were", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis.", "<tag3>"], "wordsA": ["PRO", "140", "is", "being", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "and", "participants", "are", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis."], "wordsB": ["PRO", "140", "was", "administered", "as", "a", "350mg", "subcutaneous", "dosage", "weekly", "and", "participants", "were", "monitored", "for", "viral", "rebound", "on", "a", "weekly", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p0_s0", "idA": "1175680_16_item1_p0_s0", "sentA": "CytoDyn Inc. (the Company ) was originally incorporated under the laws of Colorado on May 2, 2002 under the name RexRay Corporation (its previous name).", "sentB": "CytoDyn Inc. was originally incorporated under the laws of Colorado on May 2, 2002 under the name RexRay Corporation (our previous name).", "type": 2, "words": ["<tag1>", "CytoDyn", "Inc.", "(the", "Company", ")", "was", "originally", "incorporated", "under", "the", "laws", "of", "Colorado", "on", "May", "2,", "2002", "under", "the", "name", "RexRay", "Corporation", "(its", "previous", "name).", "<tag2>", "CytoDyn", "Inc.", "was", "originally", "incorporated", "under", "the", "laws", "of", "Colorado", "on", "May", "2,", "2002", "under", "the", "name", "RexRay", "Corporation", "(our", "previous", "name).", "<tag3>"], "wordsA": ["CytoDyn", "Inc.", "(the", "Company", ")", "was", "originally", "incorporated", "under", "the", "laws", "of", "Colorado", "on", "May", "2,", "2002", "under", "the", "name", "RexRay", "Corporation", "(its", "previous", "name)."], "wordsB": ["CytoDyn", "Inc.", "was", "originally", "incorporated", "under", "the", "laws", "of", "Colorado", "on", "May", "2,", "2002", "under", "the", "name", "RexRay", "Corporation", "(our", "previous", "name)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p0_s1", "idA": "1175680_16_item1_p0_s1", "sentA": "Effective August 27, 2015, the Company completed a reincorporation from Colorado to Delaware.", "sentB": "Effective August 27, 2015, we completed a reincorporation from Colorado to Delaware.", "type": 2, "words": ["<tag1>", "Effective", "August", "27,", "2015,", "the", "Company", "completed", "a", "reincorporation", "from", "Colorado", "to", "Delaware.", "<tag2>", "Effective", "August", "27,", "2015,", "we", "completed", "a", "reincorporation", "from", "Colorado", "to", "Delaware.", "<tag3>"], "wordsA": ["Effective", "August", "27,", "2015,", "the", "Company", "completed", "a", "reincorporation", "from", "Colorado", "to", "Delaware."], "wordsB": ["Effective", "August", "27,", "2015,", "we", "completed", "a", "reincorporation", "from", "Colorado", "to", "Delaware."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p6_s2", "idA": "1175680_16_item1_p11_s0", "sentA": "To date, PRO 140 has been tested and administered to test subjects either intravenously or as a subcutaneous injection.", "sentB": "To date, PRO 140 has been tested and administered to patients either intravenously or as a subcutaneous injection.", "type": 2, "words": ["<tag1>", "To", "date,", "PRO", "140", "has", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection.", "<tag2>", "To", "date,", "PRO", "140", "has", "been", "tested", "and", "administered", "to", "patients", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection.", "<tag3>"], "wordsA": ["To", "date,", "PRO", "140", "has", "been", "tested", "and", "administered", "to", "test", "subjects", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection."], "wordsB": ["To", "date,", "PRO", "140", "has", "been", "tested", "and", "administered", "to", "patients", "either", "intravenously", "or", "as", "a", "subcutaneous", "injection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p6_s3", "idA": "1175680_16_item1_p11_s1", "sentA": "We believe that, if PRO 140 is approved for use as an injectable by the FDA, it may nonetheless be an attractive and marketable therapeutic option for patients with healthy CCR5, particularly in the following scenarios:", "sentB": "We believe that, if PRO 140 is approved for use as an injectable by the U.S. Food and Drug Administration (the FDA ), it may nonetheless be an attractive and marketable therapeutic option for patients, particularly in the following scenarios:", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients", "with", "healthy", "CCR5,", "particularly", "in", "the", "following", "scenarios:", "<tag2>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients,", "particularly", "in", "the", "following", "scenarios:", "<tag3>"], "wordsA": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients", "with", "healthy", "CCR5,", "particularly", "in", "the", "following", "scenarios:"], "wordsB": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients,", "particularly", "in", "the", "following", "scenarios:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p38_s0", "idA": "1175680_16_item1_p12_s1", "sentA": "We believe PRO 140 has demonstrated potent (as compared to existing treatments) antiretroviral activity and an encouraging safety profile in prior clinical testing, that PRO 140 has the potential to be the first long-acting (weekly or every other week), self-administered HIV therapy, and that PRO 140 inhibit CCR5-tropic HIV while preserving CCR5 s natural activity.", "sentB": "The mechanism of action of PRO 140 has the potential to block the movement of T-cells to inflammatory sites, which could be instrumental in diminishing or eliminating inflammatory responses.", "type": 2, "words": ["<tag1>", "We", "believe", "PRO", "140", "has", "demonstrated", "potent", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "prior", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "inhibit", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "activity.", "<tag2>", "The", "mechanism", "of", "action", "of", "PRO", "140", "has", "the", "potential", "to", "block", "the", "movement", "of", "T-cells", "to", "inflammatory", "sites,", "which", "could", "be", "instrumental", "in", "diminishing", "or", "eliminating", "inflammatory", "responses.", "<tag3>"], "wordsA": ["We", "believe", "PRO", "140", "has", "demonstrated", "potent", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "prior", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "inhibit", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "activity."], "wordsB": ["The", "mechanism", "of", "action", "of", "PRO", "140", "has", "the", "potential", "to", "block", "the", "movement", "of", "T-cells", "to", "inflammatory", "sites,", "which", "could", "be", "instrumental", "in", "diminishing", "or", "eliminating", "inflammatory", "responses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p7_s1", "idA": "1175680_16_item1_p12_s1", "sentA": "We believe PRO 140 has demonstrated potent (as compared to existing treatments) antiretroviral activity and an encouraging safety profile in prior clinical testing, that PRO 140 has the potential to be the first long-acting (weekly or every other week), self-administered HIV therapy, and that PRO 140 inhibit CCR5-tropic HIV while preserving CCR5 s natural activity.", "sentB": "We believe PRO 140 has demonstrated potent (as compared to existing treatments) antiretroviral activity and an encouraging safety profile in prior clinical testing, that PRO 140 has the potential to be the first long-acting (weekly or every other week), self-administered HIV therapy, and that PRO 140 inhibits CCR5-tropic HIV while preserving CCR5 s natural function.", "type": 2, "words": ["<tag1>", "We", "believe", "PRO", "140", "has", "demonstrated", "potent", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "prior", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "inhibit", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "activity.", "<tag2>", "We", "believe", "PRO", "140", "has", "demonstrated", "potent", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "prior", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "inhibits", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "function.", "<tag3>"], "wordsA": ["We", "believe", "PRO", "140", "has", "demonstrated", "potent", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "prior", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "inhibit", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "activity."], "wordsB": ["We", "believe", "PRO", "140", "has", "demonstrated", "potent", "(as", "compared", "to", "existing", "treatments)", "antiretroviral", "activity", "and", "an", "encouraging", "safety", "profile", "in", "prior", "clinical", "testing,", "that", "PRO", "140", "has", "the", "potential", "to", "be", "the", "first", "long-acting", "(weekly", "or", "every", "other", "week),", "self-administered", "HIV", "therapy,", "and", "that", "PRO", "140", "inhibits", "CCR5-tropic", "HIV", "while", "preserving", "CCR5", "s", "natural", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p7_s2", "idA": "1175680_16_item1_p12_s2", "sentA": "We believe PRO 140 represents a distinct class of CCR5 inhibitors with unique virological and immunological properties and may provide another distinct tool to treat HIV-infected subjects.", "sentB": "We believe PRO 140 represents a distinct class of CCR5 inhibitors with unique virological and immunological properties and may provide another distinct tool to treat HIV-infected patients.", "type": 2, "words": ["<tag1>", "We", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects.", "<tag2>", "We", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "patients.", "<tag3>"], "wordsA": ["We", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "subjects."], "wordsB": ["We", "believe", "PRO", "140", "represents", "a", "distinct", "class", "of", "CCR5", "inhibitors", "with", "unique", "virological", "and", "immunological", "properties", "and", "may", "provide", "another", "distinct", "tool", "to", "treat", "HIV-infected", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p7_s3", "idA": "1175680_16_item1_p12_s3", "sentA": "Our ongoing HIV-related clinical trials, described in greater detail below, have been designed to demonstrate the proof of concept that PRO 140 monotherapy can reduce the viral load in certain HIV-infected, treatment-experienced patients.", "sentB": "Our ongoing HIV-related clinical trials, described in greater detail below, have been designed to demonstrate the proof of concept that PRO 140 monotherapy can continue to suppress the viral load in certain HIV-infected, treatment-experienced patients who had suppressed viral load on HAART, but would like an alternative treatment that provides a higher quality of life with one dose a week through a self-injection.", "type": 2, "words": ["<tag1>", "Our", "ongoing", "HIV-related", "clinical", "trials,", "described", "in", "greater", "detail", "below,", "have", "been", "designed", "to", "demonstrate", "the", "proof", "of", "concept", "that", "PRO", "140", "monotherapy", "can", "reduce", "the", "viral", "load", "in", "certain", "HIV-infected,", "treatment-experienced", "patients.", "<tag2>", "Our", "ongoing", "HIV-related", "clinical", "trials,", "described", "in", "greater", "detail", "below,", "have", "been", "designed", "to", "demonstrate", "the", "proof", "of", "concept", "that", "PRO", "140", "monotherapy", "can", "continue", "to", "suppress", "the", "viral", "load", "in", "certain", "HIV-infected,", "treatment-experienced", "patients", "who", "had", "suppressed", "viral", "load", "on", "HAART,", "but", "would", "like", "an", "alternative", "treatment", "that", "provides", "a", "higher", "quality", "of", "life", "with", "one", "dose", "a", "week", "through", "a", "self-injection.", "<tag3>"], "wordsA": ["Our", "ongoing", "HIV-related", "clinical", "trials,", "described", "in", "greater", "detail", "below,", "have", "been", "designed", "to", "demonstrate", "the", "proof", "of", "concept", "that", "PRO", "140", "monotherapy", "can", "reduce", "the", "viral", "load", "in", "certain", "HIV-infected,", "treatment-experienced", "patients."], "wordsB": ["Our", "ongoing", "HIV-related", "clinical", "trials,", "described", "in", "greater", "detail", "below,", "have", "been", "designed", "to", "demonstrate", "the", "proof", "of", "concept", "that", "PRO", "140", "monotherapy", "can", "continue", "to", "suppress", "the", "viral", "load", "in", "certain", "HIV-infected,", "treatment-experienced", "patients", "who", "had", "suppressed", "viral", "load", "on", "HAART,", "but", "would", "like", "an", "alternative", "treatment", "that", "provides", "a", "higher", "quality", "of", "life", "with", "one", "dose", "a", "week", "through", "a", "self-injection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p41_s2", "idA": "1175680_16_item1_p14_s0", "sentA": "Current Clinical Trials PRO 140 is currently being studied in four ongoing clinical trials:", "sentB": "PRO 140 is also being investigated in animal models of cancer progression and autoimmunity with positive results.", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "four", "ongoing", "clinical", "trials:", "<tag2>", "PRO", "140", "is", "also", "being", "investigated", "in", "animal", "models", "of", "cancer", "progression", "and", "autoimmunity", "with", "positive", "results.", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "four", "ongoing", "clinical", "trials:"], "wordsB": ["PRO", "140", "is", "also", "being", "investigated", "in", "animal", "models", "of", "cancer", "progression", "and", "autoimmunity", "with", "positive", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p10_s2", "idA": "1175680_16_item1_p15_s2", "sentA": "Results from these extension studies thus far indicate some patients are now reaching 24 months of suppressed viral load achieved through a successful monotherapy of PRO 140.", "sentB": "Results from these extension studies thus far indicate that eight of the nine patients in this study have surpassed two and one-half years of suppressed viral load through a successful monotherapy of PRO 140 and are approaching three years of suppressed viral load with a monotherapy.", "type": 2, "words": ["<tag1>", "Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "some", "patients", "are", "now", "reaching", "24", "months", "of", "suppressed", "viral", "load", "achieved", "through", "a", "successful", "monotherapy", "of", "PRO", "140.", "<tag2>", "Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "that", "eight", "of", "the", "nine", "patients", "in", "this", "study", "have", "surpassed", "two", "and", "one-half", "years", "of", "suppressed", "viral", "load", "through", "a", "successful", "monotherapy", "of", "PRO", "140", "and", "are", "approaching", "three", "years", "of", "suppressed", "viral", "load", "with", "a", "monotherapy.", "<tag3>"], "wordsA": ["Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "some", "patients", "are", "now", "reaching", "24", "months", "of", "suppressed", "viral", "load", "achieved", "through", "a", "successful", "monotherapy", "of", "PRO", "140."], "wordsB": ["Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "that", "eight", "of", "the", "nine", "patients", "in", "this", "study", "have", "surpassed", "two", "and", "one-half", "years", "of", "suppressed", "viral", "load", "through", "a", "successful", "monotherapy", "of", "PRO", "140", "and", "are", "approaching", "three", "years", "of", "suppressed", "viral", "load", "with", "a", "monotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p26_s2", "idA": "1175680_16_item1_p16_s0", "sentA": "Our second ongoing clinical trial is a pivotal Phase 2b/3 trial for PRO 140 as a combination therapy to existing HAART drug regimens.", "sentB": "We currently plan to submit additional data to the FDA as it becomes available to us from our pivotal Phase 2b/3 combination therapy trial.", "type": 2, "words": ["<tag1>", "Our", "second", "ongoing", "clinical", "trial", "is", "a", "pivotal", "Phase", "2b/3", "trial", "for", "PRO", "140", "as", "a", "combination", "therapy", "to", "existing", "HAART", "drug", "regimens.", "<tag2>", "We", "currently", "plan", "to", "submit", "additional", "data", "to", "the", "FDA", "as", "it", "becomes", "available", "to", "us", "from", "our", "pivotal", "Phase", "2b/3", "combination", "therapy", "trial.", "<tag3>"], "wordsA": ["Our", "second", "ongoing", "clinical", "trial", "is", "a", "pivotal", "Phase", "2b/3", "trial", "for", "PRO", "140", "as", "a", "combination", "therapy", "to", "existing", "HAART", "drug", "regimens."], "wordsB": ["We", "currently", "plan", "to", "submit", "additional", "data", "to", "the", "FDA", "as", "it", "becomes", "available", "to", "us", "from", "our", "pivotal", "Phase", "2b/3", "combination", "therapy", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p11_s1", "idA": "1175680_16_item1_p16_s1", "sentA": "The initial 25-week trial protocol included a requirement for 300 subjects.", "sentB": "The initial 25-week trial protocol included a requirement for 300 patients.", "type": 2, "words": ["<tag1>", "The", "initial", "25-week", "trial", "protocol", "included", "a", "requirement", "for", "300", "subjects.", "<tag2>", "The", "initial", "25-week", "trial", "protocol", "included", "a", "requirement", "for", "300", "patients.", "<tag3>"], "wordsA": ["The", "initial", "25-week", "trial", "protocol", "included", "a", "requirement", "for", "300", "subjects."], "wordsB": ["The", "initial", "25-week", "trial", "protocol", "included", "a", "requirement", "for", "300", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p11_s2", "idA": "1175680_16_item1_p16_s2", "sentA": "The FDA recently reduced this requirement to 150 subjects.", "sentB": "The FDA reduced this requirement to 150 patients and finally down to 30 patients.", "type": 2, "words": ["<tag1>", "The", "FDA", "recently", "reduced", "this", "requirement", "to", "150", "subjects.", "<tag2>", "The", "FDA", "reduced", "this", "requirement", "to", "150", "patients", "and", "finally", "down", "to", "30", "patients.", "<tag3>"], "wordsA": ["The", "FDA", "recently", "reduced", "this", "requirement", "to", "150", "subjects."], "wordsB": ["The", "FDA", "reduced", "this", "requirement", "to", "150", "patients", "and", "finally", "down", "to", "30", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p12_s2", "idA": "1175680_16_item1_p16_s3", "sentA": "The first subject to have successfully completed this trial has transitioned into a FDA-cleared compassionate use protocol, so as to continue on PRO 140 therapy at the request of the treating physician.", "sentB": "The first patients to have successfully completed this trial have transitioned into a FDA-cleared rollover study, in order to provide continued access to PRO 140 therapy, at the request of their treating physician.", "type": 2, "words": ["<tag1>", "The", "first", "subject", "to", "have", "successfully", "completed", "this", "trial", "has", "transitioned", "into", "a", "FDA-cleared", "compassionate", "use", "protocol,", "so", "as", "to", "continue", "on", "PRO", "140", "therapy", "at", "the", "request", "of", "the", "treating", "physician.", "<tag2>", "The", "first", "patients", "to", "have", "successfully", "completed", "this", "trial", "have", "transitioned", "into", "a", "FDA-cleared", "rollover", "study,", "in", "order", "to", "provide", "continued", "access", "to", "PRO", "140", "therapy,", "at", "the", "request", "of", "their", "treating", "physician.", "<tag3>"], "wordsA": ["The", "first", "subject", "to", "have", "successfully", "completed", "this", "trial", "has", "transitioned", "into", "a", "FDA-cleared", "compassionate", "use", "protocol,", "so", "as", "to", "continue", "on", "PRO", "140", "therapy", "at", "the", "request", "of", "the", "treating", "physician."], "wordsB": ["The", "first", "patients", "to", "have", "successfully", "completed", "this", "trial", "have", "transitioned", "into", "a", "FDA-cleared", "rollover", "study,", "in", "order", "to", "provide", "continued", "access", "to", "PRO", "140", "therapy,", "at", "the", "request", "of", "their", "treating", "physician."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p13_s0", "idA": "1175680_16_item1_p17_s0", "sentA": "The third ongoing trial is a strategic Phase 3 trial including 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "sentB": "Our third ongoing trial is an investigative Phase 2b/3 trial featuring 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "type": 2, "words": ["<tag1>", "The", "third", "ongoing", "trial", "is", "a", "strategic", "Phase", "3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag2>", "Our", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "featuring", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag3>"], "wordsA": ["The", "third", "ongoing", "trial", "is", "a", "strategic", "Phase", "3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "wordsB": ["Our", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "featuring", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p12_s0", "idA": "1175680_16_item1_p17_s1", "sentA": "The primary endpoint is the number of patients who can maintain suppressed viral load under a PRO 140 monotherapy replacing their HAART regimen for 48 weeks.", "sentB": "The primary endpoint for efficacy is defined as the amount of viral load drop after one week of therapy with PRO 140 in combination with the patient s failing HAART regimen.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks.", "<tag2>", "The", "primary", "endpoint", "for", "efficacy", "is", "defined", "as", "the", "amount", "of", "viral", "load", "drop", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks."], "wordsB": ["The", "primary", "endpoint", "for", "efficacy", "is", "defined", "as", "the", "amount", "of", "viral", "load", "drop", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p13_s1", "idA": "1175680_16_item1_p17_s1", "sentA": "The primary endpoint is the number of patients who can maintain suppressed viral load under a PRO 140 monotherapy replacing their HAART regimen for 48 weeks.", "sentB": "The primary endpoint is to assess the clinical safety of the PRO 140 monotherapy regimen and to evaluate the proportion of participants experiencing suppressed viral load.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks.", "<tag2>", "The", "primary", "endpoint", "is", "to", "assess", "the", "clinical", "safety", "of", "the", "PRO", "140", "monotherapy", "regimen", "and", "to", "evaluate", "the", "proportion", "of", "participants", "experiencing", "suppressed", "viral", "load.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks."], "wordsB": ["The", "primary", "endpoint", "is", "to", "assess", "the", "clinical", "safety", "of", "the", "PRO", "140", "monotherapy", "regimen", "and", "to", "evaluate", "the", "proportion", "of", "participants", "experiencing", "suppressed", "viral", "load."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p13_s2", "idA": "1175680_16_item1_p17_s2", "sentA": "The secondary endpoint is the number of weeks a patient is off of their ART regimen.", "sentB": "The secondary endpoint is the length of time to virologic failure.", "type": 2, "words": ["<tag1>", "The", "secondary", "endpoint", "is", "the", "number", "of", "weeks", "a", "patient", "is", "off", "of", "their", "ART", "regimen.", "<tag2>", "The", "secondary", "endpoint", "is", "the", "length", "of", "time", "to", "virologic", "failure.", "<tag3>"], "wordsA": ["The", "secondary", "endpoint", "is", "the", "number", "of", "weeks", "a", "patient", "is", "off", "of", "their", "ART", "regimen."], "wordsB": ["The", "secondary", "endpoint", "is", "the", "length", "of", "time", "to", "virologic", "failure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p15_s0", "idA": "1175680_16_item1_p18_s0", "sentA": "Our fourth ongoing trial of PRO 140 is a Phase 2 study for Graft versus Host Disease ( GvHD ) and is the first non-HIV indication for PRO 140.", "sentB": "Our fourth ongoing trial of PRO 140 is a Phase 2 study for Graft-versus-Host Disease ( GvHD ) and is the first non-HIV immunologic indication for PRO 140.", "type": 2, "words": ["<tag1>", "Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft", "versus", "Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "indication", "for", "PRO", "140.", "<tag2>", "Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft-versus-Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "immunologic", "indication", "for", "PRO", "140.", "<tag3>"], "wordsA": ["Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft", "versus", "Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "indication", "for", "PRO", "140."], "wordsB": ["Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft-versus-Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "immunologic", "indication", "for", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p35_s0", "idA": "1175680_16_item1_p18_s0", "sentA": "Our fourth ongoing trial of PRO 140 is a Phase 2 study for Graft versus Host Disease ( GvHD ) and is the first non-HIV indication for PRO 140.", "sentB": "The target of PRO 140 is the important immunologic receptor CCR5.", "type": 2, "words": ["<tag1>", "Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft", "versus", "Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "indication", "for", "PRO", "140.", "<tag2>", "The", "target", "of", "PRO", "140", "is", "the", "important", "immunologic", "receptor", "CCR5.", "<tag3>"], "wordsA": ["Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft", "versus", "Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "indication", "for", "PRO", "140."], "wordsB": ["The", "target", "of", "PRO", "140", "is", "the", "important", "immunologic", "receptor", "CCR5."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p28_s0", "idA": "1175680_16_item1_p18_s2", "sentA": "Enrollment of the first patient has not been announced.", "sentB": "Enrollment of the first patients was announced in December 2016 and enrollment is well underway.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced.", "<tag2>", "Enrollment", "of", "the", "first", "patients", "was", "announced", "in", "December", "2016", "and", "enrollment", "is", "well", "underway.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced."], "wordsB": ["Enrollment", "of", "the", "first", "patients", "was", "announced", "in", "December", "2016", "and", "enrollment", "is", "well", "underway."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p35_s2", "idA": "1175680_16_item1_p18_s7", "sentA": "We are continuing to explore opportunities for clinical applications for PRO 140 involving the CCR5 receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases and cancer.", "sentB": "This opens the potential for multiple pipeline opportunities for PRO 140.", "type": 2, "words": ["<tag1>", "We", "are", "continuing", "to", "explore", "opportunities", "for", "clinical", "applications", "for", "PRO", "140", "involving", "the", "CCR5", "receptor,", "other", "than", "HIV-related", "treatments,", "such", "as", "inflammatory", "conditions,", "autoimmune", "diseases", "and", "cancer.", "<tag2>", "This", "opens", "the", "potential", "for", "multiple", "pipeline", "opportunities", "for", "PRO", "140.", "<tag3>"], "wordsA": ["We", "are", "continuing", "to", "explore", "opportunities", "for", "clinical", "applications", "for", "PRO", "140", "involving", "the", "CCR5", "receptor,", "other", "than", "HIV-related", "treatments,", "such", "as", "inflammatory", "conditions,", "autoimmune", "diseases", "and", "cancer."], "wordsB": ["This", "opens", "the", "potential", "for", "multiple", "pipeline", "opportunities", "for", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p0_s5", "idA": "1175680_16_item1_p1_s3", "sentA": "Unless the context otherwise requires, references in this prospectus to CytoDyn, the Company, we, our, or us are to CytoDyn Inc. and its subsidiaries.", "sentB": "Unless the context otherwise requires, references to CytoDyn, the Company, we, our, or us are to CytoDyn Inc. and its subsidiaries.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "otherwise", "requires,", "references", "in", "this", "prospectus", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries.", "<tag2>", "Unless", "the", "context", "otherwise", "requires,", "references", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries.", "<tag3>"], "wordsA": ["Unless", "the", "context", "otherwise", "requires,", "references", "in", "this", "prospectus", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries."], "wordsB": ["Unless", "the", "context", "otherwise", "requires,", "references", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p20_s0", "idA": "1175680_16_item1_p22_s0", "sentA": "The extension study of our initial Phase 2b trial was designed to evaluate the efficacy, safety, and tolerability of PRO 140 monotherapy for the maintenance of viral suppression in subjects who completed 12 weeks of monotherapy in the initial Phase 2b treatment substitution trial without experiencing virologic failure.", "sentB": "The extension study of our initial Phase 2b trial was designed to evaluate the efficacy, safety, and tolerability of PRO 140 monotherapy for the maintenance of viral suppression in patients who completed 12 weeks of monotherapy in the initial Phase 2b treatment substitution trial without experiencing virologic failure.", "type": 2, "words": ["<tag1>", "The", "extension", "study", "of", "our", "initial", "Phase", "2b", "trial", "was", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "in", "subjects", "who", "completed", "12", "weeks", "of", "monotherapy", "in", "the", "initial", "Phase", "2b", "treatment", "substitution", "trial", "without", "experiencing", "virologic", "failure.", "<tag2>", "The", "extension", "study", "of", "our", "initial", "Phase", "2b", "trial", "was", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "in", "patients", "who", "completed", "12", "weeks", "of", "monotherapy", "in", "the", "initial", "Phase", "2b", "treatment", "substitution", "trial", "without", "experiencing", "virologic", "failure.", "<tag3>"], "wordsA": ["The", "extension", "study", "of", "our", "initial", "Phase", "2b", "trial", "was", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "in", "subjects", "who", "completed", "12", "weeks", "of", "monotherapy", "in", "the", "initial", "Phase", "2b", "treatment", "substitution", "trial", "without", "experiencing", "virologic", "failure."], "wordsB": ["The", "extension", "study", "of", "our", "initial", "Phase", "2b", "trial", "was", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "PRO", "140", "monotherapy", "for", "the", "maintenance", "of", "viral", "suppression", "in", "patients", "who", "completed", "12", "weeks", "of", "monotherapy", "in", "the", "initial", "Phase", "2b", "treatment", "substitution", "trial", "without", "experiencing", "virologic", "failure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p21_s0", "idA": "1175680_16_item1_p23_s0", "sentA": "For the Phase 2b extension study, 19 subjects were screened for participation and 16 were allowed to enter.", "sentB": "For the Phase 2b extension study, 21 patients were eligible, 19 patients were screened for participation, 16 were allowed to enter and 15 patients successfully completed 29 weeks of PRO 140 monotherapy.", "type": 2, "words": ["<tag1>", "For", "the", "Phase", "2b", "extension", "study,", "19", "subjects", "were", "screened", "for", "participation", "and", "16", "were", "allowed", "to", "enter.", "<tag2>", "For", "the", "Phase", "2b", "extension", "study,", "21", "patients", "were", "eligible,", "19", "patients", "were", "screened", "for", "participation,", "16", "were", "allowed", "to", "enter", "and", "15", "patients", "successfully", "completed", "29", "weeks", "of", "PRO", "140", "monotherapy.", "<tag3>"], "wordsA": ["For", "the", "Phase", "2b", "extension", "study,", "19", "subjects", "were", "screened", "for", "participation", "and", "16", "were", "allowed", "to", "enter."], "wordsB": ["For", "the", "Phase", "2b", "extension", "study,", "21", "patients", "were", "eligible,", "19", "patients", "were", "screened", "for", "participation,", "16", "were", "allowed", "to", "enter", "and", "15", "patients", "successfully", "completed", "29", "weeks", "of", "PRO", "140", "monotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p21_s1", "idA": "1175680_16_item1_p23_s2", "sentA": "Out of these 14 patients, 10 patients are currently ongoing and have completed up to 23 months of PRO 140 monotherapy without experiencing virologic failure (defined, as in the initial study, as a viral load above 400 HIV RNA particles per milliliter of blood for two consecutive weeks).", "sentB": "Of these 15 patients, nine patients are currently ongoing and have surpassed two and one-half years of PRO 140 monotherapy without experiencing virologic failure (defined, as in the initial study, as a viral load above 400 HIV RNA particles per milliliter of blood for two consecutive weeks).", "type": 2, "words": ["<tag1>", "Out", "of", "these", "14", "patients,", "10", "patients", "are", "currently", "ongoing", "and", "have", "completed", "up", "to", "23", "months", "of", "PRO", "140", "monotherapy", "without", "experiencing", "virologic", "failure", "(defined,", "as", "in", "the", "initial", "study,", "as", "a", "viral", "load", "above", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks).", "<tag2>", "Of", "these", "15", "patients,", "nine", "patients", "are", "currently", "ongoing", "and", "have", "surpassed", "two", "and", "one-half", "years", "of", "PRO", "140", "monotherapy", "without", "experiencing", "virologic", "failure", "(defined,", "as", "in", "the", "initial", "study,", "as", "a", "viral", "load", "above", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks).", "<tag3>"], "wordsA": ["Out", "of", "these", "14", "patients,", "10", "patients", "are", "currently", "ongoing", "and", "have", "completed", "up", "to", "23", "months", "of", "PRO", "140", "monotherapy", "without", "experiencing", "virologic", "failure", "(defined,", "as", "in", "the", "initial", "study,", "as", "a", "viral", "load", "above", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks)."], "wordsB": ["Of", "these", "15", "patients,", "nine", "patients", "are", "currently", "ongoing", "and", "have", "surpassed", "two", "and", "one-half", "years", "of", "PRO", "140", "monotherapy", "without", "experiencing", "virologic", "failure", "(defined,", "as", "in", "the", "initial", "study,", "as", "a", "viral", "load", "above", "400", "HIV", "RNA", "particles", "per", "milliliter", "of", "blood", "for", "two", "consecutive", "weeks)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p21_s2", "idA": "1175680_16_item1_p23_s3", "sentA": "Three patients discontinued the extension protocol due to either violating protocol design or missing weekly treatments.", "sentB": "Four patients discontinued the extension protocol for reasons not attributed to PRO 140.", "type": 2, "words": ["<tag1>", "Three", "patients", "discontinued", "the", "extension", "protocol", "due", "to", "either", "violating", "protocol", "design", "or", "missing", "weekly", "treatments.", "<tag2>", "Four", "patients", "discontinued", "the", "extension", "protocol", "for", "reasons", "not", "attributed", "to", "PRO", "140.", "<tag3>"], "wordsA": ["Three", "patients", "discontinued", "the", "extension", "protocol", "due", "to", "either", "violating", "protocol", "design", "or", "missing", "weekly", "treatments."], "wordsB": ["Four", "patients", "discontinued", "the", "extension", "protocol", "for", "reasons", "not", "attributed", "to", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p22_s1", "idA": "1175680_16_item1_p24_s1", "sentA": "The FDA recently reduced the number of required subjects in this trial from 300 to 150.", "sentB": "The FDA reduced the original number of required patients in this trial from 300 to 150 and finally to 30 patients.", "type": 2, "words": ["<tag1>", "The", "FDA", "recently", "reduced", "the", "number", "of", "required", "subjects", "in", "this", "trial", "from", "300", "to", "150.", "<tag2>", "The", "FDA", "reduced", "the", "original", "number", "of", "required", "patients", "in", "this", "trial", "from", "300", "to", "150", "and", "finally", "to", "30", "patients.", "<tag3>"], "wordsA": ["The", "FDA", "recently", "reduced", "the", "number", "of", "required", "subjects", "in", "this", "trial", "from", "300", "to", "150."], "wordsB": ["The", "FDA", "reduced", "the", "original", "number", "of", "required", "patients", "in", "this", "trial", "from", "300", "to", "150", "and", "finally", "to", "30", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p22_s2", "idA": "1175680_16_item1_p24_s2", "sentA": "We believe that, upon successful completion of this Phase 3 study, we will have the opportunity to seek accelerated approval for PRO 140 based on previously granted FDA fast-track candidate designation.", "sentB": "We believe that, upon successful completion of this Phase 2b/3 study, we will have the opportunity to seek accelerated approval for PRO 140 based on previously granted FDA fast-track designation.", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "upon", "successful", "completion", "of", "this", "Phase", "3", "study,", "we", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "candidate", "designation.", "<tag2>", "We", "believe", "that,", "upon", "successful", "completion", "of", "this", "Phase", "2b/3", "study,", "we", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "designation.", "<tag3>"], "wordsA": ["We", "believe", "that,", "upon", "successful", "completion", "of", "this", "Phase", "3", "study,", "we", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "candidate", "designation."], "wordsB": ["We", "believe", "that,", "upon", "successful", "completion", "of", "this", "Phase", "2b/3", "study,", "we", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "designation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s0", "idA": "1175680_16_item1_p24_s2", "sentA": "We believe that, upon successful completion of this Phase 3 study, we will have the opportunity to seek accelerated approval for PRO 140 based on previously granted FDA fast-track candidate designation.", "sentB": "As we progress in evaluating PRO 140 in different pathways of human disease and inflammation, we are encouraged by the opportunity to build a broad pipeline of indications.", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "upon", "successful", "completion", "of", "this", "Phase", "3", "study,", "we", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "candidate", "designation.", "<tag2>", "As", "we", "progress", "in", "evaluating", "PRO", "140", "in", "different", "pathways", "of", "human", "disease", "and", "inflammation,", "we", "are", "encouraged", "by", "the", "opportunity", "to", "build", "a", "broad", "pipeline", "of", "indications.", "<tag3>"], "wordsA": ["We", "believe", "that,", "upon", "successful", "completion", "of", "this", "Phase", "3", "study,", "we", "will", "have", "the", "opportunity", "to", "seek", "accelerated", "approval", "for", "PRO", "140", "based", "on", "previously", "granted", "FDA", "fast-track", "candidate", "designation."], "wordsB": ["As", "we", "progress", "in", "evaluating", "PRO", "140", "in", "different", "pathways", "of", "human", "disease", "and", "inflammation,", "we", "are", "encouraged", "by", "the", "opportunity", "to", "build", "a", "broad", "pipeline", "of", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p23_s0", "idA": "1175680_16_item1_p24_s3", "sentA": "The Phase 3 combination therapy trial is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "sentB": "The Phase 2b/3 combination therapy trial is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "type": 2, "words": ["<tag1>", "The", "Phase", "3", "combination", "therapy", "trial", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag2>", "The", "Phase", "2b/3", "combination", "therapy", "trial", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag3>"], "wordsA": ["The", "Phase", "3", "combination", "therapy", "trial", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "wordsB": ["The", "Phase", "2b/3", "combination", "therapy", "trial", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p25_s0", "idA": "1175680_16_item1_p25_s1", "sentA": "The study population includes treatment-experienced HIV-infected patients with CCR5-tropic virus with documented genotypic or phenotypic resistance to antiretroviral drugs within one or more drug classes, which is a second-line therapy, with additional conditions to include patients who have demonstrated evidence of HIV replication despite ongoing antiretroviral therapy and have limited treatment options.", "sentB": "The study population includes treatment-experienced HIV-infected patients with CCR5-tropic virus with documented genotypic or phenotypic resistance to at least one antiretroviral drug from three different classes or at least one drug from two classes with limited treatment options.", "type": 2, "words": ["<tag1>", "The", "study", "population", "includes", "treatment-experienced", "HIV-infected", "patients", "with", "CCR5-tropic", "virus", "with", "documented", "genotypic", "or", "phenotypic", "resistance", "to", "antiretroviral", "drugs", "within", "one", "or", "more", "drug", "classes,", "which", "is", "a", "second-line", "therapy,", "with", "additional", "conditions", "to", "include", "patients", "who", "have", "demonstrated", "evidence", "of", "HIV", "replication", "despite", "ongoing", "antiretroviral", "therapy", "and", "have", "limited", "treatment", "options.", "<tag2>", "The", "study", "population", "includes", "treatment-experienced", "HIV-infected", "patients", "with", "CCR5-tropic", "virus", "with", "documented", "genotypic", "or", "phenotypic", "resistance", "to", "at", "least", "one", "antiretroviral", "drug", "from", "three", "different", "classes", "or", "at", "least", "one", "drug", "from", "two", "classes", "with", "limited", "treatment", "options.", "<tag3>"], "wordsA": ["The", "study", "population", "includes", "treatment-experienced", "HIV-infected", "patients", "with", "CCR5-tropic", "virus", "with", "documented", "genotypic", "or", "phenotypic", "resistance", "to", "antiretroviral", "drugs", "within", "one", "or", "more", "drug", "classes,", "which", "is", "a", "second-line", "therapy,", "with", "additional", "conditions", "to", "include", "patients", "who", "have", "demonstrated", "evidence", "of", "HIV", "replication", "despite", "ongoing", "antiretroviral", "therapy", "and", "have", "limited", "treatment", "options."], "wordsB": ["The", "study", "population", "includes", "treatment-experienced", "HIV-infected", "patients", "with", "CCR5-tropic", "virus", "with", "documented", "genotypic", "or", "phenotypic", "resistance", "to", "at", "least", "one", "antiretroviral", "drug", "from", "three", "different", "classes", "or", "at", "least", "one", "drug", "from", "two", "classes", "with", "limited", "treatment", "options."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p25_s2", "idA": "1175680_16_item1_p25_s3", "sentA": "Subjects will have one or more fully active, approved drugs available for construction of a viable alternative option.", "sentB": "Patients will have one or more fully active, approved drugs available for construction of a viable alternative option.", "type": 2, "words": ["<tag1>", "Subjects", "will", "have", "one", "or", "more", "fully", "active,", "approved", "drugs", "available", "for", "construction", "of", "a", "viable", "alternative", "option.", "<tag2>", "Patients", "will", "have", "one", "or", "more", "fully", "active,", "approved", "drugs", "available", "for", "construction", "of", "a", "viable", "alternative", "option.", "<tag3>"], "wordsA": ["Subjects", "will", "have", "one", "or", "more", "fully", "active,", "approved", "drugs", "available", "for", "construction", "of", "a", "viable", "alternative", "option."], "wordsB": ["Patients", "will", "have", "one", "or", "more", "fully", "active,", "approved", "drugs", "available", "for", "construction", "of", "a", "viable", "alternative", "option."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p26_s1", "idA": "1175680_16_item1_p26_s1", "sentA": "In response to our filing, the FDA requested that the Company submit data from the population for which the breakthrough therapy is requested.", "sentB": "In response to our filing, the FDA requested that we submit data from the population for which the breakthrough therapy is requested.", "type": 2, "words": ["<tag1>", "In", "response", "to", "our", "filing,", "the", "FDA", "requested", "that", "the", "Company", "submit", "data", "from", "the", "population", "for", "which", "the", "breakthrough", "therapy", "is", "requested.", "<tag2>", "In", "response", "to", "our", "filing,", "the", "FDA", "requested", "that", "we", "submit", "data", "from", "the", "population", "for", "which", "the", "breakthrough", "therapy", "is", "requested.", "<tag3>"], "wordsA": ["In", "response", "to", "our", "filing,", "the", "FDA", "requested", "that", "the", "Company", "submit", "data", "from", "the", "population", "for", "which", "the", "breakthrough", "therapy", "is", "requested."], "wordsB": ["In", "response", "to", "our", "filing,", "the", "FDA", "requested", "that", "we", "submit", "data", "from", "the", "population", "for", "which", "the", "breakthrough", "therapy", "is", "requested."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p27_s0", "idA": "1175680_16_item1_p27_s0", "sentA": "Phase 3 Trial for HIV, as Long-term Monotherapy A strategic Phase 3 trial including 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "sentB": "Phase 2b/3 Investigative Trial for HIV, as Long-term Monotherapy An investigative Phase 2b/3 trial including 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "type": 2, "words": ["<tag1>", "Phase", "3", "Trial", "for", "HIV,", "as", "Long-term", "Monotherapy", "A", "strategic", "Phase", "3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag2>", "Phase", "2b/3", "Investigative", "Trial", "for", "HIV,", "as", "Long-term", "Monotherapy", "An", "investigative", "Phase", "2b/3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag3>"], "wordsA": ["Phase", "3", "Trial", "for", "HIV,", "as", "Long-term", "Monotherapy", "A", "strategic", "Phase", "3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "wordsB": ["Phase", "2b/3", "Investigative", "Trial", "for", "HIV,", "as", "Long-term", "Monotherapy", "An", "investigative", "Phase", "2b/3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p29_s0", "idA": "1175680_16_item1_p28_s0", "sentA": "A Phase 3, Multicenter Study to Assess the Treatment Strategy of Using PRO 140 SC as Long-Acting Single-Agent Maintenance Therapy for 48 Weeks in Virologically Suppressed Subjects with CCR5-tropic HIV-1 infection.", "sentB": "This trial is entitled a Phase 2b/3, Multicenter Study to Assess the Treatment Strategy of Using PRO 140 SC as Long-Acting Single-Agent Maintenance Therapy for 48 Weeks in Virologically Suppressed Patients with CCR5-tropic HIV-1 infection.", "type": 2, "words": ["<tag1>", "A", "Phase", "3,", "Multicenter", "Study", "to", "Assess", "the", "Treatment", "Strategy", "of", "Using", "PRO", "140", "SC", "as", "Long-Acting", "Single-Agent", "Maintenance", "Therapy", "for", "48", "Weeks", "in", "Virologically", "Suppressed", "Subjects", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag2>", "This", "trial", "is", "entitled", "a", "Phase", "2b/3,", "Multicenter", "Study", "to", "Assess", "the", "Treatment", "Strategy", "of", "Using", "PRO", "140", "SC", "as", "Long-Acting", "Single-Agent", "Maintenance", "Therapy", "for", "48", "Weeks", "in", "Virologically", "Suppressed", "Patients", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag3>"], "wordsA": ["A", "Phase", "3,", "Multicenter", "Study", "to", "Assess", "the", "Treatment", "Strategy", "of", "Using", "PRO", "140", "SC", "as", "Long-Acting", "Single-Agent", "Maintenance", "Therapy", "for", "48", "Weeks", "in", "Virologically", "Suppressed", "Subjects", "with", "CCR5-tropic", "HIV-1", "infection."], "wordsB": ["This", "trial", "is", "entitled", "a", "Phase", "2b/3,", "Multicenter", "Study", "to", "Assess", "the", "Treatment", "Strategy", "of", "Using", "PRO", "140", "SC", "as", "Long-Acting", "Single-Agent", "Maintenance", "Therapy", "for", "48", "Weeks", "in", "Virologically", "Suppressed", "Patients", "with", "CCR5-tropic", "HIV-1", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p29_s1", "idA": "1175680_16_item1_p28_s1", "sentA": "This study is a multi-center study designed to evaluate the efficacy, safety, and tolerability of the strategy of shifting clinically stable patients receiving suppressive combination antiretroviral therapy to PRO 140 monotherapy and maintaining viral suppression for 48 weeks following study entry.", "sentB": "This study is designed to evaluate the efficacy, safety, and tolerability of the strategy of shifting clinically stable patients receiving suppressive combination antiretroviral therapy to PRO 140 monotherapy and maintaining viral suppression for 48 weeks following study entry.", "type": 2, "words": ["<tag1>", "This", "study", "is", "a", "multi-center", "study", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "the", "strategy", "of", "shifting", "clinically", "stable", "patients", "receiving", "suppressive", "combination", "antiretroviral", "therapy", "to", "PRO", "140", "monotherapy", "and", "maintaining", "viral", "suppression", "for", "48", "weeks", "following", "study", "entry.", "<tag2>", "This", "study", "is", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "the", "strategy", "of", "shifting", "clinically", "stable", "patients", "receiving", "suppressive", "combination", "antiretroviral", "therapy", "to", "PRO", "140", "monotherapy", "and", "maintaining", "viral", "suppression", "for", "48", "weeks", "following", "study", "entry.", "<tag3>"], "wordsA": ["This", "study", "is", "a", "multi-center", "study", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "the", "strategy", "of", "shifting", "clinically", "stable", "patients", "receiving", "suppressive", "combination", "antiretroviral", "therapy", "to", "PRO", "140", "monotherapy", "and", "maintaining", "viral", "suppression", "for", "48", "weeks", "following", "study", "entry."], "wordsB": ["This", "study", "is", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "the", "strategy", "of", "shifting", "clinically", "stable", "patients", "receiving", "suppressive", "combination", "antiretroviral", "therapy", "to", "PRO", "140", "monotherapy", "and", "maintaining", "viral", "suppression", "for", "48", "weeks", "following", "study", "entry."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p1_s2", "idA": "1175680_16_item1_p2_s2", "sentA": "We believe that monoclonal antibodies are a new emerging class of therapeutics for the treatment of HIV to address unmet medical needs in the area of HIV and graft versus host disease.", "sentB": "We believe that monoclonal antibodies are a new emerging class of therapeutics for the treatment of HIV to address unmet medical needs in the area of HIV and other immunologic indications, such as graft-versus-host disease.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "graft", "versus", "host", "disease.", "<tag2>", "We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "other", "immunologic", "indications,", "such", "as", "graft-versus-host", "disease.", "<tag3>"], "wordsA": ["We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "graft", "versus", "host", "disease."], "wordsB": ["We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "other", "immunologic", "indications,", "such", "as", "graft-versus-host", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p35_s1", "idA": "1175680_16_item1_p30_s0", "sentA": "The CCR5 receptor is expressed on a variety of cells that play a central role in inflammatory responses.", "sentB": "The CCR5 receptor is more than the door for HIV to enter T-cells; it is also a crucial component in inflammatory responses.", "type": 2, "words": ["<tag1>", "The", "CCR5", "receptor", "is", "expressed", "on", "a", "variety", "of", "cells", "that", "play", "a", "central", "role", "in", "inflammatory", "responses.", "<tag2>", "The", "CCR5", "receptor", "is", "more", "than", "the", "door", "for", "HIV", "to", "enter", "T-cells;", "it", "is", "also", "a", "crucial", "component", "in", "inflammatory", "responses.", "<tag3>"], "wordsA": ["The", "CCR5", "receptor", "is", "expressed", "on", "a", "variety", "of", "cells", "that", "play", "a", "central", "role", "in", "inflammatory", "responses."], "wordsB": ["The", "CCR5", "receptor", "is", "more", "than", "the", "door", "for", "HIV", "to", "enter", "T-cells;", "it", "is", "also", "a", "crucial", "component", "in", "inflammatory", "responses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p36_s0", "idA": "1175680_16_item1_p30_s0", "sentA": "The CCR5 receptor is expressed on a variety of cells that play a central role in inflammatory responses.", "sentB": "The CCR5 receptor is a protein located on the surface of white blood cells that serves as a receptor for chemical attractants called chemokines.", "type": 2, "words": ["<tag1>", "The", "CCR5", "receptor", "is", "expressed", "on", "a", "variety", "of", "cells", "that", "play", "a", "central", "role", "in", "inflammatory", "responses.", "<tag2>", "The", "CCR5", "receptor", "is", "a", "protein", "located", "on", "the", "surface", "of", "white", "blood", "cells", "that", "serves", "as", "a", "receptor", "for", "chemical", "attractants", "called", "chemokines.", "<tag3>"], "wordsA": ["The", "CCR5", "receptor", "is", "expressed", "on", "a", "variety", "of", "cells", "that", "play", "a", "central", "role", "in", "inflammatory", "responses."], "wordsB": ["The", "CCR5", "receptor", "is", "a", "protein", "located", "on", "the", "surface", "of", "white", "blood", "cells", "that", "serves", "as", "a", "receptor", "for", "chemical", "attractants", "called", "chemokines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p41_s1", "idA": "1175680_16_item1_p32_s0", "sentA": "The CCR5 receptor, the target for PRO 140, is an important mediator of GvHD, especially in the organ damage that is the usual cause of death.", "sentB": "GvHD represents an unmet medical need, with patients who contract GvHD during stem cell transplant having a significantly decreased 1-year survival rate with relapsed GvHD as the leading cause of death.", "type": 2, "words": ["<tag1>", "The", "CCR5", "receptor,", "the", "target", "for", "PRO", "140,", "is", "an", "important", "mediator", "of", "GvHD,", "especially", "in", "the", "organ", "damage", "that", "is", "the", "usual", "cause", "of", "death.", "<tag2>", "GvHD", "represents", "an", "unmet", "medical", "need,", "with", "patients", "who", "contract", "GvHD", "during", "stem", "cell", "transplant", "having", "a", "significantly", "decreased", "1-year", "survival", "rate", "with", "relapsed", "GvHD", "as", "the", "leading", "cause", "of", "death.", "<tag3>"], "wordsA": ["The", "CCR5", "receptor,", "the", "target", "for", "PRO", "140,", "is", "an", "important", "mediator", "of", "GvHD,", "especially", "in", "the", "organ", "damage", "that", "is", "the", "usual", "cause", "of", "death."], "wordsB": ["GvHD", "represents", "an", "unmet", "medical", "need,", "with", "patients", "who", "contract", "GvHD", "during", "stem", "cell", "transplant", "having", "a", "significantly", "decreased", "1-year", "survival", "rate", "with", "relapsed", "GvHD", "as", "the", "leading", "cause", "of", "death."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p39_s0", "idA": "1175680_16_item1_p32_s2", "sentA": "We believe that PRO 140 has significant advantages over Maraviroc in more favorable dosing and pharmacokinetics, less toxicity and side effects, and no direct stimulation (agonist activity) of the CCR5 receptor.", "sentB": "Due to its mechanism of action, PRO 140 has significant advantages in terms of safety and reduced side effects over other CCR5 antagonists.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "PRO", "140", "has", "significant", "advantages", "over", "Maraviroc", "in", "more", "favorable", "dosing", "and", "pharmacokinetics,", "less", "toxicity", "and", "side", "effects,", "and", "no", "direct", "stimulation", "(agonist", "activity)", "of", "the", "CCR5", "receptor.", "<tag2>", "Due", "to", "its", "mechanism", "of", "action,", "PRO", "140", "has", "significant", "advantages", "in", "terms", "of", "safety", "and", "reduced", "side", "effects", "over", "other", "CCR5", "antagonists.", "<tag3>"], "wordsA": ["We", "believe", "that", "PRO", "140", "has", "significant", "advantages", "over", "Maraviroc", "in", "more", "favorable", "dosing", "and", "pharmacokinetics,", "less", "toxicity", "and", "side", "effects,", "and", "no", "direct", "stimulation", "(agonist", "activity)", "of", "the", "CCR5", "receptor."], "wordsB": ["Due", "to", "its", "mechanism", "of", "action,", "PRO", "140", "has", "significant", "advantages", "in", "terms", "of", "safety", "and", "reduced", "side", "effects", "over", "other", "CCR5", "antagonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p41_s0", "idA": "1175680_16_item1_p32_s3", "sentA": "In December 2015, we received clearance from the FDA to conduct a Phase 2 trial to evaluate the safety and efficacy of PRO 140 for prophylaxis of acute GvHD in patients with acute myeloid leukemia ( AML ) or myelodysplastic syndromes ( MDS ) undergoing allogeneic stem-cell transplantation.", "sentB": "We have initiated our first clinical trial with PRO 140 in an immunological indication a Phase 2 clinical trial with PRO 140 for Graft-versus-Host Disease (GvHD) in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation.", "type": 2, "words": ["<tag1>", "In", "December", "2015,", "we", "received", "clearance", "from", "the", "FDA", "to", "conduct", "a", "Phase", "2", "trial", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "PRO", "140", "for", "prophylaxis", "of", "acute", "GvHD", "in", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndromes", "(", "MDS", ")", "undergoing", "allogeneic", "stem-cell", "transplantation.", "<tag2>", "We", "have", "initiated", "our", "first", "clinical", "trial", "with", "PRO", "140", "in", "an", "immunological", "indication", "a", "Phase", "2", "clinical", "trial", "with", "PRO", "140", "for", "Graft-versus-Host", "Disease", "(GvHD)", "in", "patients", "with", "acute", "myeloid", "leukemia", "(AML)", "or", "myelodysplastic", "syndrome", "(MDS)", "who", "are", "undergoing", "bone", "marrow", "stem", "cell", "transplantation.", "<tag3>"], "wordsA": ["In", "December", "2015,", "we", "received", "clearance", "from", "the", "FDA", "to", "conduct", "a", "Phase", "2", "trial", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "PRO", "140", "for", "prophylaxis", "of", "acute", "GvHD", "in", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndromes", "(", "MDS", ")", "undergoing", "allogeneic", "stem-cell", "transplantation."], "wordsB": ["We", "have", "initiated", "our", "first", "clinical", "trial", "with", "PRO", "140", "in", "an", "immunological", "indication", "a", "Phase", "2", "clinical", "trial", "with", "PRO", "140", "for", "Graft-versus-Host", "Disease", "(GvHD)", "in", "patients", "with", "acute", "myeloid", "leukemia", "(AML)", "or", "myelodysplastic", "syndrome", "(MDS)", "who", "are", "undergoing", "bone", "marrow", "stem", "cell", "transplantation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p15_s2", "idA": "1175680_16_item1_p32_s5", "sentA": "Enrollment of the first patient has not been announced.", "sentB": "Enrollment of the first patient was announced in May 2017.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced.", "<tag2>", "Enrollment", "of", "the", "first", "patient", "was", "announced", "in", "May", "2017.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced."], "wordsB": ["Enrollment", "of", "the", "first", "patient", "was", "announced", "in", "May", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p33_s5", "idA": "1175680_16_item1_p32_s5", "sentA": "Enrollment of the first patient has not been announced.", "sentB": "Enrollment of the first patient was announced in May 2017.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced.", "<tag2>", "Enrollment", "of", "the", "first", "patient", "was", "announced", "in", "May", "2017.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "has", "not", "been", "announced."], "wordsB": ["Enrollment", "of", "the", "first", "patient", "was", "announced", "in", "May", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p34_s0", "idA": "1175680_16_item1_p32_s6", "sentA": "In late December 2015, we announced that we had filed with the FDA for designation of PRO 140 as an orphan drug, in connection with our GvHD Phase 2 trial and remains open at this time pending submission by the Company of additional clinical data.", "sentB": "In late December 2015, we announced that we had filed with the FDA for designation of PRO 140 as an orphan drug, in connection with our GvHD Phase 2 trial and our request remains open at this time.", "type": 2, "words": ["<tag1>", "In", "late", "December", "2015,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "for", "designation", "of", "PRO", "140", "as", "an", "orphan", "drug,", "in", "connection", "with", "our", "GvHD", "Phase", "2", "trial", "and", "remains", "open", "at", "this", "time", "pending", "submission", "by", "the", "Company", "of", "additional", "clinical", "data.", "<tag2>", "In", "late", "December", "2015,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "for", "designation", "of", "PRO", "140", "as", "an", "orphan", "drug,", "in", "connection", "with", "our", "GvHD", "Phase", "2", "trial", "and", "our", "request", "remains", "open", "at", "this", "time.", "<tag3>"], "wordsA": ["In", "late", "December", "2015,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "for", "designation", "of", "PRO", "140", "as", "an", "orphan", "drug,", "in", "connection", "with", "our", "GvHD", "Phase", "2", "trial", "and", "remains", "open", "at", "this", "time", "pending", "submission", "by", "the", "Company", "of", "additional", "clinical", "data."], "wordsB": ["In", "late", "December", "2015,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "for", "designation", "of", "PRO", "140", "as", "an", "orphan", "drug,", "in", "connection", "with", "our", "GvHD", "Phase", "2", "trial", "and", "our", "request", "remains", "open", "at", "this", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p34_s2", "idA": "1175680_16_item1_p32_s7", "sentA": "Designation as an orphan product provides potentially faster pathways to approval and other financial incentives for drugs and biologics that are intended for the safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S. Phase 2b Trial for HIV, as a Monotherapy for Treatment-Na ve Patients We recently announced a Phase 2b, randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of PRO 140 in treatment-na ve adults with HIV-1 infection.", "sentB": "Designation as an orphan product provides potentially faster pathways to approval and other financial incentives for drugs and biologics that are intended for the safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S. Immunological Applications for PRO 140 We are continuing to explore opportunities for clinical applications for PRO 140 involving the CCR5 receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases and cancer.", "type": 2, "words": ["<tag1>", "Designation", "as", "an", "orphan", "product", "provides", "potentially", "faster", "pathways", "to", "approval", "and", "other", "financial", "incentives", "for", "drugs", "and", "biologics", "that", "are", "intended", "for", "the", "safe", "and", "effective", "treatment,", "diagnosis", "or", "prevention", "of", "rare", "diseases", "or", "disorders", "that", "affect", "fewer", "than", "200,000", "people", "in", "the", "U.S.", "Phase", "2b", "Trial", "for", "HIV,", "as", "a", "Monotherapy", "for", "Treatment-Na", "ve", "Patients", "We", "recently", "announced", "a", "Phase", "2b,", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "study", "to", "assess", "the", "safety", "and", "efficacy", "of", "PRO", "140", "in", "treatment-na", "ve", "adults", "with", "HIV-1", "infection.", "<tag2>", "Designation", "as", "an", "orphan", "product", "provides", "potentially", "faster", "pathways", "to", "approval", "and", "other", "financial", "incentives", "for", "drugs", "and", "biologics", "that", "are", "intended", "for", "the", "safe", "and", "effective", "treatment,", "diagnosis", "or", "prevention", "of", "rare", "diseases", "or", "disorders", "that", "affect", "fewer", "than", "200,000", "people", "in", "the", "U.S.", "Immunological", "Applications", "for", "PRO", "140", "We", "are", "continuing", "to", "explore", "opportunities", "for", "clinical", "applications", "for", "PRO", "140", "involving", "the", "CCR5", "receptor,", "other", "than", "HIV-related", "treatments,", "such", "as", "inflammatory", "conditions,", "autoimmune", "diseases", "and", "cancer.", "<tag3>"], "wordsA": ["Designation", "as", "an", "orphan", "product", "provides", "potentially", "faster", "pathways", "to", "approval", "and", "other", "financial", "incentives", "for", "drugs", "and", "biologics", "that", "are", "intended", "for", "the", "safe", "and", "effective", "treatment,", "diagnosis", "or", "prevention", "of", "rare", "diseases", "or", "disorders", "that", "affect", "fewer", "than", "200,000", "people", "in", "the", "U.S.", "Phase", "2b", "Trial", "for", "HIV,", "as", "a", "Monotherapy", "for", "Treatment-Na", "ve", "Patients", "We", "recently", "announced", "a", "Phase", "2b,", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "study", "to", "assess", "the", "safety", "and", "efficacy", "of", "PRO", "140", "in", "treatment-na", "ve", "adults", "with", "HIV-1", "infection."], "wordsB": ["Designation", "as", "an", "orphan", "product", "provides", "potentially", "faster", "pathways", "to", "approval", "and", "other", "financial", "incentives", "for", "drugs", "and", "biologics", "that", "are", "intended", "for", "the", "safe", "and", "effective", "treatment,", "diagnosis", "or", "prevention", "of", "rare", "diseases", "or", "disorders", "that", "affect", "fewer", "than", "200,000", "people", "in", "the", "U.S.", "Immunological", "Applications", "for", "PRO", "140", "We", "are", "continuing", "to", "explore", "opportunities", "for", "clinical", "applications", "for", "PRO", "140", "involving", "the", "CCR5", "receptor,", "other", "than", "HIV-related", "treatments,", "such", "as", "inflammatory", "conditions,", "autoimmune", "diseases", "and", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s3", "idA": "1175680_16_item1_p33_s5", "sentA": "On October 16, 2012, the Company paid to Progenics $3,500,000 in cash to close the transaction.", "sentB": "On October 16, 2012, we paid to Progenics $3,500,000 in cash to close the transaction.", "type": 2, "words": ["<tag1>", "On", "October", "16,", "2012,", "the", "Company", "paid", "to", "Progenics", "$3,500,000", "in", "cash", "to", "close", "the", "transaction.", "<tag2>", "On", "October", "16,", "2012,", "we", "paid", "to", "Progenics", "$3,500,000", "in", "cash", "to", "close", "the", "transaction.", "<tag3>"], "wordsA": ["On", "October", "16,", "2012,", "the", "Company", "paid", "to", "Progenics", "$3,500,000", "in", "cash", "to", "close", "the", "transaction."], "wordsB": ["On", "October", "16,", "2012,", "we", "paid", "to", "Progenics", "$3,500,000", "in", "cash", "to", "close", "the", "transaction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s4", "idA": "1175680_16_item1_p33_s6", "sentA": "The Company is also required to pay Progenics the following milestone payments and royalties: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-US equivalent, which was paid during the year ended May 31, 2016; (ii) $5,000,000 at the time of the first US new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of up to 5% on net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years, in each case determined on a country-by country basis.", "sentB": "We are also required to pay Progenics the following milestone payments and royalties: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-U.S. equivalent, which was paid during the fiscal year ended May 31, 2016; (ii) $5,000,000 at the time of the first U.S. new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of up to 5% on net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years, in each case determined on a country-by country basis.", "type": 2, "words": ["<tag1>", "The", "Company", "is", "also", "required", "to", "pay", "Progenics", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent,", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis.", "<tag2>", "We", "are", "also", "required", "to", "pay", "Progenics", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-U.S.", "equivalent,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U.S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis.", "<tag3>"], "wordsA": ["The", "Company", "is", "also", "required", "to", "pay", "Progenics", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-US", "equivalent,", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "US", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis."], "wordsB": ["We", "are", "also", "required", "to", "pay", "Progenics", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-U.S.", "equivalent,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U.S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s5", "idA": "1175680_16_item1_p33_s7", "sentA": "During the year ended May 31, 2016, the Company paid $1.5 million of such milestones owed to Progenics as a result of the first dosing in a U.S. Phase 3 trial.", "sentB": "During the year ended May 31, 2016, we paid $1.5 million of such milestones owed to Progenics as a result of the first dosing in a U.S. Phase 3 trial.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "May", "31,", "2016,", "the", "Company", "paid", "$1.5", "million", "of", "such", "milestones", "owed", "to", "Progenics", "as", "a", "result", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial.", "<tag2>", "During", "the", "year", "ended", "May", "31,", "2016,", "we", "paid", "$1.5", "million", "of", "such", "milestones", "owed", "to", "Progenics", "as", "a", "result", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "May", "31,", "2016,", "the", "Company", "paid", "$1.5", "million", "of", "such", "milestones", "owed", "to", "Progenics", "as", "a", "result", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial."], "wordsB": ["During", "the", "year", "ended", "May", "31,", "2016,", "we", "paid", "$1.5", "million", "of", "such", "milestones", "owed", "to", "Progenics", "as", "a", "result", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s6", "idA": "1175680_16_item1_p33_s8", "sentA": "To the extent that such milestone payments and royalties are not timely made, under the terms of the Progenics Purchase Agreement, Progenics has certain repurchase rights relating to the assets sold to the Company thereunder.", "sentB": "To the extent that such milestone payments and royalties are not timely made, under the terms of the Progenics Purchase Agreement, Progenics has certain repurchase rights relating to the assets sold to us thereunder.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "Progenics", "Purchase", "Agreement,", "Progenics", "has", "certain", "repurchase", "rights", "relating", "to", "the", "assets", "sold", "to", "the", "Company", "thereunder.", "<tag2>", "To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "Progenics", "Purchase", "Agreement,", "Progenics", "has", "certain", "repurchase", "rights", "relating", "to", "the", "assets", "sold", "to", "us", "thereunder.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "Progenics", "Purchase", "Agreement,", "Progenics", "has", "certain", "repurchase", "rights", "relating", "to", "the", "assets", "sold", "to", "the", "Company", "thereunder."], "wordsB": ["To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "Progenics", "Purchase", "Agreement,", "Progenics", "has", "certain", "repurchase", "rights", "relating", "to", "the", "assets", "sold", "to", "us", "thereunder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s7", "idA": "1175680_16_item1_p34_s0", "sentA": "Payments to Progenics are in addition to payments due under a Development and License Agreement, dated April 30, 1999 (the PDL License ), between Protein Design Labs (now AbbVie Inc.) ( PDL ) and Progenics, which was assigned to the Company in the Progenics Purchase Agreement, pursuant to which the Company has an exclusive worldwide license to develop, make, have made, import, use, sell, offer to sell or have sold products that incorporate the humanized form of the PRO 140 antibody developed by PDL under the agreement and must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial, which was paid during the year ended May 31, 2016; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "sentB": "( PDL ) and Progenics, which was assigned to us in the Progenics Purchase Agreement, pursuant to which we have an exclusive worldwide license to develop, make, have made, import, use, sell, offer to sell or have sold products that incorporate the humanized form of the PRO 140 antibody developed by PDL under the agreement and must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial, which was paid during the fiscal year ended May 31, 2016; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "type": 2, "words": ["<tag1>", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "the", "Company", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "the", "Company", "has", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag2>", "(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "we", "have", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag3>"], "wordsA": ["Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "the", "Company", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "the", "Company", "has", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "wordsB": ["(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "we", "have", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s9", "idA": "1175680_16_item1_p34_s2", "sentA": "During the year ended May 31, 2016 the Company paid $1 million of such milestones.", "sentB": "During the year ended May 31, 2016, we paid $1 million of such milestones.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "May", "31,", "2016", "the", "Company", "paid", "$1", "million", "of", "such", "milestones.", "<tag2>", "During", "the", "year", "ended", "May", "31,", "2016,", "we", "paid", "$1", "million", "of", "such", "milestones.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "May", "31,", "2016", "the", "Company", "paid", "$1", "million", "of", "such", "milestones."], "wordsB": ["During", "the", "year", "ended", "May", "31,", "2016,", "we", "paid", "$1", "million", "of", "such", "milestones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s10", "idA": "1175680_16_item1_p34_s3", "sentA": "To the extent that such milestone payments and royalties are not timely made, under the terms of the PDL License, AbbVie Inc. has certain termination rights relating to the Company s license of PRO 140 thereunder.", "sentB": "To the extent that such milestone payments and royalties are not timely made, under the terms of the PDL License, AbbVie Inc. has certain termination rights relating to our license of PRO 140 thereunder.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "the", "Company", "s", "license", "of", "PRO", "140", "thereunder.", "<tag2>", "To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "our", "license", "of", "PRO", "140", "thereunder.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "the", "Company", "s", "license", "of", "PRO", "140", "thereunder."], "wordsB": ["To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "our", "license", "of", "PRO", "140", "thereunder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s11", "idA": "1175680_16_item1_p35_s0", "sentA": "Pursuant to the foregoing Progenics Purchase Agreement and PDL License, the Company accrued an expense of $2,500,000 as of May 31, 2015 in connection with the anticipated milestone payments related to the first patient dosing in a Phase 3 clinical trial, all of which was paid during the year ended May 31, 2016.", "sentB": "Pursuant to the foregoing Progenics Purchase Agreement and PDL License, we accrued an expense of $2,500,000 as of May 31, 2015 in connection with the anticipated milestone payments related to the first patient dosing in a Phase 3 clinical trial, all of which was paid during the fiscal year ended May 31, 2016.", "type": 2, "words": ["<tag1>", "Pursuant", "to", "the", "foregoing", "Progenics", "Purchase", "Agreement", "and", "PDL", "License,", "the", "Company", "accrued", "an", "expense", "of", "$2,500,000", "as", "of", "May", "31,", "2015", "in", "connection", "with", "the", "anticipated", "milestone", "payments", "related", "to", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "clinical", "trial,", "all", "of", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016.", "<tag2>", "Pursuant", "to", "the", "foregoing", "Progenics", "Purchase", "Agreement", "and", "PDL", "License,", "we", "accrued", "an", "expense", "of", "$2,500,000", "as", "of", "May", "31,", "2015", "in", "connection", "with", "the", "anticipated", "milestone", "payments", "related", "to", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "clinical", "trial,", "all", "of", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016.", "<tag3>"], "wordsA": ["Pursuant", "to", "the", "foregoing", "Progenics", "Purchase", "Agreement", "and", "PDL", "License,", "the", "Company", "accrued", "an", "expense", "of", "$2,500,000", "as", "of", "May", "31,", "2015", "in", "connection", "with", "the", "anticipated", "milestone", "payments", "related", "to", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "clinical", "trial,", "all", "of", "which", "was", "paid", "during", "the", "year", "ended", "May", "31,", "2016."], "wordsB": ["Pursuant", "to", "the", "foregoing", "Progenics", "Purchase", "Agreement", "and", "PDL", "License,", "we", "accrued", "an", "expense", "of", "$2,500,000", "as", "of", "May", "31,", "2015", "in", "connection", "with", "the", "anticipated", "milestone", "payments", "related", "to", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "clinical", "trial,", "all", "of", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s12", "idA": "1175680_16_item1_p36_s0", "sentA": "Effective July 29, 2015, the Company entered into a License Agreement (the Lonza Agreement ) with Lonza Sales AG ( Lonza ) covering Lonza s system know-how technology with respect to CytoDyn s use of proprietary cell lines to manufacture new PRO 140 material.", "sentB": "Effective July 29, 2015, we entered into a License Agreement (the Lonza Agreement ) with Lonza Sales AG ( Lonza ) covering Lonza s system know-how technology with respect to CytoDyn s use of proprietary cell lines to manufacture new PRO 140 material.", "type": 2, "words": ["<tag1>", "Effective", "July", "29,", "2015,", "the", "Company", "entered", "into", "a", "License", "Agreement", "(the", "Lonza", "Agreement", ")", "with", "Lonza", "Sales", "AG", "(", "Lonza", ")", "covering", "Lonza", "s", "system", "know-how", "technology", "with", "respect", "to", "CytoDyn", "s", "use", "of", "proprietary", "cell", "lines", "to", "manufacture", "new", "PRO", "140", "material.", "<tag2>", "Effective", "July", "29,", "2015,", "we", "entered", "into", "a", "License", "Agreement", "(the", "Lonza", "Agreement", ")", "with", "Lonza", "Sales", "AG", "(", "Lonza", ")", "covering", "Lonza", "s", "system", "know-how", "technology", "with", "respect", "to", "CytoDyn", "s", "use", "of", "proprietary", "cell", "lines", "to", "manufacture", "new", "PRO", "140", "material.", "<tag3>"], "wordsA": ["Effective", "July", "29,", "2015,", "the", "Company", "entered", "into", "a", "License", "Agreement", "(the", "Lonza", "Agreement", ")", "with", "Lonza", "Sales", "AG", "(", "Lonza", ")", "covering", "Lonza", "s", "system", "know-how", "technology", "with", "respect", "to", "CytoDyn", "s", "use", "of", "proprietary", "cell", "lines", "to", "manufacture", "new", "PRO", "140", "material."], "wordsB": ["Effective", "July", "29,", "2015,", "we", "entered", "into", "a", "License", "Agreement", "(the", "Lonza", "Agreement", ")", "with", "Lonza", "Sales", "AG", "(", "Lonza", ")", "covering", "Lonza", "s", "system", "know-how", "technology", "with", "respect", "to", "CytoDyn", "s", "use", "of", "proprietary", "cell", "lines", "to", "manufacture", "new", "PRO", "140", "material."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s14", "idA": "1175680_16_item1_p36_s2", "sentA": "In connection with this license agreement, the Company became the primary obligor of an additional 600,000, which was accrued in the first quarter of the fiscal year ended May 31, 2016 and was timely paid by June 30, 2016.", "sentB": "In connection with this license agreement, we became the primary obligor of an additional 600,000, which was accrued in the first quarter of the fiscal year ended May 31, 2016 and was timely paid by June 30, 2016.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "this", "license", "agreement,", "the", "Company", "became", "the", "primary", "obligor", "of", "an", "additional", "600,000,", "which", "was", "accrued", "in", "the", "first", "quarter", "of", "the", "fiscal", "year", "ended", "May", "31,", "2016", "and", "was", "timely", "paid", "by", "June", "30,", "2016.", "<tag2>", "In", "connection", "with", "this", "license", "agreement,", "we", "became", "the", "primary", "obligor", "of", "an", "additional", "600,000,", "which", "was", "accrued", "in", "the", "first", "quarter", "of", "the", "fiscal", "year", "ended", "May", "31,", "2016", "and", "was", "timely", "paid", "by", "June", "30,", "2016.", "<tag3>"], "wordsA": ["In", "connection", "with", "this", "license", "agreement,", "the", "Company", "became", "the", "primary", "obligor", "of", "an", "additional", "600,000,", "which", "was", "accrued", "in", "the", "first", "quarter", "of", "the", "fiscal", "year", "ended", "May", "31,", "2016", "and", "was", "timely", "paid", "by", "June", "30,", "2016."], "wordsB": ["In", "connection", "with", "this", "license", "agreement,", "we", "became", "the", "primary", "obligor", "of", "an", "additional", "600,000,", "which", "was", "accrued", "in", "the", "first", "quarter", "of", "the", "fiscal", "year", "ended", "May", "31,", "2016", "and", "was", "timely", "paid", "by", "June", "30,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p42_s15", "idA": "1175680_16_item1_p36_s3", "sentA": "Using the foreign currency exchange rates at the time of payment, the Company s license fee payment approximated US$807,000.", "sentB": "Using the foreign currency exchange rates at the time of payment, our license fee payment approximated US$807,000.", "type": 2, "words": ["<tag1>", "Using", "the", "foreign", "currency", "exchange", "rates", "at", "the", "time", "of", "payment,", "the", "Company", "s", "license", "fee", "payment", "approximated", "US$807,000.", "<tag2>", "Using", "the", "foreign", "currency", "exchange", "rates", "at", "the", "time", "of", "payment,", "our", "license", "fee", "payment", "approximated", "US$807,000.", "<tag3>"], "wordsA": ["Using", "the", "foreign", "currency", "exchange", "rates", "at", "the", "time", "of", "payment,", "the", "Company", "s", "license", "fee", "payment", "approximated", "US$807,000."], "wordsB": ["Using", "the", "foreign", "currency", "exchange", "rates", "at", "the", "time", "of", "payment,", "our", "license", "fee", "payment", "approximated", "US$807,000."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p43_s3", "idA": "1175680_16_item1_p37_s3", "sentA": "A U.S. patent, to be selected by the Company upon receipt of FDA regulatory approval, may be subject to up to a five-year patent term extension in certain instances.", "sentB": "A U.S. patent, to be selected by us upon receipt of FDA regulatory approval, may be subject to up to a five-year patent term extension in certain instances.", "type": 2, "words": ["<tag1>", "A", "U.S.", "patent,", "to", "be", "selected", "by", "the", "Company", "upon", "receipt", "of", "FDA", "regulatory", "approval,", "may", "be", "subject", "to", "up", "to", "a", "five-year", "patent", "term", "extension", "in", "certain", "instances.", "<tag2>", "A", "U.S.", "patent,", "to", "be", "selected", "by", "us", "upon", "receipt", "of", "FDA", "regulatory", "approval,", "may", "be", "subject", "to", "up", "to", "a", "five-year", "patent", "term", "extension", "in", "certain", "instances.", "<tag3>"], "wordsA": ["A", "U.S.", "patent,", "to", "be", "selected", "by", "the", "Company", "upon", "receipt", "of", "FDA", "regulatory", "approval,", "may", "be", "subject", "to", "up", "to", "a", "five-year", "patent", "term", "extension", "in", "certain", "instances."], "wordsB": ["A", "U.S.", "patent,", "to", "be", "selected", "by", "us", "upon", "receipt", "of", "FDA", "regulatory", "approval,", "may", "be", "subject", "to", "up", "to", "a", "five-year", "patent", "term", "extension", "in", "certain", "instances."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p76_s5", "idA": "1175680_16_item1_p38_s0", "sentA": "We pursue opportunities for seeking new meaningful patent protection on an ongoing basis.", "sentB": "In order to commercialize product, this scaled-up material will need to be validated under best practices, and demonstrated to meet approved specifications on an ongoing basis.", "type": 2, "words": ["<tag1>", "We", "pursue", "opportunities", "for", "seeking", "new", "meaningful", "patent", "protection", "on", "an", "ongoing", "basis.", "<tag2>", "In", "order", "to", "commercialize", "product,", "this", "scaled-up", "material", "will", "need", "to", "be", "validated", "under", "best", "practices,", "and", "demonstrated", "to", "meet", "approved", "specifications", "on", "an", "ongoing", "basis.", "<tag3>"], "wordsA": ["We", "pursue", "opportunities", "for", "seeking", "new", "meaningful", "patent", "protection", "on", "an", "ongoing", "basis."], "wordsB": ["In", "order", "to", "commercialize", "product,", "this", "scaled-up", "material", "will", "need", "to", "be", "validated", "under", "best", "practices,", "and", "demonstrated", "to", "meet", "approved", "specifications", "on", "an", "ongoing", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p45_s2", "idA": "1175680_16_item1_p39_s2", "sentA": "See related risk factors under the heading Risk Factors above.", "sentB": "See related risk factors under the heading Risk Factors below.", "type": 2, "words": ["<tag1>", "See", "related", "risk", "factors", "under", "the", "heading", "Risk", "Factors", "above.", "<tag2>", "See", "related", "risk", "factors", "under", "the", "heading", "Risk", "Factors", "below.", "<tag3>"], "wordsA": ["See", "related", "risk", "factors", "under", "the", "heading", "Risk", "Factors", "above."], "wordsB": ["See", "related", "risk", "factors", "under", "the", "heading", "Risk", "Factors", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p12_s1", "idA": "1175680_16_item1_p39_s7", "sentA": "Accordingly, this period of data exclusivity is expected to provide at least a 12-year term of protection against competing products shown to be biosimilar or interchangeable with PRO 140.", "sentB": "Patient enrollment is expected to be completed in July 2017 and we will announce whether the trial has achieved its primary endpoint as soon as that determination is available.", "type": 2, "words": ["<tag1>", "Accordingly,", "this", "period", "of", "data", "exclusivity", "is", "expected", "to", "provide", "at", "least", "a", "12-year", "term", "of", "protection", "against", "competing", "products", "shown", "to", "be", "biosimilar", "or", "interchangeable", "with", "PRO", "140.", "<tag2>", "Patient", "enrollment", "is", "expected", "to", "be", "completed", "in", "July", "2017", "and", "we", "will", "announce", "whether", "the", "trial", "has", "achieved", "its", "primary", "endpoint", "as", "soon", "as", "that", "determination", "is", "available.", "<tag3>"], "wordsA": ["Accordingly,", "this", "period", "of", "data", "exclusivity", "is", "expected", "to", "provide", "at", "least", "a", "12-year", "term", "of", "protection", "against", "competing", "products", "shown", "to", "be", "biosimilar", "or", "interchangeable", "with", "PRO", "140."], "wordsB": ["Patient", "enrollment", "is", "expected", "to", "be", "completed", "in", "July", "2017", "and", "we", "will", "announce", "whether", "the", "trial", "has", "achieved", "its", "primary", "endpoint", "as", "soon", "as", "that", "determination", "is", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p25_s3", "idA": "1175680_16_item1_p39_s7", "sentA": "Accordingly, this period of data exclusivity is expected to provide at least a 12-year term of protection against competing products shown to be biosimilar or interchangeable with PRO 140.", "sentB": "Enrollment is expected to be completed in July 2017 followed by an evaluation of the primary endpoint soon thereafter.", "type": 2, "words": ["<tag1>", "Accordingly,", "this", "period", "of", "data", "exclusivity", "is", "expected", "to", "provide", "at", "least", "a", "12-year", "term", "of", "protection", "against", "competing", "products", "shown", "to", "be", "biosimilar", "or", "interchangeable", "with", "PRO", "140.", "<tag2>", "Enrollment", "is", "expected", "to", "be", "completed", "in", "July", "2017", "followed", "by", "an", "evaluation", "of", "the", "primary", "endpoint", "soon", "thereafter.", "<tag3>"], "wordsA": ["Accordingly,", "this", "period", "of", "data", "exclusivity", "is", "expected", "to", "provide", "at", "least", "a", "12-year", "term", "of", "protection", "against", "competing", "products", "shown", "to", "be", "biosimilar", "or", "interchangeable", "with", "PRO", "140."], "wordsB": ["Enrollment", "is", "expected", "to", "be", "completed", "in", "July", "2017", "followed", "by", "an", "evaluation", "of", "the", "primary", "endpoint", "soon", "thereafter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p46_s1", "idA": "1175680_16_item1_p41_s0", "sentA": "Information with respect to our current patent portfolio as of May 31, 2016, is set forth below.", "sentB": "Information with respect to our current patent portfolio as of May 31, 2017, is set forth below.", "type": 2, "words": ["<tag1>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2016,", "is", "set", "forth", "below.", "<tag2>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2017,", "is", "set", "forth", "below.", "<tag3>"], "wordsA": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2016,", "is", "set", "forth", "below."], "wordsB": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2017,", "is", "set", "forth", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p50_s1", "idA": "1175680_16_item1_p45_s1", "sentA": "For example, there are federal and state health care laws and regulations that apply to the operation of clinical laboratories, the business relationships between health care providers and suppliers, the privacy and security of health information and the conduct of clinical research.", "sentB": "For example, there are federal and state health care laws and regulations that apply to the conduct of clinical research, the business relationships between health care providers and suppliers and the privacy and security of health information.", "type": 2, "words": ["<tag1>", "For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "operation", "of", "clinical", "laboratories,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers,", "the", "privacy", "and", "security", "of", "health", "information", "and", "the", "conduct", "of", "clinical", "research.", "<tag2>", "For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "conduct", "of", "clinical", "research,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers", "and", "the", "privacy", "and", "security", "of", "health", "information.", "<tag3>"], "wordsA": ["For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "operation", "of", "clinical", "laboratories,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers,", "the", "privacy", "and", "security", "of", "health", "information", "and", "the", "conduct", "of", "clinical", "research."], "wordsB": ["For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "conduct", "of", "clinical", "research,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers", "and", "the", "privacy", "and", "security", "of", "health", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p52_s0", "idA": "1175680_16_item1_p47_s0", "sentA": "In the United States, biological products have long been subject to regulation by various federal and state agencies, primarily as to product safety, efficacy, manufacturing, advertising, labeling, import, export and safety reporting.", "sentB": "In the United States, biological products such as PRO 140 have long been subject to regulation by various federal and state agencies, primarily as to product research, development, approval, safety, efficacy, manufacturing, advertising, labeling, import, export and safety reporting.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "biological", "products", "have", "long", "been", "subject", "to", "regulation", "by", "various", "federal", "and", "state", "agencies,", "primarily", "as", "to", "product", "safety,", "efficacy,", "manufacturing,", "advertising,", "labeling,", "import,", "export", "and", "safety", "reporting.", "<tag2>", "In", "the", "United", "States,", "biological", "products", "such", "as", "PRO", "140", "have", "long", "been", "subject", "to", "regulation", "by", "various", "federal", "and", "state", "agencies,", "primarily", "as", "to", "product", "research,", "development,", "approval,", "safety,", "efficacy,", "manufacturing,", "advertising,", "labeling,", "import,", "export", "and", "safety", "reporting.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "biological", "products", "have", "long", "been", "subject", "to", "regulation", "by", "various", "federal", "and", "state", "agencies,", "primarily", "as", "to", "product", "safety,", "efficacy,", "manufacturing,", "advertising,", "labeling,", "import,", "export", "and", "safety", "reporting."], "wordsB": ["In", "the", "United", "States,", "biological", "products", "such", "as", "PRO", "140", "have", "long", "been", "subject", "to", "regulation", "by", "various", "federal", "and", "state", "agencies,", "primarily", "as", "to", "product", "research,", "development,", "approval,", "safety,", "efficacy,", "manufacturing,", "advertising,", "labeling,", "import,", "export", "and", "safety", "reporting."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p52_s1", "idA": "1175680_16_item1_p47_s1", "sentA": "The exercise of broad regulatory powers by the FDA through its Center for Devices and Radiological Health and its Center for Biological Evaluation and Research continues to result in increases in the amounts of testing and documentation for FDA clearance of current and new biologic products.", "sentB": "The exercise of broad regulatory powers by the FDA through its Center for Biological Evaluation and Research and other functions continues to require from companies large amounts of testing and documentation prior to FDA approval of current and new biologic products and while they are marketed.", "type": 2, "words": ["<tag1>", "The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Devices", "and", "Radiological", "Health", "and", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "continues", "to", "result", "in", "increases", "in", "the", "amounts", "of", "testing", "and", "documentation", "for", "FDA", "clearance", "of", "current", "and", "new", "biologic", "products.", "<tag2>", "The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "and", "other", "functions", "continues", "to", "require", "from", "companies", "large", "amounts", "of", "testing", "and", "documentation", "prior", "to", "FDA", "approval", "of", "current", "and", "new", "biologic", "products", "and", "while", "they", "are", "marketed.", "<tag3>"], "wordsA": ["The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Devices", "and", "Radiological", "Health", "and", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "continues", "to", "result", "in", "increases", "in", "the", "amounts", "of", "testing", "and", "documentation", "for", "FDA", "clearance", "of", "current", "and", "new", "biologic", "products."], "wordsB": ["The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "and", "other", "functions", "continues", "to", "require", "from", "companies", "large", "amounts", "of", "testing", "and", "documentation", "prior", "to", "FDA", "approval", "of", "current", "and", "new", "biologic", "products", "and", "while", "they", "are", "marketed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p52_s2", "idA": "1175680_16_item1_p48_s0", "sentA": "The FDA can ban certain biological products; detain or seize adulterated or misbranded biological products; order repair, replacement or refund of these products; and require notification of health professionals and others with regard to biological products that present unreasonable risks of substantial harm to the public health.", "sentB": "When marketing commences, the FDA can ban certain biological products; detain or seize adulterated or misbranded biological products; order repair, replacement or refund of these products; and require notification of health professionals and others with regard to biological products that present unreasonable risks of substantial harm to the public health.", "type": 2, "words": ["<tag1>", "The", "FDA", "can", "ban", "certain", "biological", "products;", "detain", "or", "seize", "adulterated", "or", "misbranded", "biological", "products;", "order", "repair,", "replacement", "or", "refund", "of", "these", "products;", "and", "require", "notification", "of", "health", "professionals", "and", "others", "with", "regard", "to", "biological", "products", "that", "present", "unreasonable", "risks", "of", "substantial", "harm", "to", "the", "public", "health.", "<tag2>", "When", "marketing", "commences,", "the", "FDA", "can", "ban", "certain", "biological", "products;", "detain", "or", "seize", "adulterated", "or", "misbranded", "biological", "products;", "order", "repair,", "replacement", "or", "refund", "of", "these", "products;", "and", "require", "notification", "of", "health", "professionals", "and", "others", "with", "regard", "to", "biological", "products", "that", "present", "unreasonable", "risks", "of", "substantial", "harm", "to", "the", "public", "health.", "<tag3>"], "wordsA": ["The", "FDA", "can", "ban", "certain", "biological", "products;", "detain", "or", "seize", "adulterated", "or", "misbranded", "biological", "products;", "order", "repair,", "replacement", "or", "refund", "of", "these", "products;", "and", "require", "notification", "of", "health", "professionals", "and", "others", "with", "regard", "to", "biological", "products", "that", "present", "unreasonable", "risks", "of", "substantial", "harm", "to", "the", "public", "health."], "wordsB": ["When", "marketing", "commences,", "the", "FDA", "can", "ban", "certain", "biological", "products;", "detain", "or", "seize", "adulterated", "or", "misbranded", "biological", "products;", "order", "repair,", "replacement", "or", "refund", "of", "these", "products;", "and", "require", "notification", "of", "health", "professionals", "and", "others", "with", "regard", "to", "biological", "products", "that", "present", "unreasonable", "risks", "of", "substantial", "harm", "to", "the", "public", "health."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p61_s2", "idA": "1175680_16_item1_p49_s1", "sentA": "Failure to comply with applicable regulations can result in refusal by the FDA to approve product license applications.", "sentB": "Violations of these laws can result in significant liability, criminal penalties and being barred from government reimbursement programs such as Medicare and Medicaid.", "type": 2, "words": ["<tag1>", "Failure", "to", "comply", "with", "applicable", "regulations", "can", "result", "in", "refusal", "by", "the", "FDA", "to", "approve", "product", "license", "applications.", "<tag2>", "Violations", "of", "these", "laws", "can", "result", "in", "significant", "liability,", "criminal", "penalties", "and", "being", "barred", "from", "government", "reimbursement", "programs", "such", "as", "Medicare", "and", "Medicaid.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "applicable", "regulations", "can", "result", "in", "refusal", "by", "the", "FDA", "to", "approve", "product", "license", "applications."], "wordsB": ["Violations", "of", "these", "laws", "can", "result", "in", "significant", "liability,", "criminal", "penalties", "and", "being", "barred", "from", "government", "reimbursement", "programs", "such", "as", "Medicare", "and", "Medicaid."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p53_s3", "idA": "1175680_16_item1_p49_s3", "sentA": "Pharmaceutical products such as PRO140 may not be commercially marketed without prior approval from the FDA and comparable agencies in foreign countries.", "sentB": "Pharmaceutical products such as PRO 140 may not be commercially marketed without prior approval from the FDA and comparable agencies in foreign countries.", "type": 2, "words": ["<tag1>", "Pharmaceutical", "products", "such", "as", "PRO140", "may", "not", "be", "commercially", "marketed", "without", "prior", "approval", "from", "the", "FDA", "and", "comparable", "agencies", "in", "foreign", "countries.", "<tag2>", "Pharmaceutical", "products", "such", "as", "PRO", "140", "may", "not", "be", "commercially", "marketed", "without", "prior", "approval", "from", "the", "FDA", "and", "comparable", "agencies", "in", "foreign", "countries.", "<tag3>"], "wordsA": ["Pharmaceutical", "products", "such", "as", "PRO140", "may", "not", "be", "commercially", "marketed", "without", "prior", "approval", "from", "the", "FDA", "and", "comparable", "agencies", "in", "foreign", "countries."], "wordsB": ["Pharmaceutical", "products", "such", "as", "PRO", "140", "may", "not", "be", "commercially", "marketed", "without", "prior", "approval", "from", "the", "FDA", "and", "comparable", "agencies", "in", "foreign", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p54_s0", "idA": "1175680_16_item1_p49_s4", "sentA": "In the United States, the process for obtaining FDA approval for products like PRO140 typically includes pre-clinical studies, the filing of an Investigational New Drug application, or IND, human clinical trials and filing and approval of either a New Drug Application, or NDA, for chemical pharmaceutical products, or a BLA (biologics license application) for biological pharmaceutical products, such as PRO 140.", "sentB": "In the United States, the process for obtaining FDA approval for products like PRO 140 typically includes pre-clinical studies, the filing of an Investigational New Drug application, or IND, human clinical trials and filing and approval of either a New Drug Application, or NDA, for chemical pharmaceutical products, or a BLA (biologics license application) for biological pharmaceutical products, such as PRO 140.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "the", "process", "for", "obtaining", "FDA", "approval", "for", "products", "like", "PRO140", "typically", "includes", "pre-clinical", "studies,", "the", "filing", "of", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "human", "clinical", "trials", "and", "filing", "and", "approval", "of", "either", "a", "New", "Drug", "Application,", "or", "NDA,", "for", "chemical", "pharmaceutical", "products,", "or", "a", "BLA", "(biologics", "license", "application)", "for", "biological", "pharmaceutical", "products,", "such", "as", "PRO", "140.", "<tag2>", "In", "the", "United", "States,", "the", "process", "for", "obtaining", "FDA", "approval", "for", "products", "like", "PRO", "140", "typically", "includes", "pre-clinical", "studies,", "the", "filing", "of", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "human", "clinical", "trials", "and", "filing", "and", "approval", "of", "either", "a", "New", "Drug", "Application,", "or", "NDA,", "for", "chemical", "pharmaceutical", "products,", "or", "a", "BLA", "(biologics", "license", "application)", "for", "biological", "pharmaceutical", "products,", "such", "as", "PRO", "140.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "the", "process", "for", "obtaining", "FDA", "approval", "for", "products", "like", "PRO140", "typically", "includes", "pre-clinical", "studies,", "the", "filing", "of", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "human", "clinical", "trials", "and", "filing", "and", "approval", "of", "either", "a", "New", "Drug", "Application,", "or", "NDA,", "for", "chemical", "pharmaceutical", "products,", "or", "a", "BLA", "(biologics", "license", "application)", "for", "biological", "pharmaceutical", "products,", "such", "as", "PRO", "140."], "wordsB": ["In", "the", "United", "States,", "the", "process", "for", "obtaining", "FDA", "approval", "for", "products", "like", "PRO", "140", "typically", "includes", "pre-clinical", "studies,", "the", "filing", "of", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "human", "clinical", "trials", "and", "filing", "and", "approval", "of", "either", "a", "New", "Drug", "Application,", "or", "NDA,", "for", "chemical", "pharmaceutical", "products,", "or", "a", "BLA", "(biologics", "license", "application)", "for", "biological", "pharmaceutical", "products,", "such", "as", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p2_s2", "idA": "1175680_16_item1_p4_s0", "sentA": "PRO 140 We believe the PRO 140 antibody shows promise as a powerful anti-viral agent while not being a chemically synthesized drug, which means fewer side effects, lower toxicity and less frequent dosing requirements, as compared to daily drug therapies currently in use for the treatment of HIV.", "sentB": "PRO 140 We believe the PRO 140 antibody shows promise as a powerful anti-viral agent with the advantage of fewer side effects, lower toxicity and less frequent dosing requirements, as compared to daily drug therapies currently in use for the treatment of HIV.", "type": 2, "words": ["<tag1>", "PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use", "for", "the", "treatment", "of", "HIV.", "<tag2>", "PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "with", "the", "advantage", "of", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use", "for", "the", "treatment", "of", "HIV.", "<tag3>"], "wordsA": ["PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use", "for", "the", "treatment", "of", "HIV."], "wordsB": ["PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "with", "the", "advantage", "of", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use", "for", "the", "treatment", "of", "HIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p6_s1", "idA": "1175680_16_item1_p4_s0", "sentA": "PRO 140 We believe the PRO 140 antibody shows promise as a powerful anti-viral agent while not being a chemically synthesized drug, which means fewer side effects, lower toxicity and less frequent dosing requirements, as compared to daily drug therapies currently in use for the treatment of HIV.", "sentB": "PRO 140, as a single agent therapy, has also demonstrated that it could replace HAART altogether for a subpopulation of R5 patients who have suppressed viral load with HAART, but are seeking an alternative treatment that allows the patient an improved quality of life, with the advantages of fewer side effects, lower toxicity and less frequent dosing requirements.", "type": 2, "words": ["<tag1>", "PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use", "for", "the", "treatment", "of", "HIV.", "<tag2>", "PRO", "140,", "as", "a", "single", "agent", "therapy,", "has", "also", "demonstrated", "that", "it", "could", "replace", "HAART", "altogether", "for", "a", "subpopulation", "of", "R5", "patients", "who", "have", "suppressed", "viral", "load", "with", "HAART,", "but", "are", "seeking", "an", "alternative", "treatment", "that", "allows", "the", "patient", "an", "improved", "quality", "of", "life,", "with", "the", "advantages", "of", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements.", "<tag3>"], "wordsA": ["PRO", "140", "We", "believe", "the", "PRO", "140", "antibody", "shows", "promise", "as", "a", "powerful", "anti-viral", "agent", "while", "not", "being", "a", "chemically", "synthesized", "drug,", "which", "means", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements,", "as", "compared", "to", "daily", "drug", "therapies", "currently", "in", "use", "for", "the", "treatment", "of", "HIV."], "wordsB": ["PRO", "140,", "as", "a", "single", "agent", "therapy,", "has", "also", "demonstrated", "that", "it", "could", "replace", "HAART", "altogether", "for", "a", "subpopulation", "of", "R5", "patients", "who", "have", "suppressed", "viral", "load", "with", "HAART,", "but", "are", "seeking", "an", "alternative", "treatment", "that", "allows", "the", "patient", "an", "improved", "quality", "of", "life,", "with", "the", "advantages", "of", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p54_s1", "idA": "1175680_16_item1_p50_s2", "sentA": "If the FDA has comments or questions, they must be resolved to the satisfaction of the FDA before clinical trials can begin.", "sentB": "The results of pre-clinical testing, which include laboratory evaluation of product chemistry and formulation, animal studies to assess the potential safety and efficacy of the product and its formulations, details concerning the drug manufacturing process and its controls, and proposed clinical trial protocols and other information must be submitted to the FDA as part of an IND that must be reviewed and become effective before clinical testing can begin.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "has", "comments", "or", "questions,", "they", "must", "be", "resolved", "to", "the", "satisfaction", "of", "the", "FDA", "before", "clinical", "trials", "can", "begin.", "<tag2>", "The", "results", "of", "pre-clinical", "testing,", "which", "include", "laboratory", "evaluation", "of", "product", "chemistry", "and", "formulation,", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "and", "its", "formulations,", "details", "concerning", "the", "drug", "manufacturing", "process", "and", "its", "controls,", "and", "proposed", "clinical", "trial", "protocols", "and", "other", "information", "must", "be", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "that", "must", "be", "reviewed", "and", "become", "effective", "before", "clinical", "testing", "can", "begin.", "<tag3>"], "wordsA": ["If", "the", "FDA", "has", "comments", "or", "questions,", "they", "must", "be", "resolved", "to", "the", "satisfaction", "of", "the", "FDA", "before", "clinical", "trials", "can", "begin."], "wordsB": ["The", "results", "of", "pre-clinical", "testing,", "which", "include", "laboratory", "evaluation", "of", "product", "chemistry", "and", "formulation,", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "and", "its", "formulations,", "details", "concerning", "the", "drug", "manufacturing", "process", "and", "its", "controls,", "and", "proposed", "clinical", "trial", "protocols", "and", "other", "information", "must", "be", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "that", "must", "be", "reviewed", "and", "become", "effective", "before", "clinical", "testing", "can", "begin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p54_s5", "idA": "1175680_16_item1_p50_s3", "sentA": "In addition, the FDA, an IRB or we may, at any time, impose a clinical hold on ongoing clinical trials.", "sentB": "In addition, protocols for new clinical trials must be submitted to the FDA and the FDA, an IRB or we may, at any time, impose a clinical hold on ongoing clinical trials.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials.", "<tag2>", "In", "addition,", "protocols", "for", "new", "clinical", "trials", "must", "be", "submitted", "to", "the", "FDA", "and", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials.", "<tag3>"], "wordsA": ["In", "addition,", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials."], "wordsB": ["In", "addition,", "protocols", "for", "new", "clinical", "trials", "must", "be", "submitted", "to", "the", "FDA", "and", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p76_s6", "idA": "1175680_16_item1_p50_s4", "sentA": "If the FDA imposes a clinical hold, clinical trials cannot commence or recommence without FDA authorization and then only under terms authorized by the FDA.", "sentB": "GMP material will be produced, as needed, to support clinical trials for all therapeutic indications and until commercial product is approved by the FDA.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "imposes", "a", "clinical", "hold,", "clinical", "trials", "cannot", "commence", "or", "recommence", "without", "FDA", "authorization", "and", "then", "only", "under", "terms", "authorized", "by", "the", "FDA.", "<tag2>", "GMP", "material", "will", "be", "produced,", "as", "needed,", "to", "support", "clinical", "trials", "for", "all", "therapeutic", "indications", "and", "until", "commercial", "product", "is", "approved", "by", "the", "FDA.", "<tag3>"], "wordsA": ["If", "the", "FDA", "imposes", "a", "clinical", "hold,", "clinical", "trials", "cannot", "commence", "or", "recommence", "without", "FDA", "authorization", "and", "then", "only", "under", "terms", "authorized", "by", "the", "FDA."], "wordsB": ["GMP", "material", "will", "be", "produced,", "as", "needed,", "to", "support", "clinical", "trials", "for", "all", "therapeutic", "indications", "and", "until", "commercial", "product", "is", "approved", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p57_s0", "idA": "1175680_16_item1_p51_s1", "sentA": "In complying with cGMPs, we must expend time, money and effort in the areas of training, production and quality control within our own organization and at our contract manufacturing laboratories.", "sentB": "effort in the areas of training, production and quality control within our own organization and at any contract manufacturing facilities that we use.", "type": 2, "words": ["<tag1>", "In", "complying", "with", "cGMPs,", "we", "must", "expend", "time,", "money", "and", "effort", "in", "the", "areas", "of", "training,", "production", "and", "quality", "control", "within", "our", "own", "organization", "and", "at", "our", "contract", "manufacturing", "laboratories.", "<tag2>", "effort", "in", "the", "areas", "of", "training,", "production", "and", "quality", "control", "within", "our", "own", "organization", "and", "at", "any", "contract", "manufacturing", "facilities", "that", "we", "use.", "<tag3>"], "wordsA": ["In", "complying", "with", "cGMPs,", "we", "must", "expend", "time,", "money", "and", "effort", "in", "the", "areas", "of", "training,", "production", "and", "quality", "control", "within", "our", "own", "organization", "and", "at", "our", "contract", "manufacturing", "laboratories."], "wordsB": ["effort", "in", "the", "areas", "of", "training,", "production", "and", "quality", "control", "within", "our", "own", "organization", "and", "at", "any", "contract", "manufacturing", "facilities", "that", "we", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p34_s1", "idA": "1175680_16_item1_p51_s3", "sentA": "Following approval of the NDA or BLA, we and our third-party manufacturers remain subject to periodic inspections by the FDA.", "sentB": "We have submitted additional data from specific animal studies as requested by the FDA.", "type": 2, "words": ["<tag1>", "Following", "approval", "of", "the", "NDA", "or", "BLA,", "we", "and", "our", "third-party", "manufacturers", "remain", "subject", "to", "periodic", "inspections", "by", "the", "FDA.", "<tag2>", "We", "have", "submitted", "additional", "data", "from", "specific", "animal", "studies", "as", "requested", "by", "the", "FDA.", "<tag3>"], "wordsA": ["Following", "approval", "of", "the", "NDA", "or", "BLA,", "we", "and", "our", "third-party", "manufacturers", "remain", "subject", "to", "periodic", "inspections", "by", "the", "FDA."], "wordsB": ["We", "have", "submitted", "additional", "data", "from", "specific", "animal", "studies", "as", "requested", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p57_s3", "idA": "1175680_16_item1_p51_s4", "sentA": "We also face similar inspections coordinated by the EMEA by inspectors from particular E.U. member countries that conduct inspections on behalf of the European Union and from other foreign regulatory authorities.", "sentB": "We also may face similar inspections coordinated by the EMEA, by inspectors from particular E.U. member countries that conduct inspections on behalf of the European Union and from other foreign regulatory authorities.", "type": 2, "words": ["<tag1>", "We", "also", "face", "similar", "inspections", "coordinated", "by", "the", "EMEA", "by", "inspectors", "from", "particular", "E.U.", "member", "countries", "that", "conduct", "inspections", "on", "behalf", "of", "the", "European", "Union", "and", "from", "other", "foreign", "regulatory", "authorities.", "<tag2>", "We", "also", "may", "face", "similar", "inspections", "coordinated", "by", "the", "EMEA,", "by", "inspectors", "from", "particular", "E.U.", "member", "countries", "that", "conduct", "inspections", "on", "behalf", "of", "the", "European", "Union", "and", "from", "other", "foreign", "regulatory", "authorities.", "<tag3>"], "wordsA": ["We", "also", "face", "similar", "inspections", "coordinated", "by", "the", "EMEA", "by", "inspectors", "from", "particular", "E.U.", "member", "countries", "that", "conduct", "inspections", "on", "behalf", "of", "the", "European", "Union", "and", "from", "other", "foreign", "regulatory", "authorities."], "wordsB": ["We", "also", "may", "face", "similar", "inspections", "coordinated", "by", "the", "EMEA,", "by", "inspectors", "from", "particular", "E.U.", "member", "countries", "that", "conduct", "inspections", "on", "behalf", "of", "the", "European", "Union", "and", "from", "other", "foreign", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p60_s5", "idA": "1175680_16_item1_p55_s0", "sentA": "Once an NDA or BLA is approved, a product will be subject to certain post-approval requirements, including requirements for adverse event reporting and submission of periodic reports to the FDA, recordkeeping, product sampling and distribution, and, as discussed above, may be subject to mandatory post-market study and REMS requirements.", "sentB": "Once a BLA is approved, a product will be subject to certain post-approval requirements, including requirements for adverse event reporting and submission of periodic reports to the FDA, recordkeeping, product sampling and distribution, and, as discussed above, may be subject to mandatory post-market study and REMS requirements.", "type": 2, "words": ["<tag1>", "Once", "an", "NDA", "or", "BLA", "is", "approved,", "a", "product", "will", "be", "subject", "to", "certain", "post-approval", "requirements,", "including", "requirements", "for", "adverse", "event", "reporting", "and", "submission", "of", "periodic", "reports", "to", "the", "FDA,", "recordkeeping,", "product", "sampling", "and", "distribution,", "and,", "as", "discussed", "above,", "may", "be", "subject", "to", "mandatory", "post-market", "study", "and", "REMS", "requirements.", "<tag2>", "Once", "a", "BLA", "is", "approved,", "a", "product", "will", "be", "subject", "to", "certain", "post-approval", "requirements,", "including", "requirements", "for", "adverse", "event", "reporting", "and", "submission", "of", "periodic", "reports", "to", "the", "FDA,", "recordkeeping,", "product", "sampling", "and", "distribution,", "and,", "as", "discussed", "above,", "may", "be", "subject", "to", "mandatory", "post-market", "study", "and", "REMS", "requirements.", "<tag3>"], "wordsA": ["Once", "an", "NDA", "or", "BLA", "is", "approved,", "a", "product", "will", "be", "subject", "to", "certain", "post-approval", "requirements,", "including", "requirements", "for", "adverse", "event", "reporting", "and", "submission", "of", "periodic", "reports", "to", "the", "FDA,", "recordkeeping,", "product", "sampling", "and", "distribution,", "and,", "as", "discussed", "above,", "may", "be", "subject", "to", "mandatory", "post-market", "study", "and", "REMS", "requirements."], "wordsB": ["Once", "a", "BLA", "is", "approved,", "a", "product", "will", "be", "subject", "to", "certain", "post-approval", "requirements,", "including", "requirements", "for", "adverse", "event", "reporting", "and", "submission", "of", "periodic", "reports", "to", "the", "FDA,", "recordkeeping,", "product", "sampling", "and", "distribution,", "and,", "as", "discussed", "above,", "may", "be", "subject", "to", "mandatory", "post-market", "study", "and", "REMS", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p61_s0", "idA": "1175680_16_item1_p55_s3", "sentA": "The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.", "sentB": "The U.S. Department of Justice, or DOJ, the Office of the Inspector General of the Department of Health and Human Services, or OIG, the FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.", "type": 2, "words": ["<tag1>", "The", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability.", "<tag2>", "The", "U.S.", "Department", "of", "Justice,", "or", "DOJ,", "the", "Office", "of", "the", "Inspector", "General", "of", "the", "Department", "of", "Health", "and", "Human", "Services,", "or", "OIG,", "the", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability.", "<tag3>"], "wordsA": ["The", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability."], "wordsB": ["The", "U.S.", "Department", "of", "Justice,", "or", "DOJ,", "the", "Office", "of", "the", "Inspector", "General", "of", "the", "Department", "of", "Health", "and", "Human", "Services,", "or", "OIG,", "the", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p3_s1", "idA": "1175680_16_item1_p5_s1", "sentA": "PRO 140 blocks HIV from entering a cell by binding to a molecule called the C-C chemokine receptor type 5 ( CCR5 ), a normal cell surface co-receptor protein to which certain strains of HIV, referred to as R5 strains, attach as part of HIV s entry into a cell.", "sentB": "PRO 140 blocks HIV from entering a cell by binding to a molecule called the C-C chemokine receptor type 5 ( CCR5 ), a normal cell surface receptor protein to which certain strains of HIV, referred to as R5 strains, attach as part of HIV s entry into a cell.", "type": 2, "words": ["<tag1>", "PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "the", "C-C", "chemokine", "receptor", "type", "5", "(", "CCR5", "),", "a", "normal", "cell", "surface", "co-receptor", "protein", "to", "which", "certain", "strains", "of", "HIV,", "referred", "to", "as", "R5", "strains,", "attach", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell.", "<tag2>", "PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "the", "C-C", "chemokine", "receptor", "type", "5", "(", "CCR5", "),", "a", "normal", "cell", "surface", "receptor", "protein", "to", "which", "certain", "strains", "of", "HIV,", "referred", "to", "as", "R5", "strains,", "attach", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell.", "<tag3>"], "wordsA": ["PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "the", "C-C", "chemokine", "receptor", "type", "5", "(", "CCR5", "),", "a", "normal", "cell", "surface", "co-receptor", "protein", "to", "which", "certain", "strains", "of", "HIV,", "referred", "to", "as", "R5", "strains,", "attach", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell."], "wordsB": ["PRO", "140", "blocks", "HIV", "from", "entering", "a", "cell", "by", "binding", "to", "a", "molecule", "called", "the", "C-C", "chemokine", "receptor", "type", "5", "(", "CCR5", "),", "a", "normal", "cell", "surface", "receptor", "protein", "to", "which", "certain", "strains", "of", "HIV,", "referred", "to", "as", "R5", "strains,", "attach", "as", "part", "of", "HIV", "s", "entry", "into", "a", "cell."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p64_s0", "idA": "1175680_16_item1_p60_s0", "sentA": "We are subject to a variety of federal, state and local environmental protection measures.", "sentB": "Environmental We are subject to a variety of federal, state and local environmental protection measures.", "type": 2, "words": ["<tag1>", "We", "are", "subject", "to", "a", "variety", "of", "federal,", "state", "and", "local", "environmental", "protection", "measures.", "<tag2>", "Environmental", "We", "are", "subject", "to", "a", "variety", "of", "federal,", "state", "and", "local", "environmental", "protection", "measures.", "<tag3>"], "wordsA": ["We", "are", "subject", "to", "a", "variety", "of", "federal,", "state", "and", "local", "environmental", "protection", "measures."], "wordsB": ["Environmental", "We", "are", "subject", "to", "a", "variety", "of", "federal,", "state", "and", "local", "environmental", "protection", "measures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p65_s1", "idA": "1175680_16_item1_p62_s0", "sentA": "Our current business strategy is to focus primarily on our PRO 140 Phase 3 trials, seeking additional indications in trials that we will sponsor and fund (subject to the availability of sufficient capital to pursue additional paths to approval), to manage our Phase 2 trial for GvHD and to continue to evaluate and leverage the clinical data from our recently completed Phase 2b treatment substitution trial.", "sentB": "Our current business strategy is to focus primarily on our PRO 140 Phase 2b/3 pivotal and investigative trials, to manage our Phase 2 trial for GvHD and to continue to explore other immunologic indications for PRO 140, as described above.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "is", "to", "focus", "primarily", "on", "our", "PRO", "140", "Phase", "3", "trials,", "seeking", "additional", "indications", "in", "trials", "that", "we", "will", "sponsor", "and", "fund", "(subject", "to", "the", "availability", "of", "sufficient", "capital", "to", "pursue", "additional", "paths", "to", "approval),", "to", "manage", "our", "Phase", "2", "trial", "for", "GvHD", "and", "to", "continue", "to", "evaluate", "and", "leverage", "the", "clinical", "data", "from", "our", "recently", "completed", "Phase", "2b", "treatment", "substitution", "trial.", "<tag2>", "Our", "current", "business", "strategy", "is", "to", "focus", "primarily", "on", "our", "PRO", "140", "Phase", "2b/3", "pivotal", "and", "investigative", "trials,", "to", "manage", "our", "Phase", "2", "trial", "for", "GvHD", "and", "to", "continue", "to", "explore", "other", "immunologic", "indications", "for", "PRO", "140,", "as", "described", "above.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "is", "to", "focus", "primarily", "on", "our", "PRO", "140", "Phase", "3", "trials,", "seeking", "additional", "indications", "in", "trials", "that", "we", "will", "sponsor", "and", "fund", "(subject", "to", "the", "availability", "of", "sufficient", "capital", "to", "pursue", "additional", "paths", "to", "approval),", "to", "manage", "our", "Phase", "2", "trial", "for", "GvHD", "and", "to", "continue", "to", "evaluate", "and", "leverage", "the", "clinical", "data", "from", "our", "recently", "completed", "Phase", "2b", "treatment", "substitution", "trial."], "wordsB": ["Our", "current", "business", "strategy", "is", "to", "focus", "primarily", "on", "our", "PRO", "140", "Phase", "2b/3", "pivotal", "and", "investigative", "trials,", "to", "manage", "our", "Phase", "2", "trial", "for", "GvHD", "and", "to", "continue", "to", "explore", "other", "immunologic", "indications", "for", "PRO", "140,", "as", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p66_s1", "idA": "1175680_16_item1_p63_s1", "sentA": "These studies are closely monitored and may be conducted in patients, but are usually conducted in a small number of healthy volunteer subjects.", "sentB": "These studies are closely monitored and may be conducted in patients, but are usually conducted in a small number of healthy volunteer patients.", "type": 2, "words": ["<tag1>", "These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "subjects.", "<tag2>", "These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "patients.", "<tag3>"], "wordsA": ["These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "subjects."], "wordsB": ["These", "studies", "are", "closely", "monitored", "and", "may", "be", "conducted", "in", "patients,", "but", "are", "usually", "conducted", "in", "a", "small", "number", "of", "healthy", "volunteer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p67_s0", "idA": "1175680_16_item1_p64_s0", "sentA": "Phase 1 studies of PRO 140 have been conducted and completed by or on behalf of Progenics by Dr. Jacobson and others prior to our acquisition of PRO 140.", "sentB": "Phase 1 studies of PRO 140 have been conducted and completed by or on behalf of Progenics by certain principal investigators prior to our acquisition of PRO 140.", "type": 2, "words": ["<tag1>", "Phase", "1", "studies", "of", "PRO", "140", "have", "been", "conducted", "and", "completed", "by", "or", "on", "behalf", "of", "Progenics", "by", "Dr.", "Jacobson", "and", "others", "prior", "to", "our", "acquisition", "of", "PRO", "140.", "<tag2>", "Phase", "1", "studies", "of", "PRO", "140", "have", "been", "conducted", "and", "completed", "by", "or", "on", "behalf", "of", "Progenics", "by", "certain", "principal", "investigators", "prior", "to", "our", "acquisition", "of", "PRO", "140.", "<tag3>"], "wordsA": ["Phase", "1", "studies", "of", "PRO", "140", "have", "been", "conducted", "and", "completed", "by", "or", "on", "behalf", "of", "Progenics", "by", "Dr.", "Jacobson", "and", "others", "prior", "to", "our", "acquisition", "of", "PRO", "140."], "wordsB": ["Phase", "1", "studies", "of", "PRO", "140", "have", "been", "conducted", "and", "completed", "by", "or", "on", "behalf", "of", "Progenics", "by", "certain", "principal", "investigators", "prior", "to", "our", "acquisition", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p68_s4", "idA": "1175680_16_item1_p65_s4", "sentA": "We are required to pay significant fees to third parties upon the first patient dosing in a Phase 3 trial of PRO 140.", "sentB": "We were required to pay significant fees to third parties upon the first patient dosing in a Phase 3 trial of PRO 140, and we may be required to make additional fee payments to third parties upon the completion of additional milestones.", "type": 2, "words": ["<tag1>", "We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140.", "<tag2>", "We", "were", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140,", "and", "we", "may", "be", "required", "to", "make", "additional", "fee", "payments", "to", "third", "parties", "upon", "the", "completion", "of", "additional", "milestones.", "<tag3>"], "wordsA": ["We", "are", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140."], "wordsB": ["We", "were", "required", "to", "pay", "significant", "fees", "to", "third", "parties", "upon", "the", "first", "patient", "dosing", "in", "a", "Phase", "3", "trial", "of", "PRO", "140,", "and", "we", "may", "be", "required", "to", "make", "additional", "fee", "payments", "to", "third", "parties", "upon", "the", "completion", "of", "additional", "milestones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p71_s0", "idA": "1175680_16_item1_p68_s0", "sentA": "Maraviroc like all other HIV approved drugs must be taken daily and are believed to have significant side effects.", "sentB": "Maraviroc, like all other HIV approved drugs, must be taken daily and are believed to have significant side effects.", "type": 2, "words": ["<tag1>", "Maraviroc", "like", "all", "other", "HIV", "approved", "drugs", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects.", "<tag2>", "Maraviroc,", "like", "all", "other", "HIV", "approved", "drugs,", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects.", "<tag3>"], "wordsA": ["Maraviroc", "like", "all", "other", "HIV", "approved", "drugs", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects."], "wordsB": ["Maraviroc,", "like", "all", "other", "HIV", "approved", "drugs,", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p72_s4", "idA": "1175680_16_item1_p69_s4", "sentA": "Upon approval, we believe that PRO 140 will be the only approved drug outside of the main four classes of drugs approved for HIV since 2007.", "sentB": "If approved, we believe that PRO 140 will be the only approved drug outside of the main four classes of drugs approved for HIV since 2007.", "type": 2, "words": ["<tag1>", "Upon", "approval,", "we", "believe", "that", "PRO", "140", "will", "be", "the", "only", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007.", "<tag2>", "If", "approved,", "we", "believe", "that", "PRO", "140", "will", "be", "the", "only", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007.", "<tag3>"], "wordsA": ["Upon", "approval,", "we", "believe", "that", "PRO", "140", "will", "be", "the", "only", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007."], "wordsB": ["If", "approved,", "we", "believe", "that", "PRO", "140", "will", "be", "the", "only", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p3_s2", "idA": "1175680_16_item1_p6_s1", "sentA": "Moreover, these trials suggest that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "sentB": "PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggest", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag2>", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggest", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "wordsB": ["PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p40_s0", "idA": "1175680_16_item1_p6_s1", "sentA": "Moreover, these trials suggest that PRO 140 does not affect the normal function of the CCR5 co-receptor for HIV.", "sentB": "Prior studies have demonstrated that PRO 140 does not cause direct activation of T-cells.", "type": 2, "words": ["<tag1>", "Moreover,", "these", "trials", "suggest", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV.", "<tag2>", "Prior", "studies", "have", "demonstrated", "that", "PRO", "140", "does", "not", "cause", "direct", "activation", "of", "T-cells.", "<tag3>"], "wordsA": ["Moreover,", "these", "trials", "suggest", "that", "PRO", "140", "does", "not", "affect", "the", "normal", "function", "of", "the", "CCR5", "co-receptor", "for", "HIV."], "wordsB": ["Prior", "studies", "have", "demonstrated", "that", "PRO", "140", "does", "not", "cause", "direct", "activation", "of", "T-cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p76_s7", "idA": "1175680_16_item1_p72_s1", "sentA": "We expect to depend on third-party suppliers and manufacturing organizations for all of our clinical trial quantities of PRO 140, in addition to previously manufactured supplies of PRO 140.", "sentB": "We will rely on CMO s for all of our developmental and commercial needs.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "depend", "on", "third-party", "suppliers", "and", "manufacturing", "organizations", "for", "all", "of", "our", "clinical", "trial", "quantities", "of", "PRO", "140,", "in", "addition", "to", "previously", "manufactured", "supplies", "of", "PRO", "140.", "<tag2>", "We", "will", "rely", "on", "CMO", "s", "for", "all", "of", "our", "developmental", "and", "commercial", "needs.", "<tag3>"], "wordsA": ["We", "expect", "to", "depend", "on", "third-party", "suppliers", "and", "manufacturing", "organizations", "for", "all", "of", "our", "clinical", "trial", "quantities", "of", "PRO", "140,", "in", "addition", "to", "previously", "manufactured", "supplies", "of", "PRO", "140."], "wordsB": ["We", "will", "rely", "on", "CMO", "s", "for", "all", "of", "our", "developmental", "and", "commercial", "needs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p40_s1", "idA": "1175680_16_item1_p72_s6", "sentA": "This process has been completed and all PRO 140 drug substance can be used in our clinical trials.", "sentB": "We have already reported encouraging human safety data for our clinical trials with PRO 140 in HIV-infected patients.", "type": 2, "words": ["<tag1>", "This", "process", "has", "been", "completed", "and", "all", "PRO", "140", "drug", "substance", "can", "be", "used", "in", "our", "clinical", "trials.", "<tag2>", "We", "have", "already", "reported", "encouraging", "human", "safety", "data", "for", "our", "clinical", "trials", "with", "PRO", "140", "in", "HIV-infected", "patients.", "<tag3>"], "wordsA": ["This", "process", "has", "been", "completed", "and", "all", "PRO", "140", "drug", "substance", "can", "be", "used", "in", "our", "clinical", "trials."], "wordsB": ["We", "have", "already", "reported", "encouraging", "human", "safety", "data", "for", "our", "clinical", "trials", "with", "PRO", "140", "in", "HIV-infected", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p76_s8", "idA": "1175680_16_item1_p73_s0", "sentA": "Research and Development Costs Our research and development expenses totaled approximately $13.7 million and $15.2 million for the fiscal years ended May 31, 2016 and May 31, 2015, respectively.", "sentB": "Research and Development Costs Our research and development expenses totaled approximately $20.2 million and $13.7 million for the fiscal years ended May 31, 2017 and May 31, 2016, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$13.7", "million", "and", "$15.2", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2016", "and", "May", "31,", "2015,", "respectively.", "<tag2>", "Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$20.2", "million", "and", "$13.7", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2017", "and", "May", "31,", "2016,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$13.7", "million", "and", "$15.2", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2016", "and", "May", "31,", "2015,", "respectively."], "wordsB": ["Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$20.2", "million", "and", "$13.7", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2017", "and", "May", "31,", "2016,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p76_s9", "idA": "1175680_16_item1_p73_s1", "sentA": "We expect the Company s research and development expenses to continue to increase in future periods as the activity within the Company s clinical trials expands and the Company s biologics manufacturing processes and related regulatory compliance activities increase.", "sentB": "We expect our research and development expenses to continue to increase in future periods as the activity within our clinical trials expands and our biologics manufacturing processes and related regulatory compliance activities increase.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "Company", "s", "research", "and", "development", "expenses", "to", "continue", "to", "increase", "in", "future", "periods", "as", "the", "activity", "within", "the", "Company", "s", "clinical", "trials", "expands", "and", "the", "Company", "s", "biologics", "manufacturing", "processes", "and", "related", "regulatory", "compliance", "activities", "increase.", "<tag2>", "We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "increase", "in", "future", "periods", "as", "the", "activity", "within", "our", "clinical", "trials", "expands", "and", "our", "biologics", "manufacturing", "processes", "and", "related", "regulatory", "compliance", "activities", "increase.", "<tag3>"], "wordsA": ["We", "expect", "the", "Company", "s", "research", "and", "development", "expenses", "to", "continue", "to", "increase", "in", "future", "periods", "as", "the", "activity", "within", "the", "Company", "s", "clinical", "trials", "expands", "and", "the", "Company", "s", "biologics", "manufacturing", "processes", "and", "related", "regulatory", "compliance", "activities", "increase."], "wordsB": ["We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "increase", "in", "future", "periods", "as", "the", "activity", "within", "our", "clinical", "trials", "expands", "and", "our", "biologics", "manufacturing", "processes", "and", "related", "regulatory", "compliance", "activities", "increase."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p76_s10", "idA": "1175680_16_item1_p74_s0", "sentA": "Employees and Consultants We have five full-time employees, our CEO, CFO, Senior Vice President of Manufacturing, Associate Director Process Sciences and Director of Accounting, as well as several independent consultants assisting us with our clinical trials of PRO 140 and manufacturing activities.", "sentB": "Employees and Consultants We have six full-time employees, as well as several independent consultants assisting us with our clinical trials of PRO 140 and manufacturing activities.", "type": 2, "words": ["<tag1>", "Employees", "and", "Consultants", "We", "have", "five", "full-time", "employees,", "our", "CEO,", "CFO,", "Senior", "Vice", "President", "of", "Manufacturing,", "Associate", "Director", "Process", "Sciences", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities.", "<tag2>", "Employees", "and", "Consultants", "We", "have", "six", "full-time", "employees,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities.", "<tag3>"], "wordsA": ["Employees", "and", "Consultants", "We", "have", "five", "full-time", "employees,", "our", "CEO,", "CFO,", "Senior", "Vice", "President", "of", "Manufacturing,", "Associate", "Director", "Process", "Sciences", "and", "Director", "of", "Accounting,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities."], "wordsB": ["Employees", "and", "Consultants", "We", "have", "six", "full-time", "employees,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_17_item1_p4_s2", "idA": "1175680_16_item1_p8_s0", "sentA": "We believe PRO 140 is uniquely positioned to address a growing HIV market as an alternative or in addition to current therapies, which are failing primarily due to drug resistance.", "sentB": "We believe PRO 140 is uniquely positioned to address a growing HIV market, as an alternative, or in addition to current therapies, which are failing primarily due to compliance, which causes drug resistance.", "type": 2, "words": ["<tag1>", "We", "believe", "PRO", "140", "is", "uniquely", "positioned", "to", "address", "a", "growing", "HIV", "market", "as", "an", "alternative", "or", "in", "addition", "to", "current", "therapies,", "which", "are", "failing", "primarily", "due", "to", "drug", "resistance.", "<tag2>", "We", "believe", "PRO", "140", "is", "uniquely", "positioned", "to", "address", "a", "growing", "HIV", "market,", "as", "an", "alternative,", "or", "in", "addition", "to", "current", "therapies,", "which", "are", "failing", "primarily", "due", "to", "compliance,", "which", "causes", "drug", "resistance.", "<tag3>"], "wordsA": ["We", "believe", "PRO", "140", "is", "uniquely", "positioned", "to", "address", "a", "growing", "HIV", "market", "as", "an", "alternative", "or", "in", "addition", "to", "current", "therapies,", "which", "are", "failing", "primarily", "due", "to", "drug", "resistance."], "wordsB": ["We", "believe", "PRO", "140", "is", "uniquely", "positioned", "to", "address", "a", "growing", "HIV", "market,", "as", "an", "alternative,", "or", "in", "addition", "to", "current", "therapies,", "which", "are", "failing", "primarily", "due", "to", "compliance,", "which", "causes", "drug", "resistance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p0_s8", "idA": "1175680_17_item1_p0_s4", "sentA": "We do not intend to incorporate any contents from our website into this annual report.", "sentB": "Information on the operation of the Public Reference Room can be obtained by calling the SEC at 1-800-SEC-0330.We do not intend to incorporate any contents from our website into this annual report.", "type": 2, "words": ["<tag1>", "We", "do", "not", "intend", "to", "incorporate", "any", "contents", "from", "our", "website", "into", "this", "annual", "report.", "<tag2>", "Information", "on", "the", "operation", "of", "the", "Public", "Reference", "Room", "can", "be", "obtained", "by", "calling", "the", "SEC", "at", "1-800-SEC-0330.We", "do", "not", "intend", "to", "incorporate", "any", "contents", "from", "our", "website", "into", "this", "annual", "report.", "<tag3>"], "wordsA": ["We", "do", "not", "intend", "to", "incorporate", "any", "contents", "from", "our", "website", "into", "this", "annual", "report."], "wordsB": ["Information", "on", "the", "operation", "of", "the", "Public", "Reference", "Room", "can", "be", "obtained", "by", "calling", "the", "SEC", "at", "1-800-SEC-0330.We", "do", "not", "intend", "to", "incorporate", "any", "contents", "from", "our", "website", "into", "this", "annual", "report."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p0_s9", "idA": "1175680_17_item1_p0_s5", "sentA": "Unless the context otherwise requires, references to CytoDyn, the Company, we, our, or us are to CytoDyn Inc. and its subsidiaries.", "sentB": "Unless the context otherwise requires, references in this prospectus to CytoDyn, the Company, we, our, or us are to CytoDyn Inc. and its subsidiaries.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "otherwise", "requires,", "references", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries.", "<tag2>", "Unless", "the", "context", "otherwise", "requires,", "references", "in", "this", "prospectus", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries.", "<tag3>"], "wordsA": ["Unless", "the", "context", "otherwise", "requires,", "references", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries."], "wordsB": ["Unless", "the", "context", "otherwise", "requires,", "references", "in", "this", "prospectus", "to", "CytoDyn,", "the", "Company,", "we,", "our,", "or", "us", "are", "to", "CytoDyn", "Inc.", "and", "its", "subsidiaries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p17_s1", "idA": "1175680_17_item1_p10_s1", "sentA": "Several patients are continuing in extension studies of this monotherapy trial by taking a weekly injection of PRO 140.", "sentB": "These patients are continuing in extension studies of this monotherapy trial by self-administering a weekly injection of PRO 140.", "type": 2, "words": ["<tag1>", "Several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "trial", "by", "taking", "a", "weekly", "injection", "of", "PRO", "140.", "<tag2>", "These", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "trial", "by", "self-administering", "a", "weekly", "injection", "of", "PRO", "140.", "<tag3>"], "wordsA": ["Several", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "trial", "by", "taking", "a", "weekly", "injection", "of", "PRO", "140."], "wordsB": ["These", "patients", "are", "continuing", "in", "extension", "studies", "of", "this", "monotherapy", "trial", "by", "self-administering", "a", "weekly", "injection", "of", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p12_s1", "idA": "1175680_17_item1_p10_s2", "sentA": "Results from these extension studies thus far indicate that eight of the nine patients in this study have surpassed two and one-half years of suppressed viral load through a successful monotherapy of PRO 140 and are approaching three years of suppressed viral load with a monotherapy.", "sentB": "There are a total of six patients in this extension study and each has surpassed three and one-half years of suppressed viral load with PRO 140 as a single agent therapy.", "type": 2, "words": ["<tag1>", "Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "that", "eight", "of", "the", "nine", "patients", "in", "this", "study", "have", "surpassed", "two", "and", "one-half", "years", "of", "suppressed", "viral", "load", "through", "a", "successful", "monotherapy", "of", "PRO", "140", "and", "are", "approaching", "three", "years", "of", "suppressed", "viral", "load", "with", "a", "monotherapy.", "<tag2>", "There", "are", "a", "total", "of", "six", "patients", "in", "this", "extension", "study", "and", "each", "has", "surpassed", "three", "and", "one-half", "years", "of", "suppressed", "viral", "load", "with", "PRO", "140", "as", "a", "single", "agent", "therapy.", "<tag3>"], "wordsA": ["Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "that", "eight", "of", "the", "nine", "patients", "in", "this", "study", "have", "surpassed", "two", "and", "one-half", "years", "of", "suppressed", "viral", "load", "through", "a", "successful", "monotherapy", "of", "PRO", "140", "and", "are", "approaching", "three", "years", "of", "suppressed", "viral", "load", "with", "a", "monotherapy."], "wordsB": ["There", "are", "a", "total", "of", "six", "patients", "in", "this", "extension", "study", "and", "each", "has", "surpassed", "three", "and", "one-half", "years", "of", "suppressed", "viral", "load", "with", "PRO", "140", "as", "a", "single", "agent", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p17_s0", "idA": "1175680_17_item1_p10_s2", "sentA": "Results from these extension studies thus far indicate that eight of the nine patients in this study have surpassed two and one-half years of suppressed viral load through a successful monotherapy of PRO 140 and are approaching three years of suppressed viral load with a monotherapy.", "sentB": "Phase 2b Extension Study for HIV, as Monotherapy Currently, there are a total of six patients in this ongoing extension study and each has surpassed three and one-half years of suppressed viral load with PRO 140 as a single agent therapy.", "type": 2, "words": ["<tag1>", "Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "that", "eight", "of", "the", "nine", "patients", "in", "this", "study", "have", "surpassed", "two", "and", "one-half", "years", "of", "suppressed", "viral", "load", "through", "a", "successful", "monotherapy", "of", "PRO", "140", "and", "are", "approaching", "three", "years", "of", "suppressed", "viral", "load", "with", "a", "monotherapy.", "<tag2>", "Phase", "2b", "Extension", "Study", "for", "HIV,", "as", "Monotherapy", "Currently,", "there", "are", "a", "total", "of", "six", "patients", "in", "this", "ongoing", "extension", "study", "and", "each", "has", "surpassed", "three", "and", "one-half", "years", "of", "suppressed", "viral", "load", "with", "PRO", "140", "as", "a", "single", "agent", "therapy.", "<tag3>"], "wordsA": ["Results", "from", "these", "extension", "studies", "thus", "far", "indicate", "that", "eight", "of", "the", "nine", "patients", "in", "this", "study", "have", "surpassed", "two", "and", "one-half", "years", "of", "suppressed", "viral", "load", "through", "a", "successful", "monotherapy", "of", "PRO", "140", "and", "are", "approaching", "three", "years", "of", "suppressed", "viral", "load", "with", "a", "monotherapy."], "wordsB": ["Phase", "2b", "Extension", "Study", "for", "HIV,", "as", "Monotherapy", "Currently,", "there", "are", "a", "total", "of", "six", "patients", "in", "this", "ongoing", "extension", "study", "and", "each", "has", "surpassed", "three", "and", "one-half", "years", "of", "suppressed", "viral", "load", "with", "PRO", "140", "as", "a", "single", "agent", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p17_s2", "idA": "1175680_17_item1_p11_s0", "sentA": "Our second ongoing clinical trial is a pivotal Phase 2b/3 trial for PRO 140 as a combination therapy with existing HAART drug regimens.", "sentB": "This is a pivotal 25-week trial for PRO 140 as a combination therapy to existing HAART drug regimens.", "type": 2, "words": ["<tag1>", "Our", "second", "ongoing", "clinical", "trial", "is", "a", "pivotal", "Phase", "2b/3", "trial", "for", "PRO", "140", "as", "a", "combination", "therapy", "with", "existing", "HAART", "drug", "regimens.", "<tag2>", "This", "is", "a", "pivotal", "25-week", "trial", "for", "PRO", "140", "as", "a", "combination", "therapy", "to", "existing", "HAART", "drug", "regimens.", "<tag3>"], "wordsA": ["Our", "second", "ongoing", "clinical", "trial", "is", "a", "pivotal", "Phase", "2b/3", "trial", "for", "PRO", "140", "as", "a", "combination", "therapy", "with", "existing", "HAART", "drug", "regimens."], "wordsB": ["This", "is", "a", "pivotal", "25-week", "trial", "for", "PRO", "140", "as", "a", "combination", "therapy", "to", "existing", "HAART", "drug", "regimens."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p13_s3", "idA": "1175680_17_item1_p12_s0", "sentA": "The primary endpoint for efficacy is defined as the amount of viral load drop after one week of therapy with PRO 140 in combination with the patient s failing HAART regimen.", "sentB": "The primary endpoint for efficacy was defined as 0.5log of viral load drop after one week of therapy with PRO 140 in combination with the patient s failing HAART regimen.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "efficacy", "is", "defined", "as", "the", "amount", "of", "viral", "load", "drop", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen.", "<tag2>", "The", "primary", "endpoint", "for", "efficacy", "was", "defined", "as", "0.5log", "of", "viral", "load", "drop", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "efficacy", "is", "defined", "as", "the", "amount", "of", "viral", "load", "drop", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen."], "wordsB": ["The", "primary", "endpoint", "for", "efficacy", "was", "defined", "as", "0.5log", "of", "viral", "load", "drop", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p17_s5", "idA": "1175680_17_item1_p12_s0", "sentA": "The primary endpoint for efficacy is defined as the amount of viral load drop after one week of therapy with PRO 140 in combination with the patient s failing HAART regimen.", "sentB": "The primary endpoint for efficacy was defined as 0.5log reduction in viral load after one week of therapy with PRO 140 in combination with the patient s failing HAART regimen.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "efficacy", "is", "defined", "as", "the", "amount", "of", "viral", "load", "drop", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen.", "<tag2>", "The", "primary", "endpoint", "for", "efficacy", "was", "defined", "as", "0.5log", "reduction", "in", "viral", "load", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "efficacy", "is", "defined", "as", "the", "amount", "of", "viral", "load", "drop", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen."], "wordsB": ["The", "primary", "endpoint", "for", "efficacy", "was", "defined", "as", "0.5log", "reduction", "in", "viral", "load", "after", "one", "week", "of", "therapy", "with", "PRO", "140", "in", "combination", "with", "the", "patient", "s", "failing", "HAART", "regimen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p17_s7", "idA": "1175680_17_item1_p12_s2", "sentA": "The first patients to have successfully completed this trial have transitioned into a FDA-cleared rollover study, in order to provide continued access to PRO 140 therapy, at the request of their treating physician.", "sentB": "Nearly all patients have successfully completed this trial and most of the patients have transitioned into a FDA-cleared rollover study, in order to provide continued access to PRO 140 therapy, at the request of their treating physician.", "type": 2, "words": ["<tag1>", "The", "first", "patients", "to", "have", "successfully", "completed", "this", "trial", "have", "transitioned", "into", "a", "FDA-cleared", "rollover", "study,", "in", "order", "to", "provide", "continued", "access", "to", "PRO", "140", "therapy,", "at", "the", "request", "of", "their", "treating", "physician.", "<tag2>", "Nearly", "all", "patients", "have", "successfully", "completed", "this", "trial", "and", "most", "of", "the", "patients", "have", "transitioned", "into", "a", "FDA-cleared", "rollover", "study,", "in", "order", "to", "provide", "continued", "access", "to", "PRO", "140", "therapy,", "at", "the", "request", "of", "their", "treating", "physician.", "<tag3>"], "wordsA": ["The", "first", "patients", "to", "have", "successfully", "completed", "this", "trial", "have", "transitioned", "into", "a", "FDA-cleared", "rollover", "study,", "in", "order", "to", "provide", "continued", "access", "to", "PRO", "140", "therapy,", "at", "the", "request", "of", "their", "treating", "physician."], "wordsB": ["Nearly", "all", "patients", "have", "successfully", "completed", "this", "trial", "and", "most", "of", "the", "patients", "have", "transitioned", "into", "a", "FDA-cleared", "rollover", "study,", "in", "order", "to", "provide", "continued", "access", "to", "PRO", "140", "therapy,", "at", "the", "request", "of", "their", "treating", "physician."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p19_s4", "idA": "1175680_17_item1_p12_s2", "sentA": "The first patients to have successfully completed this trial have transitioned into a FDA-cleared rollover study, in order to provide continued access to PRO 140 therapy, at the request of their treating physician.", "sentB": "Patients who are completing this trial are transitioning to a roll-over protocol, as requested by the treating physicians to enable the patients to have continued access to PRO 140 as a single-agent, self-injection maintenance therapy.", "type": 2, "words": ["<tag1>", "The", "first", "patients", "to", "have", "successfully", "completed", "this", "trial", "have", "transitioned", "into", "a", "FDA-cleared", "rollover", "study,", "in", "order", "to", "provide", "continued", "access", "to", "PRO", "140", "therapy,", "at", "the", "request", "of", "their", "treating", "physician.", "<tag2>", "Patients", "who", "are", "completing", "this", "trial", "are", "transitioning", "to", "a", "roll-over", "protocol,", "as", "requested", "by", "the", "treating", "physicians", "to", "enable", "the", "patients", "to", "have", "continued", "access", "to", "PRO", "140", "as", "a", "single-agent,", "self-injection", "maintenance", "therapy.", "<tag3>"], "wordsA": ["The", "first", "patients", "to", "have", "successfully", "completed", "this", "trial", "have", "transitioned", "into", "a", "FDA-cleared", "rollover", "study,", "in", "order", "to", "provide", "continued", "access", "to", "PRO", "140", "therapy,", "at", "the", "request", "of", "their", "treating", "physician."], "wordsB": ["Patients", "who", "are", "completing", "this", "trial", "are", "transitioning", "to", "a", "roll-over", "protocol,", "as", "requested", "by", "the", "treating", "physicians", "to", "enable", "the", "patients", "to", "have", "continued", "access", "to", "PRO", "140", "as", "a", "single-agent,", "self-injection", "maintenance", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p15_s0", "idA": "1175680_17_item1_p13_s0", "sentA": "Our third ongoing trial is an investigative Phase 2b/3 trial featuring 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "sentB": "The third ongoing trial is an investigative Phase 2b/3 trial including 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy.", "type": 2, "words": ["<tag1>", "Our", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "featuring", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag2>", "The", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy.", "<tag3>"], "wordsA": ["Our", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "featuring", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "wordsB": ["The", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "including", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p15_s1", "idA": "1175680_17_item1_p13_s0", "sentA": "Our third ongoing trial is an investigative Phase 2b/3 trial featuring 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "sentB": "This is a 48-week trial in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "type": 2, "words": ["<tag1>", "Our", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "featuring", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag2>", "This", "is", "a", "48-week", "trial", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag3>"], "wordsA": ["Our", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "featuring", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "wordsB": ["This", "is", "a", "48-week", "trial", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p19_s0", "idA": "1175680_17_item1_p13_s0", "sentA": "Our third ongoing trial is an investigative Phase 2b/3 trial featuring 300 patients to assess the treatment strategy of using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "sentB": "This is a trial of 300 patients that assesses using PRO 140 subcutaneously as a long-acting single-agent maintenance therapy for 48 weeks in patients with suppressed viral load with CCR5-tropic HIV-1 infection.", "type": 2, "words": ["<tag1>", "Our", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "featuring", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag2>", "This", "is", "a", "trial", "of", "300", "patients", "that", "assesses", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection.", "<tag3>"], "wordsA": ["Our", "third", "ongoing", "trial", "is", "an", "investigative", "Phase", "2b/3", "trial", "featuring", "300", "patients", "to", "assess", "the", "treatment", "strategy", "of", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "wordsB": ["This", "is", "a", "trial", "of", "300", "patients", "that", "assesses", "using", "PRO", "140", "subcutaneously", "as", "a", "long-acting", "single-agent", "maintenance", "therapy", "for", "48", "weeks", "in", "patients", "with", "suppressed", "viral", "load", "with", "CCR5-tropic", "HIV-1", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p19_s1", "idA": "1175680_17_item1_p13_s1", "sentA": "The primary endpoint is to assess the clinical safety of the PRO 140 monotherapy regimen and to evaluate the proportion of participants experiencing suppressed viral load.", "sentB": "The primary endpoint is the proportion of participants with a suppressed viral load to those who experienced virologic failure.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "to", "assess", "the", "clinical", "safety", "of", "the", "PRO", "140", "monotherapy", "regimen", "and", "to", "evaluate", "the", "proportion", "of", "participants", "experiencing", "suppressed", "viral", "load.", "<tag2>", "The", "primary", "endpoint", "is", "the", "proportion", "of", "participants", "with", "a", "suppressed", "viral", "load", "to", "those", "who", "experienced", "virologic", "failure.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "to", "assess", "the", "clinical", "safety", "of", "the", "PRO", "140", "monotherapy", "regimen", "and", "to", "evaluate", "the", "proportion", "of", "participants", "experiencing", "suppressed", "viral", "load."], "wordsB": ["The", "primary", "endpoint", "is", "the", "proportion", "of", "participants", "with", "a", "suppressed", "viral", "load", "to", "those", "who", "experienced", "virologic", "failure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p19_s2", "idA": "1175680_17_item1_p13_s2", "sentA": "The secondary endpoint is the length of time to virologic failure.", "sentB": "The secondary endpoint is length of time to virologic failure.", "type": 2, "words": ["<tag1>", "The", "secondary", "endpoint", "is", "the", "length", "of", "time", "to", "virologic", "failure.", "<tag2>", "The", "secondary", "endpoint", "is", "length", "of", "time", "to", "virologic", "failure.", "<tag3>"], "wordsA": ["The", "secondary", "endpoint", "is", "the", "length", "of", "time", "to", "virologic", "failure."], "wordsB": ["The", "secondary", "endpoint", "is", "length", "of", "time", "to", "virologic", "failure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p16_s0", "idA": "1175680_17_item1_p15_s0", "sentA": "Our fourth ongoing trial of PRO 140 is a Phase 2 study for Graft-versus-Host Disease ( GvHD ) and is the first non-HIV immunologic indication for PRO 140.", "sentB": "Our fourth ongoing trial of PRO 140 is a Phase 2 study for GvHD and is the first non-HIV, immunologic indication for PRO 140.", "type": 2, "words": ["<tag1>", "Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft-versus-Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "immunologic", "indication", "for", "PRO", "140.", "<tag2>", "Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "GvHD", "and", "is", "the", "first", "non-HIV,", "immunologic", "indication", "for", "PRO", "140.", "<tag3>"], "wordsA": ["Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "Graft-versus-Host", "Disease", "(", "GvHD", ")", "and", "is", "the", "first", "non-HIV", "immunologic", "indication", "for", "PRO", "140."], "wordsB": ["Our", "fourth", "ongoing", "trial", "of", "PRO", "140", "is", "a", "Phase", "2", "study", "for", "GvHD", "and", "is", "the", "first", "non-HIV,", "immunologic", "indication", "for", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p16_s1", "idA": "1175680_17_item1_p15_s1", "sentA": "This trial, a randomized, double-blind, placebo-controlled, multi-center 100-day study with 60 patients is designed to evaluate the feasibility of the use of PRO 140 as an add-on therapy to standard GvHD prophylaxis treatment for prevention of acute GvHD in adult patients with acute myeloid leukemia ( AML ) or myelodysplastic syndrome ( MDS ) undergoing allogeneic hematopoietic stem cell transplantation ( HST ).", "sentB": "This trial is designed to evaluate the feasibility of the use of PRO 140 as an add-on therapy to standard GvHD prophylaxis treatment for prevention of acute GvHD in adult patients with acute myeloid leukemia ( AML ) or myelodysplastic syndrome ( MDS ) undergoing allogeneic hematopoietic stem cell transplantation ( HST ).", "type": 2, "words": ["<tag1>", "This", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "100-day", "study", "with", "60", "patients", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ").", "<tag2>", "This", "trial", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ").", "<tag3>"], "wordsA": ["This", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "100-day", "study", "with", "60", "patients", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ")."], "wordsB": ["This", "trial", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p20_s0", "idA": "1175680_17_item1_p15_s1", "sentA": "This trial, a randomized, double-blind, placebo-controlled, multi-center 100-day study with 60 patients is designed to evaluate the feasibility of the use of PRO 140 as an add-on therapy to standard GvHD prophylaxis treatment for prevention of acute GvHD in adult patients with acute myeloid leukemia ( AML ) or myelodysplastic syndrome ( MDS ) undergoing allogeneic hematopoietic stem cell transplantation ( HST ).", "sentB": "Phase 2 Trial for Graft-versus-Host Disease This Phase 2 multi-center 100-day study with 60 patients is designed to evaluate the feasibility of the use of PRO 140 as an add-on therapy to standard GvHD prophylaxis treatment for prevention of acute GvHD in adult patients with acute myeloid leukemia ( AML ) or myelodysplastic syndrome ( MDS ) undergoing allogeneic hematopoietic stem cell transplantation ( HST ).", "type": 2, "words": ["<tag1>", "This", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "100-day", "study", "with", "60", "patients", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ").", "<tag2>", "Phase", "2", "Trial", "for", "Graft-versus-Host", "Disease", "This", "Phase", "2", "multi-center", "100-day", "study", "with", "60", "patients", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ").", "<tag3>"], "wordsA": ["This", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "multi-center", "100-day", "study", "with", "60", "patients", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ")."], "wordsB": ["Phase", "2", "Trial", "for", "Graft-versus-Host", "Disease", "This", "Phase", "2", "multi-center", "100-day", "study", "with", "60", "patients", "is", "designed", "to", "evaluate", "the", "feasibility", "of", "the", "use", "of", "PRO", "140", "as", "an", "add-on", "therapy", "to", "standard", "GvHD", "prophylaxis", "treatment", "for", "prevention", "of", "acute", "GvHD", "in", "adult", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "or", "myelodysplastic", "syndrome", "(", "MDS", ")", "undergoing", "allogeneic", "hematopoietic", "stem", "cell", "transplantation", "(", "HST", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p20_s1", "idA": "1175680_17_item1_p15_s2", "sentA": "Enrollment of the first patient was announced in May 2017.", "sentB": "Enrollment of the first patient was announced in May of 2017.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "was", "announced", "in", "May", "2017.", "<tag2>", "Enrollment", "of", "the", "first", "patient", "was", "announced", "in", "May", "of", "2017.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "was", "announced", "in", "May", "2017."], "wordsB": ["Enrollment", "of", "the", "first", "patient", "was", "announced", "in", "May", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p16_s3", "idA": "1175680_17_item1_p16_s2", "sentA": "An extension study of this trial is currently ongoing, as described in greater detail below.", "sentB": "In March 2018, we announced the completion of a planned interim analysis of trial data on the first 10 patients enrolled, which resulted in certain amendments to the trial protocol described in greater detail below.", "type": 2, "words": ["<tag1>", "An", "extension", "study", "of", "this", "trial", "is", "currently", "ongoing,", "as", "described", "in", "greater", "detail", "below.", "<tag2>", "In", "March", "2018,", "we", "announced", "the", "completion", "of", "a", "planned", "interim", "analysis", "of", "trial", "data", "on", "the", "first", "10", "patients", "enrolled,", "which", "resulted", "in", "certain", "amendments", "to", "the", "trial", "protocol", "described", "in", "greater", "detail", "below.", "<tag3>"], "wordsA": ["An", "extension", "study", "of", "this", "trial", "is", "currently", "ongoing,", "as", "described", "in", "greater", "detail", "below."], "wordsB": ["In", "March", "2018,", "we", "announced", "the", "completion", "of", "a", "planned", "interim", "analysis", "of", "trial", "data", "on", "the", "first", "10", "patients", "enrolled,", "which", "resulted", "in", "certain", "amendments", "to", "the", "trial", "protocol", "described", "in", "greater", "detail", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p1_s0", "idA": "1175680_17_item1_p1_s0", "sentA": "We are a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus ( HIV ) infection.", "sentB": "We are a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies to treat HIV infection.", "type": 2, "words": ["<tag1>", "We", "are", "a", "clinical-stage", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection.", "<tag2>", "We", "are", "a", "clinical-stage", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "HIV", "infection.", "<tag3>"], "wordsA": ["We", "are", "a", "clinical-stage", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection."], "wordsB": ["We", "are", "a", "clinical-stage", "biotechnology", "company", "focused", "on", "the", "clinical", "development", "and", "potential", "commercialization", "of", "humanized", "monoclonal", "antibodies", "to", "treat", "HIV", "infection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p1_s2", "idA": "1175680_17_item1_p1_s2", "sentA": "We believe that monoclonal antibodies are a new emerging class of therapeutics for the treatment of HIV to address unmet medical needs in the area of HIV and other immunologic indications, such as graft-versus-host disease.", "sentB": "We believe that monoclonal antibodies are a new emerging class of therapeutics for the treatment of HIV to address unmet medical needs in the area of HIV and other immunologic indications, such as Graft versus Host Disease ( GvHD ) and certain types of cancer.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "other", "immunologic", "indications,", "such", "as", "graft-versus-host", "disease.", "<tag2>", "We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "other", "immunologic", "indications,", "such", "as", "Graft", "versus", "Host", "Disease", "(", "GvHD", ")", "and", "certain", "types", "of", "cancer.", "<tag3>"], "wordsA": ["We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "other", "immunologic", "indications,", "such", "as", "graft-versus-host", "disease."], "wordsB": ["We", "believe", "that", "monoclonal", "antibodies", "are", "a", "new", "emerging", "class", "of", "therapeutics", "for", "the", "treatment", "of", "HIV", "to", "address", "unmet", "medical", "needs", "in", "the", "area", "of", "HIV", "and", "other", "immunologic", "indications,", "such", "as", "Graft", "versus", "Host", "Disease", "(", "GvHD", ")", "and", "certain", "types", "of", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p20_s2", "idA": "1175680_17_item1_p21_s2", "sentA": "Four patients discontinued the extension protocol for reasons not attributed to PRO 140.", "sentB": "On October 5, 2017, the Company announced that the FDA had granted orphan drug designation to PRO 140 for the prevention of GvHD.", "type": 2, "words": ["<tag1>", "Four", "patients", "discontinued", "the", "extension", "protocol", "for", "reasons", "not", "attributed", "to", "PRO", "140.", "<tag2>", "On", "October", "5,", "2017,", "the", "Company", "announced", "that", "the", "FDA", "had", "granted", "orphan", "drug", "designation", "to", "PRO", "140", "for", "the", "prevention", "of", "GvHD.", "<tag3>"], "wordsA": ["Four", "patients", "discontinued", "the", "extension", "protocol", "for", "reasons", "not", "attributed", "to", "PRO", "140."], "wordsB": ["On", "October", "5,", "2017,", "the", "Company", "announced", "that", "the", "FDA", "had", "granted", "orphan", "drug", "designation", "to", "PRO", "140", "for", "the", "prevention", "of", "GvHD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p14_s0", "idA": "1175680_17_item1_p23_s0", "sentA": "The Phase 2b/3 combination therapy trial is designed to allow PRO 140 as a component of a HAART regimen for treatment experienced patients.", "sentB": "Patients for the safety analysis in a Biologics License Application will be provided by all of our HIV trials, providing that those patients have been on a PRO 140 therapy for 24 weeks, with the same or higher dose as the combination therapy trial.", "type": 2, "words": ["<tag1>", "The", "Phase", "2b/3", "combination", "therapy", "trial", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients.", "<tag2>", "Patients", "for", "the", "safety", "analysis", "in", "a", "Biologics", "License", "Application", "will", "be", "provided", "by", "all", "of", "our", "HIV", "trials,", "providing", "that", "those", "patients", "have", "been", "on", "a", "PRO", "140", "therapy", "for", "24", "weeks,", "with", "the", "same", "or", "higher", "dose", "as", "the", "combination", "therapy", "trial.", "<tag3>"], "wordsA": ["The", "Phase", "2b/3", "combination", "therapy", "trial", "is", "designed", "to", "allow", "PRO", "140", "as", "a", "component", "of", "a", "HAART", "regimen", "for", "treatment", "experienced", "patients."], "wordsB": ["Patients", "for", "the", "safety", "analysis", "in", "a", "Biologics", "License", "Application", "will", "be", "provided", "by", "all", "of", "our", "HIV", "trials,", "providing", "that", "those", "patients", "have", "been", "on", "a", "PRO", "140", "therapy", "for", "24", "weeks,", "with", "the", "same", "or", "higher", "dose", "as", "the", "combination", "therapy", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p18_s0", "idA": "1175680_17_item1_p27_s1", "sentA": "The primary endpoint is the number of patients who can maintain suppressed viral load under a PRO 140 monotherapy replacing their HAART regimen for 48 weeks.", "sentB": "This study is designed for patients who successfully complete the Phase 2b/3 Combination Therapy trial and for whom the treating physicians request a continuation of PRO 140 therapy in order to maintain suppressed viral load.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks.", "<tag2>", "This", "study", "is", "designed", "for", "patients", "who", "successfully", "complete", "the", "Phase", "2b/3", "Combination", "Therapy", "trial", "and", "for", "whom", "the", "treating", "physicians", "request", "a", "continuation", "of", "PRO", "140", "therapy", "in", "order", "to", "maintain", "suppressed", "viral", "load.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "the", "number", "of", "patients", "who", "can", "maintain", "suppressed", "viral", "load", "under", "a", "PRO", "140", "monotherapy", "replacing", "their", "HAART", "regimen", "for", "48", "weeks."], "wordsB": ["This", "study", "is", "designed", "for", "patients", "who", "successfully", "complete", "the", "Phase", "2b/3", "Combination", "Therapy", "trial", "and", "for", "whom", "the", "treating", "physicians", "request", "a", "continuation", "of", "PRO", "140", "therapy", "in", "order", "to", "maintain", "suppressed", "viral", "load."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p19_s5", "idA": "1175680_17_item1_p28_s0", "sentA": "Enrollment of the first patients was announced in December 2016 and enrollment is well underway.", "sentB": "The first patients were enrolled in December 2016 and enrollment is now continuing beyond 300 patients in order to evaluate the response rate of two higher dose arms.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patients", "was", "announced", "in", "December", "2016", "and", "enrollment", "is", "well", "underway.", "<tag2>", "The", "first", "patients", "were", "enrolled", "in", "December", "2016", "and", "enrollment", "is", "now", "continuing", "beyond", "300", "patients", "in", "order", "to", "evaluate", "the", "response", "rate", "of", "two", "higher", "dose", "arms.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patients", "was", "announced", "in", "December", "2016", "and", "enrollment", "is", "well", "underway."], "wordsB": ["The", "first", "patients", "were", "enrolled", "in", "December", "2016", "and", "enrollment", "is", "now", "continuing", "beyond", "300", "patients", "in", "order", "to", "evaluate", "the", "response", "rate", "of", "two", "higher", "dose", "arms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p2_s1", "idA": "1175680_17_item1_p2_s1", "sentA": "We acquired the asset from Progenics in October 2012, as described under PRO 140 Acquisition and Licensing Arrangements below.", "sentB": "We acquired the asset from Progenics in October 2012, as described in PRO 140 Acquisition and Licensing Arrangements below, and have recently advanced PRO 140 through achieving primary endpoint in a Phase 2b/3 pivotal trial for HIV combination therapy and are progressing forward with the preparation and filing of a biologics license application.", "type": 2, "words": ["<tag1>", "We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012,", "as", "described", "under", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "below.", "<tag2>", "We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012,", "as", "described", "in", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "below,", "and", "have", "recently", "advanced", "PRO", "140", "through", "achieving", "primary", "endpoint", "in", "a", "Phase", "2b/3", "pivotal", "trial", "for", "HIV", "combination", "therapy", "and", "are", "progressing", "forward", "with", "the", "preparation", "and", "filing", "of", "a", "biologics", "license", "application.", "<tag3>"], "wordsA": ["We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012,", "as", "described", "under", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "below."], "wordsB": ["We", "acquired", "the", "asset", "from", "Progenics", "in", "October", "2012,", "as", "described", "in", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "below,", "and", "have", "recently", "advanced", "PRO", "140", "through", "achieving", "primary", "endpoint", "in", "a", "Phase", "2b/3", "pivotal", "trial", "for", "HIV", "combination", "therapy", "and", "are", "progressing", "forward", "with", "the", "preparation", "and", "filing", "of", "a", "biologics", "license", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p20_s3", "idA": "1175680_17_item1_p30_s0", "sentA": "Phase 2 Trial for Graft-versus-Host Disease In June 2015, we announced that Company-sponsored research data has expanded the potential clinical indications for PRO 140 to include certain inflammatory diseases, autoimmunity, transplantation and cancer.", "sentB": "In March 2018, we announced that the Independent Data Monitoring Committee ( IDMC ) for PRO 140 Phase 2 trial in GvHD had completed a planned interim analysis of trial data on the first 10 patients enrolled.", "type": 2, "words": ["<tag1>", "Phase", "2", "Trial", "for", "Graft-versus-Host", "Disease", "In", "June", "2015,", "we", "announced", "that", "Company-sponsored", "research", "data", "has", "expanded", "the", "potential", "clinical", "indications", "for", "PRO", "140", "to", "include", "certain", "inflammatory", "diseases,", "autoimmunity,", "transplantation", "and", "cancer.", "<tag2>", "In", "March", "2018,", "we", "announced", "that", "the", "Independent", "Data", "Monitoring", "Committee", "(", "IDMC", ")", "for", "PRO", "140", "Phase", "2", "trial", "in", "GvHD", "had", "completed", "a", "planned", "interim", "analysis", "of", "trial", "data", "on", "the", "first", "10", "patients", "enrolled.", "<tag3>"], "wordsA": ["Phase", "2", "Trial", "for", "Graft-versus-Host", "Disease", "In", "June", "2015,", "we", "announced", "that", "Company-sponsored", "research", "data", "has", "expanded", "the", "potential", "clinical", "indications", "for", "PRO", "140", "to", "include", "certain", "inflammatory", "diseases,", "autoimmunity,", "transplantation", "and", "cancer."], "wordsB": ["In", "March", "2018,", "we", "announced", "that", "the", "Independent", "Data", "Monitoring", "Committee", "(", "IDMC", ")", "for", "PRO", "140", "Phase", "2", "trial", "in", "GvHD", "had", "completed", "a", "planned", "interim", "analysis", "of", "trial", "data", "on", "the", "first", "10", "patients", "enrolled."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p16_s2", "idA": "1175680_17_item1_p34_s0", "sentA": "In late December 2015, we announced that we had filed with the FDA for designation of PRO 140 as an orphan drug, in connection with our GvHD Phase 2 trial and our request remains open at this time.", "sentB": "On October 5, 2017, we announced that the FDA had granted orphan drug designation to PRO 140 for the prevention of GvHD.", "type": 2, "words": ["<tag1>", "In", "late", "December", "2015,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "for", "designation", "of", "PRO", "140", "as", "an", "orphan", "drug,", "in", "connection", "with", "our", "GvHD", "Phase", "2", "trial", "and", "our", "request", "remains", "open", "at", "this", "time.", "<tag2>", "On", "October", "5,", "2017,", "we", "announced", "that", "the", "FDA", "had", "granted", "orphan", "drug", "designation", "to", "PRO", "140", "for", "the", "prevention", "of", "GvHD.", "<tag3>"], "wordsA": ["In", "late", "December", "2015,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "for", "designation", "of", "PRO", "140", "as", "an", "orphan", "drug,", "in", "connection", "with", "our", "GvHD", "Phase", "2", "trial", "and", "our", "request", "remains", "open", "at", "this", "time."], "wordsB": ["On", "October", "5,", "2017,", "we", "announced", "that", "the", "FDA", "had", "granted", "orphan", "drug", "designation", "to", "PRO", "140", "for", "the", "prevention", "of", "GvHD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p20_s4", "idA": "1175680_17_item1_p34_s1", "sentA": "We have submitted additional data from specific animal studies as requested by the FDA.", "sentB": "Following this review of data from the first 10 patients in the Phase 2 trial, we filed amendments to the protocol with the FDA.", "type": 2, "words": ["<tag1>", "We", "have", "submitted", "additional", "data", "from", "specific", "animal", "studies", "as", "requested", "by", "the", "FDA.", "<tag2>", "Following", "this", "review", "of", "data", "from", "the", "first", "10", "patients", "in", "the", "Phase", "2", "trial,", "we", "filed", "amendments", "to", "the", "protocol", "with", "the", "FDA.", "<tag3>"], "wordsA": ["We", "have", "submitted", "additional", "data", "from", "specific", "animal", "studies", "as", "requested", "by", "the", "FDA."], "wordsB": ["Following", "this", "review", "of", "data", "from", "the", "first", "10", "patients", "in", "the", "Phase", "2", "trial,", "we", "filed", "amendments", "to", "the", "protocol", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p21_s0", "idA": "1175680_17_item1_p34_s2", "sentA": "Designation as an orphan product provides potentially faster pathways to approval and other financial incentives for drugs and biologics that are intended for the safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S. Immunological Applications for PRO 140 We are continuing to explore opportunities for clinical applications for PRO 140 involving the CCR5 receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases and cancer.", "sentB": "Immunological Applications for PRO 140 We are continuing to explore opportunities for clinical applications for PRO 140 involving the CCR5 receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases and cancer.", "type": 2, "words": ["<tag1>", "Designation", "as", "an", "orphan", "product", "provides", "potentially", "faster", "pathways", "to", "approval", "and", "other", "financial", "incentives", "for", "drugs", "and", "biologics", "that", "are", "intended", "for", "the", "safe", "and", "effective", "treatment,", "diagnosis", "or", "prevention", "of", "rare", "diseases", "or", "disorders", "that", "affect", "fewer", "than", "200,000", "people", "in", "the", "U.S.", "Immunological", "Applications", "for", "PRO", "140", "We", "are", "continuing", "to", "explore", "opportunities", "for", "clinical", "applications", "for", "PRO", "140", "involving", "the", "CCR5", "receptor,", "other", "than", "HIV-related", "treatments,", "such", "as", "inflammatory", "conditions,", "autoimmune", "diseases", "and", "cancer.", "<tag2>", "Immunological", "Applications", "for", "PRO", "140", "We", "are", "continuing", "to", "explore", "opportunities", "for", "clinical", "applications", "for", "PRO", "140", "involving", "the", "CCR5", "receptor,", "other", "than", "HIV-related", "treatments,", "such", "as", "inflammatory", "conditions,", "autoimmune", "diseases", "and", "cancer.", "<tag3>"], "wordsA": ["Designation", "as", "an", "orphan", "product", "provides", "potentially", "faster", "pathways", "to", "approval", "and", "other", "financial", "incentives", "for", "drugs", "and", "biologics", "that", "are", "intended", "for", "the", "safe", "and", "effective", "treatment,", "diagnosis", "or", "prevention", "of", "rare", "diseases", "or", "disorders", "that", "affect", "fewer", "than", "200,000", "people", "in", "the", "U.S.", "Immunological", "Applications", "for", "PRO", "140", "We", "are", "continuing", "to", "explore", "opportunities", "for", "clinical", "applications", "for", "PRO", "140", "involving", "the", "CCR5", "receptor,", "other", "than", "HIV-related", "treatments,", "such", "as", "inflammatory", "conditions,", "autoimmune", "diseases", "and", "cancer."], "wordsB": ["Immunological", "Applications", "for", "PRO", "140", "We", "are", "continuing", "to", "explore", "opportunities", "for", "clinical", "applications", "for", "PRO", "140", "involving", "the", "CCR5", "receptor,", "other", "than", "HIV-related", "treatments,", "such", "as", "inflammatory", "conditions,", "autoimmune", "diseases", "and", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p20_s6", "idA": "1175680_17_item1_p35_s0", "sentA": "The target of PRO 140 is the important immunologic receptor CCR5.", "sentB": "The amendments also provide for a 50% increase in the dose of PRO 140 (to 525 mg) to more closely mimic preclinical dosing.", "type": 2, "words": ["<tag1>", "The", "target", "of", "PRO", "140", "is", "the", "important", "immunologic", "receptor", "CCR5.", "<tag2>", "The", "amendments", "also", "provide", "for", "a", "50%", "increase", "in", "the", "dose", "of", "PRO", "140", "(to", "525", "mg)", "to", "more", "closely", "mimic", "preclinical", "dosing.", "<tag3>"], "wordsA": ["The", "target", "of", "PRO", "140", "is", "the", "important", "immunologic", "receptor", "CCR5."], "wordsB": ["The", "amendments", "also", "provide", "for", "a", "50%", "increase", "in", "the", "dose", "of", "PRO", "140", "(to", "525", "mg)", "to", "more", "closely", "mimic", "preclinical", "dosing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p0_s6", "idA": "1175680_17_item1_p37_s0", "sentA": "At the site of an inflammatory reaction, chemokines are released.", "sentB": "The address of the site is www.sec.gov .", "type": 2, "words": ["<tag1>", "At", "the", "site", "of", "an", "inflammatory", "reaction,", "chemokines", "are", "released.", "<tag2>", "The", "address", "of", "the", "site", "is", "www.sec.gov", ".", "<tag3>"], "wordsA": ["At", "the", "site", "of", "an", "inflammatory", "reaction,", "chemokines", "are", "released."], "wordsB": ["The", "address", "of", "the", "site", "is", "www.sec.gov", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p26_s0", "idA": "1175680_17_item1_p39_s0", "sentA": "Due to its mechanism of action, PRO 140 has significant advantages in terms of safety and reduced side effects over other CCR5 antagonists.", "sentB": "Due to our mechanism of action, we believe PRO 140 has significant advantages in terms of safety and reduced side effects over other CCR5 antagonists.", "type": 2, "words": ["<tag1>", "Due", "to", "its", "mechanism", "of", "action,", "PRO", "140", "has", "significant", "advantages", "in", "terms", "of", "safety", "and", "reduced", "side", "effects", "over", "other", "CCR5", "antagonists.", "<tag2>", "Due", "to", "our", "mechanism", "of", "action,", "we", "believe", "PRO", "140", "has", "significant", "advantages", "in", "terms", "of", "safety", "and", "reduced", "side", "effects", "over", "other", "CCR5", "antagonists.", "<tag3>"], "wordsA": ["Due", "to", "its", "mechanism", "of", "action,", "PRO", "140", "has", "significant", "advantages", "in", "terms", "of", "safety", "and", "reduced", "side", "effects", "over", "other", "CCR5", "antagonists."], "wordsB": ["Due", "to", "our", "mechanism", "of", "action,", "we", "believe", "PRO", "140", "has", "significant", "advantages", "in", "terms", "of", "safety", "and", "reduced", "side", "effects", "over", "other", "CCR5", "antagonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p27_s2", "idA": "1175680_17_item1_p41_s0", "sentA": "We have initiated our first clinical trial with PRO 140 in an immunological indication a Phase 2 clinical trial with PRO 140 for Graft-versus-Host Disease (GvHD) in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation.", "sentB": "We have initiated our first clinical trial with PRO 140 in an immunological indication a Phase 2 clinical trial with PRO 140 for GvHD in patients with AML or MDS who are undergoing bone marrow stem cell transplantation.", "type": 2, "words": ["<tag1>", "We", "have", "initiated", "our", "first", "clinical", "trial", "with", "PRO", "140", "in", "an", "immunological", "indication", "a", "Phase", "2", "clinical", "trial", "with", "PRO", "140", "for", "Graft-versus-Host", "Disease", "(GvHD)", "in", "patients", "with", "acute", "myeloid", "leukemia", "(AML)", "or", "myelodysplastic", "syndrome", "(MDS)", "who", "are", "undergoing", "bone", "marrow", "stem", "cell", "transplantation.", "<tag2>", "We", "have", "initiated", "our", "first", "clinical", "trial", "with", "PRO", "140", "in", "an", "immunological", "indication", "a", "Phase", "2", "clinical", "trial", "with", "PRO", "140", "for", "GvHD", "in", "patients", "with", "AML", "or", "MDS", "who", "are", "undergoing", "bone", "marrow", "stem", "cell", "transplantation.", "<tag3>"], "wordsA": ["We", "have", "initiated", "our", "first", "clinical", "trial", "with", "PRO", "140", "in", "an", "immunological", "indication", "a", "Phase", "2", "clinical", "trial", "with", "PRO", "140", "for", "Graft-versus-Host", "Disease", "(GvHD)", "in", "patients", "with", "acute", "myeloid", "leukemia", "(AML)", "or", "myelodysplastic", "syndrome", "(MDS)", "who", "are", "undergoing", "bone", "marrow", "stem", "cell", "transplantation."], "wordsB": ["We", "have", "initiated", "our", "first", "clinical", "trial", "with", "PRO", "140", "in", "an", "immunological", "indication", "a", "Phase", "2", "clinical", "trial", "with", "PRO", "140", "for", "GvHD", "in", "patients", "with", "AML", "or", "MDS", "who", "are", "undergoing", "bone", "marrow", "stem", "cell", "transplantation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p27_s6", "idA": "1175680_17_item1_p42_s1", "sentA": "Other Product Candidates Until the clinical trials for PRO 140 have advanced further, we do not plan to devote any resources towards the development, research, testing, approval or commercialization of other product candidates.", "sentB": "Other Product Candidates Except as otherwise disclosed above, until the clinical trials for PRO 140 have advanced further, we do not plan to devote any resources towards the development, research, testing, approval or commercialization of other product candidates.", "type": 2, "words": ["<tag1>", "Other", "Product", "Candidates", "Until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval", "or", "commercialization", "of", "other", "product", "candidates.", "<tag2>", "Other", "Product", "Candidates", "Except", "as", "otherwise", "disclosed", "above,", "until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval", "or", "commercialization", "of", "other", "product", "candidates.", "<tag3>"], "wordsA": ["Other", "Product", "Candidates", "Until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval", "or", "commercialization", "of", "other", "product", "candidates."], "wordsB": ["Other", "Product", "Candidates", "Except", "as", "otherwise", "disclosed", "above,", "until", "the", "clinical", "trials", "for", "PRO", "140", "have", "advanced", "further,", "we", "do", "not", "plan", "to", "devote", "any", "resources", "towards", "the", "development,", "research,", "testing,", "approval", "or", "commercialization", "of", "other", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p28_s6", "idA": "1175680_17_item1_p42_s10", "sentA": "To the extent that such milestone payments and royalties are not timely made, under the terms of the PDL License, AbbVie Inc. has certain termination rights relating to our license of PRO 140 thereunder.", "sentB": "To the extent that such remaining milestone payments and royalties are not timely made, under the terms of the PDL License, AbbVie Inc. has certain termination rights relating to our license of PRO 140 thereunder.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "our", "license", "of", "PRO", "140", "thereunder.", "<tag2>", "To", "the", "extent", "that", "such", "remaining", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "our", "license", "of", "PRO", "140", "thereunder.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "our", "license", "of", "PRO", "140", "thereunder."], "wordsB": ["To", "the", "extent", "that", "such", "remaining", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "PDL", "License,", "AbbVie", "Inc.", "has", "certain", "termination", "rights", "relating", "to", "our", "license", "of", "PRO", "140", "thereunder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p29_s0", "idA": "1175680_17_item1_p42_s12", "sentA": "Effective July 29, 2015, we entered into a License Agreement (the Lonza Agreement ) with Lonza Sales AG ( Lonza ) covering Lonza s system know-how technology with respect to CytoDyn s use of proprietary cell lines to manufacture new PRO 140 material.", "sentB": "Effective July 29, 2015, we entered into a License Agreement (the Lonza Agreement ) with Lonza Sales AG ( Lonza ) covering Lonza s system know-how technology with respect to our use of proprietary cell lines to manufacture new PRO 140 material.", "type": 2, "words": ["<tag1>", "Effective", "July", "29,", "2015,", "we", "entered", "into", "a", "License", "Agreement", "(the", "Lonza", "Agreement", ")", "with", "Lonza", "Sales", "AG", "(", "Lonza", ")", "covering", "Lonza", "s", "system", "know-how", "technology", "with", "respect", "to", "CytoDyn", "s", "use", "of", "proprietary", "cell", "lines", "to", "manufacture", "new", "PRO", "140", "material.", "<tag2>", "Effective", "July", "29,", "2015,", "we", "entered", "into", "a", "License", "Agreement", "(the", "Lonza", "Agreement", ")", "with", "Lonza", "Sales", "AG", "(", "Lonza", ")", "covering", "Lonza", "s", "system", "know-how", "technology", "with", "respect", "to", "our", "use", "of", "proprietary", "cell", "lines", "to", "manufacture", "new", "PRO", "140", "material.", "<tag3>"], "wordsA": ["Effective", "July", "29,", "2015,", "we", "entered", "into", "a", "License", "Agreement", "(the", "Lonza", "Agreement", ")", "with", "Lonza", "Sales", "AG", "(", "Lonza", ")", "covering", "Lonza", "s", "system", "know-how", "technology", "with", "respect", "to", "CytoDyn", "s", "use", "of", "proprietary", "cell", "lines", "to", "manufacture", "new", "PRO", "140", "material."], "wordsB": ["Effective", "July", "29,", "2015,", "we", "entered", "into", "a", "License", "Agreement", "(the", "Lonza", "Agreement", ")", "with", "Lonza", "Sales", "AG", "(", "Lonza", ")", "covering", "Lonza", "s", "system", "know-how", "technology", "with", "respect", "to", "our", "use", "of", "proprietary", "cell", "lines", "to", "manufacture", "new", "PRO", "140", "material."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p29_s1", "idA": "1175680_17_item1_p42_s17", "sentA": "The licensor does not charge an annual license fee of 300,000 when it serves as the manufacturer.", "sentB": "The Lonza Agreement provides for an annual license fee and future royalty payments, both of which varies based on whether Lonza, or we or our strategic partner manufactures PRO 140.", "type": 2, "words": ["<tag1>", "The", "licensor", "does", "not", "charge", "an", "annual", "license", "fee", "of", "300,000", "when", "it", "serves", "as", "the", "manufacturer.", "<tag2>", "The", "Lonza", "Agreement", "provides", "for", "an", "annual", "license", "fee", "and", "future", "royalty", "payments,", "both", "of", "which", "varies", "based", "on", "whether", "Lonza,", "or", "we", "or", "our", "strategic", "partner", "manufactures", "PRO", "140.", "<tag3>"], "wordsA": ["The", "licensor", "does", "not", "charge", "an", "annual", "license", "fee", "of", "300,000", "when", "it", "serves", "as", "the", "manufacturer."], "wordsB": ["The", "Lonza", "Agreement", "provides", "for", "an", "annual", "license", "fee", "and", "future", "royalty", "payments,", "both", "of", "which", "varies", "based", "on", "whether", "Lonza,", "or", "we", "or", "our", "strategic", "partner", "manufactures", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p29_s2", "idA": "1175680_17_item1_p42_s18", "sentA": "However, we currently use an independent party as a contract manufacturer.", "sentB": "We currently use an independent party as a contract manufacturer for PRO 140.", "type": 2, "words": ["<tag1>", "However,", "we", "currently", "use", "an", "independent", "party", "as", "a", "contract", "manufacturer.", "<tag2>", "We", "currently", "use", "an", "independent", "party", "as", "a", "contract", "manufacturer", "for", "PRO", "140.", "<tag3>"], "wordsA": ["However,", "we", "currently", "use", "an", "independent", "party", "as", "a", "contract", "manufacturer."], "wordsB": ["We", "currently", "use", "an", "independent", "party", "as", "a", "contract", "manufacturer", "for", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p15_s4", "idA": "1175680_17_item1_p42_s19", "sentA": "If that arrangement continues, the annual license fee of 300,000 would continue to apply, as well as a royalty of 1.0% of the net selling price upon commercialization of PRO 140 (excluding value added taxes and similar amounts).", "sentB": "The Company is currently exploring a higher dose arm (525 mg), which is a 50% increase from the original dosage (350 mg), as well as a 700mg dose.", "type": 2, "words": ["<tag1>", "If", "that", "arrangement", "continues,", "the", "annual", "license", "fee", "of", "300,000", "would", "continue", "to", "apply,", "as", "well", "as", "a", "royalty", "of", "1.0%", "of", "the", "net", "selling", "price", "upon", "commercialization", "of", "PRO", "140", "(excluding", "value", "added", "taxes", "and", "similar", "amounts).", "<tag2>", "The", "Company", "is", "currently", "exploring", "a", "higher", "dose", "arm", "(525", "mg),", "which", "is", "a", "50%", "increase", "from", "the", "original", "dosage", "(350", "mg),", "as", "well", "as", "a", "700mg", "dose.", "<tag3>"], "wordsA": ["If", "that", "arrangement", "continues,", "the", "annual", "license", "fee", "of", "300,000", "would", "continue", "to", "apply,", "as", "well", "as", "a", "royalty", "of", "1.0%", "of", "the", "net", "selling", "price", "upon", "commercialization", "of", "PRO", "140", "(excluding", "value", "added", "taxes", "and", "similar", "amounts)."], "wordsB": ["The", "Company", "is", "currently", "exploring", "a", "higher", "dose", "arm", "(525", "mg),", "which", "is", "a", "50%", "increase", "from", "the", "original", "dosage", "(350", "mg),", "as", "well", "as", "a", "700mg", "dose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p29_s3", "idA": "1175680_17_item1_p42_s19", "sentA": "If that arrangement continues, the annual license fee of 300,000 would continue to apply, as well as a royalty of 1.0% of the net selling price upon commercialization of PRO 140 (excluding value added taxes and similar amounts).", "sentB": "Therefore, if this arrangement continues, an annual license fee of 300,000 (approximately US$400,000 given current exchange rate) would continue to apply, as well as a royalty, up to, 2% of the net selling price upon commercialization of PRO 140, excluding value added taxes and similar amounts.", "type": 2, "words": ["<tag1>", "If", "that", "arrangement", "continues,", "the", "annual", "license", "fee", "of", "300,000", "would", "continue", "to", "apply,", "as", "well", "as", "a", "royalty", "of", "1.0%", "of", "the", "net", "selling", "price", "upon", "commercialization", "of", "PRO", "140", "(excluding", "value", "added", "taxes", "and", "similar", "amounts).", "<tag2>", "Therefore,", "if", "this", "arrangement", "continues,", "an", "annual", "license", "fee", "of", "300,000", "(approximately", "US$400,000", "given", "current", "exchange", "rate)", "would", "continue", "to", "apply,", "as", "well", "as", "a", "royalty,", "up", "to,", "2%", "of", "the", "net", "selling", "price", "upon", "commercialization", "of", "PRO", "140,", "excluding", "value", "added", "taxes", "and", "similar", "amounts.", "<tag3>"], "wordsA": ["If", "that", "arrangement", "continues,", "the", "annual", "license", "fee", "of", "300,000", "would", "continue", "to", "apply,", "as", "well", "as", "a", "royalty", "of", "1.0%", "of", "the", "net", "selling", "price", "upon", "commercialization", "of", "PRO", "140", "(excluding", "value", "added", "taxes", "and", "similar", "amounts)."], "wordsB": ["Therefore,", "if", "this", "arrangement", "continues,", "an", "annual", "license", "fee", "of", "300,000", "(approximately", "US$400,000", "given", "current", "exchange", "rate)", "would", "continue", "to", "apply,", "as", "well", "as", "a", "royalty,", "up", "to,", "2%", "of", "the", "net", "selling", "price", "upon", "commercialization", "of", "PRO", "140,", "excluding", "value", "added", "taxes", "and", "similar", "amounts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p28_s0", "idA": "1175680_17_item1_p42_s2", "sentA": "We acquired PRO 140, as well as certain other related assets, including the existing inventory of PRO 140 bulk drug substance, intellectual property, and FDA regulatory filings, pursuant to an Asset Purchase Agreement, dated as of July 25, 2012 (the Progenics Purchase Agreement ), between CytoDyn and Progenics.", "sentB": "PRO 140 Acquisition and Licensing Arrangements We originally acquired PRO 140, as well as certain other related assets, including the existing inventory of PRO 140 bulk drug substance, intellectual property, and FDA regulatory filings, pursuant to an Asset Purchase Agreement, dated as of July 25, 2012 (the Progenics Purchase Agreement ), between CytoDyn and Progenics Pharmaceuticals, Inc. ( Progenics ).", "type": 2, "words": ["<tag1>", "We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Purchase", "Agreement", "),", "between", "CytoDyn", "and", "Progenics.", "<tag2>", "PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "We", "originally", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Purchase", "Agreement", "),", "between", "CytoDyn", "and", "Progenics", "Pharmaceuticals,", "Inc.", "(", "Progenics", ").", "<tag3>"], "wordsA": ["We", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Purchase", "Agreement", "),", "between", "CytoDyn", "and", "Progenics."], "wordsB": ["PRO", "140", "Acquisition", "and", "Licensing", "Arrangements", "We", "originally", "acquired", "PRO", "140,", "as", "well", "as", "certain", "other", "related", "assets,", "including", "the", "existing", "inventory", "of", "PRO", "140", "bulk", "drug", "substance,", "intellectual", "property,", "and", "FDA", "regulatory", "filings,", "pursuant", "to", "an", "Asset", "Purchase", "Agreement,", "dated", "as", "of", "July", "25,", "2012", "(the", "Progenics", "Purchase", "Agreement", "),", "between", "CytoDyn", "and", "Progenics", "Pharmaceuticals,", "Inc.", "(", "Progenics", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p10_s5", "idA": "1175680_17_item1_p42_s3", "sentA": "On October 16, 2012, we paid to Progenics $3,500,000 in cash to close the transaction.", "sentB": "It is also expected that Dr. Pestell will join our Board of Directors at the closing of the transaction.", "type": 2, "words": ["<tag1>", "On", "October", "16,", "2012,", "we", "paid", "to", "Progenics", "$3,500,000", "in", "cash", "to", "close", "the", "transaction.", "<tag2>", "It", "is", "also", "expected", "that", "Dr.", "Pestell", "will", "join", "our", "Board", "of", "Directors", "at", "the", "closing", "of", "the", "transaction.", "<tag3>"], "wordsA": ["On", "October", "16,", "2012,", "we", "paid", "to", "Progenics", "$3,500,000", "in", "cash", "to", "close", "the", "transaction."], "wordsB": ["It", "is", "also", "expected", "that", "Dr.", "Pestell", "will", "join", "our", "Board", "of", "Directors", "at", "the", "closing", "of", "the", "transaction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p28_s1", "idA": "1175680_17_item1_p42_s4", "sentA": "We are also required to pay Progenics the following milestone payments and royalties: (i) $1,500,000 at the time of the first dosing in a U.S. Phase 3 trial or non-U.S. equivalent, which was paid during the fiscal year ended May 31, 2016; (ii) $5,000,000 at the time of the first U.S. new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (iii) royalty payments of up to 5% on net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years, in each case determined on a country-by country basis.", "sentB": "Pursuant to the Progenics Purchase Agreement, we are required to pay Progenics a remaining milestone payment and royalties as follows: (i) $5,000,000 at the time of the first U,S. new drug application approval by the FDA or other non-U.S. approval for the sale of PRO 140; and (ii) royalty payments of up to 5% on net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years, in each case determined on a country-by country basis.", "type": 2, "words": ["<tag1>", "We", "are", "also", "required", "to", "pay", "Progenics", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-U.S.", "equivalent,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U.S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis.", "<tag2>", "Pursuant", "to", "the", "Progenics", "Purchase", "Agreement,", "we", "are", "required", "to", "pay", "Progenics", "a", "remaining", "milestone", "payment", "and", "royalties", "as", "follows:", "(i)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U,S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(ii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis.", "<tag3>"], "wordsA": ["We", "are", "also", "required", "to", "pay", "Progenics", "the", "following", "milestone", "payments", "and", "royalties:", "(i)", "$1,500,000", "at", "the", "time", "of", "the", "first", "dosing", "in", "a", "U.S.", "Phase", "3", "trial", "or", "non-U.S.", "equivalent,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U.S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(iii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis."], "wordsB": ["Pursuant", "to", "the", "Progenics", "Purchase", "Agreement,", "we", "are", "required", "to", "pay", "Progenics", "a", "remaining", "milestone", "payment", "and", "royalties", "as", "follows:", "(i)", "$5,000,000", "at", "the", "time", "of", "the", "first", "U,S.", "new", "drug", "application", "approval", "by", "the", "FDA", "or", "other", "non-U.S.", "approval", "for", "the", "sale", "of", "PRO", "140;", "and", "(ii)", "royalty", "payments", "of", "up", "to", "5%", "on", "net", "sales", "during", "the", "period", "beginning", "on", "the", "date", "of", "the", "first", "commercial", "sale", "of", "PRO", "140", "until", "the", "later", "of", "(a)", "the", "expiration", "of", "the", "last", "to", "expire", "patent", "included", "in", "the", "acquired", "assets,", "and", "(b)", "10", "years,", "in", "each", "case", "determined", "on", "a", "country-by", "country", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p28_s2", "idA": "1175680_17_item1_p42_s6", "sentA": "To the extent that such milestone payments and royalties are not timely made, under the terms of the Progenics Purchase Agreement, Progenics has certain repurchase rights relating to the assets sold to us thereunder.", "sentB": "To the extent that such remaining milestone payment and royalties are not timely made, under the terms of the Progenics Purchase Agreement, Progenics has certain repurchase rights relating to the assets sold to us thereunder.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "Progenics", "Purchase", "Agreement,", "Progenics", "has", "certain", "repurchase", "rights", "relating", "to", "the", "assets", "sold", "to", "us", "thereunder.", "<tag2>", "To", "the", "extent", "that", "such", "remaining", "milestone", "payment", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "Progenics", "Purchase", "Agreement,", "Progenics", "has", "certain", "repurchase", "rights", "relating", "to", "the", "assets", "sold", "to", "us", "thereunder.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "such", "milestone", "payments", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "Progenics", "Purchase", "Agreement,", "Progenics", "has", "certain", "repurchase", "rights", "relating", "to", "the", "assets", "sold", "to", "us", "thereunder."], "wordsB": ["To", "the", "extent", "that", "such", "remaining", "milestone", "payment", "and", "royalties", "are", "not", "timely", "made,", "under", "the", "terms", "of", "the", "Progenics", "Purchase", "Agreement,", "Progenics", "has", "certain", "repurchase", "rights", "relating", "to", "the", "assets", "sold", "to", "us", "thereunder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p28_s3", "idA": "1175680_17_item1_p42_s7", "sentA": "( PDL ) and Progenics, which was assigned to us in the Progenics Purchase Agreement, pursuant to which we have an exclusive worldwide license to develop, make, have made, import, use, sell, offer to sell or have sold products that incorporate the humanized form of the PRO 140 antibody developed by PDL under the agreement and must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial, which was paid during the fiscal year ended May 31, 2016; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "sentB": "Payments to Progenics are in addition to payments due under a Development and License Agreement, dated April 30, 1999 (the PDL License ), between Protein Design Labs (now AbbVie Inc.) and Progenics, which was assigned to us in the Progenics Purchase Agreement, pursuant to which we have an exclusive worldwide license to develop, make, have made, import, use, sell, offer to sell or have sold products that incorporate the humanized form of the PRO 140 antibody developed under the agreement.", "type": 2, "words": ["<tag1>", "(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "we", "have", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag2>", "Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "we", "have", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "under", "the", "agreement.", "<tag3>"], "wordsA": ["(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "we", "have", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "wordsB": ["Payments", "to", "Progenics", "are", "in", "addition", "to", "payments", "due", "under", "a", "Development", "and", "License", "Agreement,", "dated", "April", "30,", "1999", "(the", "PDL", "License", "),", "between", "Protein", "Design", "Labs", "(now", "AbbVie", "Inc.)", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "we", "have", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "under", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p28_s4", "idA": "1175680_17_item1_p42_s7", "sentA": "( PDL ) and Progenics, which was assigned to us in the Progenics Purchase Agreement, pursuant to which we have an exclusive worldwide license to develop, make, have made, import, use, sell, offer to sell or have sold products that incorporate the humanized form of the PRO 140 antibody developed by PDL under the agreement and must pay additional milestone payments and royalties as follows: (i) $1,000,000 upon initiation of a Phase 3 clinical trial, which was paid during the fiscal year ended May 31, 2016; (ii) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (iii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iv) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "sentB": "Pursuant to the PDL License, we are required to pay AbbVie Inc. remaining milestone payments and royalties as follows: (i) $500,000 upon filing a Biologic License Application with the FDA or non-U.S. equivalent regulatory body; (ii) $500,000 upon FDA approval or approval by another non-U.S. equivalent regulatory body; and (iii) royalties of up to 7.5% of net sales for the longer of 10 years and the date of expiration of the last to expire licensed patent.", "type": 2, "words": ["<tag1>", "(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "we", "have", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag2>", "Pursuant", "to", "the", "PDL", "License,", "we", "are", "required", "to", "pay", "AbbVie", "Inc.", "remaining", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(ii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iii)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent.", "<tag3>"], "wordsA": ["(", "PDL", ")", "and", "Progenics,", "which", "was", "assigned", "to", "us", "in", "the", "Progenics", "Purchase", "Agreement,", "pursuant", "to", "which", "we", "have", "an", "exclusive", "worldwide", "license", "to", "develop,", "make,", "have", "made,", "import,", "use,", "sell,", "offer", "to", "sell", "or", "have", "sold", "products", "that", "incorporate", "the", "humanized", "form", "of", "the", "PRO", "140", "antibody", "developed", "by", "PDL", "under", "the", "agreement", "and", "must", "pay", "additional", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$1,000,000", "upon", "initiation", "of", "a", "Phase", "3", "clinical", "trial,", "which", "was", "paid", "during", "the", "fiscal", "year", "ended", "May", "31,", "2016;", "(ii)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(iii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iv)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "wordsB": ["Pursuant", "to", "the", "PDL", "License,", "we", "are", "required", "to", "pay", "AbbVie", "Inc.", "remaining", "milestone", "payments", "and", "royalties", "as", "follows:", "(i)", "$500,000", "upon", "filing", "a", "Biologic", "License", "Application", "with", "the", "FDA", "or", "non-U.S.", "equivalent", "regulatory", "body;", "(ii)", "$500,000", "upon", "FDA", "approval", "or", "approval", "by", "another", "non-U.S.", "equivalent", "regulatory", "body;", "and", "(iii)", "royalties", "of", "up", "to", "7.5%", "of", "net", "sales", "for", "the", "longer", "of", "10", "years", "and", "the", "date", "of", "expiration", "of", "the", "last", "to", "expire", "licensed", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p30_s1", "idA": "1175680_17_item1_p43_s1", "sentA": "We may file patent applications in the U.S., Canada, China, Japan, European countries that are party to the European Patent Convention and other countries on a selective basis in order to protect inventions we consider to be important to the development of our business.", "sentB": "We may file patent applications in the U.S., Canada, China, and Japan, European countries that are party to the European Patent Convention and other countries on a selective basis in order to protect inventions we consider to be important to the development of our business.", "type": 2, "words": ["<tag1>", "We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "China,", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag2>", "We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "China,", "and", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag3>"], "wordsA": ["We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "China,", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business."], "wordsB": ["We", "may", "file", "patent", "applications", "in", "the", "U.S.,", "Canada,", "China,", "and", "Japan,", "European", "countries", "that", "are", "party", "to", "the", "European", "Patent", "Convention", "and", "other", "countries", "on", "a", "selective", "basis", "in", "order", "to", "protect", "inventions", "we", "consider", "to", "be", "important", "to", "the", "development", "of", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p16_s5", "idA": "1175680_17_item1_p45_s2", "sentA": "See related risk factors under the heading Risk Factors below.", "sentB": "See Liquidity and Capital Resources under the heading Management s Discussion and Analysis of Financial Condition and Results of Operations below.", "type": 2, "words": ["<tag1>", "See", "related", "risk", "factors", "under", "the", "heading", "Risk", "Factors", "below.", "<tag2>", "See", "Liquidity", "and", "Capital", "Resources", "under", "the", "heading", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operations", "below.", "<tag3>"], "wordsA": ["See", "related", "risk", "factors", "under", "the", "heading", "Risk", "Factors", "below."], "wordsB": ["See", "Liquidity", "and", "Capital", "Resources", "under", "the", "heading", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operations", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p33_s1", "idA": "1175680_17_item1_p46_s1", "sentA": "Information with respect to our current patent portfolio as of May 31, 2017, is set forth below.", "sentB": "Information with respect to our current patent portfolio as of May 31, 2018, is set forth below.", "type": 2, "words": ["<tag1>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2017,", "is", "set", "forth", "below.", "<tag2>", "Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2018,", "is", "set", "forth", "below.", "<tag3>"], "wordsA": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2017,", "is", "set", "forth", "below."], "wordsB": ["Information", "with", "respect", "to", "our", "current", "patent", "portfolio", "as", "of", "May", "31,", "2018,", "is", "set", "forth", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p35_s0", "idA": "1175680_17_item1_p48_s0", "sentA": "(2) PRO 140 patents and applications relate to HIV-1 and GvHD treatments.", "sentB": "(2) PRO 140 patents and applications relate to HIV-1, GvHD, and cancer treatments.", "type": 2, "words": ["<tag1>", "(2)", "PRO", "140", "patents", "and", "applications", "relate", "to", "HIV-1", "and", "GvHD", "treatments.", "<tag2>", "(2)", "PRO", "140", "patents", "and", "applications", "relate", "to", "HIV-1,", "GvHD,", "and", "cancer", "treatments.", "<tag3>"], "wordsA": ["(2)", "PRO", "140", "patents", "and", "applications", "relate", "to", "HIV-1", "and", "GvHD", "treatments."], "wordsB": ["(2)", "PRO", "140", "patents", "and", "applications", "relate", "to", "HIV-1,", "GvHD,", "and", "cancer", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p37_s1", "idA": "1175680_17_item1_p50_s1", "sentA": "For example, there are federal and state health care laws and regulations that apply to the conduct of clinical research, the business relationships between health care providers and suppliers and the privacy and security of health information.", "sentB": "For example, there are federal and state health care laws and regulations that apply to the operation of clinical laboratories, the business relationships between health care providers and suppliers, the privacy and security of health information and the conduct of clinical research.", "type": 2, "words": ["<tag1>", "For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "conduct", "of", "clinical", "research,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers", "and", "the", "privacy", "and", "security", "of", "health", "information.", "<tag2>", "For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "operation", "of", "clinical", "laboratories,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers,", "the", "privacy", "and", "security", "of", "health", "information", "and", "the", "conduct", "of", "clinical", "research.", "<tag3>"], "wordsA": ["For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "conduct", "of", "clinical", "research,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers", "and", "the", "privacy", "and", "security", "of", "health", "information."], "wordsB": ["For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "operation", "of", "clinical", "laboratories,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers,", "the", "privacy", "and", "security", "of", "health", "information", "and", "the", "conduct", "of", "clinical", "research."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p47_s2", "idA": "1175680_17_item1_p50_s1", "sentA": "For example, there are federal and state health care laws and regulations that apply to the conduct of clinical research, the business relationships between health care providers and suppliers and the privacy and security of health information.", "sentB": "State law and regulations also apply to the operation of clinical laboratories.", "type": 2, "words": ["<tag1>", "For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "conduct", "of", "clinical", "research,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers", "and", "the", "privacy", "and", "security", "of", "health", "information.", "<tag2>", "State", "law", "and", "regulations", "also", "apply", "to", "the", "operation", "of", "clinical", "laboratories.", "<tag3>"], "wordsA": ["For", "example,", "there", "are", "federal", "and", "state", "health", "care", "laws", "and", "regulations", "that", "apply", "to", "the", "conduct", "of", "clinical", "research,", "the", "business", "relationships", "between", "health", "care", "providers", "and", "suppliers", "and", "the", "privacy", "and", "security", "of", "health", "information."], "wordsB": ["State", "law", "and", "regulations", "also", "apply", "to", "the", "operation", "of", "clinical", "laboratories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p39_s0", "idA": "1175680_17_item1_p52_s0", "sentA": "In the United States, biological products such as PRO 140 have long been subject to regulation by various federal and state agencies, primarily as to product research, development, approval, safety, efficacy, manufacturing, advertising, labeling, import, export and safety reporting.", "sentB": "In the United States, biological products have long been subject to regulation by various federal and state agencies, primarily as to product safety, efficacy, manufacturing, advertising, labeling, import, export and safety reporting.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "biological", "products", "such", "as", "PRO", "140", "have", "long", "been", "subject", "to", "regulation", "by", "various", "federal", "and", "state", "agencies,", "primarily", "as", "to", "product", "research,", "development,", "approval,", "safety,", "efficacy,", "manufacturing,", "advertising,", "labeling,", "import,", "export", "and", "safety", "reporting.", "<tag2>", "In", "the", "United", "States,", "biological", "products", "have", "long", "been", "subject", "to", "regulation", "by", "various", "federal", "and", "state", "agencies,", "primarily", "as", "to", "product", "safety,", "efficacy,", "manufacturing,", "advertising,", "labeling,", "import,", "export", "and", "safety", "reporting.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "biological", "products", "such", "as", "PRO", "140", "have", "long", "been", "subject", "to", "regulation", "by", "various", "federal", "and", "state", "agencies,", "primarily", "as", "to", "product", "research,", "development,", "approval,", "safety,", "efficacy,", "manufacturing,", "advertising,", "labeling,", "import,", "export", "and", "safety", "reporting."], "wordsB": ["In", "the", "United", "States,", "biological", "products", "have", "long", "been", "subject", "to", "regulation", "by", "various", "federal", "and", "state", "agencies,", "primarily", "as", "to", "product", "safety,", "efficacy,", "manufacturing,", "advertising,", "labeling,", "import,", "export", "and", "safety", "reporting."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p39_s1", "idA": "1175680_17_item1_p52_s1", "sentA": "The exercise of broad regulatory powers by the FDA through its Center for Biological Evaluation and Research and other functions continues to require from companies large amounts of testing and documentation prior to FDA approval of current and new biologic products and while they are marketed.", "sentB": "The exercise of broad regulatory powers by the FDA through its Center for Devices and Radiological Health and its Center for Biological Evaluation and Research continues to result in increases in the amounts of testing and documentation for FDA clearance of current and new biologic products.", "type": 2, "words": ["<tag1>", "The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "and", "other", "functions", "continues", "to", "require", "from", "companies", "large", "amounts", "of", "testing", "and", "documentation", "prior", "to", "FDA", "approval", "of", "current", "and", "new", "biologic", "products", "and", "while", "they", "are", "marketed.", "<tag2>", "The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Devices", "and", "Radiological", "Health", "and", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "continues", "to", "result", "in", "increases", "in", "the", "amounts", "of", "testing", "and", "documentation", "for", "FDA", "clearance", "of", "current", "and", "new", "biologic", "products.", "<tag3>"], "wordsA": ["The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "and", "other", "functions", "continues", "to", "require", "from", "companies", "large", "amounts", "of", "testing", "and", "documentation", "prior", "to", "FDA", "approval", "of", "current", "and", "new", "biologic", "products", "and", "while", "they", "are", "marketed."], "wordsB": ["The", "exercise", "of", "broad", "regulatory", "powers", "by", "the", "FDA", "through", "its", "Center", "for", "Devices", "and", "Radiological", "Health", "and", "its", "Center", "for", "Biological", "Evaluation", "and", "Research", "continues", "to", "result", "in", "increases", "in", "the", "amounts", "of", "testing", "and", "documentation", "for", "FDA", "clearance", "of", "current", "and", "new", "biologic", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p40_s0", "idA": "1175680_17_item1_p52_s2", "sentA": "When marketing commences, the FDA can ban certain biological products; detain or seize adulterated or misbranded biological products; order repair, replacement or refund of these products; and require notification of health professionals and others with regard to biological products that present unreasonable risks of substantial harm to the public health.", "sentB": "The FDA can ban certain biological products; detain or seize adulterated or misbranded biological products; order repair, replacement or refund of these products; and require notification of health professionals and others with regard to biological products that present unreasonable risks of substantial harm to the public health.", "type": 2, "words": ["<tag1>", "When", "marketing", "commences,", "the", "FDA", "can", "ban", "certain", "biological", "products;", "detain", "or", "seize", "adulterated", "or", "misbranded", "biological", "products;", "order", "repair,", "replacement", "or", "refund", "of", "these", "products;", "and", "require", "notification", "of", "health", "professionals", "and", "others", "with", "regard", "to", "biological", "products", "that", "present", "unreasonable", "risks", "of", "substantial", "harm", "to", "the", "public", "health.", "<tag2>", "The", "FDA", "can", "ban", "certain", "biological", "products;", "detain", "or", "seize", "adulterated", "or", "misbranded", "biological", "products;", "order", "repair,", "replacement", "or", "refund", "of", "these", "products;", "and", "require", "notification", "of", "health", "professionals", "and", "others", "with", "regard", "to", "biological", "products", "that", "present", "unreasonable", "risks", "of", "substantial", "harm", "to", "the", "public", "health.", "<tag3>"], "wordsA": ["When", "marketing", "commences,", "the", "FDA", "can", "ban", "certain", "biological", "products;", "detain", "or", "seize", "adulterated", "or", "misbranded", "biological", "products;", "order", "repair,", "replacement", "or", "refund", "of", "these", "products;", "and", "require", "notification", "of", "health", "professionals", "and", "others", "with", "regard", "to", "biological", "products", "that", "present", "unreasonable", "risks", "of", "substantial", "harm", "to", "the", "public", "health."], "wordsB": ["The", "FDA", "can", "ban", "certain", "biological", "products;", "detain", "or", "seize", "adulterated", "or", "misbranded", "biological", "products;", "order", "repair,", "replacement", "or", "refund", "of", "these", "products;", "and", "require", "notification", "of", "health", "professionals", "and", "others", "with", "regard", "to", "biological", "products", "that", "present", "unreasonable", "risks", "of", "substantial", "harm", "to", "the", "public", "health."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p42_s0", "idA": "1175680_17_item1_p54_s0", "sentA": "In the United States, the process for obtaining FDA approval for products like PRO 140 typically includes pre-clinical studies, the filing of an Investigational New Drug application, or IND, human clinical trials and filing and approval of either a New Drug Application, or NDA, for chemical pharmaceutical products, or a BLA (biologics license application) for biological pharmaceutical products, such as PRO 140.", "sentB": "In the United States, the process for obtaining FDA approval for products like PRO 140 typically includes pre-clinical studies, the filing of an Investigational New Drug application ( IND ), human clinical trials and filing and approval of either a New Drug Application ( NDA ), for chemical pharmaceutical products, or a Biologics License Application ( BLA ) for biological pharmaceutical products, such as PRO 140.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "the", "process", "for", "obtaining", "FDA", "approval", "for", "products", "like", "PRO", "140", "typically", "includes", "pre-clinical", "studies,", "the", "filing", "of", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "human", "clinical", "trials", "and", "filing", "and", "approval", "of", "either", "a", "New", "Drug", "Application,", "or", "NDA,", "for", "chemical", "pharmaceutical", "products,", "or", "a", "BLA", "(biologics", "license", "application)", "for", "biological", "pharmaceutical", "products,", "such", "as", "PRO", "140.", "<tag2>", "In", "the", "United", "States,", "the", "process", "for", "obtaining", "FDA", "approval", "for", "products", "like", "PRO", "140", "typically", "includes", "pre-clinical", "studies,", "the", "filing", "of", "an", "Investigational", "New", "Drug", "application", "(", "IND", "),", "human", "clinical", "trials", "and", "filing", "and", "approval", "of", "either", "a", "New", "Drug", "Application", "(", "NDA", "),", "for", "chemical", "pharmaceutical", "products,", "or", "a", "Biologics", "License", "Application", "(", "BLA", ")", "for", "biological", "pharmaceutical", "products,", "such", "as", "PRO", "140.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "the", "process", "for", "obtaining", "FDA", "approval", "for", "products", "like", "PRO", "140", "typically", "includes", "pre-clinical", "studies,", "the", "filing", "of", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "human", "clinical", "trials", "and", "filing", "and", "approval", "of", "either", "a", "New", "Drug", "Application,", "or", "NDA,", "for", "chemical", "pharmaceutical", "products,", "or", "a", "BLA", "(biologics", "license", "application)", "for", "biological", "pharmaceutical", "products,", "such", "as", "PRO", "140."], "wordsB": ["In", "the", "United", "States,", "the", "process", "for", "obtaining", "FDA", "approval", "for", "products", "like", "PRO", "140", "typically", "includes", "pre-clinical", "studies,", "the", "filing", "of", "an", "Investigational", "New", "Drug", "application", "(", "IND", "),", "human", "clinical", "trials", "and", "filing", "and", "approval", "of", "either", "a", "New", "Drug", "Application", "(", "NDA", "),", "for", "chemical", "pharmaceutical", "products,", "or", "a", "Biologics", "License", "Application", "(", "BLA", ")", "for", "biological", "pharmaceutical", "products,", "such", "as", "PRO", "140."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p42_s2", "idA": "1175680_17_item1_p54_s2", "sentA": "The study protocol and informed consent information for patients in clinical trials must also be submitted to an independent institutional review board, or IRB, for approval.", "sentB": "The study protocol and informed consent information for patients in clinical trials must also be submitted to an independent institutional review board ( IRB ), for approval.", "type": 2, "words": ["<tag1>", "The", "study", "protocol", "and", "informed", "consent", "information", "for", "patients", "in", "clinical", "trials", "must", "also", "be", "submitted", "to", "an", "independent", "institutional", "review", "board,", "or", "IRB,", "for", "approval.", "<tag2>", "The", "study", "protocol", "and", "informed", "consent", "information", "for", "patients", "in", "clinical", "trials", "must", "also", "be", "submitted", "to", "an", "independent", "institutional", "review", "board", "(", "IRB", "),", "for", "approval.", "<tag3>"], "wordsA": ["The", "study", "protocol", "and", "informed", "consent", "information", "for", "patients", "in", "clinical", "trials", "must", "also", "be", "submitted", "to", "an", "independent", "institutional", "review", "board,", "or", "IRB,", "for", "approval."], "wordsB": ["The", "study", "protocol", "and", "informed", "consent", "information", "for", "patients", "in", "clinical", "trials", "must", "also", "be", "submitted", "to", "an", "independent", "institutional", "review", "board", "(", "IRB", "),", "for", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p42_s5", "idA": "1175680_17_item1_p54_s5", "sentA": "In addition, protocols for new clinical trials must be submitted to the FDA and the FDA, an IRB or we may, at any time, impose a clinical hold on ongoing clinical trials.", "sentB": "In addition, the FDA, an IRB or we may, at any time, impose a clinical hold on ongoing clinical trials.", "type": 2, "words": ["<tag1>", "In", "addition,", "protocols", "for", "new", "clinical", "trials", "must", "be", "submitted", "to", "the", "FDA", "and", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials.", "<tag2>", "In", "addition,", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials.", "<tag3>"], "wordsA": ["In", "addition,", "protocols", "for", "new", "clinical", "trials", "must", "be", "submitted", "to", "the", "FDA", "and", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials."], "wordsB": ["In", "addition,", "the", "FDA,", "an", "IRB", "or", "we", "may,", "at", "any", "time,", "impose", "a", "clinical", "hold", "on", "ongoing", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p42_s7", "idA": "1175680_17_item1_p54_s7", "sentA": "Our non-clinical and clinical studies must conform to the FDA s Good Laboratory Practice, or GLP, and Good Clinical Practice, or GCP, requirements, which are designed to ensure the quality and integrity of submitted data and protect the rights and well-being of study patients.", "sentB": "Our non-clinical and clinical studies must conform to the FDA s Good Laboratory Practice ( GLP ), and Good Clinical Practice ( GCP ), requirements, which are designed to ensure the quality and integrity of submitted data and protect the rights and well-being of study patients.", "type": 2, "words": ["<tag1>", "Our", "non-clinical", "and", "clinical", "studies", "must", "conform", "to", "the", "FDA", "s", "Good", "Laboratory", "Practice,", "or", "GLP,", "and", "Good", "Clinical", "Practice,", "or", "GCP,", "requirements,", "which", "are", "designed", "to", "ensure", "the", "quality", "and", "integrity", "of", "submitted", "data", "and", "protect", "the", "rights", "and", "well-being", "of", "study", "patients.", "<tag2>", "Our", "non-clinical", "and", "clinical", "studies", "must", "conform", "to", "the", "FDA", "s", "Good", "Laboratory", "Practice", "(", "GLP", "),", "and", "Good", "Clinical", "Practice", "(", "GCP", "),", "requirements,", "which", "are", "designed", "to", "ensure", "the", "quality", "and", "integrity", "of", "submitted", "data", "and", "protect", "the", "rights", "and", "well-being", "of", "study", "patients.", "<tag3>"], "wordsA": ["Our", "non-clinical", "and", "clinical", "studies", "must", "conform", "to", "the", "FDA", "s", "Good", "Laboratory", "Practice,", "or", "GLP,", "and", "Good", "Clinical", "Practice,", "or", "GCP,", "requirements,", "which", "are", "designed", "to", "ensure", "the", "quality", "and", "integrity", "of", "submitted", "data", "and", "protect", "the", "rights", "and", "well-being", "of", "study", "patients."], "wordsB": ["Our", "non-clinical", "and", "clinical", "studies", "must", "conform", "to", "the", "FDA", "s", "Good", "Laboratory", "Practice", "(", "GLP", "),", "and", "Good", "Clinical", "Practice", "(", "GCP", "),", "requirements,", "which", "are", "designed", "to", "ensure", "the", "quality", "and", "integrity", "of", "submitted", "data", "and", "protect", "the", "rights", "and", "well-being", "of", "study", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p42_s8", "idA": "1175680_17_item1_p54_s8", "sentA": "Information for certain clinical trials also must be publicly disclosed within certain time limits on the clinical trial registry and results databank maintained by the National Institutes of Health, or NIH.", "sentB": "Information for certain clinical trials also must be publicly disclosed within certain time limits on the clinical trial registry and results databank maintained by the National Institutes of Health ( NIH ).", "type": 2, "words": ["<tag1>", "Information", "for", "certain", "clinical", "trials", "also", "must", "be", "publicly", "disclosed", "within", "certain", "time", "limits", "on", "the", "clinical", "trial", "registry", "and", "results", "databank", "maintained", "by", "the", "National", "Institutes", "of", "Health,", "or", "NIH.", "<tag2>", "Information", "for", "certain", "clinical", "trials", "also", "must", "be", "publicly", "disclosed", "within", "certain", "time", "limits", "on", "the", "clinical", "trial", "registry", "and", "results", "databank", "maintained", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ").", "<tag3>"], "wordsA": ["Information", "for", "certain", "clinical", "trials", "also", "must", "be", "publicly", "disclosed", "within", "certain", "time", "limits", "on", "the", "clinical", "trial", "registry", "and", "results", "databank", "maintained", "by", "the", "National", "Institutes", "of", "Health,", "or", "NIH."], "wordsB": ["Information", "for", "certain", "clinical", "trials", "also", "must", "be", "publicly", "disclosed", "within", "certain", "time", "limits", "on", "the", "clinical", "trial", "registry", "and", "results", "databank", "maintained", "by", "the", "National", "Institutes", "of", "Health", "(", "NIH", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p43_s0", "idA": "1175680_17_item1_p56_s0", "sentA": "Among the conditions for an NDA or BLA approval is the requirement that the manufacturing operations conform on an ongoing basis with current Good Manufacturing Practices, or cGMPs.", "sentB": "Among the conditions for an NDA or BLA approval is the requirement that the manufacturing operations conform on an ongoing basis with current Good Manufacturing Practices ( cGMPs ).", "type": 2, "words": ["<tag1>", "Among", "the", "conditions", "for", "an", "NDA", "or", "BLA", "approval", "is", "the", "requirement", "that", "the", "manufacturing", "operations", "conform", "on", "an", "ongoing", "basis", "with", "current", "Good", "Manufacturing", "Practices,", "or", "cGMPs.", "<tag2>", "Among", "the", "conditions", "for", "an", "NDA", "or", "BLA", "approval", "is", "the", "requirement", "that", "the", "manufacturing", "operations", "conform", "on", "an", "ongoing", "basis", "with", "current", "Good", "Manufacturing", "Practices", "(", "cGMPs", ").", "<tag3>"], "wordsA": ["Among", "the", "conditions", "for", "an", "NDA", "or", "BLA", "approval", "is", "the", "requirement", "that", "the", "manufacturing", "operations", "conform", "on", "an", "ongoing", "basis", "with", "current", "Good", "Manufacturing", "Practices,", "or", "cGMPs."], "wordsB": ["Among", "the", "conditions", "for", "an", "NDA", "or", "BLA", "approval", "is", "the", "requirement", "that", "the", "manufacturing", "operations", "conform", "on", "an", "ongoing", "basis", "with", "current", "Good", "Manufacturing", "Practices", "(", "cGMPs", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p43_s1", "idA": "1175680_17_item1_p57_s0", "sentA": "effort in the areas of training, production and quality control within our own organization and at any contract manufacturing facilities that we use.", "sentB": "In complying with cGMPs, we must expend time, money and effort in the areas of training, production and quality control within our own organization and at our contract manufacturing laboratories.", "type": 2, "words": ["<tag1>", "effort", "in", "the", "areas", "of", "training,", "production", "and", "quality", "control", "within", "our", "own", "organization", "and", "at", "any", "contract", "manufacturing", "facilities", "that", "we", "use.", "<tag2>", "In", "complying", "with", "cGMPs,", "we", "must", "expend", "time,", "money", "and", "effort", "in", "the", "areas", "of", "training,", "production", "and", "quality", "control", "within", "our", "own", "organization", "and", "at", "our", "contract", "manufacturing", "laboratories.", "<tag3>"], "wordsA": ["effort", "in", "the", "areas", "of", "training,", "production", "and", "quality", "control", "within", "our", "own", "organization", "and", "at", "any", "contract", "manufacturing", "facilities", "that", "we", "use."], "wordsB": ["In", "complying", "with", "cGMPs,", "we", "must", "expend", "time,", "money", "and", "effort", "in", "the", "areas", "of", "training,", "production", "and", "quality", "control", "within", "our", "own", "organization", "and", "at", "our", "contract", "manufacturing", "laboratories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p43_s4", "idA": "1175680_17_item1_p57_s3", "sentA": "We also may face similar inspections coordinated by the EMEA, by inspectors from particular E.U. member countries that conduct inspections on behalf of the European Union and from other foreign regulatory authorities.", "sentB": "We also face similar inspections coordinated by the European Medicines Agency by inspectors from particular European Union ( EU ) member countries that conduct inspections on behalf of the EU and from other foreign regulatory authorities.", "type": 2, "words": ["<tag1>", "We", "also", "may", "face", "similar", "inspections", "coordinated", "by", "the", "EMEA,", "by", "inspectors", "from", "particular", "E.U.", "member", "countries", "that", "conduct", "inspections", "on", "behalf", "of", "the", "European", "Union", "and", "from", "other", "foreign", "regulatory", "authorities.", "<tag2>", "We", "also", "face", "similar", "inspections", "coordinated", "by", "the", "European", "Medicines", "Agency", "by", "inspectors", "from", "particular", "European", "Union", "(", "EU", ")", "member", "countries", "that", "conduct", "inspections", "on", "behalf", "of", "the", "EU", "and", "from", "other", "foreign", "regulatory", "authorities.", "<tag3>"], "wordsA": ["We", "also", "may", "face", "similar", "inspections", "coordinated", "by", "the", "EMEA,", "by", "inspectors", "from", "particular", "E.U.", "member", "countries", "that", "conduct", "inspections", "on", "behalf", "of", "the", "European", "Union", "and", "from", "other", "foreign", "regulatory", "authorities."], "wordsB": ["We", "also", "face", "similar", "inspections", "coordinated", "by", "the", "European", "Medicines", "Agency", "by", "inspectors", "from", "particular", "European", "Union", "(", "EU", ")", "member", "countries", "that", "conduct", "inspections", "on", "behalf", "of", "the", "EU", "and", "from", "other", "foreign", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p45_s0", "idA": "1175680_17_item1_p58_s0", "sentA": "Regulatory requirements and approval processes in E.U. countries are similar in principle to those in the United States and can be at least as costly and uncertain.", "sentB": "Regulatory requirements and approval processes in EU countries are similar in principle to those in the United States and can be at least as costly and uncertain.", "type": 2, "words": ["<tag1>", "Regulatory", "requirements", "and", "approval", "processes", "in", "E.U.", "countries", "are", "similar", "in", "principle", "to", "those", "in", "the", "United", "States", "and", "can", "be", "at", "least", "as", "costly", "and", "uncertain.", "<tag2>", "Regulatory", "requirements", "and", "approval", "processes", "in", "EU", "countries", "are", "similar", "in", "principle", "to", "those", "in", "the", "United", "States", "and", "can", "be", "at", "least", "as", "costly", "and", "uncertain.", "<tag3>"], "wordsA": ["Regulatory", "requirements", "and", "approval", "processes", "in", "E.U.", "countries", "are", "similar", "in", "principle", "to", "those", "in", "the", "United", "States", "and", "can", "be", "at", "least", "as", "costly", "and", "uncertain."], "wordsB": ["Regulatory", "requirements", "and", "approval", "processes", "in", "EU", "countries", "are", "similar", "in", "principle", "to", "those", "in", "the", "United", "States", "and", "can", "be", "at", "least", "as", "costly", "and", "uncertain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p45_s1", "idA": "1175680_17_item1_p59_s0", "sentA": "The European Union has established a unified centralized filing and approval system administered by the Committee for Medicinal Products for Human Use designed to reduce the administrative burden of processing applications for pharmaceutical products derived from new technologies.", "sentB": "The EU has established a unified centralized filing and approval system administered by the Committee for Medicinal Products for Human Use designed to reduce the administrative burden of processing applications for pharmaceutical products derived from new technologies.", "type": 2, "words": ["<tag1>", "The", "European", "Union", "has", "established", "a", "unified", "centralized", "filing", "and", "approval", "system", "administered", "by", "the", "Committee", "for", "Medicinal", "Products", "for", "Human", "Use", "designed", "to", "reduce", "the", "administrative", "burden", "of", "processing", "applications", "for", "pharmaceutical", "products", "derived", "from", "new", "technologies.", "<tag2>", "The", "EU", "has", "established", "a", "unified", "centralized", "filing", "and", "approval", "system", "administered", "by", "the", "Committee", "for", "Medicinal", "Products", "for", "Human", "Use", "designed", "to", "reduce", "the", "administrative", "burden", "of", "processing", "applications", "for", "pharmaceutical", "products", "derived", "from", "new", "technologies.", "<tag3>"], "wordsA": ["The", "European", "Union", "has", "established", "a", "unified", "centralized", "filing", "and", "approval", "system", "administered", "by", "the", "Committee", "for", "Medicinal", "Products", "for", "Human", "Use", "designed", "to", "reduce", "the", "administrative", "burden", "of", "processing", "applications", "for", "pharmaceutical", "products", "derived", "from", "new", "technologies."], "wordsB": ["The", "EU", "has", "established", "a", "unified", "centralized", "filing", "and", "approval", "system", "administered", "by", "the", "Committee", "for", "Medicinal", "Products", "for", "Human", "Use", "designed", "to", "reduce", "the", "administrative", "burden", "of", "processing", "applications", "for", "pharmaceutical", "products", "derived", "from", "new", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p5_s0", "idA": "1175680_17_item1_p5_s0", "sentA": "In seven clinical trials previously conducted, PRO 140 was generally well tolerated, and no drug-related serious adverse events, or SAEs, or dose-proportional adverse events, or AEs, were reported.", "sentB": "In seven clinical trials previously conducted, PRO 140 was generally well tolerated, and no drug-related serious adverse events ( SAE s ), or dose-proportional adverse events ( AE s ), were reported.", "type": 2, "words": ["<tag1>", "In", "seven", "clinical", "trials", "previously", "conducted,", "PRO", "140", "was", "generally", "well", "tolerated,", "and", "no", "drug-related", "serious", "adverse", "events,", "or", "SAEs,", "or", "dose-proportional", "adverse", "events,", "or", "AEs,", "were", "reported.", "<tag2>", "In", "seven", "clinical", "trials", "previously", "conducted,", "PRO", "140", "was", "generally", "well", "tolerated,", "and", "no", "drug-related", "serious", "adverse", "events", "(", "SAE", "s", "),", "or", "dose-proportional", "adverse", "events", "(", "AE", "s", "),", "were", "reported.", "<tag3>"], "wordsA": ["In", "seven", "clinical", "trials", "previously", "conducted,", "PRO", "140", "was", "generally", "well", "tolerated,", "and", "no", "drug-related", "serious", "adverse", "events,", "or", "SAEs,", "or", "dose-proportional", "adverse", "events,", "or", "AEs,", "were", "reported."], "wordsB": ["In", "seven", "clinical", "trials", "previously", "conducted,", "PRO", "140", "was", "generally", "well", "tolerated,", "and", "no", "drug-related", "serious", "adverse", "events", "(", "SAE", "s", "),", "or", "dose-proportional", "adverse", "events", "(", "AE", "s", "),", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p10_s7", "idA": "1175680_17_item1_p60_s0", "sentA": "In addition to obtaining regulatory approval of products, it is generally necessary to obtain regulatory approval of the facility in which the product will be manufactured.", "sentB": "The final terms of the transaction will be available upon the execution of definitive documentation.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "obtaining", "regulatory", "approval", "of", "products,", "it", "is", "generally", "necessary", "to", "obtain", "regulatory", "approval", "of", "the", "facility", "in", "which", "the", "product", "will", "be", "manufactured.", "<tag2>", "The", "final", "terms", "of", "the", "transaction", "will", "be", "available", "upon", "the", "execution", "of", "definitive", "documentation.", "<tag3>"], "wordsA": ["In", "addition", "to", "obtaining", "regulatory", "approval", "of", "products,", "it", "is", "generally", "necessary", "to", "obtain", "regulatory", "approval", "of", "the", "facility", "in", "which", "the", "product", "will", "be", "manufactured."], "wordsB": ["The", "final", "terms", "of", "the", "transaction", "will", "be", "available", "upon", "the", "execution", "of", "definitive", "documentation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p46_s4", "idA": "1175680_17_item1_p60_s4", "sentA": "Newly discovered or developed safety or efficacy data may require changes to an approved product s approved labeling, including the addition of new warnings and contraindications, the imposition of additional mandatory post-market studies or clinical trials, or the imposition of or revisions to a REMS program, including distribution and/or use restrictions.", "sentB": "Newly discovered or developed safety or efficacy data may require changes to an approved product s approved labeling, including the addition of new warnings and contraindications, the imposition of additional mandatory post-market studies or clinical trials, or the imposition of or revisions to a risk evaluation mitigation strategies ( REMS ) program, including distribution and/or use restrictions.", "type": 2, "words": ["<tag1>", "Newly", "discovered", "or", "developed", "safety", "or", "efficacy", "data", "may", "require", "changes", "to", "an", "approved", "product", "s", "approved", "labeling,", "including", "the", "addition", "of", "new", "warnings", "and", "contraindications,", "the", "imposition", "of", "additional", "mandatory", "post-market", "studies", "or", "clinical", "trials,", "or", "the", "imposition", "of", "or", "revisions", "to", "a", "REMS", "program,", "including", "distribution", "and/or", "use", "restrictions.", "<tag2>", "Newly", "discovered", "or", "developed", "safety", "or", "efficacy", "data", "may", "require", "changes", "to", "an", "approved", "product", "s", "approved", "labeling,", "including", "the", "addition", "of", "new", "warnings", "and", "contraindications,", "the", "imposition", "of", "additional", "mandatory", "post-market", "studies", "or", "clinical", "trials,", "or", "the", "imposition", "of", "or", "revisions", "to", "a", "risk", "evaluation", "mitigation", "strategies", "(", "REMS", ")", "program,", "including", "distribution", "and/or", "use", "restrictions.", "<tag3>"], "wordsA": ["Newly", "discovered", "or", "developed", "safety", "or", "efficacy", "data", "may", "require", "changes", "to", "an", "approved", "product", "s", "approved", "labeling,", "including", "the", "addition", "of", "new", "warnings", "and", "contraindications,", "the", "imposition", "of", "additional", "mandatory", "post-market", "studies", "or", "clinical", "trials,", "or", "the", "imposition", "of", "or", "revisions", "to", "a", "REMS", "program,", "including", "distribution", "and/or", "use", "restrictions."], "wordsB": ["Newly", "discovered", "or", "developed", "safety", "or", "efficacy", "data", "may", "require", "changes", "to", "an", "approved", "product", "s", "approved", "labeling,", "including", "the", "addition", "of", "new", "warnings", "and", "contraindications,", "the", "imposition", "of", "additional", "mandatory", "post-market", "studies", "or", "clinical", "trials,", "or", "the", "imposition", "of", "or", "revisions", "to", "a", "risk", "evaluation", "mitigation", "strategies", "(", "REMS", ")", "program,", "including", "distribution", "and/or", "use", "restrictions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p46_s8", "idA": "1175680_17_item1_p61_s0", "sentA": "The U.S. Department of Justice, or DOJ, the Office of the Inspector General of the Department of Health and Human Services, or OIG, the FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.", "sentB": "The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.", "type": 2, "words": ["<tag1>", "The", "U.S.", "Department", "of", "Justice,", "or", "DOJ,", "the", "Office", "of", "the", "Inspector", "General", "of", "the", "Department", "of", "Health", "and", "Human", "Services,", "or", "OIG,", "the", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability.", "<tag2>", "The", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability.", "<tag3>"], "wordsA": ["The", "U.S.", "Department", "of", "Justice,", "or", "DOJ,", "the", "Office", "of", "the", "Inspector", "General", "of", "the", "Department", "of", "Health", "and", "Human", "Services,", "or", "OIG,", "the", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability."], "wordsB": ["The", "FDA", "and", "other", "agencies", "actively", "enforce", "the", "laws", "and", "regulations", "prohibiting", "the", "promotion", "of", "off", "label", "uses,", "and", "a", "company", "that", "is", "found", "to", "have", "improperly", "promoted", "off-label", "uses", "may", "be", "subject", "to", "significant", "liability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p47_s0", "idA": "1175680_17_item1_p64_s0", "sentA": "Environmental We are subject to a variety of federal, state and local environmental protection measures.", "sentB": "Regulation of Laboratory Operations Clinical laboratories that perform laboratory testing (except for research purposes only) on human patients are subject to regulation under Clinical Laboratory Improvement Amendments ( CLIA ).", "type": 2, "words": ["<tag1>", "Environmental", "We", "are", "subject", "to", "a", "variety", "of", "federal,", "state", "and", "local", "environmental", "protection", "measures.", "<tag2>", "Regulation", "of", "Laboratory", "Operations", "Clinical", "laboratories", "that", "perform", "laboratory", "testing", "(except", "for", "research", "purposes", "only)", "on", "human", "patients", "are", "subject", "to", "regulation", "under", "Clinical", "Laboratory", "Improvement", "Amendments", "(", "CLIA", ").", "<tag3>"], "wordsA": ["Environmental", "We", "are", "subject", "to", "a", "variety", "of", "federal,", "state", "and", "local", "environmental", "protection", "measures."], "wordsB": ["Regulation", "of", "Laboratory", "Operations", "Clinical", "laboratories", "that", "perform", "laboratory", "testing", "(except", "for", "research", "purposes", "only)", "on", "human", "patients", "are", "subject", "to", "regulation", "under", "Clinical", "Laboratory", "Improvement", "Amendments", "(", "CLIA", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p4_s3", "idA": "1175680_17_item1_p67_s4", "sentA": "In some cases, depending upon the need for a new drug, a particular drug candidate may be licensed for sale in interstate commerce after a pivotal Phase 2 trial.", "sentB": "There are several factors giving rise to compliance issues, such as, toxicity and side effects, coupled with the need for a strict regimen of daily dosing.", "type": 2, "words": ["<tag1>", "In", "some", "cases,", "depending", "upon", "the", "need", "for", "a", "new", "drug,", "a", "particular", "drug", "candidate", "may", "be", "licensed", "for", "sale", "in", "interstate", "commerce", "after", "a", "pivotal", "Phase", "2", "trial.", "<tag2>", "There", "are", "several", "factors", "giving", "rise", "to", "compliance", "issues,", "such", "as,", "toxicity", "and", "side", "effects,", "coupled", "with", "the", "need", "for", "a", "strict", "regimen", "of", "daily", "dosing.", "<tag3>"], "wordsA": ["In", "some", "cases,", "depending", "upon", "the", "need", "for", "a", "new", "drug,", "a", "particular", "drug", "candidate", "may", "be", "licensed", "for", "sale", "in", "interstate", "commerce", "after", "a", "pivotal", "Phase", "2", "trial."], "wordsB": ["There", "are", "several", "factors", "giving", "rise", "to", "compliance", "issues,", "such", "as,", "toxicity", "and", "side", "effects,", "coupled", "with", "the", "need", "for", "a", "strict", "regimen", "of", "daily", "dosing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p27_s5", "idA": "1175680_17_item1_p69_s2", "sentA": "Advancing PRO 140 to commercialization is our highest priority.", "sentB": "We are also expanding the clinical focus with PRO 140 to include the evaluation in certain cancer and immunological indications where CCR5 antagonism has shown initial promise.", "type": 2, "words": ["<tag1>", "Advancing", "PRO", "140", "to", "commercialization", "is", "our", "highest", "priority.", "<tag2>", "We", "are", "also", "expanding", "the", "clinical", "focus", "with", "PRO", "140", "to", "include", "the", "evaluation", "in", "certain", "cancer", "and", "immunological", "indications", "where", "CCR5", "antagonism", "has", "shown", "initial", "promise.", "<tag3>"], "wordsA": ["Advancing", "PRO", "140", "to", "commercialization", "is", "our", "highest", "priority."], "wordsB": ["We", "are", "also", "expanding", "the", "clinical", "focus", "with", "PRO", "140", "to", "include", "the", "evaluation", "in", "certain", "cancer", "and", "immunological", "indications", "where", "CCR5", "antagonism", "has", "shown", "initial", "promise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p6_s1", "idA": "1175680_17_item1_p6_s1", "sentA": "PRO 140, as a single agent therapy, has also demonstrated that it could replace HAART altogether for a subpopulation of R5 patients who have suppressed viral load with HAART, but are seeking an alternative treatment that allows the patient an improved quality of life, with the advantages of fewer side effects, lower toxicity and less frequent dosing requirements.", "sentB": "PRO 140, as a single agent therapy, has also demonstrated that it could replace highly active antiretroviral therapy ( HAART ) altogether for a subpopulation of R5 patients who have suppressed viral load with HAART, but are seeking an alternative treatment that allows the patient an improved quality of life, with the advantages of fewer side effects, lower toxicity and less frequent dosing requirements.", "type": 2, "words": ["<tag1>", "PRO", "140,", "as", "a", "single", "agent", "therapy,", "has", "also", "demonstrated", "that", "it", "could", "replace", "HAART", "altogether", "for", "a", "subpopulation", "of", "R5", "patients", "who", "have", "suppressed", "viral", "load", "with", "HAART,", "but", "are", "seeking", "an", "alternative", "treatment", "that", "allows", "the", "patient", "an", "improved", "quality", "of", "life,", "with", "the", "advantages", "of", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements.", "<tag2>", "PRO", "140,", "as", "a", "single", "agent", "therapy,", "has", "also", "demonstrated", "that", "it", "could", "replace", "highly", "active", "antiretroviral", "therapy", "(", "HAART", ")", "altogether", "for", "a", "subpopulation", "of", "R5", "patients", "who", "have", "suppressed", "viral", "load", "with", "HAART,", "but", "are", "seeking", "an", "alternative", "treatment", "that", "allows", "the", "patient", "an", "improved", "quality", "of", "life,", "with", "the", "advantages", "of", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements.", "<tag3>"], "wordsA": ["PRO", "140,", "as", "a", "single", "agent", "therapy,", "has", "also", "demonstrated", "that", "it", "could", "replace", "HAART", "altogether", "for", "a", "subpopulation", "of", "R5", "patients", "who", "have", "suppressed", "viral", "load", "with", "HAART,", "but", "are", "seeking", "an", "alternative", "treatment", "that", "allows", "the", "patient", "an", "improved", "quality", "of", "life,", "with", "the", "advantages", "of", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements."], "wordsB": ["PRO", "140,", "as", "a", "single", "agent", "therapy,", "has", "also", "demonstrated", "that", "it", "could", "replace", "highly", "active", "antiretroviral", "therapy", "(", "HAART", ")", "altogether", "for", "a", "subpopulation", "of", "R5", "patients", "who", "have", "suppressed", "viral", "load", "with", "HAART,", "but", "are", "seeking", "an", "alternative", "treatment", "that", "allows", "the", "patient", "an", "improved", "quality", "of", "life,", "with", "the", "advantages", "of", "fewer", "side", "effects,", "lower", "toxicity", "and", "less", "frequent", "dosing", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p10_s3", "idA": "1175680_17_item1_p6_s3", "sentA": "We believe that, if PRO 140 is approved for use as an injectable by the U.S. Food and Drug Administration (the FDA ), it may nonetheless be an attractive and marketable therapeutic option for patients, particularly in the following scenarios:", "sentB": "At the same time, we remain committed to advancing our clinical programs with PRO 140 in HIV and GvHD, and is continuing with our previously announced plans to submit a Biologics License Application ( BLA ) to the U.S. Food and Drug Administration (the FDA ) for PRO 140 as a combination therapy for HIV.", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients,", "particularly", "in", "the", "following", "scenarios:", "<tag2>", "At", "the", "same", "time,", "we", "remain", "committed", "to", "advancing", "our", "clinical", "programs", "with", "PRO", "140", "in", "HIV", "and", "GvHD,", "and", "is", "continuing", "with", "our", "previously", "announced", "plans", "to", "submit", "a", "Biologics", "License", "Application", "(", "BLA", ")", "to", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", ")", "for", "PRO", "140", "as", "a", "combination", "therapy", "for", "HIV.", "<tag3>"], "wordsA": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients,", "particularly", "in", "the", "following", "scenarios:"], "wordsB": ["At", "the", "same", "time,", "we", "remain", "committed", "to", "advancing", "our", "clinical", "programs", "with", "PRO", "140", "in", "HIV", "and", "GvHD,", "and", "is", "continuing", "with", "our", "previously", "announced", "plans", "to", "submit", "a", "Biologics", "License", "Application", "(", "BLA", ")", "to", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", ")", "for", "PRO", "140", "as", "a", "combination", "therapy", "for", "HIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p7_s1", "idA": "1175680_17_item1_p6_s3", "sentA": "We believe that, if PRO 140 is approved for use as an injectable by the U.S. Food and Drug Administration (the FDA ), it may nonetheless be an attractive and marketable therapeutic option for patients, particularly in the following scenarios:", "sentB": "We believe that, if PRO 140 is approved for use as an injectable by the FDA, it may nonetheless be an attractive and marketable therapeutic option for patients, particularly in the following scenarios:", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients,", "particularly", "in", "the", "following", "scenarios:", "<tag2>", "We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients,", "particularly", "in", "the", "following", "scenarios:", "<tag3>"], "wordsA": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients,", "particularly", "in", "the", "following", "scenarios:"], "wordsB": ["We", "believe", "that,", "if", "PRO", "140", "is", "approved", "for", "use", "as", "an", "injectable", "by", "the", "FDA,", "it", "may", "nonetheless", "be", "an", "attractive", "and", "marketable", "therapeutic", "option", "for", "patients,", "particularly", "in", "the", "following", "scenarios:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p57_s0", "idA": "1175680_17_item1_p71_s0", "sentA": "Maraviroc, like all other HIV approved drugs, must be taken daily and are believed to have significant side effects.", "sentB": "Maraviroc like all other HIV approved drugs must be taken daily and are believed to have side effects and toxicity.", "type": 2, "words": ["<tag1>", "Maraviroc,", "like", "all", "other", "HIV", "approved", "drugs,", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects.", "<tag2>", "Maraviroc", "like", "all", "other", "HIV", "approved", "drugs", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "side", "effects", "and", "toxicity.", "<tag3>"], "wordsA": ["Maraviroc,", "like", "all", "other", "HIV", "approved", "drugs,", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "significant", "side", "effects."], "wordsB": ["Maraviroc", "like", "all", "other", "HIV", "approved", "drugs", "must", "be", "taken", "daily", "and", "are", "believed", "to", "have", "side", "effects", "and", "toxicity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p58_s1", "idA": "1175680_17_item1_p72_s1", "sentA": "Currently there are only five different classes of drugs.", "sentB": "Currently there are only five different classes of drugs from which four are primarily used to construct a HAART regimen.", "type": 2, "words": ["<tag1>", "Currently", "there", "are", "only", "five", "different", "classes", "of", "drugs.", "<tag2>", "Currently", "there", "are", "only", "five", "different", "classes", "of", "drugs", "from", "which", "four", "are", "primarily", "used", "to", "construct", "a", "HAART", "regimen.", "<tag3>"], "wordsA": ["Currently", "there", "are", "only", "five", "different", "classes", "of", "drugs."], "wordsB": ["Currently", "there", "are", "only", "five", "different", "classes", "of", "drugs", "from", "which", "four", "are", "primarily", "used", "to", "construct", "a", "HAART", "regimen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p58_s2", "idA": "1175680_17_item1_p72_s2", "sentA": "Each class of drugs has many drugs available in that class except the entry inhibitor (EI) class.", "sentB": "Each of these four classes of drugs has many drugs available in its respective class, except the entry inhibitor ( EI ) class, which has only two drugs available.", "type": 2, "words": ["<tag1>", "Each", "class", "of", "drugs", "has", "many", "drugs", "available", "in", "that", "class", "except", "the", "entry", "inhibitor", "(EI)", "class.", "<tag2>", "Each", "of", "these", "four", "classes", "of", "drugs", "has", "many", "drugs", "available", "in", "its", "respective", "class,", "except", "the", "entry", "inhibitor", "(", "EI", ")", "class,", "which", "has", "only", "two", "drugs", "available.", "<tag3>"], "wordsA": ["Each", "class", "of", "drugs", "has", "many", "drugs", "available", "in", "that", "class", "except", "the", "entry", "inhibitor", "(EI)", "class."], "wordsB": ["Each", "of", "these", "four", "classes", "of", "drugs", "has", "many", "drugs", "available", "in", "its", "respective", "class,", "except", "the", "entry", "inhibitor", "(", "EI", ")", "class,", "which", "has", "only", "two", "drugs", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p58_s3", "idA": "1175680_17_item1_p72_s3", "sentA": "The only drug in EI class approved by the FDA is Maraviroc, a drug taken orally twice a day.", "sentB": "The only two drugs in the EI class approved by the FDA are Maraviroc, a small molecule drug (which is taken orally once or twice a day) and Ibalizumab (which is an IV infusion administered once every two weeks).", "type": 2, "words": ["<tag1>", "The", "only", "drug", "in", "EI", "class", "approved", "by", "the", "FDA", "is", "Maraviroc,", "a", "drug", "taken", "orally", "twice", "a", "day.", "<tag2>", "The", "only", "two", "drugs", "in", "the", "EI", "class", "approved", "by", "the", "FDA", "are", "Maraviroc,", "a", "small", "molecule", "drug", "(which", "is", "taken", "orally", "once", "or", "twice", "a", "day)", "and", "Ibalizumab", "(which", "is", "an", "IV", "infusion", "administered", "once", "every", "two", "weeks).", "<tag3>"], "wordsA": ["The", "only", "drug", "in", "EI", "class", "approved", "by", "the", "FDA", "is", "Maraviroc,", "a", "drug", "taken", "orally", "twice", "a", "day."], "wordsB": ["The", "only", "two", "drugs", "in", "the", "EI", "class", "approved", "by", "the", "FDA", "are", "Maraviroc,", "a", "small", "molecule", "drug", "(which", "is", "taken", "orally", "once", "or", "twice", "a", "day)", "and", "Ibalizumab", "(which", "is", "an", "IV", "infusion", "administered", "once", "every", "two", "weeks)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p58_s4", "idA": "1175680_17_item1_p72_s4", "sentA": "If approved, we believe that PRO 140 will be the only approved drug outside of the main four classes of drugs approved for HIV since 2007.", "sentB": "If approved, we believe that PRO 140 will be only the second approved drug outside of the main four classes of drugs approved for HIV since 2007.", "type": 2, "words": ["<tag1>", "If", "approved,", "we", "believe", "that", "PRO", "140", "will", "be", "the", "only", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007.", "<tag2>", "If", "approved,", "we", "believe", "that", "PRO", "140", "will", "be", "only", "the", "second", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007.", "<tag3>"], "wordsA": ["If", "approved,", "we", "believe", "that", "PRO", "140", "will", "be", "the", "only", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007."], "wordsB": ["If", "approved,", "we", "believe", "that", "PRO", "140", "will", "be", "only", "the", "second", "approved", "drug", "outside", "of", "the", "main", "four", "classes", "of", "drugs", "approved", "for", "HIV", "since", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p58_s5", "idA": "1175680_17_item1_p73_s0", "sentA": "The only other monoclonal antibody in clinical development for HIV, that we are aware of, is TMB-335 referred to as ibalizumab being developed by TiaMed Biologics.", "sentB": "The only other monoclonal antibody that recently received FDA approval is TMB-335, also referred to as Ibalizumab, which was developed by TaiMed Biologics.", "type": 2, "words": ["<tag1>", "The", "only", "other", "monoclonal", "antibody", "in", "clinical", "development", "for", "HIV,", "that", "we", "are", "aware", "of,", "is", "TMB-335", "referred", "to", "as", "ibalizumab", "being", "developed", "by", "TiaMed", "Biologics.", "<tag2>", "The", "only", "other", "monoclonal", "antibody", "that", "recently", "received", "FDA", "approval", "is", "TMB-335,", "also", "referred", "to", "as", "Ibalizumab,", "which", "was", "developed", "by", "TaiMed", "Biologics.", "<tag3>"], "wordsA": ["The", "only", "other", "monoclonal", "antibody", "in", "clinical", "development", "for", "HIV,", "that", "we", "are", "aware", "of,", "is", "TMB-335", "referred", "to", "as", "ibalizumab", "being", "developed", "by", "TiaMed", "Biologics."], "wordsB": ["The", "only", "other", "monoclonal", "antibody", "that", "recently", "received", "FDA", "approval", "is", "TMB-335,", "also", "referred", "to", "as", "Ibalizumab,", "which", "was", "developed", "by", "TaiMed", "Biologics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p62_s0", "idA": "1175680_17_item1_p75_s1", "sentA": "In seeking to manufacture, distribute and market the potential drugs we hope to have approved, we face competition from established pharmaceutical companies..", "sentB": "In seeking to manufacture, distribute and market the potential drugs we hope to have approved, we face competition from established pharmaceutical companies.", "type": 2, "words": ["<tag1>", "In", "seeking", "to", "manufacture,", "distribute", "and", "market", "the", "potential", "drugs", "we", "hope", "to", "have", "approved,", "we", "face", "competition", "from", "established", "pharmaceutical", "companies..", "<tag2>", "In", "seeking", "to", "manufacture,", "distribute", "and", "market", "the", "potential", "drugs", "we", "hope", "to", "have", "approved,", "we", "face", "competition", "from", "established", "pharmaceutical", "companies.", "<tag3>"], "wordsA": ["In", "seeking", "to", "manufacture,", "distribute", "and", "market", "the", "potential", "drugs", "we", "hope", "to", "have", "approved,", "we", "face", "competition", "from", "established", "pharmaceutical", "companies.."], "wordsB": ["In", "seeking", "to", "manufacture,", "distribute", "and", "market", "the", "potential", "drugs", "we", "hope", "to", "have", "approved,", "we", "face", "competition", "from", "established", "pharmaceutical", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p10_s1", "idA": "1175680_17_item1_p76_s1", "sentA": "We expect to depend on third-party manufacturing organizations and suppliers for all of our clinical trial quantities of PRO 140, in addition to previously manufactured supplies of PRO 140.", "sentB": "Proposed ProstaGene Transaction On July 12, 2018, we announced a strategic expansion of our clinical focus to include the evaluation of PRO 140 in certain cancer and immunological indications where CCR5 antagonism has shown initial promise.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "depend", "on", "third-party", "manufacturing", "organizations", "and", "suppliers", "for", "all", "of", "our", "clinical", "trial", "quantities", "of", "PRO", "140,", "in", "addition", "to", "previously", "manufactured", "supplies", "of", "PRO", "140.", "<tag2>", "Proposed", "ProstaGene", "Transaction", "On", "July", "12,", "2018,", "we", "announced", "a", "strategic", "expansion", "of", "our", "clinical", "focus", "to", "include", "the", "evaluation", "of", "PRO", "140", "in", "certain", "cancer", "and", "immunological", "indications", "where", "CCR5", "antagonism", "has", "shown", "initial", "promise.", "<tag3>"], "wordsA": ["We", "expect", "to", "depend", "on", "third-party", "manufacturing", "organizations", "and", "suppliers", "for", "all", "of", "our", "clinical", "trial", "quantities", "of", "PRO", "140,", "in", "addition", "to", "previously", "manufactured", "supplies", "of", "PRO", "140."], "wordsB": ["Proposed", "ProstaGene", "Transaction", "On", "July", "12,", "2018,", "we", "announced", "a", "strategic", "expansion", "of", "our", "clinical", "focus", "to", "include", "the", "evaluation", "of", "PRO", "140", "in", "certain", "cancer", "and", "immunological", "indications", "where", "CCR5", "antagonism", "has", "shown", "initial", "promise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p63_s10", "idA": "1175680_17_item1_p76_s10", "sentA": "Employees and Consultants We have six full-time employees, as well as several independent consultants assisting us with our clinical trials of PRO 140 and manufacturing activities.", "sentB": "Employees and Consultants We currently have six full-time employees, as well as several independent consultants assisting us with our clinical trials of PRO 140 and manufacturing activities.", "type": 2, "words": ["<tag1>", "Employees", "and", "Consultants", "We", "have", "six", "full-time", "employees,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities.", "<tag2>", "Employees", "and", "Consultants", "We", "currently", "have", "six", "full-time", "employees,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities.", "<tag3>"], "wordsA": ["Employees", "and", "Consultants", "We", "have", "six", "full-time", "employees,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities."], "wordsB": ["Employees", "and", "Consultants", "We", "currently", "have", "six", "full-time", "employees,", "as", "well", "as", "several", "independent", "consultants", "assisting", "us", "with", "our", "clinical", "trials", "of", "PRO", "140", "and", "manufacturing", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p63_s4", "idA": "1175680_17_item1_p76_s4", "sentA": "We have also contracted with a suitable CMO who will fill, label, and package product into the final commercial package for commercial sale.", "sentB": "We have also contracted with a suitable CMO to fill, label, and package product into the final commercial package for commercial use.", "type": 2, "words": ["<tag1>", "We", "have", "also", "contracted", "with", "a", "suitable", "CMO", "who", "will", "fill,", "label,", "and", "package", "product", "into", "the", "final", "commercial", "package", "for", "commercial", "sale.", "<tag2>", "We", "have", "also", "contracted", "with", "a", "suitable", "CMO", "to", "fill,", "label,", "and", "package", "product", "into", "the", "final", "commercial", "package", "for", "commercial", "use.", "<tag3>"], "wordsA": ["We", "have", "also", "contracted", "with", "a", "suitable", "CMO", "who", "will", "fill,", "label,", "and", "package", "product", "into", "the", "final", "commercial", "package", "for", "commercial", "sale."], "wordsB": ["We", "have", "also", "contracted", "with", "a", "suitable", "CMO", "to", "fill,", "label,", "and", "package", "product", "into", "the", "final", "commercial", "package", "for", "commercial", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p63_s6", "idA": "1175680_17_item1_p76_s6", "sentA": "GMP material will be produced, as needed, to support clinical trials for all therapeutic indications and until commercial product is approved by the FDA.", "sentB": "GMP material will be produced as needed to support clinical trials for all therapeutic indications and until commercial product is approved by the FDA.", "type": 2, "words": ["<tag1>", "GMP", "material", "will", "be", "produced,", "as", "needed,", "to", "support", "clinical", "trials", "for", "all", "therapeutic", "indications", "and", "until", "commercial", "product", "is", "approved", "by", "the", "FDA.", "<tag2>", "GMP", "material", "will", "be", "produced", "as", "needed", "to", "support", "clinical", "trials", "for", "all", "therapeutic", "indications", "and", "until", "commercial", "product", "is", "approved", "by", "the", "FDA.", "<tag3>"], "wordsA": ["GMP", "material", "will", "be", "produced,", "as", "needed,", "to", "support", "clinical", "trials", "for", "all", "therapeutic", "indications", "and", "until", "commercial", "product", "is", "approved", "by", "the", "FDA."], "wordsB": ["GMP", "material", "will", "be", "produced", "as", "needed", "to", "support", "clinical", "trials", "for", "all", "therapeutic", "indications", "and", "until", "commercial", "product", "is", "approved", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p63_s8", "idA": "1175680_17_item1_p76_s8", "sentA": "Research and Development Costs Our research and development expenses totaled approximately $20.2 million and $13.7 million for the fiscal years ended May 31, 2017 and May 31, 2016, respectively.", "sentB": "Research and Development Costs Our research and development expenses totaled approximately $38.2 million, $20.2 million and $13.7 million for the fiscal years ended May 31, 2018, May 31, 2017 and May 31, 2016, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$20.2", "million", "and", "$13.7", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2017", "and", "May", "31,", "2016,", "respectively.", "<tag2>", "Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$38.2", "million,", "$20.2", "million", "and", "$13.7", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2018,", "May", "31,", "2017", "and", "May", "31,", "2016,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$20.2", "million", "and", "$13.7", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2017", "and", "May", "31,", "2016,", "respectively."], "wordsB": ["Research", "and", "Development", "Costs", "Our", "research", "and", "development", "expenses", "totaled", "approximately", "$38.2", "million,", "$20.2", "million", "and", "$13.7", "million", "for", "the", "fiscal", "years", "ended", "May", "31,", "2018,", "May", "31,", "2017", "and", "May", "31,", "2016,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p8_s0", "idA": "1175680_17_item1_p7_s0", "sentA": "Patients who choose not to start their highly active antiretroviral therapy ( HAART ) regimen immediately after being infected with HIV.", "sentB": "Patients who choose not to start their HAART regimen immediately after being infected with HIV.", "type": 2, "words": ["<tag1>", "Patients", "who", "choose", "not", "to", "start", "their", "highly", "active", "antiretroviral", "therapy", "(", "HAART", ")", "regimen", "immediately", "after", "being", "infected", "with", "HIV.", "<tag2>", "Patients", "who", "choose", "not", "to", "start", "their", "HAART", "regimen", "immediately", "after", "being", "infected", "with", "HIV.", "<tag3>"], "wordsA": ["Patients", "who", "choose", "not", "to", "start", "their", "highly", "active", "antiretroviral", "therapy", "(", "HAART", ")", "regimen", "immediately", "after", "being", "infected", "with", "HIV."], "wordsB": ["Patients", "who", "choose", "not", "to", "start", "their", "HAART", "regimen", "immediately", "after", "being", "infected", "with", "HIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1175680_18_item1_p11_s0", "idA": "1175680_17_item1_p9_s1", "sentA": "Current Clinical Trials PRO 140 is currently being studied in four ongoing clinical trials:", "sentB": "Current Clinical Trials PRO 140 is currently being studied in four clinical trials:", "type": 2, "words": ["<tag1>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "four", "ongoing", "clinical", "trials:", "<tag2>", "Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "four", "clinical", "trials:", "<tag3>"], "wordsA": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "four", "ongoing", "clinical", "trials:"], "wordsB": ["Current", "Clinical", "Trials", "PRO", "140", "is", "currently", "being", "studied", "in", "four", "clinical", "trials:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
